"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value"
"CHEMBL267894";"AMOBARBITAL";"4.0";"226.28";"0";"1.18";"AMOBARBITAL";"CCC1(CCC(C)C)C(=O)NC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1372";"OXIGLUTATIONE";"4.0";"612.64";"3";"-3.88";"GLUTATHIONE, OXIDIZED FORM";"N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL64894";"GENTIAN VIOLET";"4.0";"407.99";"0";"4.46";"GENTIAN VIOLET";"CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL427888";"";"None";"413.43";"0";"2.08";"13";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(CO)o1";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"20.69";"0.39";"6.47";"6.47";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL390191";"";"None";"368.51";"0";"2.52";"3f";"Cc1nc(CSc2nc(N[C@H](C)CO)c3sc(N)nc3n2)cs1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"18.78";"0.41";"4.40";"6.30";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL434";"ISOPROTERENOL";"4.0";"211.26";"0";"1.13";"Isoproterenol";"CC(C)NCC(O)c1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL414894";"";"None";"383.45";"0";"3.03";"7";"C[C@@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(N)sc12";"IC50";"'='";"63.1";"nM";"7.20";"";"";"UO_0000065";"18.78";"0.39";"4.17";"7.43";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL3658277";"";"None";"435.31";"1";"5.75";"BDBM150904";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1ccc(Cl)c(Cl)c1";"IC50";"'='";"1850.0";"nM";"5.73";"";"290414";"UO_0000065";"13.17";"0.28";"-0.02";"9.71";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658288";"";"None";"434.46";"0";"3.63";"BDBM150915";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1ccc(-c2nn[nH]n2)cc1";"IC50";"'='";"1150.0";"nM";"5.94";"";"290425";"UO_0000065";"13.67";"0.26";"2.31";"5.23";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658293";"";"None";"434.41";"1";"5.47";"BDBM150920";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1cccc(C(F)(F)F)c1";"IC50";"'>'";"10000.0";"nM";"";"";"290430";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658301";"";"None";"406.44";"1";"5.19";"BDBM150928";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1ccc2occc2c1";"IC50";"'>'";"5000.0";"nM";"";"";"290438";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658313";"";"None";"436.53";"1";"5.97";"BDBM150940";"Cc1c(C(=O)CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)sc2ccccc12";"IC50";"'>'";"10000.0";"nM";"";"";"290450";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658328";"";"None";"423.49";"1";"5.06";"BDBM150956";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2nc3ccccc3s2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290466";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL271703";"";"None";"378.41";"0";"2.37";"17";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(N)cnc12";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"21.55";"0.43";"5.78";"7.42";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL85872";"";"None";"335.35";"0";"4.30";"23";"FC(F)(F)c1ccc(-c2nc(S)n(Cc3ccccc3)n2)cc1";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"16.56";"0.33";"1.25";"18.08";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL380052";"";"None";"338.32";"0";"1.93";"10";"COC(=O)c1cccc(/N=c2\c(O)c(O)\c2=N/c2ccccc2)c1O";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"21.51";"0.40";"5.35";"6.51";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL401938";"";"None";"460.49";"0";"3.65";"23";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cc(-c2ccncc2)co1";"IC50";"'='";"9.5";"nM";"8.02";"";"";"UO_0000065";"17.42";"0.32";"4.37";"6.43";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL3609014";"";"None";"457.27";"None";"None";"25";"O=C(Nc1ccc(F)cc1)c1ccc(N(Cc2ccccn2)Cc2ccc(B(O)O)cn2)nc1";"IC50";"'='";"4850.0";"nM";"5.31";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3609021";"";"None";"447.24";"None";"None";"31";"O=C(Nc1ccc(F)cc1)c1cnc(N(Cc2ccc(B(O)O)cn2)Cc2ccco2)nc1";"IC50";"'='";"655.0";"nM";"6.18";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3426944";"";"None";"466.22";"None";"None";"6, SX-517";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cc(OC(F)(F)F)ccc2B(O)O)nc1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL932";"DIPYRIDAMOLE";"4.0";"504.64";"2";"-0.02";"DIPYRIDAMOLE";"OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1261";"CITRIC ACID";"4.0";"192.12";"0";"-1.25";"CITRIC ACID";"O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL549";"CITALOPRAM";"4.0";"324.40";"0";"3.81";"CITALOPRAM";"CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL379438";"";"None";"325.28";"0";"2.22";"3e";"O=c1c(O)c(Nc2ccc([N+](=O)[O-])cc2O)/c1=N/c1ccccc1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"23.54";"0.44";"5.44";"6.12";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL238724";"";"None";"314.73";"0";"3.13";"3h";"O=c1c(Nc2ccccc2)c(Nc2cc(Cl)ccc2O)c1=O";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"23.09";"0.45";"4.14";"9.27";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL391372";"";"None";"359.18";"0";"3.24";"3k";"O=c1c(Nc2ccccc2O)c(Nc2ccccc2Br)c1=O";"IC50";"'='";"51.0";"nM";"7.29";"";"";"UO_0000065";"20.30";"0.45";"4.05";"9.30";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL1521";"ZALEPLON";"4.0";"305.34";"0";"2.64";"ZALEPLON";"CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1386";"TRANSPLATIN";"3.0";"300.05";"None";"None";"TRANS-PLATINUM(II)DIAMMINE DICHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL98350";"LY-294002";"-1.0";"307.35";"0";"3.30";"LY-294002";"O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL373067";"";"None";"290.37";"0";"2.67";"4";"Nc1nc2nc(SCc3ccccc3)nc(O)c2s1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"20.27";"0.42";"3.22";"6.93";"0";"CHEMBL862382";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 membranes by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149469";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307715";"";"";""
"CHEMBL201799";"";"None";"270.38";"0";"2.66";"1";"CCCCCSc1nc(O)c2sc(N)nc2n1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"18.49";"0.40";"2.34";"5.89";"0";"CHEMBL862382";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 membranes by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149469";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307715";"";"";""
"CHEMBL233260";"";"None";"416.36";"0";"4.06";"30";"C[C@H](CO)Nc1nc(SCc2cccc(Cl)c2Cl)nc2nc(N)sc12";"IC50";"'='";"15.85";"nM";"7.80";"";"";"UO_0000065";"18.73";"0.43";"3.74";"8.05";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL245182";"";"None";"455.56";"0";"3.27";"18";"CCN(CC)c1nc2nc(SCc3cccc(F)c3F)nc(NC(CO)CO)c2s1";"IC50";"'='";"1584.89";"nM";"5.80";"";"";"UO_0000065";"12.73";"0.26";"2.53";"6.14";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL389792";"";"None";"413.48";"0";"2.39";"4";"CC(CO)(CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(N)sc12";"IC50";"'='";"79.43";"nM";"7.10";"";"";"UO_0000065";"17.17";"0.36";"4.71";"6.06";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL403084";"";"None";"413.47";"0";"3.55";"27";"Cc1cc2[nH]c(-c3ccc(F)cc3)c(CCCC(=O)NS(C)(=O)=O)c2cc1C#N";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"18.67";"0.36";"4.17";"7.51";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL415690";"BETADEX";"3.0";"1134.99";"None";"None";"BETA CYCLODEXTRIN";"OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]8CO)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)O[C@@H]3CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1456";"MYCOPHENOLATE MOFETIL";"4.0";"433.50";"0";"2.52";"MYCOPHENOLATE MOFETIL";"COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL14";"CARBACHOL";"4.0";"182.65";"0";"-0.21";"CARBACHOL";"C[N+](C)(C)CCOC(N)=O.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL642";"ACEBUTOLOL";"4.0";"336.43";"0";"2.37";"ACEBUTOLOL";"CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL389621";"HYDROCORTISONE";"4.0";"362.47";"0";"1.78";"HYDROCORTISONE";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL534";"KETOTIFEN";"4.0";"309.43";"0";"4.01";"KETOTIFEN";"CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL728";"PROCHLORPERAZINE";"4.0";"373.95";"0";"4.58";"PROCHLORPERAZINE";"CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL311350";"PIROMIDIC ACID";"2.0";"288.31";"0";"1.11";"PIROMIDIC ACID";"CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1390";"";"None";"344.50";"0";"4.08";"MEDROXYPROGESTERONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1451";"TRIAMCINOLONE";"4.0";"394.44";"0";"0.62";"TRIAMCINOLONE";"C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL218334";"";"None";"435.94";"0";"3.78";"6g";"CC(C)c1ccccc1N/C(=N\C#N)Nc1ccc(Cl)c(S(=O)(=O)N(C)C)c1O";"IC50";"'='";"112.0";"nM";"6.95";"";"Antagonist";"UO_0000065";"15.94";"0.33";"3.17";"5.90";"0";"CHEMBL908413";"Displacement of [125I]IL8 from CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139694";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"ANTAGONIST";""
"CHEMBL60889";"MOSAPRIDE";"3.0";"421.90";"0";"3.09";"MOSAPRIDE";"CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201117";"METHOCARBAMOL";"4.0";"241.24";"0";"0.53";"METHOCARBAMOL";"COc1ccccc1OCC(O)COC(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3105087";"";"None";"321.35";"0";"3.57";"31";"CCc1cnn2c(O)cc(CSc3cccc(F)c3F)nc12";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3105086";"";"None";"318.31";"0";"2.88";"30";"N#Cc1cnn2c(O)cc(CSc3cccc(F)c3F)nc12";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3105078";"";"None";"370.38";"0";"4.07";"22";"Oc1cc(CSc2cccc(F)c2F)nc2nc(-c3ccccc3)nn12";"IC50";"'='";"850.0";"nM";"6.07";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3104914";"";"None";"336.37";"0";"3.52";"20";"CC(C)c1nc2nc(CSc3cccc(F)c3F)cc(O)n2n1";"IC50";"'='";"910.0";"nM";"6.04";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL84719";"";"None";"335.35";"0";"4.30";"22";"FC(F)(F)c1cccc(-c2nc(S)n(Cc3ccccc3)n2)c1";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"16.27";"0.32";"1.16";"17.77";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL60066";"";"None";"266.66";"0";"2.36";"4a";"O=C(Nc1ccc(F)cc1)c1ccc(Cl)[n+]([O-])c1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"22.50";"0.46";"3.64";"10.71";"0";"CHEMBL662153";"Evaluated using an SPA assay with recombinant human [125I]IL-8 and membranes prepared from Sf9 cells expressing human CXCR2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133879";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2001";"CHEMBL3308860";"";"";""
"CHEMBL160";"CYCLOSPORINE";"4.0";"1202.63";"None";"None";"CYCLOSPORIN A";"C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL516";"CYPROHEPTADINE";"4.0";"287.41";"0";"4.70";"CYPROHEPTADINE";"CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL93";"ZILEUTON";"4.0";"236.30";"0";"2.73";"ZILEUTON";"CC(c1cc2ccccc2s1)N(O)C(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200679";"ZINC CHLORIDE";"4.0";"136.30";"None";"None";"ZINC CHLORIDE";"[Cl-].[Cl-].[Zn+2]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909070";"NAFENOPIN";"2.0";"310.39";"0";"4.40";"NAFENOPIN";"CC(C)(Oc1ccc(C2CCCc3ccccc32)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL27446";"";"None";"366.60";"0";"4.32";"1g";"N#Cc1ccc(NC(=O)Nc2ccccc2Br)c(O)c1Cl";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"20.89";"0.50";"3.34";"8.99";"0";"CHEMBL656551";"Inhibition of binding of IL-8 to membranes of cloned CXC chemokine receptor 2 expressed in CHO Cells using [125I]IL-8 radioligand";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149089";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL428";"TROVAFLOXACIN";"4.0";"416.36";"0";"1.89";"TROVAFLOXACIN";"N[C@@H]1[C@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL85497";"";"None";"285.35";"0";"3.42";"30";"Fc1ccccc1-c1nc(S)n(Cc2ccccc2)n1";"IC50";"'='";"890.0";"nM";"6.05";"";"";"UO_0000065";"21.20";"0.41";"2.63";"19.70";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL233973";"";"None";"365.80";"0";"2.83";"9r";"CC(=O)c1ccccc1NC1=NS(=O)(=O)c2cc(Cl)cc(O)c2N1";"IC50";"'='";"4500.0";"nM";"5.35";"";"";"UO_0000065";"14.62";"0.30";"2.52";"4.96";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL234395";"";"None";"402.66";"0";"3.39";"9f";"O=S1(=O)N=C(Nc2ccc(Br)cc2)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"5100.0";"nM";"5.29";"";"";"UO_0000065";"13.14";"0.33";"1.90";"5.83";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL393047";"";"None";"402.66";"0";"3.39";"9d";"O=S1(=O)N=C(Nc2ccccc2Br)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL896517";"Antagonist activity at CXCR2 receptor expressed in CHOK1 cells assessed as human IL8-induced calcium mobilization by FLIPR";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307512";"";"";""
"CHEMBL233551";"";"None";"303.77";"0";"1.90";"11a";"CC[C@@H](C)NC1=NS(=O)(=O)c2cc(Cl)cc(O)c2N1";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"15.88";"0.35";"2.92";"5.31";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL257269";"";"None";"378.40";"0";"2.68";"24";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2[nH]c(=O)ccc12";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"17.06";"0.34";"3.78";"7.10";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL214047";"";"None";"345.40";"0";"1.70";"22";"CCC(CC)/N=c1\c(O)c(O)\c1=N/c1cccc(C(=O)N(C)C)c1O";"IC50";"'='";"19.1";"nM";"7.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL866149";"Inhibition of chemotaxis of CHO cells expressing human CXCR2";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL3704560";"";"None";"523.54";"1";"2.60";"BDBM172353";"COC(=O)C1CCCN1C(=O)c1cccc(Nc2c(NC(c3ccc(C)o3)C3(C)COC3)c(=O)c2=O)c1O";"IC50";"'='";"962.0";"nM";"6.02";"";"317333";"UO_0000065";"11.49";"0.22";"3.42";"4.08";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3704561";"";"None";"441.51";"0";"2.68";"BDBM172354";"CN(C)C(=O)c1cccc(Nc2c(NC(c3cccs3)C3(C)COC3)c(=O)c2=O)c1O";"IC50";"'='";"106.0";"nM";"6.97";"";"317312";"UO_0000065";"15.80";"0.31";"4.29";"6.46";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL257178";"";"None";"453.42";"0";"4.13";"25";"N#Cc1ccc2[nH]c(-c3ccc(F)cc3)c(CCCC(=O)NS(=O)(=O)C(F)(F)F)c2c1";"IC50";"'='";"87.0";"nM";"7.06";"";"";"UO_0000065";"15.57";"0.31";"2.93";"6.87";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL403497";"";"None";"456.54";"0";"3.87";"30";"CCN(CC)S(=O)(=O)NC(=O)CCCc1c(-c2ccc(F)cc2)[nH]c2ccc(C#N)cc12";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"13.05";"0.25";"2.09";"5.62";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL380947";"";"None";"397.48";"0";"3.42";"29";"CC(C)(CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(N)sc12";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"19.76";"0.41";"4.43";"8.10";"0";"CHEMBL862382";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 membranes by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149469";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307715";"";"";""
"CHEMBL203715";"";"None";"453.59";"0";"4.94";"26";"CC[C@H](CO)Nc1nc(SCc2cccc(Oc3ccccc3)c2)nc2nc(N)sc12";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"14.23";"0.28";"1.52";"6.08";"0";"CHEMBL862382";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 membranes by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149469";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307715";"";"";""
"CHEMBL370387";"";"None";"326.35";"0";"2.94";"20";"Nc1nc2nc(SCc3cccc(F)c3F)nc(O)c2s1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"20.13";"0.43";"3.63";"7.74";"0";"CHEMBL862382";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 membranes by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149469";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307715";"";"";""
"CHEMBL218744";"";"None";"565.49";"1";"3.64";"6r";"CCC(CC)(NS(=O)(=O)c1cccc(N/C(=N/C#N)Nc2ccccc2Br)c1O)N1CCOCC1";"IC50";"'='";"12.0";"nM";"7.92";"";"Antagonist";"UO_0000065";"14.01";"0.31";"4.28";"5.70";"0";"CHEMBL908413";"Displacement of [125I]IL8 from CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139694";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"ANTAGONIST";""
"CHEMBL220797";"";"None";"411.85";"0";"2.80";"6b";"CN(C)S(=O)(=O)c1c(Cl)ccc(N/C(=N/C#N)Nc2ccccc2F)c1O";"IC50";"'='";"9.0";"nM";"8.05";"";"Antagonist";"UO_0000065";"19.54";"0.41";"5.25";"6.83";"0";"CHEMBL908413";"Displacement of [125I]IL8 from CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139694";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"ANTAGONIST";""
"CHEMBL254370";"";"None";"393.44";"0";"3.00";"15";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccccc1";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL912820";"Inhibition of CXCL1-induced human neutrophil chemotaxis";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL392821";"";"None";"262.70";"0";"3.69";"Table 1 C5R8";"O=C(Nc1ccccc1)Nc1cc(Cl)ccc1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL537441";"";"None";"561.88";"1";"3.11";"10j";"CN1CCCN(S(=O)(=O)c2c(Cl)ccc(Nc3c(Nc4ccccc4Cl)c(=O)c3=O)c2O)CC1.Cl";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"14.65";"0.31";"4.59";"6.47";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL85267";"";"None";"267.36";"0";"3.28";"2";"Sc1nc(-c2ccccc2)nn1Cc1ccccc1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"21.02";"0.40";"2.34";"18.30";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL3342269";"";"None";"382.23";"None";"None";"BDBM150811";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccccc2B(O)O)nc1";"IC50";"'='";"38.0";"nM";"7.42";"";"290321";"UO_0000065";"19.41";"None";"None";"None";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL105";"MITOMYCIN";"4.0";"334.33";"0";"-1.65";"MITOMYCIN C";"CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3645130";"";"None";"399.47";"0";"3.95";"BDBM100342";"CC(C)(NC(=O)c1sc2ccccc2c1OCCOc1ccccc1)C(=O)O";"IC50";"'='";"1760.0";"nM";"5.75";"";"217536";"UO_0000065";"";"";"";"";"0";"CHEMBL3705309";"Calcium Fluorescence Assay (FLIPR) : CXCR2 inhibition using calcium fluorescence assay (FLIPR).";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638729";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3342291";"";"None";"338.41";"0";"4.77";"BDBM150821";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccccc2)nc1";"IC50";"'='";"393.0";"nM";"6.41";"";"290331";"UO_0000065";"18.93";"0.36";"1.64";"15.26";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658242";"";"None";"420.53";"1";"6.49";"BDBM150840";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc(-c3ccsc3)cc2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290350";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658249";"";"None";"389.46";"1";"5.31";"BDBM150865";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2nccc3ccccc23)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290375";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658253";"";"None";"480.48";"0";"4.16";"BDBM150869";"O=C(Nc1ccc(F)cc1)c1ccc(SCCCN2C(=O)c3ccc([N+](=O)[O-])cc3C2=O)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290379";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658254";"";"None";"494.50";"0";"4.55";"BDBM150870";"O=C(Nc1ccc(F)cc1)c1ccc(SCCCCN2C(=O)c3ccc([N+](=O)[O-])cc3C2=O)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290380";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658275";"";"None";"384.41";"0";"4.59";"BDBM150902";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1cccc(F)c1";"IC50";"'>'";"10000.0";"nM";"";"";"290412";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342315";"";"None";"408.24";"None";"None";"BDBM150970";"O=C(O)c1ccc(NC(=O)c2ccc(SCc3ccccc3B(O)O)nc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"290481";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1162935";"";"None";"379.42";"0";"2.61";"13";"C[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccccc1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"20.48";"0.38";"5.16";"7.87";"0";"CHEMBL909848";"Displacement of [125I]hCXCL8 from human CXCR2 receptor expressed in BaF3 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307634";"";"";""
"CHEMBL221039";"";"None";"446.29";"0";"3.45";"6i";"CN(C)S(=O)(=O)c1c(Cl)ccc(N/C(=N/C#N)Nc2cccc(Cl)c2F)c1O";"IC50";"'='";"29.0";"nM";"7.54";"";"Antagonist";"UO_0000065";"16.89";"0.37";"4.09";"6.40";"0";"CHEMBL908413";"Displacement of [125I]IL8 from CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139694";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"ANTAGONIST";""
"CHEMBL85045";"";"None";"301.80";"0";"3.94";"34";"Sc1nc(-c2ccccc2Cl)nn1Cc1ccccc1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"21.03";"0.43";"2.41";"20.67";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL1089";"PHENELZINE";"4.0";"136.20";"0";"0.69";"PHENELZINE";"NNCCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL239767";"";"None";"352.14";"0";"3.71";"Table 1 C5R13";"O=C(Nc1ccc([N+](=O)[O-])cc1O)Nc1ccccc1Br";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"21.75";"0.50";"3.95";"7.33";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL241677";"";"None";"242.28";"0";"3.34";"Table 1 C5R7";"Cc1ccc(O)c(NC(=O)Nc2ccccc2)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL240458";"";"None";"534.49";"0";"2.25";"10p";"CN1CCCN(C(=O)c2cccc(Nc3c(Nc4ccccc4)c(=O)c3=O)c2O)CC1.O=C(O)C(F)(F)F";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"17.50";"0.32";"5.11";"7.21";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL392473";"";"None";"520.46";"0";"1.86";"10o";"CN1CCN(C(=O)c2cccc(Nc3c(Nc4ccccc4)c(=O)c3=O)c2O)CC1.O=C(O)C(F)(F)F";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"18.62";"0.34";"5.71";"7.42";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL238743";"";"None";"357.75";"0";"2.23";"10l";"NC(=O)c1c(Cl)ccc(Nc2c(Nc3ccccc3)c(=O)c2=O)c1O";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"21.95";"0.43";"5.62";"6.46";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL268291";"DIMETHYLFORMAMIDE";"None";"73.10";"0";"-0.30";"N,N-DIMETHYLFORMAMIDE";"CN(C)C=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL502620";"ACLARUBICIN";"3.0";"811.88";"2";"3.16";"ACLARUBICIN";"CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL234177";"";"None";"323.76";"0";"2.63";"9t";"O=S1(=O)N=C(Nc2ccccc2Cl)Nc2c(O)cccc21";"IC50";"'='";"5200.0";"nM";"5.28";"";"";"UO_0000065";"16.32";"0.34";"2.65";"5.82";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL394799";"";"None";"381.91";"0";"3.41";"28";"C[C@H](CO)Nc1nc(SCc2cccc(Cl)c2)nc2nc(N)sc12";"IC50";"'='";"12.59";"nM";"7.90";"";"";"UO_0000065";"20.69";"0.45";"4.49";"8.15";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL245180";"";"None";"397.48";"0";"3.49";"16";"CNc1nc2nc(SCc3cccc(F)c3F)nc(N[C@H](C)CO)c2s1";"IC50";"'='";"7.943";"nM";"8.10";"";"";"UO_0000065";"20.38";"0.43";"4.61";"9.76";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL397237";"";"None";"383.45";"0";"3.03";"6";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(N)sc12";"IC50";"'='";"3.981";"nM";"8.40";"";"";"UO_0000065";"21.91";"0.46";"5.37";"8.66";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL1592";"QUINAPRIL";"4.0";"438.52";"0";"2.57";"QUINAPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL392181";"";"None";"294.31";"0";"2.78";"3d";"Cc1ccc(Nc2c(Nc3ccccc3)c(=O)c2=O)c(O)c1";"IC50";"'='";"205.0";"nM";"6.69";"";"";"UO_0000065";"22.73";"0.42";"3.91";"8.53";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL404661";"";"None";"454.32";"0";"3.54";"37";"CS(=O)(=O)NC(=O)NCCc1c(-c2ccc(F)cc2)[nH]c2ccc(Br)cc12";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"14.53";"0.33";"3.06";"7.25";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL401512";"";"None";"411.43";"0";"3.14";"9";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cccc(F)c1";"IC50";"'='";"4.9";"nM";"8.31";"";"";"UO_0000065";"20.20";"0.38";"5.17";"8.42";"1";"CHEMBL929862";"Displacement of [125I]IL8 from human CXCR2 by SPA assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141536";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL255481";"";"None";"453.33";"0";"4.14";"19";"CS(=O)(=O)NC(=O)CCCc1c(-c2ccc(F)cc2)[nH]c2ccc(Br)cc12";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"14.93";"0.34";"2.63";"8.57";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL253714";"";"None";"417.85";"0";"3.24";"45";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cc(Cl)co1";"IC50";"'='";"3.8";"nM";"8.42";"";"";"UO_0000065";"20.15";"0.40";"5.18";"7.53";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL250699";"";"None";"357.79";"0";"4.87";"A-803467";"COc1cc(NC(=O)c2ccc(-c3ccc(Cl)cc3)o2)cc(OC)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL935640";"Displacement of [125I]IL8 from CXCR2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142222";"1";"Scientific Literature";"Proc Natl Acad Sci U S A";"2007";"None";"";"";""
"CHEMBL3609006";"";"None";"380.19";"None";"None";"22";"CN(Cc1ccc(B(O)O)cn1)c1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'='";"81.0";"nM";"7.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL39835";"";"None";"306.32";"0";"2.65";"5h";"O=C(O)CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"19.33";"0.39";"3.27";"7.47";"0";"CHEMBL656549";"Displacement of [125I]IL-8 from CHO cell membranes expressing human CX3C chemokine receptor 2 (CXCR2 filter mat binding assay)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"CHEMBL3308072";"";"";""
"CHEMBL393253";"";"None";"376.20";"0";"3.42";"9g";"O=S1(=O)N=C(Nc2cccc(F)c2Cl)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"460.0";"nM";"6.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL896517";"Antagonist activity at CXCR2 receptor expressed in CHOK1 cells assessed as human IL8-induced calcium mobilization by FLIPR";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307512";"";"";""
"CHEMBL183222";"";"None";"448.73";"0";"3.70";"5b";"CN(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2ccccc2Br)c1O";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"17.65";"0.43";"4.22";"8.02";"0";"CHEMBL828744";"Concentration required to inhibit [125I]IL-8 binding towards C-X-C chemokine receptor type 2 of human expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137097";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3308072";"";"";""
"CHEMBL59734";"";"None";"280.69";"0";"2.04";"4g";"O=C(NCc1ccc(F)cc1)c1ccc(Cl)[n+]([O-])c1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL662153";"Evaluated using an SPA assay with recombinant human [125I]IL-8 and membranes prepared from Sf9 cells expressing human CXCR2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133879";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2001";"CHEMBL3308860";"";"";""
"CHEMBL3701186";"";"None";"481.51";"0";"2.03";"BDBM172326";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N4CC[C@H](O)C4)c3O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"1088.0";"nM";"5.96";"";"317335";"UO_0000065";"12.38";"0.23";"3.93";"4.22";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL376621";"";"None";"499.98";"0";"4.24";"6d";"CN(C)S(=O)(=O)c1c(Cl)ccc(N/C(=N/C#N)Nc2ccccc2OCc2ccccc2)c1O";"IC50";"'='";"9.0";"nM";"8.05";"";"Antagonist";"UO_0000065";"16.09";"0.32";"3.81";"6.33";"0";"CHEMBL908413";"Displacement of [125I]IL8 from CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139694";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"ANTAGONIST";""
"CHEMBL58619";"";"None";"386.40";"0";"2.69";"7g";"O=C(Nc1ccc(F)cc1)c1ccc(S(=O)(=O)Cc2ccccc2)[n+]([O-])c1";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"16.96";"0.33";"3.86";"7.27";"0";"CHEMBL662153";"Evaluated using an SPA assay with recombinant human [125I]IL-8 and membranes prepared from Sf9 cells expressing human CXCR2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133879";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2001";"CHEMBL3308860";"";"";""
"CHEMBL1210154";"";"None";"336.42";"1";"5.39";"10i";"C/C(=N\OC(=O)Nc1ccccc1)c1cccc(-c2cccs2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1212477";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208724";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3307715";"";"";""
"CHEMBL3609013";"";"None";"456.29";"None";"None";"24";"O=C(Nc1ccc(F)cc1)c1ccc(N(Cc2ccccc2)Cc2ccc(B(O)O)cn2)nc1";"IC50";"'='";"298.0";"nM";"6.53";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL163";"RITONAVIR";"4.0";"720.96";"2";"5.91";"RITONAVIR";"CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3609012";"";"None";"381.18";"None";"None";"23";"CN(Cc1ccc(B(O)O)cn1)c1ncc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'='";"933.0";"nM";"6.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL508338";"THIMEROSAL";"4.0";"404.82";"None";"None";"THIMEROSAL";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL828";"PHENOTHIAZINE";"2.0";"199.28";"0";"3.89";"PHENOTHIAZINE";"c1ccc2c(c1)Nc1ccccc1S2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL787";"MONTELUKAST";"4.0";"586.20";"2";"8.95";"MONTELUKAST";"CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4527955";"";"None";"464.92";"1";"6.29";"36";"C[C@@H](NC1=C(C(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)C(=O)CC(C)(C)C1)c1ccccc1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"12.05";"0.24";"-0.69";"9.63";"0";"CHEMBL4324682";"Antagonist activity at CXCR2 (unknown origin) expressed in human U2OS cells cp-expressing betaarrestin-2/TEV protease and beta lactamase assessed as effect on beta-arrestin2 recruitment preincubated for 30 mins followed by IL-8 addition and further incubated for 5 hrs subsequently adding CCF4-AM staining and measured after 2 hrs by Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321855";"1";"Scientific Literature";"Eur J Med Chem";"2020";"CHEMBL3307757";"";"";""
"CHEMBL54";"HALOPERIDOL";"4.0";"375.87";"0";"4.43";"HALOPERIDOL";"O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1405";"ESTRONE";"4.0";"270.37";"0";"3.82";"ESTRONE";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL262777";"VANCOMYCIN";"4.0";"1449.27";"None";"None";"VANCOMYCIN";"CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL762";"OXYMETAZOLINE";"4.0";"260.38";"0";"2.85";"OXYMETAZOLINE";"Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL485549";"NIFURSOL";"2.0";"365.21";"0";"1.47";"NIFURSOL";"O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL92401";"IPRONIAZID";"4.0";"179.22";"0";"0.72";"IPRONIAZID";"CC(C)NNC(=O)c1ccncc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3654440";"";"None";"396.44";"0";"4.69";"BDBM150823";"CC(=O)Oc1ccccc1CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"5000.0";"nM";"";"";"290333";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2220427";"ERYTHROMYCIN PROPIONATE";"4.0";"790.00";"2";"2.75";"ERYTHROMYCIN PROPIONATE";"CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL283196";"ALPHA-NAPHTHOFLAVONE";"None";"272.30";"0";"4.61";"ALPHA-NAPHTHOFLAVONE";"O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL577738";"";"None";"318.33";"0";"0.37";"5a";"CCNNc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O";"IC50";"'='";"5490.0";"nM";"5.26";"";"";"UO_0000065";"16.53";"0.31";"4.89";"4.75";"0";"CHEMBL1043639";"Displacement of [125I]IL-8 from human CXCR2 expressed in mouse BaF3 cells by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156021";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307634";"";"";""
"CHEMBL576886";"";"None";"360.37";"0";"0.63";"5c";"CCN(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)C(C)=O";"IC50";"'='";"3290.0";"nM";"5.48";"";"";"UO_0000065";"15.21";"0.29";"4.85";"4.61";"0";"CHEMBL1043639";"Displacement of [125I]IL-8 from human CXCR2 expressed in mouse BaF3 cells by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156021";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307634";"";"";""
"CHEMBL576886";"";"None";"360.37";"0";"0.63";"5c";"CCN(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)C(C)=O";"IC50";"'='";"1250.0";"nM";"5.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1043642";"Antagonist activity at CXCR2 expressed in CHO cells assessed as inhibition of IL-8-induced chemotaxis";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156021";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL277100";"TEMAFLOXACIN";"4.0";"417.39";"0";"2.90";"TEMAFLOXACIN";"CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL64";"ISONIAZID";"4.0";"137.14";"0";"-0.31";"Isoniazid";"NNC(=O)c1ccncc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL498847";"SECNIDAZOLE";"4.0";"185.18";"0";"0.48";"SECNIDAZOLE";"Cc1ncc([N+](=O)[O-])n1CC(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL201842";"";"None";"382.47";"0";"4.46";"19";"Nc1nc2nc(SCc3cccc(Oc4ccccc4)c3)nc(O)c2s1";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"16.52";"0.33";"1.86";"6.71";"0";"CHEMBL862382";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 membranes by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149469";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307715";"";"";""
"CHEMBL380732";"";"None";"397.48";"0";"3.42";"28";"CC[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(N)sc12";"IC50";"'='";"9.5";"nM";"8.02";"";"";"UO_0000065";"20.18";"0.42";"4.60";"8.27";"0";"CHEMBL862382";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 membranes by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149469";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307715";"";"";""
"CHEMBL232846";"";"None";"365.46";"0";"2.89";"25";"C[C@H](CO)Nc1nc(SCc2ccccc2F)nc2nc(N)sc12";"IC50";"'='";"12.59";"nM";"7.90";"";"";"UO_0000065";"21.62";"0.45";"5.01";"8.15";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL154111";"SALSALATE";"4.0";"258.23";"0";"2.31";"SALSALATE";"O=C(Oc1ccccc1C(=O)O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL452861";"(-)-PROPANOLOL ";"2.0";"259.35";"0";"2.58";"S-(-)-PROPRANOLOL";"CC(C)NC[C@H](O)COc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL395340";"";"None";"439.56";"0";"4.66";"15";"CC[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(NC(C)C)sc12";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.93";"0.33";"2.34";"8.44";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL578807";"";"None";"440.43";"0";"2.06";"5i";"CCN(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)C(=O)c1ccc(F)cc1";"IC50";"'='";"840.0";"nM";"6.08";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1043642";"Antagonist activity at CXCR2 expressed in CHO cells assessed as inhibition of IL-8-induced chemotaxis";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156021";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL3941989";"";"None";"481.98";"0";"4.54";"Ex 4";"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@@H]2C[C@H]3CC[C@@H](C2)N3C)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3930695";"";"None";"437.95";"0";"3.78";"Ex 20";"CCc1ccccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CCNCC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL209859";"";"None";"305.29";"0";"2.18";"7";"N#Cc1ccc(Nc2c(O)c(=O)/c2=N\c2ccccc2)c(O)c1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"27.92";"0.51";"6.34";"8.06";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL253706";"";"None";"478.51";"0";"3.86";"25";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cc(-c2c(C)noc2C)co1";"IC50";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"16.97";"0.32";"4.26";"5.89";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL385715";"";"None";"399.47";"0";"3.06";"18";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cccs1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"20.58";"0.40";"5.16";"8.33";"0";"CHEMBL909848";"Displacement of [125I]hCXCL8 from human CXCR2 receptor expressed in BaF3 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307634";"";"";""
"CHEMBL4780042";"";"None";"417.60";"1";"5.24";"15";"CCOC(=O)c1c(NC(=S)Nc2ccc(N(C)C)cc2)sc2c1C(C)CCC2";"IC50";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"12.95";"0.26";"0.17";"10.09";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4799102";"";"None";"376.51";"0";"3.96";"26";"CCOC(=O)c1c(NC(=S)Nc2cnccn2)sc2c1C(C)CCC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"";""
"CHEMBL4780039";"";"None";"402.54";"0";"4.49";"27";"CCOC(=O)c1c(NC(=S)NC(=O)c2ccccc2)sc2c1C(C)CCC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"";""
"CHEMBL4788391";"";"None";"390.53";"0";"4.59";"38";"CC(C)(C)OC(=O)c1c(NC(=S)Nc2ccccc2)sc2c1CCOC2";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"14.44";"0.30";"1.05";"9.46";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4796430";"";"None";"389.55";"0";"4.16";"41";"CC(C)(C)OC(=O)c1c(NC(=S)Nc2ccccc2)sc2c1CCNC2";"IC50";"'='";"8700.0";"nM";"5.06";"";"";"UO_0000065";"12.99";"0.27";"0.90";"8.11";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4800238";"";"None";"494.68";"1";"7.74";"47";"CC1CCCc2sc(NC(=S)Nc3ccc(Oc4ccccc4)cc3)c(C(=O)OC(C)(C)C)c21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"";""
"CHEMBL312883";"";"None";"292.37";"0";"3.15";"21";"N#Cc1ccc(-c2nc(S)n(Cc3ccccc3)n2)cc1";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"18.66";"0.35";"2.31";"10.01";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL404520";"CHLORTETRACYCLINE";"4.0";"478.89";"1";"0.44";"CHLORTETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL84755";"";"None";"301.80";"0";"3.94";"29";"Sc1nc(-c2cccc(Cl)c2)nn1Cc1ccccc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"19.88";"0.41";"2.06";"19.54";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL850";"SPARFLOXACIN";"4.0";"392.41";"0";"2.08";"SPARFLOXACIN";"C[C@@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@H](C)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL62108";"";"None";"364.40";"0";"2.43";"7d";"O=C(Nc1ccc(F)cc1)c1ccc(S(=O)(=O)C2CCCC2)[n+]([O-])c1";"IC50";"'='";"460.0";"nM";"6.34";"";"";"UO_0000065";"17.39";"0.35";"3.91";"7.03";"0";"CHEMBL662153";"Evaluated using an SPA assay with recombinant human [125I]IL-8 and membranes prepared from Sf9 cells expressing human CXCR2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133879";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2001";"CHEMBL3308860";"";"";""
"CHEMBL1751";"DIGOXIN";"4.0";"780.95";"3";"2.22";"DIGOXIN";"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909056";"COBALT(II) ACETYLACETONATE";"None";"257.15";"None";"None";"COBALT(II) ACETYLACETONATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1140";"NIACINAMIDE";"4.0";"122.13";"0";"0.18";"nicotinamide";"NC(=O)c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1123";"DICYCLOMINE";"4.0";"309.49";"0";"4.40";"DICYCLOMINE";"CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL61";"PODOFILOX";"4.0";"414.41";"0";"2.41";"PODOPHYLLOTOXIN";"COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL57";"NEVIRAPINE";"4.0";"266.30";"0";"2.65";"NEVIRAPINE";"Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909051";"";"None";"347.38";"0";"4.80";"4-(PHENYLMETHYL)-1-[2-(TRIFLUOROMETHYL)BENZOYL]-PIPERIDINE";"O=C(c1ccccc1C(F)(F)F)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL888";"GEMCITABINE";"4.0";"263.20";"0";"-1.29";"GEMCITABINE";"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1481";"GLIMEPIRIDE";"4.0";"490.63";"0";"3.07";"GLIMEPIRIDE";"CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909057";"COPPER(II) OXIDE";"None";"79.55";"None";"None";"COPPER(II) OXIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL856";"PRIMIDONE";"4.0";"218.26";"0";"0.54";"PRIMIDONE";"CCC1(c2ccccc2)C(=O)NCNC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200845";"HALCINONIDE";"4.0";"454.97";"0";"3.89";"HALCINONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1198";"PRAMOXINE";"4.0";"293.41";"0";"2.97";"PRAMOXINE";"CCCCOc1ccc(OCCCN2CCOCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL562";"GRISEOFULVIN";"4.0";"352.77";"0";"2.81";"GRISEOFULVIN";"COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1105";"6-METHOXY-2-NAPHTHYLACETIC ACID";"-1.0";"216.24";"0";"2.48";"6-METHOXY-2-NAPHTHYLACETIC ACID";"COc1ccc2cc(CC(=O)O)ccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL93645";"ACECLOFENAC";"4.0";"354.19";"0";"3.91";"ACECLOFENAC";"O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL467";"HYDROXYUREA";"4.0";"76.05";"0";"-0.96";"HYDROXYUREA";"NC(=O)NO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL37161";"FENBENDAZOLE";"2.0";"299.36";"0";"3.89";"FENBENDAZOLE";"COC(=O)Nc1nc2cc(Sc3ccccc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL306043";"GOLD SODIUM THIOMALATE";"4.0";"346.11";"None";"None";"GOLD SODIUM THIOMALATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL914";"FEXOFENADINE";"4.0";"501.67";"2";"5.51";"FEXOFENADINE";"CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL12856";"INAMRINONE";"4.0";"187.20";"0";"1.02";"AMRINONE";"Nc1cc(-c2ccncc2)c[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL113";"CAFFEINE";"4.0";"194.19";"0";"-1.03";"CAFFEINE";"Cn1c(=O)c2c(ncn2C)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL521";"IBUPROFEN";"4.0";"206.28";"0";"3.07";"Ibuprofen";"CC(C)Cc1ccc(C(C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL660";"AMANTADINE";"4.0";"151.25";"0";"1.91";"AMANTADINE";"NC12CC3CC(CC(C3)C1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL502896";"CETRAXATE HYDROCHLORIDE";"-1.0";"341.83";"0";"2.37";"CETRAXATE";"Cl.NC[C@H]1CC[C@H](C(=O)Oc2ccc(CCC(=O)O)cc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL508112";"BENZOTHIAZYL DISULFIDE";"None";"332.50";"1";"5.71";"BENZOTHIAZYL DISULFIDE";"c1ccc2sc(SSc3nc4ccccc4s3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3957549";"";"None";"574.06";"2";"5.88";"Ex 27";"CCOC(=O)N1CCC(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3ccccc3Oc3ccccc3)c2O)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL83292";"";"None";"336.25";"0";"4.59";"33";"Sc1nc(-c2cc(Cl)ccc2Cl)nn1Cc1ccccc1";"IC50";"'='";"670.0";"nM";"6.17";"";"";"UO_0000065";"18.36";"0.40";"1.58";"20.10";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL49080";"CLENBUTEROL";"4.0";"277.19";"0";"3.00";"CLENBUTEROL";"CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3818820";"";"None";"479.77";"0";"4.95";"19";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCOCC2)c1O)Nc1cccc(Cl)c1Cl";"IC50";"'='";"6.31";"nM";"8.20";"";"";"UO_0000065";"17.09";"0.39";"3.25";"7.83";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL403";"SULBACTAM";"4.0";"233.24";"0";"-0.79";"SULBACTAM";"CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL26830";"";"None";"366.60";"0";"4.32";"1h";"N#Cc1c(Cl)ccc(NC(=O)Nc2ccccc2Br)c1O";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"19.76";"0.47";"2.92";"8.51";"0";"CHEMBL656551";"Inhibition of binding of IL-8 to membranes of cloned CXC chemokine receptor 2 expressed in CHO Cells using [125I]IL-8 radioligand";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149089";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL1208572";"SALINOMYCIN";"2.0";"751.01";"2";"6.19";"SALINOMYCIN";"CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1539";"SULFADOXINE";"4.0";"310.34";"0";"0.88";"SULFADOXINE";"COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL159";"VINBLASTINE";"4.0";"810.99";"2";"3.99";"1";"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL81";"RALOXIFENE";"4.0";"473.59";"1";"6.08";"RALOXIFENE";"O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL521589";"BAMBUTEROL";"3.0";"367.45";"0";"2.23";"BAMBUTEROL";"CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL689";"MANNITOL";"4.0";"182.17";"1";"-3.59";"MANNITOL";"OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL710";"FINASTERIDE";"4.0";"372.55";"0";"3.81";"FINASTERIDE";"CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL85117";"";"None";"350.27";"0";"4.78";"41";"Sc1nc(-c2ccc(Cl)cc2Cl)nn1CCc1ccccc1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"18.12";"0.39";"1.57";"20.67";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL844";"BRIMONIDINE";"4.0";"292.14";"0";"1.76";"BRIMONIDINE";"Brc1c(NC2=NCCN2)ccc2nccnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1024";"IFOSFAMIDE";"4.0";"261.09";"0";"1.88";"IFOSFAMIDE";"O=P1(NCCCl)OCCCN1CCCl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3933806";"";"None";"513.98";"1";"4.53";"Ex 32";"CCOC(=O)N1CCC(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3C)c2O)CC1";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3912422";"";"None";"528.03";"2";"5.54";"Ex 33";"O=C(Nc1ccccc1Oc1ccccc1)Nc1ccc(Cl)c(S(=O)(=O)C2C[C@H]3CC[C@@H](C2)N3)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3950195";"";"None";"475.86";"0";"3.15";"Ex 35";"O=C(Nc1ccc(Cl)c(S(=O)(=O)[C@@H]2CCNC2)c1O)Nc1cccc2c1OC(F)(F)O2";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL557555";"CIPROFIBRATE";"4.0";"289.16";"0";"3.59";"CIPROFIBRATE";"CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL741";"LAMOTRIGINE";"4.0";"256.10";"0";"2.01";"LAMOTRIGINE";"Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL716";"QUETIAPINE";"4.0";"383.52";"0";"2.86";"QUETIAPINE";"OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL9";"NORFLOXACIN";"4.0";"319.34";"0";"1.27";"Norfloxacin";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL558";"MEXILETINE";"4.0";"179.26";"0";"2.03";"MEXILETINE";"Cc1cccc(C)c1OCC(C)N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL19236";"MOXONIDINE";"4.0";"241.68";"0";"0.82";"MOXONIDINE";"COc1nc(C)nc(Cl)c1NC1=NCCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL137";"METRONIDAZOLE";"4.0";"171.16";"0";"0.09";"METRONIDAZOLE";"Cc1ncc([N+](=O)[O-])n1CCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL650";"METHYLPREDNISOLONE";"4.0";"374.48";"0";"1.80";"METHYLPREDNISOLONE";"C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)CO)[C@@]2(C)C=CC(=O)C=C12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL28009";"";"None";"411.05";"0";"4.43";"1f";"N#Cc1ccc(NC(=O)Nc2ccccc2Br)c(O)c1Br";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"20.00";"0.53";"3.79";"9.66";"0";"CHEMBL656551";"Inhibition of binding of IL-8 to membranes of cloned CXC chemokine receptor 2 expressed in CHO Cells using [125I]IL-8 radioligand";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149089";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL216602";"";"None";"383.40";"0";"2.51";"21";"Cc1ccc([C@@H](C)Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)o1";"IC50";"'='";"5.4";"nM";"8.27";"";"";"UO_0000065";"21.56";"0.40";"5.76";"7.39";"0";"CHEMBL909848";"Displacement of [125I]hCXCL8 from human CXCR2 receptor expressed in BaF3 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307634";"";"";""
"CHEMBL380732";"";"None";"397.48";"0";"3.42";"8";"CC[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(N)sc12";"IC50";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"19.12";"0.40";"4.18";"7.84";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL211468";"";"None";"351.36";"0";"1.85";"15";"CN(C)C(=O)c1cccc(/N=c2\c(O)c(O)\c2=N/c2ccccc2)c1O";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL866149";"Inhibition of chemotaxis of CHO cells expressing human CXCR2";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL424887";"";"None";"359.38";"0";"0.69";"20";"CN(C)C(=O)c1cccc(/N=c2\c(O)c(O)\c2=N/C2CCOCC2)c1O";"IC50";"'='";"171.0";"nM";"6.77";"";"";"UO_0000065";"18.83";"0.36";"6.08";"5.89";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL3426947";"";"None";"348.21";"None";"None";"BDBM150820";"O=C(Nc1ccc(F)cc1)c1ccc(SCCCCB(O)O)nc1";"IC50";"'='";"689.0";"nM";"6.16";"";"290330";"UO_0000065";"17.70";"None";"None";"None";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL115769";"";"None";"334.35";"0";"3.97";"RWJ-68354";"COc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"SULFADIAZINE";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1762";"TOCAINIDE";"4.0";"192.26";"0";"1.59";"TOCAINIDE";"Cc1cccc(C)c1NC(=O)C(C)N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL431511";"";"None";"320.35";"0";"2.74";"5b";"COC(=O)CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"23.40";"0.47";"4.75";"10.98";"0";"CHEMBL656548";"Displacement of [125I]IL-8 from CHO cell membranes expressing human CX3C chemokine receptor 2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"CHEMBL3308072";"";"";""
"CHEMBL84753";"";"None";"336.25";"0";"4.59";"37";"Sc1nc(-c2cccc(Cl)c2Cl)nn1Cc1ccccc1";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"19.20";"0.42";"1.87";"21.02";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL3310794";"";"None";"294.33";"0";"3.63";"31";"Oc1cc(C2CC2)nc(SCc2cccc(F)c2F)n1";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL13";"METOPROLOL";"4.0";"267.37";"0";"1.61";"METOPROLOL";"COCCc1ccc(OCC(O)CNC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200623";"ETHYLESTRENOL";"4.0";"288.48";"1";"5.09";"ETHYLESTRENOL";"CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL95764";"GLYPHOSATE";"None";"169.07";"0";"-1.20";"GLYPHOSATE";"O=C(O)CNCP(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1447";"LINCOMYCIN";"4.0";"406.55";"0";"-0.86";"5c (lincomycin)";"CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL717";"MEDROXYPROGESTERONE ACETATE";"4.0";"386.53";"0";"4.66";"MEDROXYPROGESTERONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL86754";"IODOQUINOL";"2.0";"396.95";"0";"3.15";"SID855609";"Oc1c(I)cc(I)c2cccnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL954";"ENCLOMIPHENE";"3.0";"405.97";"1";"6.56";"CLOMIPHENE";"CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL334255";"CETYLPYRIDINIUM BROMIDE";"None";"384.45";"1";"6.46";"CETYLPYRIDINIUM BROMIDE";"CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL136478";"SODIUM NITROPRUSSIDE";"4.0";"261.92";"None";"None";"SODIUM NITROPRUSSIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL253506";"";"None";"394.43";"0";"2.39";"40";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccncc1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"18.51";"0.34";"4.91";"6.54";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL325372";"METHYLPARABEN";"-1.0";"152.15";"0";"1.18";"METHYLPARABEN";"COC(=O)c1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL116";"AMPRENAVIR";"4.0";"505.64";"1";"2.40";"AMPRENAVIR";"CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL469";"KETOROLAC";"4.0";"255.27";"0";"2.29";"KETOROLAC";"O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL340978";"BENOXAPROFEN";"4.0";"301.73";"0";"4.34";"BENOXAPROFEN";"CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL404811";"DIGITONIN";"None";"1229.32";"None";"None";"DIGITONIN";"C[C@@H]1CC[C@@]2(OC1)O[C@H]1[C@@H](O)[C@H]3[C@@H]4CC[C@H]5C[C@@H](O[C@@H]6O[C@H](CO)[C@H](O[C@@H]7O[C@H](CO)C(O)[C@H](O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3927944";"";"None";"493.89";"0";"4.11";"Ex 19";"O=C(Nc1ccccc1OC(F)(F)F)Nc1ccc(Cl)c(S(=O)(=O)C2CCNCC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3930695";"";"None";"437.95";"0";"3.78";"Ex 20";"CCc1ccccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CCNCC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3910320";"";"None";"487.97";"0";"4.62";"Ex 26";"O=C(Nc1ccccc1Oc1ccccc1)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCNC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3912422";"";"None";"528.03";"2";"5.54";"Ex 33";"O=C(Nc1ccccc1Oc1ccccc1)Nc1ccc(Cl)c(S(=O)(=O)C2C[C@H]3CC[C@@H](C2)N3)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL141343";"";"None";"520.72";"1";"4.21";"U-78517F";"Cc1c(C)c2c(c(C)c1O)CCC(C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL441144";"";"None";"393.62";"0";"3.89";"10c";"O=c1c(Nc2ccc(Cl)cc2O)c(Nc2ccccc2Br)c1=O";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"19.04";"0.45";"3.60";"9.56";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL424694";"";"None";"280.28";"0";"2.31";"3a";"O=c1c(O)c(Nc2ccccc2)/c1=N/c1ccccc1O";"IC50";"'='";"235.0";"nM";"6.63";"";"";"UO_0000065";"23.65";"0.43";"4.32";"8.09";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL129";"ZIDOVUDINE";"4.0";"267.24";"0";"-0.20";"ZIDOVUDINE";"Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL70927";"DEFERIPRONE";"4.0";"139.15";"0";"0.40";"DEFERIPRONE";"Cc1c(O)c(=O)ccn1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL21731";"MAPROTILINE";"4.0";"277.41";"0";"4.21";"MAPROTILINE";"CNCCCC12CCC(c3ccccc31)c1ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1712923";"IRSOGLADINE MALEATE";"1.0";"372.17";"0";"2.01";"IRSOGLADINE MALEATE";"Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1.O=C(O)/C=C\C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL29";"BENZYLPENICILLIN";"4.0";"334.40";"0";"0.86";"PENICILLIN G";"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL19299";"LOXOPROFEN";"4.0";"246.31";"0";"2.79";"LOXOPROFEN";"CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1169";"AMINOSALICYLIC ACID";"4.0";"153.14";"0";"0.67";"AMINOSALICYLIC ACID";"Nc1ccc(C(=O)O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL154";"NAPROXEN";"4.0";"230.26";"0";"3.04";"NAPROXEN";"COc1ccc2cc([C@H](C)C(=O)O)ccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3950351";"";"None";"493.89";"0";"3.97";"Ex 5";"O=C(Nc1ccccc1OC(F)(F)F)Nc1ccc(Cl)c(S(=O)(=O)CC2CCNC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL1651906";"STREPTOZOCIN";"4.0";"265.22";"0";"-2.89";"STREPTOZOTOCIN";"CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL488025";"EXISULIND";"3.0";"372.42";"0";"4.03";"SULINDAC SULFONE";"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL980";"GUAIFENESIN";"4.0";"198.22";"0";"0.43";"GUAIFENESIN";"COc1ccccc1OCC(O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL820";"BUSULFAN";"4.0";"246.31";"0";"-0.28";"SID67633";"CS(=O)(=O)OCCCCOS(C)(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL25719";"GERANIOL";"None";"154.25";"0";"2.67";"GERANIOL";"CC(C)=CCC/C(C)=C/CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1159650";"CLOBETASOL PROPIONATE";"4.0";"466.98";"0";"4.10";"CLOBETASOL PROPIONATE";"CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1726";"NISOLDIPINE";"4.0";"388.42";"0";"3.20";"NISOLDIPINE";"COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL878";"METOLAZONE";"4.0";"365.84";"0";"2.71";"METOLAZONE";"Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3342288";"";"None";"419.48";"1";"5.73";"26";"Cc1onc(-c2ccccc2)c1CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL50588";"EMETINE";"2.0";"480.65";"0";"4.94";"EMETINE";"CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1297";"FENOPROFEN";"4.0";"242.27";"0";"3.67";"FENOPROFEN";"CC(C(=O)O)c1cccc(Oc2ccccc2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3039597";"GENTAMICIN";"4.0";"1390.73";"None";"None";"GENTAMICIN";"CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H](N)C[C@@H]2N)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL134";"CLONIDINE";"4.0";"230.10";"0";"2.36";"CLONIDINE";"Clc1cccc(Cl)c1NC1=NCCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1619";"CLADRIBINE";"4.0";"285.69";"0";"-0.30";"CLADRIBINE";"Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL902";"FAMOTIDINE";"4.0";"337.46";"0";"-0.77";"FAMOTIDINE";"NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL294199";"CAPSAICIN";"4.0";"305.42";"0";"3.79";"CAPSAICIN";"COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1077";"BROMFENAC";"4.0";"334.17";"0";"2.89";"BROMFENAC";"Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1440";"TETRACYCLINE";"4.0";"444.44";"1";"-0.21";"TETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1371125";"BENZO[E]PYRENE";"None";"252.32";"1";"5.74";"BENZO[E]PYRENE";"c1ccc2c(c1)c1cccc3ccc4cccc2c4c31";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL430381";"";"None";"439.51";"0";"3.00";"13";"OCC(CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(NC3CC3)sc12";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.93";"0.33";"4.00";"6.78";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL1477";"CERIVASTATIN";"4.0";"459.56";"0";"4.88";"CERIVASTATIN";"COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL313493";"METHANESULFONIC ACID METHYL ESTER";"None";"110.13";"0";"-0.41";"METHYL METHANESULFONATE";"COS(C)(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3310776";"";"None";"399.42";"0";"4.61";"13";"COc1ccc(-c2nc(SCc3cccc(F)c3F)nc(O)c2C#N)cc1C";"IC50";"'='";"4600.0";"nM";"5.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3310777";"";"None";"371.37";"0";"4.00";"14";"N#Cc1c(O)nc(SCc2cccc(F)c2F)nc1-c1ccc(O)cc1";"IC50";"'='";"780.0";"nM";"6.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL141";"LAMIVUDINE";"4.0";"229.26";"0";"-0.59";"LAMIVUDINE";"Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL62193";"SULFADIMETHOXINE";"4.0";"310.34";"0";"0.88";"SULFADIMETHOXINE";"COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL422";"TRIFLUOPERAZINE";"4.0";"407.51";"0";"4.95";"trifluoperazine";"CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL267744";"TICRYNAFEN";"4.0";"331.18";"0";"3.75";"TICRYNAFEN";"O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL714";"ALBUTEROL";"4.0";"239.31";"0";"1.31";"SALBUTAMOL";"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL36994";"ANIRACETAM";"2.0";"219.24";"0";"1.46";"ANIRACETAM";"COc1ccc(C(=O)N2CCCC2=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL87285";"ANDROSTERONE";"None";"290.45";"0";"3.96";"ANDROSTERONE";"C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL81977";"3-AMINOBENZAMIDE";"None";"136.15";"0";"0.37";"3-AMINOBENZAMIDE";"NC(=O)c1cccc(N)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL211501";"ANTIMYCIN A";"None";"548.63";"1";"3.48";"ANTIMYCIN A";"CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL990";"BUTENAFINE";"4.0";"317.48";"1";"5.77";"BUTENAFINE";"CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL768";"ESMOLOL";"4.0";"295.38";"0";"1.53";"ESMOLOL";"COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3310770";"";"None";"432.48";"0";"3.96";"6";"CS(=O)(=O)Nc1nc(SCc2cccc(F)c2F)nc(-c2ccccc2)c1C#N";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL85";"RISPERIDONE";"4.0";"410.49";"0";"3.59";"RISPERIDONE";"Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1908355";"TENIDAP";"2.0";"320.76";"0";"3.25";"TENIDAP";"NC(=O)N1C(=O)/C(=C(\O)c2cccs2)c2cc(Cl)ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1082";"AMOXICILLIN";"4.0";"365.41";"0";"0.02";"AMOXICILLIN";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL234926";"ALLYL ALCOHOL";"None";"58.08";"0";"0.16";"ALLYL ALCOHOL";"C=CCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL270299";"BAY-11-7085";"None";"249.34";"0";"2.80";"BAY-117085";"CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL495778";"PENICILLIC ACID";"None";"170.16";"0";"0.34";"PENICILLIC ACID";"C=C(C)C1(O)OC(=O)C=C1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL445";"NORTRIPTYLINE";"4.0";"263.38";"0";"3.83";"NORTRIPTYLINE";"CNCCC=C1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1491";"AMLODIPINE";"4.0";"408.88";"0";"2.27";"AMLODIPINE";"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL119385";"NEFLAMAPIMOD";"2.0";"436.27";"1";"5.49";"VX-745";"O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1366";"AURANOFIN";"4.0";"678.49";"None";"None";"AURANOFIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL30327";"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN";"None";"321.97";"1";"6.20";"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN";"Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL535818";"";"None";"407.10";"0";"3.91";"4";"Cl.NCc1c(Cl)ccc(NC(=O)Nc2ccccc2Br)c1O";"IC50";"'='";"114.0";"nM";"6.94";"";"";"UO_0000065";"18.73";"0.45";"3.03";"7.95";"0";"CHEMBL828744";"Concentration required to inhibit [125I]IL-8 binding towards C-X-C chemokine receptor type 2 of human expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137097";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3308072";"";"";""
"CHEMBL79";"LIDOCAINE";"4.0";"234.34";"0";"2.58";"LIDOCAINE";"CCN(CC)CC(=O)Nc1c(C)cccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL490";"PAROXETINE";"4.0";"329.37";"0";"3.33";"PAROXETINE";"Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2107797";"NORGESTREL";"4.0";"312.45";"0";"3.88";"NORGESTREL";"C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL715";"OLANZAPINE";"4.0";"312.44";"0";"3.44";"OLANZAPINE";"Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL567";"PERPHENAZINE";"4.0";"403.98";"0";"3.94";"PERPHENAZINE";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL936";"DIPHENIDOL";"4.0";"309.45";"0";"4.19";"DIPHENIDOL";"OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL413";"SIROLIMUS";"4.0";"914.19";"3";"6.18";"Rapamycin";"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL802";"MINOXIDIL";"4.0";"209.25";"0";"-0.13";"MINOXIDIL";"Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1384";"KANAMYCIN";"4.0";"484.50";"2";"-7.29";"KANAMYCIN";"NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL181";"DIAZOXIDE";"4.0";"230.68";"0";"1.68";"DIAZOXIDE";"CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL510139";"CITRININ";"None";"250.25";"0";"1.72";"CITRININ";"CC1=C2C(=CO[C@H](C)[C@H]2C)C(O)=C(C(=O)O)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL178";"DAUNORUBICIN";"4.0";"527.53";"2";"1.03";"DAUNORUBICIN";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL6273";"FLEROXACIN";"2.0";"369.34";"0";"1.70";"FLEROXACIN";"CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL189";"MILRINONE";"4.0";"211.22";"0";"1.62";"MILRINONE";"Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL20883";"TEGAFUR";"4.0";"200.17";"0";"-0.02";"TEGAFUR";"O=c1[nH]c(=O)n(C2CCCO2)cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL506";"PRIMAQUINE";"4.0";"259.35";"0";"2.78";"PRIMAQUINE";"COc1cc(NC(C)CCCN)c2ncccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL233059";"";"None";"365.46";"0";"2.89";"26";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2)nc2nc(N)sc12";"IC50";"'='";"15.85";"nM";"7.80";"";"";"UO_0000065";"21.34";"0.44";"4.91";"8.05";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL233259";"";"None";"381.91";"0";"3.41";"27";"C[C@H](CO)Nc1nc(SCc2ccccc2Cl)nc2nc(N)sc12";"IC50";"'='";"31.62";"nM";"7.50";"";"";"UO_0000065";"19.64";"0.43";"4.09";"7.74";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL252852";"";"None";"411.46";"0";"3.15";"8";"CCc1ccc(C(CC)Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)o1";"IC50";"'='";"4.1";"nM";"8.39";"";"";"UO_0000065";"20.38";"0.38";"5.24";"7.50";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL407030";"";"None";"1281.13";"None";"None";"GAMMA-CYCLODEXTRIN";"OC[C@H]1OC2C3[C@@H](CO)OC(O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]9[C@H](O)[C@@H](O)C(OC1[C@H](O)[C@H]2O)O[C@@H]9CO)O[C@@H]8CO)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)[C@H](O)[C@H]3O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL513";"CARMUSTINE";"4.0";"214.05";"0";"1.16";"SID479311";"O=NN(CCCl)C(=O)NCCCl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3342276";"";"None";"435.55";"1";"6.20";"14, 35";"Cc1nc(-c2ccc(CSc3ccc(C(=O)Nc4ccc(F)cc4)cn3)cc2)cs1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL611";"TERAZOSIN";"4.0";"387.44";"0";"1.06";"TERAZOSIN";"COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL42442";"OXFENDAZOLE";"2.0";"315.35";"0";"2.91";"OXFENDAZOLE";"COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL17157";"TERFENADINE";"4.0";"471.69";"1";"6.45";"TERFENADINE";"CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL415324";"TRANILAST";"3.0";"327.34";"0";"3.05";"TRANILAST";"COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL253051";"";"None";"417.85";"0";"3.24";"10";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(Cl)o1";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"19.91";"0.39";"5.08";"7.44";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL437";"SULFATHIAZOLE";"4.0";"255.32";"0";"1.53";"3a";"Nc1ccc(S(=O)(=O)Nc2nccs2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL603";"ZAFIRLUKAST";"4.0";"575.69";"2";"5.70";"ZAFIRLUKAST";"COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL637";"VENLAFAXINE";"4.0";"277.41";"0";"3.04";"VENLAFAXINE";"COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL479";"THIORIDAZINE";"4.0";"370.59";"1";"5.89";"THIORIDAZINE";"CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3104908";"";"None";"432.43";"0";"4.61";"10";"Oc1cc(CSc2cccc(OC(F)(F)F)c2)nc2nc(Cc3ccccc3)nn12";"IC50";"'='";"6400.0";"nM";"5.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3104905";"";"None";"374.43";"0";"2.98";"7";"N#Cc1cccnc1SCc1cc(O)n2nc(Cc3ccccc3)nc2n1";"IC50";"'='";"13000.0";"nM";"4.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3104900";"";"None";"348.43";"0";"3.71";"2";"Oc1cc(CSc2ccccc2)nc2nc(Cc3ccccc3)nn12";"IC50";"'='";"820.0";"nM";"6.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL1437942";"";"None";"271.35";"0";"3.04";"1";"Cc1cc2nc(CSc3ccccc3)cc(O)n2n1";"IC50";"'='";"10300.0";"nM";"4.99";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3342322";"";"None";"479.39";"None";"None";"62";"O=C(c1ccc(SCc2ccccc2B(O)O)nc1)N(CC1CCCCN1)c1ccc(F)cc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL191";"LOSARTAN";"4.0";"422.92";"0";"4.27";"LOSARTAN";"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1069";"VALSARTAN";"4.0";"435.53";"0";"4.16";"VALSARTAN";"CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909063";"LEAD(IV) ACETATE";"None";"443.38";"None";"None";"LEAD(IV) ACETATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1475";"TRIOXSALEN";"4.0";"228.25";"0";"3.46";"TRIOXSALEN";"Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL841";"LOPERAMIDE";"4.0";"477.05";"1";"5.09";"LOPERAMIDE";"CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL897";"PROBENECID";"4.0";"285.37";"0";"2.20";"PROBENECID";"CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1349";"VALACYCLOVIR";"4.0";"324.34";"0";"-0.80";"VALACYCLOVIR";"CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL518924";"MAVORIXAFOR";"3.0";"349.48";"0";"3.58";"2, AMD-070";"NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1107989";"Displacement of radiolabeled IL8 from CXCR2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156989";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1400945";"PREGNENOLONE CARBONITRILE ";"None";"341.50";"0";"4.26";"PREGNENOLONE-16ALPHA-CARBONITRILE";"CC(=O)[C@H]1[C@H](C#N)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3104912";"";"None";"384.41";"0";"3.99";"14";"Oc1cc(CSc2cccc(F)c2F)nc2nc(Cc3ccccc3)nn12";"IC50";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"16.86";"0.33";"2.49";"10.24";"0";"CHEMBL3107239";"Displacement of [125I]GRO-alpha from human recombinant CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3342299";"";"None";"435.55";"1";"6.20";"BDBM150848";"Cc1nc(-c2cccc(CSc3ccc(C(=O)Nc4ccc(F)cc4)cn3)c2)cs1";"IC50";"'>'";"5000.0";"nM";"";"";"290358";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658260";"";"None";"380.40";"0";"4.30";"BDBM150876";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc3nonc3c2)nc1";"IC50";"'='";"216.0";"nM";"6.67";"";"290386";"UO_0000065";"17.52";"0.34";"2.37";"8.24";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658267";"";"None";"517.61";"2";"5.96";"BDBM150890";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cc3ccccc3n2S(=O)(=O)c2ccccc2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290400";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658302";"";"None";"406.44";"1";"5.19";"BDBM150929";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2coc3ccccc23)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290439";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658307";"";"None";"448.54";"1";"6.18";"BDBM150934";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2ccc(-c3ccccc3)s2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290444";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658318";"";"None";"467.91";"1";"5.76";"BDBM150945";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2cc(-c3ccc(Cl)cc3)no2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290455";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL95";"TACRINE";"4.0";"198.27";"0";"2.70";"TACRINE";"Nc1c2c(nc3ccccc13)CCCC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4070629";"";"None";"460.96";"0";"3.96";"63";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2(CCF)CCOCC2)c1O";"IC50";"'='";"31.62";"nM";"7.50";"";"";"UO_0000065";"16.27";"0.34";"3.54";"7.16";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL36715";"PIRACETAM";"4.0";"142.16";"0";"-0.91";"PIRACETAM";"NC(=O)CN1CCCC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201216";"DAPIPRAZOLE";"4.0";"325.46";"0";"2.29";"DAPIPRAZOLE";"Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201024";"METHSCOPOLAMINE BROMIDE";"None";"398.30";"0";"1.06";"METHSCOPOLAMINE BROMIDE";"C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@H]1O[C@H]12.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4084474";"";"None";"374.89";"0";"3.54";"18";"CC1CCC(NC(=O)Nc2ccc(Cl)c(S(=O)(=O)C(C)C)c2O)C1";"IC50";"'='";"199.53";"nM";"6.70";"";"";"UO_0000065";"17.87";"0.38";"3.16";"7.02";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL216981";"NAVARIXIN";"2.0";"397.43";"0";"2.90";"Navarixin";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1";"IC50";"'='";"680.0";"nM";"6.17";"";"";"UO_0000065";"15.52";"0.29";"3.27";"5.51";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL1902981";"EPERISONE";"3.0";"259.39";"0";"3.55";"EPERISONE";"CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL500";"PINDOLOL";"4.0";"248.33";"0";"1.91";"Pindolol";"CC(C)NCC(O)COc1cccc2[nH]ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1544";"LIOTHYRONINE";"4.0";"650.98";"1";"3.95";"3,3',5-TRIIODO-L-THYRONINE";"N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL838";"BENAZEPRIL";"4.0";"424.50";"0";"2.57";"BENAZEPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL504";"DIMETHYL SULFOXIDE";"4.0";"78.14";"0";"-0.01";"DIMETHYL SULFOXIDE";"C[S+](C)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1237";"LISINOPRIL ANHYDROUS";"4.0";"405.50";"0";"1.24";"LISINOPRIL";"NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4084077";"";"None";"402.90";"0";"3.08";"54";"COCC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)N[C@@H]2CCC=C2C)c1O";"IC50";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"15.88";"0.34";"3.32";"6.11";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL441687";"GLYCYRRHIZIN";"2.0";"822.94";"3";"2.25";"GA";"CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL402794";"BIS(2-ETHYLHEXYL)PHTHALATE";"None";"390.56";"1";"6.43";"BIS(2-ETHYLHEXYL)PHTHALATE";"CCCC[C@@H](CC)COC(=O)c1ccccc1C(=O)OC[C@@H](CC)CCCC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3970321";"";"None";"441.91";"0";"3.66";"Ex 18";"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CCNCC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3915083";"";"None";"479.86";"0";"3.72";"Ex 34";"O=C(Nc1ccccc1OC(F)(F)F)Nc1ccc(Cl)c(S(=O)(=O)[C@@H]2CCNC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3426944";"";"None";"466.22";"None";"None";"BDBM150812";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cc(OC(F)(F)F)ccc2B(O)O)nc1";"IC50";"'='";"22.0";"nM";"7.66";"";"290322";"UO_0000065";"16.42";"None";"None";"None";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3426952";"";"None";"382.23";"None";"None";"BDBM150818";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc(B(O)O)cc2)nc1";"IC50";"'='";"899.0";"nM";"6.05";"";"290328";"UO_0000065";"15.82";"None";"None";"None";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342294";"";"None";"422.40";"1";"5.66";"BDBM150853";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cccc(OC(F)(F)F)c2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290363";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342288";"";"None";"419.48";"1";"5.73";"BDBM150856";"Cc1onc(-c2ccccc2)c1CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"5000.0";"nM";"";"";"290366";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658244";"";"None";"419.49";"0";"4.65";"BDBM150859";"Cc1c(CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)nnn1-c1ccccc1";"IC50";"'>'";"5000.0";"nM";"";"";"290369";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658304";"";"None";"406.44";"1";"5.19";"BDBM150931";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2cc3ccccc3o2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290441";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658327";"";"None";"373.43";"0";"3.90";"BDBM150955";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2ccsn2)nc1";"IC50";"'='";"2240.0";"nM";"5.65";"";"290465";"UO_0000065";"15.13";"0.31";"1.75";"7.85";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342314";"";"None";"448.23";"None";"None";"BDBM150969";"O=C(Nc1ccc(OC(F)(F)F)cc1)c1ccc(SCc2ccccc2B(O)O)nc1";"IC50";"'='";"278.0";"nM";"6.56";"";"290480";"UO_0000065";"14.63";"None";"None";"None";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658340";"";"None";"384.20";"None";"None";"BDBM150978";"O=C(Nc1ccc(F)cn1)c1cnc(SCc2ccccc2B(O)O)nc1";"IC50";"'='";"116.0";"nM";"6.94";"";"290488";"UO_0000065";"18.05";"None";"None";"None";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658346";"";"None";"371.39";"0";"2.88";"BDBM150984";"O=C(Nc1ccc(F)cn1)c1ccc([S+]([O-])Cc2ccccc2O)nc1";"IC50";"'='";"7210.0";"nM";"5.14";"";"290494";"UO_0000065";"13.85";"0.27";"2.26";"5.24";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658348";"";"None";"455.39";"0";"3.78";"BDBM150986";"O=C(Nc1ccc(F)cn1)c1ccc([S+]([O-])Cc2cc(OC(F)(F)F)ccc2O)nc1";"IC50";"'='";"1230.0";"nM";"5.91";"";"290496";"UO_0000065";"12.98";"0.26";"2.13";"5.50";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4060778";"";"None";"495.95";"0";"4.08";"47";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CCN(CC(F)(F)F)CC2)c1O";"IC50";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"13.11";"0.28";"2.42";"6.58";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4059587";"";"None";"437.35";"0";"3.39";"36'";"CC(C)(CCO)S(=O)(=O)c1c(Cl)ccc(NC(=O)N[C@H]2CCC=C2Cl)c1O";"IC50";"'='";"79.43";"nM";"7.10";"";"";"UO_0000065";"16.23";"0.36";"3.71";"6.13";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4063949";"";"None";"407.28";"0";"2.62";"38";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2COC2)c1O)N[C@@H]1CCC=C1Cl";"IC50";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"15.96";"0.36";"3.88";"6.21";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4060139";"";"None";"437.35";"0";"3.39";"36";"CC(C)(CCO)S(=O)(=O)c1c(Cl)ccc(NC(=O)N[C@@H]2CCC=C2Cl)c1O";"IC50";"'='";"0.2512";"nM";"9.60";"";"";"UO_0000065";"21.95";"0.49";"6.21";"8.30";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL1016";"CANDESARTAN";"3.0";"440.46";"0";"4.03";"CANDESARTAN";"CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL48449";"CANTHARIDIN";"4.0";"196.20";"0";"0.64";"CANTHARIDIN";"C[C@@]12C(=O)OC(=O)[C@]1(C)[C@H]1CC[C@@H]2O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL388590";"BENZBROMARONE";"4.0";"424.09";"1";"5.46";"SID170465792";"CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1230813";"ALFADEX";"2.0";"972.85";"3";"-13.05";"ALPHA-CYCLODEXTRIN";"OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)O[C@@H]3CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3818331";"";"None";"490.38";"0";"4.74";"23";"CCN1CCC(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1";"IC50";"'='";"158.49";"nM";"6.80";"";"";"UO_0000065";"13.87";"0.30";"2.06";"6.89";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3104899";"";"None";"305.28";"0";"1.99";"32";"OCc1cc2nc(CCc3cccc(F)c3F)cc(O)n2n1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL564201";"6-AZAURIDINE";"None";"245.19";"0";"-3.46";"SID8139884";"O=c1cnn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL276832";"HYDRALAZINE";"4.0";"160.18";"0";"0.92";"HYDRALAZINE";"NNc1nncc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL203266";"TRIMETAZIDINE";"4.0";"266.34";"0";"1.12";"TRIMETAZIDINE";"COc1ccc(CN2CCNCC2)c(OC)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4081963";"";"None";"414.91";"0";"3.23";"65";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CCCOC2)c1O";"IC50";"'='";"1.585";"nM";"8.80";"";"";"UO_0000065";"21.21";"0.45";"5.57";"8.40";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4066904";"";"None";"445.46";"0";"4.00";"53";"CC1=CCC[C@H]1NC(=O)Nc1ccc(C#N)c(S(=O)(=O)C(C)(C)CC(F)(F)F)c1O";"IC50";"'='";"0.1585";"nM";"9.80";"";"";"UO_0000065";"22.00";"0.45";"5.80";"8.22";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4068799";"";"None";"407.32";"0";"4.02";"34";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)NC2CCCC=C2Cl)c1O";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"19.64";"0.44";"3.98";"8.38";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL488";"AMINOGLUTETHIMIDE";"4.0";"232.28";"0";"1.35";"AMINOGLUTETHIMIDE";"CCC1(c2ccc(N)cc2)CCC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200391";"TROMETHAMINE";"4.0";"121.14";"0";"-2.34";"TROMETHAMINE";"NC(CO)(CO)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL19224";"PAPAVERINE";"4.0";"339.39";"0";"3.86";"PAPAVERINE";"COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL5314360";"ACONITINE";"-1.0";"645.75";"2";"0.65";"ACONITINE";"CCN1C[C@]2(COC)[C@H](O)C[C@H](OC)[C@@]34[C@@H]5C[C@@]6(O)[C@H](OC(=O)c7ccccc7)[C@@H]5[C@@](OC(C)=O)([C@@H]([C@H](OC)[C@H]23)[C@@H]14)[C@@H](O)[C@@H]6OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL712";"ANISINDIONE";"4.0";"252.27";"0";"2.86";"ANISINDIONE";"COc1ccc(C2C(=O)c3ccccc3C2=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL429682";"";"None";"461.54";"0";"2.82";"22";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(NS(C)(=O)=O)sc12";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"17.99";"0.39";"5.48";"7.09";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL185259";"";"None";"376.04";"1";"5.11";"2";"O=C(Nc1ccccc1Br)Nc1ccc(Cl)c(Cl)c1O";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"19.15";"0.49";"2.09";"11.74";"0";"CHEMBL828744";"Concentration required to inhibit [125I]IL-8 binding towards C-X-C chemokine receptor type 2 of human expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137097";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3308072";"";"";""
"CHEMBL85390";"";"None";"257.32";"0";"2.88";"20";"Sc1nc(-c2ccco2)nn1Cc1ccccc1";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"20.90";"0.41";"2.50";"12.26";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL3104911";"";"None";"417.32";"1";"5.02";"13";"Oc1cc(CSc2cccc(Cl)c2Cl)nc2nc(Cc3ccccc3)nn12";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL216603";"";"None";"409.44";"0";"2.90";"22";"Cc1ccc([C@H](Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2CC2)o1";"IC50";"'='";"3.6";"nM";"8.44";"";"";"UO_0000065";"20.62";"0.38";"5.54";"7.55";"0";"CHEMBL909848";"Displacement of [125I]hCXCL8 from human CXCR2 receptor expressed in BaF3 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307634";"";"";""
"CHEMBL233262";"";"None";"351.46";"0";"2.74";"31";"CC(C)(CO)Nc1nc(SCc2ccco2)nc2nc(N)sc12";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"19.92";"0.42";"4.26";"6.36";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL399203";"";"None";"426.41";"0";"3.68";"9aa";"O=[N+]([O-])c1cc(O)c2c(c1)S(=O)(=O)N=C(Nc1ccccc1Oc1ccccc1)N2";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL896517";"Antagonist activity at CXCR2 receptor expressed in CHOK1 cells assessed as human IL8-induced calcium mobilization by FLIPR";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3654445";"";"None";"482.36";"None";"None";"BDBM150829";"CC1(C)OB(c2ccc(F)cc2CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)OC1(C)C";"IC50";"'='";"1230.0";"nM";"5.91";"";"290339";"UO_0000065";"12.25";"None";"None";"None";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658250";"";"None";"403.48";"1";"5.62";"BDBM150866";"Cc1ccc2cc(CSc3ccc(C(=O)Nc4ccc(F)cc4)cn3)ccc2n1";"IC50";"'>'";"10000.0";"nM";"";"";"290376";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342290";"";"None";"435.55";"1";"6.20";"BDBM150881";"Cc1nc(-c2ccccc2)sc1CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'='";"1210.0";"nM";"5.92";"";"290391";"UO_0000065";"13.59";"0.27";"-0.28";"10.78";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658290";"";"None";"450.41";"1";"5.35";"BDBM150917";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1ccc(OC(F)(F)F)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"290427";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658291";"";"None";"432.42";"1";"5.05";"BDBM150918";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1ccc(OC(F)F)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"290428";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL231924";"";"None";"368.76";"0";"2.54";"9ab";"O=[N+]([O-])c1cc(O)c2c(c1)S(=O)(=O)N=C(Nc1ccccc1Cl)N2";"IC50";"'='";"81.0";"nM";"7.09";"";"";"UO_0000065";"19.23";"0.40";"4.55";"5.29";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL399203";"";"None";"426.41";"0";"3.68";"9aa";"O=[N+]([O-])c1cc(O)c2c(c1)S(=O)(=O)N=C(Nc1ccccc1Oc1ccccc1)N2";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"17.04";"0.33";"3.59";"5.08";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL397808";"";"None";"407.76";"0";"3.53";"9p";"O=S1(=O)N=C(Nc2ccccc2OC(F)(F)F)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"930.0";"nM";"6.03";"";"";"UO_0000065";"14.79";"0.32";"2.50";"6.03";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3342269";"";"None";"382.23";"None";"None";"5";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccccc2B(O)O)nc1";"IC50";"'='";"356.0";"nM";"6.45";"";"";"UO_0000065";"16.87";"None";"None";"None";"0";"CHEMBL3427962";"Inhibition of CXCR2 (unknown origin) transfected with RBL cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425456";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3654438";"";"None";"417.46";"0";"4.09";"BDBM150262";"CC(C)(NC(=O)c1ccc2ccsc2c1OCCOc1ccc(F)cc1)C(=O)O";"IC50";"'='";"800.0";"nM";"6.10";"";"289677";"UO_0000065";"";"";"";"";"0";"CHEMBL3705676";"Calcium Fluorescence Assay: The assay is based on the detection of intracellular calcium changes detected by the selective, calcium-chelating dye, Fluo-4 (Molecular Probes). A large fluorescence intensity increase is observed upon calcium association with Fluo-4. The dye is delivered to the cell interior using an acetoxymethylester form of Fluo-4, where the intracellular esterase activity results in the charged species being released and trapped within the cytoplasm of the cell. hence, influx of calcium to this cytoplasmic pocket, via release from intracellular pools and the phospholipase C cascade can be detected. By co-expressing the CXCR2 receptor and the promiscuous Galpha 16 protein, activation of this chemokine receptor is directed into this phospholipase C cascade resulting in intracellular calcium mobilization.The CHOK1 cells stably transfected with human CXCR2 and the promiscuous Galpha 16 protein were maintained in a log phase of growth at 37 C. and 5% CO2 in the following media: Iscove's.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638454";"37";"BindingDB Database";"";"2015";"CHEMBL3307512";"";"";""
"CHEMBL511";"PYRILAMINE";"4.0";"285.39";"0";"2.66";"PYRILAMINE";"COc1ccc(CN(CCN(C)C)c2ccccn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL442";"ERGOTAMINE";"4.0";"581.67";"1";"1.99";"ERGOTAMINE";"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3950351";"";"None";"493.89";"0";"3.97";"Ex 5";"O=C(Nc1ccccc1OC(F)(F)F)Nc1ccc(Cl)c(S(=O)(=O)CC2CCNC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3952713";"";"None";"434.28";"0";"3.23";"Ex 8";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CNC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3915083";"";"None";"479.86";"0";"3.72";"Ex 34";"O=C(Nc1ccccc1OC(F)(F)F)Nc1ccc(Cl)c(S(=O)(=O)[C@@H]2CCNC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3952903";"";"None";"467.95";"0";"4.19";"Ex 36";"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2C[C@H]3CC[C@@H](C2)N3)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3960024";"";"None";"462.33";"0";"4.01";"Ex 3";"O=C(Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCCNC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3946021";"";"None";"441.91";"0";"3.52";"Ex 7";"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)CC2CCNC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3910854";"";"None";"462.33";"0";"3.87";"Ex 10";"O=C(Nc1ccc(Cl)c(S(=O)(=O)CC2CCNC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3929680";"";"None";"445.33";"0";"3.26";"Ex 12";"O=C(Nc1cccnc1Cl)Nc1ccc(Cl)c(S(=O)(=O)C2CCCNC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3916281";"";"None";"478.79";"0";"4.52";"Ex 16";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCCNC2)c1O)Nc1cccc(Cl)c1Cl";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3971309";"";"None";"427.89";"0";"3.27";"Ex 24";"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCNC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3952903";"";"None";"467.95";"0";"4.19";"Ex 36";"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2C[C@H]3CC[C@@H](C2)N3)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3966527";"";"None";"448.30";"0";"3.62";"Ex 29";"O=C(Nc1ccc(Cl)c(S(=O)(=O)[C@@H]2CCNC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3910320";"";"None";"487.97";"0";"4.62";"Ex 26";"O=C(Nc1ccccc1Oc1ccccc1)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCNC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL1201203";"BENZTROPINE";"4.0";"307.44";"0";"4.42";"BENZTROPINE";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(c1ccccc1)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3949893";"";"None";"445.33";"0";"3.26";"Ex 2";"O=C(Nc1cccnc1Cl)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCCNC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3901031";"";"None";"413.86";"0";"2.88";"Ex 9";"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CNC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL773";"GLYCINE";"4.0";"75.07";"0";"-0.97";"GLYCINE";"NCC(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3648348";"";"None";"523.50";"2";"5.53";"BDBM103369";"O=C(NC1(C(=O)O)CCOCC1)c1cc(F)c2ccccc2c1OCc1ccc(SC(F)(F)F)cc1";"IC50";"'='";"6000.0";"nM";"5.22";"";"221251";"UO_0000065";"";"";"";"";"0";"CHEMBL3705069";"Calicum Fluorescence Assay: The assay is based on the detection of intracellular calcium changes detected by the selective, calcium-chelating dye, Fluo-4 (Molecular Probes).";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639002";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL376180";"AMINOPTERIN";"2.0";"440.42";"1";"0.24";"AMINOPTERIN";"Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4781979";"";"None";"338.37";"0";"1.73";"A3";"CN(C)C(=O)c1cccc(NC2=NC(=O)C(c3ccccc3)N2)c1O";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"";""
"CHEMBL1200558";"BACITRACIN";"4.0";"1422.72";"None";"None";"BACITRACIN";"CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3953988";"";"None";"441.91";"0";"3.66";"Ex 14";"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CCCNC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3927944";"";"None";"493.89";"0";"4.11";"Ex 19";"O=C(Nc1ccccc1OC(F)(F)F)Nc1ccc(Cl)c(S(=O)(=O)C2CCNCC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3960024";"";"None";"462.33";"0";"4.01";"Ex 3";"O=C(Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCCNC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3973880";"";"None";"431.30";"0";"2.87";"Ex 23";"O=C(Nc1cccnc1Cl)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCNC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL2105807";"MADURAMICIN";"2.0";"934.17";"2";"4.32";"MADURAMICIN";"CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C.N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3426944";"";"None";"466.22";"None";"None";"6";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cc(OC(F)(F)F)ccc2B(O)O)nc1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"16.47";"None";"None";"None";"0";"CHEMBL3427962";"Inhibition of CXCR2 (unknown origin) transfected with RBL cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425456";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL27769";"STANOLONE";"2.0";"290.45";"0";"3.96";"STANOLONE";"C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL122";"ROFECOXIB";"4.0";"314.36";"0";"2.56";"ROFECOXIB";"CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL438";"SULFAMERAZINE";"4.0";"264.31";"0";"1.17";"SULFAMERAZINE";"Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3342306";"";"None";"396.44";"0";"4.55";"46";"COC(=O)c1ccc(CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3310771";"";"None";"426.49";"0";"4.77";"7";"CC(C)(CO)Nc1nc(SCc2cccc(F)c2F)nc(-c2ccccc2)c1C#N";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3354833";"";"None";"371.85";"0";"2.62";"3b";"CCc1cc(=O)nc(Nc2ccc(Cl)c(S(=O)(=O)C(C)C)c2O)[nH]1";"IC50";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"17.75";"0.38";"3.98";"5.88";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3355235";"";"None";"399.90";"0";"3.35";"3e";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)cc(C(C)(C)C)[nH]2)c1O";"IC50";"'='";"6.31";"nM";"8.20";"";"";"UO_0000065";"20.51";"0.43";"4.85";"7.31";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3355243";"";"None";"403.86";"0";"3.26";"3m";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)cc(C(C)(C)F)[nH]2)c1O";"IC50";"'='";"125.89";"nM";"6.90";"";"";"UO_0000065";"17.09";"0.36";"3.64";"6.15";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3355247";"";"None";"417.89";"0";"3.49";"3q";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)c(F)c(C(C)(C)C)[nH]2)c1O";"IC50";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"18.19";"0.38";"4.11";"6.78";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3310791";"";"None";"311.41";"0";"3.96";"28";"CC(C)(Sc1nc(O)c(C#N)c(C2CC2)n1)c1ccccc1";"IC50";"'='";"6400.0";"nM";"5.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3912983";"";"None";"448.30";"0";"3.62";"Ex 25; Ex 29";"O=C(Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCNC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL1064";"SIMVASTATIN";"4.0";"418.57";"0";"4.59";"SIMVASTATIN";"CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL9514";"NOCODAZOLE";"2.0";"301.33";"0";"3.03";"NOCODAZOLE";"COC(=O)Nc1nc2cc(C(=O)c3cccs3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3818827";"";"None";"490.38";"0";"4.74";"26";"CN1CCC[C@H](S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.27";"0.31";"2.26";"7.09";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3819603";"";"None";"505.40";"1";"4.20";"8";"CC(C)N1CCN(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1";"IC50";"'='";"1.585";"nM";"8.80";"";"";"UO_0000065";"17.41";"0.38";"4.60";"8.63";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3817880";"";"None";"508.81";"1";"4.79";"10";"C[C@@H]1CN(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(Cl)c3Cl)c2O)C[C@H](C)O1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"15.72";"0.35";"3.21";"7.41";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3819295";"";"None";"423.70";"0";"4.79";"11";"CCS(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2cccc(Cl)c2Cl)c1O";"IC50";"'='";"0.5012";"nM";"9.30";"";"";"UO_0000065";"21.95";"0.51";"4.51";"9.74";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3818323";"";"None";"412.25";"0";"4.72";"30";"O=C(Nc1ccc(Cl)c(C(=O)N2CCCC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"21.83";"0.46";"4.28";"11.02";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3819382";"";"None";"491.37";"0";"3.81";"7";"CCN1CCN(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1";"IC50";"'='";"1995.26";"nM";"5.70";"";"";"UO_0000065";"11.60";"0.25";"1.89";"5.59";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3819569";"";"None";"435.30";"1";"5.05";"14";"CC(C)(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2cccc(F)c2Cl)c1O";"IC50";"'='";"39.81";"nM";"7.40";"";"";"UO_0000065";"17.00";"0.37";"2.35";"7.75";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3819480";"";"None";"461.34";"1";"5.59";"17";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCCCC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"79.43";"nM";"7.10";"";"";"UO_0000065";"15.39";"0.33";"1.51";"7.43";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL383235";"";"None";"361.50";"0";"3.14";"23";"CC[C@@H](CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12";"IC50";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"14.96";"0.31";"2.27";"5.58";"0";"CHEMBL862382";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 membranes by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149469";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307715";"";"";""
"CHEMBL3609004";"";"None";"365.17";"None";"None";"14";"O=C(Nc1ccc(F)cc1)c1ccc(NCc2ccc(B(O)O)cc2)nc1";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL359670";"";"None";"420.67";"0";"3.10";"5a";"NS(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2ccccc2Br)c1O";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"19.39";"0.48";"5.05";"6.71";"0";"CHEMBL828744";"Concentration required to inhibit [125I]IL-8 binding towards C-X-C chemokine receptor type 2 of human expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137097";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3308072";"";"";""
"CHEMBL309253";"";"None";"336.25";"0";"4.59";"45";"Sc1nc(-c2ccccc2Cl)nn1Cc1cccc(Cl)c1";"IC50";"'<'";"28.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL103";"PROGESTERONE";"4.0";"314.47";"0";"4.72";"PROGESTERONE";"CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL257006";"";"None";"366.40";"0";"2.30";"15";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2[nH]c(N)nc12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"21.52";"0.43";"5.59";"6.99";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL3426944";"";"None";"466.22";"None";"None";"6";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cc(OC(F)(F)F)ccc2B(O)O)nc1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"14.77";"None";"None";"None";"0";"CHEMBL3427963";"Inhibition of CXCR2 (unknown origin) expressed in PathHunter celline by beta-arrestin assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425456";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3105082";"";"None";"373.38";"0";"4.57";"26";"Cc1ccoc1-c1cc2nc(CSc3cccc(F)c3F)cc(O)n2n1";"IC50";"'='";"870.0";"nM";"6.06";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3104912";"";"None";"384.41";"0";"3.99";"14";"Oc1cc(CSc2cccc(F)c2F)nc2nc(Cc3ccccc3)nn12";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3104906";"";"None";"408.48";"0";"3.73";"8";"COc1ccc(SCc2cc(O)n3nc(Cc4ccccc4)nc3n2)c(OC)c1";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL1437942";"";"None";"271.35";"0";"3.04";"1";"Cc1cc2nc(CSc3ccccc3)cc(O)n2n1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"21.00";"0.41";"2.66";"11.30";"0";"CHEMBL3107239";"Displacement of [125I]GRO-alpha from human recombinant CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL286398";"PROPYLENE GLYCOL";"3.0";"76.10";"0";"-0.64";"PROPYLENE GLYCOL";"CC(O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL295416";"PIRINIXIC ACID";"2.0";"323.81";"0";"3.67";"PIRINIXIC ACID";"Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1255837";"DIHYDROERGOCRISTINE MESYLATE";"None";"707.85";"1";"2.72";"DIHYDROERGOCRISTINE MESYLATE";"CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL685";"MEBENDAZOLE";"4.0";"295.30";"0";"2.97";"MEBENDAZOLE";"COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL195433";"";"None";"486.66";"1";"5.43";"65";"CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.27";"0.20";"-0.43";"6.73";"0";"CHEMBL828098";"Inhibition of C-X-C chemokine receptor type 2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143552";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL1200604";"TROPICAMIDE";"4.0";"284.36";"0";"2.21";"TROPICAMIDE";"CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL216602";"";"None";"383.40";"0";"2.51";"21";"Cc1ccc([C@@H](C)Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)o1";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL912820";"Inhibition of CXCL1-induced human neutrophil chemotaxis";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL395342";"";"None";"439.56";"0";"4.30";"17";"CCN(CC)c1nc2nc(SCc3cccc(F)c3F)nc(N[C@H](C)CO)c2s1";"IC50";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"14.56";"0.30";"2.10";"8.63";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL233550";"";"None";"372.23";"0";"2.96";"10b";"O=S1(=O)N=C(NCc2ccccc2Cl)Nc2c(O)cc(Cl)cc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL998";"LORATADINE";"4.0";"382.89";"0";"4.89";"SID56424146";"CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL84158";"TIAPRIDE";"3.0";"328.43";"0";"1.17";"TIAPRIDE";"CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3609018";"";"None";"457.27";"None";"None";"7";"O=C(Nc1ccc(F)cc1)c1cnc(N(Cc2ccccc2)Cc2ccc(B(O)O)cn2)nc1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3701185";"";"None";"481.51";"0";"2.03";"BDBM172325";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N4CC[C@@H](O)C4)c3O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"341.0";"nM";"6.47";"";"317323";"UO_0000065";"13.43";"0.25";"4.44";"4.58";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3609009";"";"None";"380.19";"None";"None";"19";"CN(Cc1cccc(B(O)O)c1)c1ncc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3609005";"";"None";"379.20";"None";"None";"15";"CN(Cc1ccc(B(O)O)cc1)c1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL1444";"LETROZOLE";"4.0";"285.31";"0";"2.66";"LETROZOLE";"N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1650";"CORTISONE ACETATE";"4.0";"402.49";"0";"2.56";"CORTISONE ACETATE";"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL487894";"DIPYRONE SODIUM";"None";"333.35";"0";"0.77";"DIPYRONE";"Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.[Na+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1515611";"BROMISOVALUM";"2.0";"223.07";"0";"0.60";"BROMISOVALUM";"CC(C)C(Br)C(=O)NC(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3704567";"";"None";"403.82";"0";"2.87";"BDBM172360";"Cc1ccc(C(Nc2c(Nc3ccc(Cl)nc3O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"502.0";"nM";"6.30";"";"317328";"UO_0000065";"15.60";"0.31";"3.43";"5.54";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1393";"SPIRONOLACTONE";"4.0";"416.58";"0";"4.85";"SPIRONOLACTONE";"CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3951311";"";"None";"493.89";"0";"4.11";"Ex 13";"O=C(Nc1ccccc1OC(F)(F)F)Nc1ccc(Cl)c(S(=O)(=O)C2CCCNC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL4800297";"";"None";"345.81";"0";"1.51";"B6";"CC1NC(Nc2ccc(Cl)c(S(=O)(=O)C(C)C)c2O)=NC1=O";"IC50";"'='";"269.0";"nM";"6.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL37858";"SARAFLOXACIN";"-1.0";"385.37";"0";"2.38";"SARAFLOXACIN";"O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL435";"HYDROCHLOROTHIAZIDE";"4.0";"297.75";"0";"-0.35";"HYDROCHLOROTHIAZIDE";"NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL8";"CIPROFLOXACIN";"4.0";"331.35";"0";"1.58";"Ciprofloxacin";"O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3951994";"";"None";"455.54";"0";"3.38";"BDBM236795";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2CCCS2)o1";"IC50";"'='";"56.0";"nM";"7.25";"";"412463";"UO_0000065";"15.92";"0.31";"3.87";"6.48";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3951994";"";"None";"455.54";"0";"3.38";"BDBM236795";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2CCCS2)o1";"IC50";"'='";"134.0";"nM";"6.87";"";"412464";"UO_0000065";"15.09";"0.29";"3.49";"6.14";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968340";"";"None";"541.60";"1";"3.89";"BDBM236802";"COC(=O)[C@@H]1CCCN1C(=O)c1cccc(Nc2c(N[C@H](c3ccc(C)o3)[C@@H]3CCCS3)c(=O)c2=O)c1F";"IC50";"'='";"982.0";"nM";"6.01";"";"412469";"UO_0000065";"11.09";"0.22";"2.12";"5.09";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3906175";"";"None";"555.63";"1";"4.28";"BDBM236805";"CCOC(=O)[C@@H]1CCCN1C(=O)c1cccc(Nc2c(NC(c3ccc(C)o3)C3CCCS3)c(=O)c2=O)c1F";"IC50";"'='";"106.0";"nM";"6.97";"";"412471";"UO_0000065";"12.55";"0.24";"2.69";"5.91";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3934321";"";"None";"439.47";"0";"2.67";"BDBM236781";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)[C@@H]2CCCO2)o1";"IC50";"'='";"83.0";"nM";"7.08";"";"412482";"UO_0000065";"16.11";"0.30";"4.41";"5.85";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3956663";"";"None";"469.49";"0";"2.64";"BDBM236783";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)[C@@H]2COC(C)(C)O2)o1";"IC50";"'='";"1253.0";"nM";"5.90";"";"412484";"UO_0000065";"12.57";"0.24";"3.26";"4.53";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3963336";"";"None";"541.60";"1";"3.89";"BDBM236784";"COC(=O)[C@@H]1CCCN1C(=O)c1cccc(Nc2c(NC(c3ccc(C)o3)C3CCCS3)c(=O)c2=O)c1F";"IC50";"'='";"294.0";"nM";"6.53";"";"412485";"UO_0000065";"12.06";"0.23";"2.64";"5.54";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3947915";"";"None";"385.45";"0";"3.08";"BDBM236785";"Cc1ccc(C(Nc2c(Nc3cccnc3O)c(=O)c2=O)C2CCCS2)o1";"IC50";"'='";"23.0";"nM";"7.64";"";"412486";"UO_0000065";"19.82";"0.39";"4.56";"7.31";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3901913";"";"None";"539.61";"1";"3.46";"BDBM236789";"COC(=O)[C@H]1CCCN1C(=O)c1cccc(Nc2c(NC(c3ccc(C)o3)C3CCCS3)c(=O)c2=O)c1O";"IC50";"'='";"21.0";"nM";"7.68";"";"412490";"UO_0000065";"14.23";"0.28";"4.22";"5.56";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3956601";"";"None";"489.98";"0";"4.04";"BDBM236790";"Cc1ccc(C(Nc2c(Nc3ccc(Cl)c(C(=O)N(C)C)c3O)c(=O)c2=O)C2CCCS2)o1";"IC50";"'='";"69.0";"nM";"7.16";"";"412491";"UO_0000065";"14.62";"0.30";"3.12";"6.40";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3818917";"";"None";"477.35";"0";"3.42";"6";"CN1CCN(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1";"IC50";"'='";"0.7943";"nM";"9.10";"";"";"UO_0000065";"19.06";"0.41";"5.68";"8.92";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3818793";"";"None";"465.74";"0";"4.56";"18";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCOC2)c1O)Nc1cccc(Cl)c1Cl";"IC50";"'='";"0.5012";"nM";"9.30";"";"";"UO_0000065";"19.97";"0.45";"4.74";"8.88";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3818269";"";"None";"478.79";"0";"4.52";"20";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCNCC2)c1O)Nc1cccc(Cl)c1Cl";"IC50";"'='";"1.995";"nM";"8.70";"";"";"UO_0000065";"18.17";"0.41";"4.18";"8.09";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3818458";"";"None";"479.77";"0";"3.59";"4";"O=C(Nc1ccc(Cl)c(S(=O)(=O)N2CCNCC2)c1O)Nc1cccc(Cl)c1Cl";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.42";"0.24";"1.41";"4.51";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3819512";"";"None";"476.36";"0";"4.35";"22";"CN1CCC(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1";"IC50";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"15.95";"0.35";"3.25";"7.70";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3819221";"";"None";"426.28";"1";"5.11";"31";"O=C(Nc1ccc(Cl)c(C(=O)N2CCCCC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"6.31";"nM";"8.20";"";"";"UO_0000065";"19.24";"0.40";"3.09";"10.04";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4067429";"";"None";"414.91";"0";"3.23";"68";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@@]2(C)CCOC2)c1O";"IC50";"'='";"5.2";"nM";"8.28";"";"";"UO_0000065";"19.97";"0.42";"5.05";"7.91";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3704556";"";"None";"465.51";"0";"2.63";"BDBM172348";"COc1cccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2(C)COC2)c1";"IC50";"'='";"475.0";"nM";"6.32";"";"317327";"UO_0000065";"13.58";"0.25";"3.69";"5.40";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342316";"";"None";"432.27";"None";"None";"56";"O=C(Nc1ccc(-c2nn[nH]n2)cc1)c1ccc(SCc2ccccc2B(O)O)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342274";"";"None";"398.40";"0";"4.79";"12";"CCOP(=O)(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)OCC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL252698";"";"None";"384.39";"0";"1.98";"31";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccno1";"IC50";"'='";"9.8";"nM";"8.01";"";"";"UO_0000065";"20.84";"0.39";"6.03";"6.42";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL430116";"";"None";"384.39";"0";"1.98";"28";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ncco1";"IC50";"'='";"8.6";"nM";"8.07";"";"";"UO_0000065";"20.98";"0.39";"6.09";"6.46";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL401940";"";"None";"399.47";"0";"3.06";"48";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccsc1";"IC50";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"21.20";"0.41";"5.41";"8.58";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL4076428";"";"None";"453.99";"0";"3.68";"51";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2C[C@H](N3CCCC3)C2)c1O";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.42";"0.32";"3.32";"7.09";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3892666";"";"None";"489.88";"0";"3.54";"Ex 22";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCNCC2)c1O)Nc1cccc2c1OC(F)(F)O2";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3948111";"";"None";"501.99";"2";"5.01";"Ex 28";"O=C(Nc1ccccc1Oc1ccccc1)Nc1ccc(Cl)c(S(=O)(=O)C2CCNCC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3933806";"";"None";"513.98";"1";"4.53";"Ex 32";"CCOC(=O)N1CCC(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3C)c2O)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3966527";"";"None";"448.30";"0";"3.62";"Ex 29";"O=C(Nc1ccc(Cl)c(S(=O)(=O)[C@@H]2CCNC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3645132";"";"None";"435.52";"0";"4.92";"BDBM100344";"CC(C)CC(C)(NC(=O)c1ccc2ccccc2c1OCCOc1ccccc1)C(=O)O";"IC50";"'='";"2560.0";"nM";"5.59";"";"217538";"UO_0000065";"";"";"";"";"0";"CHEMBL3705309";"Calcium Fluorescence Assay (FLIPR) : CXCR2 inhibition using calcium fluorescence assay (FLIPR).";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638729";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"CLOZAPINE";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909048";"";"None";"313.83";"0";"4.43";"1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"O=C(c1ccccc1Cl)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL253705";"";"None";"465.53";"0";"4.32";"24";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cc(-c2ccsc2)co1";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"17.37";"0.33";"3.77";"7.23";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL257027";"";"None";"331.40";"0";"1.73";"28";"C[C@H](CO)Nc1nc(SCc2ccccc2)nc2[nH]c(=O)[nH]c12";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"16.90";"0.33";"3.87";"5.25";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL256668";"";"None";"379.39";"0";"2.08";"23";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2[nH]c(=O)cnc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"23.72";"0.47";"6.92";"8.67";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL3704573";"";"None";"565.05";"1";"2.41";"BDBM172372";"Cc1ccc([C@H](Nc2c(Nc3ccc(Cl)c(S(=O)(=O)N4CCN(C)CC4)c3O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"30.0";"nM";"7.52";"";"317338";"UO_0000065";"13.31";"0.27";"5.11";"5.32";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL201921";"";"None";"313.45";"0";"2.36";"12";"CCCCCSc1nc(NCCO)c2sc(N)nc2n1";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"16.45";"0.35";"2.79";"5.32";"0";"CHEMBL862382";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 membranes by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149469";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307715";"";"";""
"CHEMBL214162";"";"None";"343.38";"0";"1.46";"19";"CN(C)C(=O)c1cccc(/N=c2\c(O)c(O)\c2=N/C2CCCC2)c1O";"IC50";"'='";"144.8";"nM";"6.84";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL866149";"Inhibition of chemotaxis of CHO cells expressing human CXCR2";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL377397";"";"None";"337.34";"0";"1.50";"12";"CNC(=O)c1cccc(/N=c2\c(O)c(O)\c2=N/c2ccccc2)c1O";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"22.70";"0.42";"6.16";"6.69";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL213147";"";"None";"391.43";"0";"2.20";"21";"CN(C)C(=O)c1cccc(/N=c2\c(O)c(O)\c2=N/[C@@H]2CCc3ccccc32)c1O";"IC50";"'='";"548.0";"nM";"6.26";"";"";"UO_0000065";"16.00";"0.29";"4.06";"5.92";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL214047";"";"None";"345.40";"0";"1.70";"22";"CCC(CC)/N=c1\c(O)c(O)\c1=N/c1cccc(C(=O)N(C)C)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"24.03";"0.45";"6.60";"7.85";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL401512";"";"None";"411.43";"0";"3.14";"16";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cccc(F)c1";"IC50";"'='";"4.9";"nM";"8.31";"";"";"UO_0000065";"20.20";"0.38";"5.17";"8.42";"0";"CHEMBL909848";"Displacement of [125I]hCXCL8 from human CXCR2 receptor expressed in BaF3 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307634";"";"";""
"CHEMBL219347";"";"None";"393.44";"0";"3.00";"14";"CC[C@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccccc1";"IC50";"'='";"234.0";"nM";"6.63";"";"";"UO_0000065";"16.85";"0.31";"3.63";"6.72";"0";"CHEMBL909848";"Displacement of [125I]hCXCL8 from human CXCR2 receptor expressed in BaF3 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307634";"";"";""
"CHEMBL233552";"";"None";"315.78";"0";"2.05";"11b";"O=S1(=O)N=C(NC2CCCC2)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"14.88";"0.32";"2.65";"5.18";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3704572";"";"None";"473.91";"0";"3.18";"BDBM172371";"Cc1ccc([C@H](Nc2c(Nc3ccc(Cl)c(C(=O)N(C)C)c3O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"373.0";"nM";"6.43";"";"317337";"UO_0000065";"13.56";"0.27";"3.25";"5.31";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL254978";"";"None";"462.51";"0";"4.08";"16";"N#Cc1ccc2[nH]c(-c3ccc(F)cc3)c(CCNC(=O)NS(=O)(=O)c3ccccc3)c2c1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"14.82";"0.28";"2.77";"5.97";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL1200624";"ETHYNODIOL DIACETATE";"4.0";"384.52";"0";"4.43";"ETHYNODIOL DIACETATE";"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL252557";"GLYCOLIC ACID";"2.0";"76.05";"0";"-0.94";"GLYCOLIC ACID";"O=C(O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL384467";"DEXAMETHASONE";"4.0";"392.47";"0";"1.90";"Dexamethasone";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201237";"LEVOBUNOLOL";"4.0";"291.39";"0";"2.33";"LEVOBUNOLOL";"CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL14060";"PHENOL";"4.0";"94.11";"0";"1.39";"PHENOL";"Oc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1144";"PRAVASTATIN";"4.0";"424.53";"0";"2.44";"PRAVASTATIN";"CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3350037";"";"None";"1019.26";"None";"None";"OCTREOTIDE";"C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1319362";"HOMATROPINE HYDROBROMIDE";"4.0";"356.26";"0";"1.89";"HOMATROPINE HYDROBROMIDE";"Br.CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(O)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1365675";"AMITRAZ";"2.0";"293.41";"0";"4.87";"AMITRAZ";"Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1062";"HYDROXYPROGESTERONE";"2.0";"330.47";"0";"3.84";"HYDROXYPROGESTERONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL622";"ETODOLAC";"4.0";"287.36";"0";"3.38";"ETODOLAC";"CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL88";"CYCLOPHOSPHAMIDE ANHYDROUS";"4.0";"261.09";"0";"1.88";"CYCLOPHOSPHAMIDE";"O=P1(N(CCCl)CCCl)NCCCO1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL275742";"DEXPROPRANOLOL";"-1.0";"259.35";"0";"2.58";"R-(+)-PROPRANOLOL";"CC(C)NC[C@@H](O)COc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3609019";"";"None";"458.26";"None";"None";"26";"O=C(Nc1ccc(F)cc1)c1cnc(N(Cc2ccccn2)Cc2ccc(B(O)O)cn2)nc1";"IC50";"'='";"4310.0";"nM";"5.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL219916";"DOMPERIDONE";"4.0";"425.92";"0";"3.35";"DOMPERIDONE";"O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL24441";"BETAHISTINE";"4.0";"136.20";"0";"0.84";"BETAHISTINE";"CNCCc1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL290106";"BITHIONOL";"4.0";"356.06";"1";"5.86";"BITHIONOL";"Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4062881";"";"None";"386.90";"0";"3.85";"33";"CC1=CCCCC1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)C)c1O";"IC50";"'='";"12.59";"nM";"7.90";"";"";"UO_0000065";"20.42";"0.43";"4.05";"8.27";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4084135";"";"None";"442.97";"0";"3.86";"56";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)(C)[C@H]2CCOC2)c1O";"IC50";"'='";"1.585";"nM";"8.80";"";"";"UO_0000065";"19.87";"0.41";"4.94";"8.40";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL440405";"";"None";"399.45";"0";"3.24";"17";"CS(=O)(=O)NC(=O)CCCc1c(-c2ccc(F)cc2)[nH]c2ccc(C#N)cc12";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"17.88";"0.35";"3.90";"6.95";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL404062";"";"None";"475.55";"0";"4.81";"22";"N#Cc1ccc2[nH]c(-c3ccc(F)cc3)c(CCCC(=O)NS(=O)(=O)Cc3ccccc3)c2c1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"12.31";"0.24";"1.04";"5.69";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL258038";"";"None";"456.54";"0";"3.92";"31";"CCCCNS(=O)(=O)NC(=O)CCCc1c(-c2ccc(F)cc2)[nH]c2ccc(C#N)cc12";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"13.05";"0.25";"2.04";"5.19";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL184147";"";"None";"341.59";"0";"4.45";"1";"O=C(Nc1ccc(Cl)cc1O)Nc1ccccc1Br";"IC50";"'='";"906.0";"nM";"6.04";"";"";"UO_0000065";"17.69";"0.43";"1.59";"9.85";"0";"CHEMBL828744";"Concentration required to inhibit [125I]IL-8 binding towards C-X-C chemokine receptor type 2 of human expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137097";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3308072";"";"";""
"CHEMBL1909075";"";"None";"None";"None";"None";"QUINOLONE, CHEMI-LINZ ; CYANAMID";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL918";"PHENACEMIDE";"4.0";"178.19";"0";"0.42";"PHENACEMIDE";"NC(=O)NC(=O)Cc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1191";"SULFAMETHIZOLE";"4.0";"270.34";"0";"1.23";"SULFAMETHIZOLE";"Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1221";"SULCONAZOLE";"4.0";"397.76";"1";"6.52";"SULCONAZOLE";"Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL294095";"";"None";"324.33";"0";"1.51";"7b";"CCS(=O)(=O)c1ccc(C(=O)Nc2ccc(F)cc2)c[n+]1[O-]";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"21.23";"0.43";"5.38";"7.64";"0";"CHEMBL662153";"Evaluated using an SPA assay with recombinant human [125I]IL-8 and membranes prepared from Sf9 cells expressing human CXCR2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133879";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2001";"CHEMBL3308860";"";"";""
"CHEMBL402728";"";"None";"369.50";"0";"2.23";"30f";"Cc1nc(CSc2nc(N[C@H](C)CO)c3sc(=O)[nH]c3n2)cs1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"19.54";"0.43";"4.99";"6.96";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL272705";"";"None";"338.41";"0";"2.06";"30e";"C[C@H](CO)Nc1nc(SCc2ccco2)nc2[nH]c(=O)sc12";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"24.53";"0.52";"6.24";"7.98";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL253505";"";"None";"396.45";"0";"2.34";"39";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cccn1C";"IC50";"'='";"815.0";"nM";"6.09";"";"";"UO_0000065";"15.36";"0.29";"3.75";"5.87";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL3342283";"";"None";"370.45";"0";"4.15";"21, 29";"Cc1n[nH]c(C)c1CCSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL1490";"TRIHEXYPHENIDYL";"4.0";"301.47";"0";"4.33";"TRIHEXYPHENIDYL";"OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL408";"TROGLITAZONE";"4.0";"441.55";"0";"4.37";"TROGLITAZONE";"Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1643";"RIBAVIRIN";"4.0";"244.21";"0";"-3.01";"RIBAVIRIN";"NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL127516";"BUTAMBEN";"4.0";"193.25";"0";"2.23";"BUTAMBEN";"CCCCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3342282";"";"None";"332.40";"0";"3.74";"20";"O=C(Nc1ccc(F)cc1)c1ccc(SCC2CCCO2)nc1";"IC50";"'='";"540.0";"nM";"6.27";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3609016";"";"None";"446.25";"None";"None";"30";"O=C(Nc1ccc(F)cc1)c1ccc(N(Cc2ccc(B(O)O)cn2)Cc2ccco2)nc1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL934";"METYRAPONE";"4.0";"226.28";"0";"2.64";"METYRAPONE";"CC(C)(C(=O)c1cccnc1)c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3354824";"";"None";"397.88";"0";"2.93";"2c";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)c3c([nH]2)CCCC3)c1O";"IC50";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"16.34";"0.34";"3.57";"5.80";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3355237";"";"None";"397.88";"0";"3.32";"3g";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)cc(C3CCC3)[nH]2)c1O";"IC50";"'='";"15.85";"nM";"7.80";"";"";"UO_0000065";"19.60";"0.41";"4.48";"6.95";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL250689";"";"None";"465.61";"1";"5.66";"32";"CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL828098";"Inhibition of C-X-C chemokine receptor type 2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143552";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL570042";"";"None";"394.43";"0";"2.29";"5d";"CCN(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccccc1";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1043642";"Antagonist activity at CXCR2 expressed in CHO cells assessed as inhibition of IL-8-induced chemotaxis";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156021";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL585928";"";"None";"395.42";"0";"1.68";"5g";"CCN(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccccn1";"IC50";"'='";"75.0";"nM";"7.12";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1043642";"Antagonist activity at CXCR2 expressed in CHO cells assessed as inhibition of IL-8-induced chemotaxis";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156021";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL4781097";"";"None";"374.53";"1";"5.17";"11";"CCOC(=O)c1c(NC(=S)Nc2ccccc2)sc2c1C(C)CCC2";"IC50";"'='";"6400.0";"nM";"5.19";"";"";"UO_0000065";"13.87";"0.28";"0.02";"10.31";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4798282";"";"None";"404.56";"1";"5.18";"13";"CCOC(=O)c1c(NC(=S)Nc2ccc(OC)cc2)sc2c1C(C)CCC2";"IC50";"'='";"4400.0";"nM";"5.36";"";"";"UO_0000065";"13.24";"0.27";"0.18";"8.99";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4780140";"";"None";"388.56";"0";"4.85";"25";"CCOC(=O)c1c(NC(=S)NCc2ccccc2)sc2c1C(C)CCC2";"IC50";"'='";"6700.0";"nM";"5.17";"";"";"UO_0000065";"13.32";"0.27";"0.32";"10.27";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4778886";"";"None";"346.48";"0";"4.70";"29";"CC1CCCc2sc(NC(=S)Nc3ccccc3)c(C(=O)O)c21";"IC50";"'='";"6700.0";"nM";"5.17";"";"";"UO_0000065";"14.93";"0.31";"0.47";"8.43";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4786878";"";"None";"402.59";"1";"5.95";"31";"CC1CCCc2sc(NC(=S)Nc3ccccc3)c(C(=O)OC(C)(C)C)c21";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"13.92";"0.28";"-0.35";"11.12";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4792599";"";"None";"390.53";"0";"4.84";"39";"CC(C)(C)OC(=O)c1c(NC(=S)Nc2ccccc2)sc2c1CCCO2";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"13.79";"0.28";"0.55";"9.04";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL3967642";"";"None";"462.33";"0";"4.01";"Ex 17";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCNCC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3971309";"";"None";"427.89";"0";"3.27";"Ex 24";"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCNC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3936567";"";"None";"488.37";"0";"4.54";"Ex 31";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2C[C@H]3CC[C@@H](C2)N3)c1O)Nc1cccc(F)c1Cl";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL253255";"";"None";"454.48";"0";"2.29";"15";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C(=O)N(C)C)o1";"IC50";"'='";"171.0";"nM";"6.77";"";"";"UO_0000065";"14.89";"0.28";"4.48";"5.12";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL404249";"";"None";"397.43";"0";"2.90";"7";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1";"IC50";"'='";"5.7";"nM";"8.24";"";"";"UO_0000065";"20.74";"0.39";"5.34";"7.37";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL1093137";"";"None";"488.64";"1";"5.72";"(S)-15g";"c1ccc(CNCc2ccc(CN(Cc3nc4ccccc4[nH]3)[C@H]3CCCc4cccnc43)cc2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1107989";"Displacement of radiolabeled IL8 from CXCR2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156989";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL216981";"NAVARIXIN";"2.0";"397.43";"0";"2.90";"4, SCH-527123";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"21.60";"0.40";"5.69";"7.67";"0";"CHEMBL909848";"Displacement of [125I]hCXCL8 from human CXCR2 receptor expressed in BaF3 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307634";"";"";""
"CHEMBL3701189";"";"None";"412.44";"0";"2.88";"BDBM172331";"Cc1ccc(C(Nc2c(Nc3cccc(C(C)O)c3O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"549.0";"nM";"6.26";"";"317329";"UO_0000065";"15.18";"0.29";"3.38";"5.17";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3704555";"";"None";"453.50";"0";"2.83";"BDBM172347";"Cc1cc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2(C)COC2)oc1C";"IC50";"'='";"244.0";"nM";"6.61";"";"317317";"UO_0000065";"14.58";"0.27";"3.78";"5.46";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3609017";"";"None";"425.19";"None";"None";"28";"O=C(O)CN(Cc1ccc(B(O)O)cn1)c1ncc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL1688888";"";"None";"395.32";"0";"3.40";"13";"Cc1nn(C)c2ncc(C(=O)NC(=O)Nc3ccc(F)c(C(F)(F)F)c3)cc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1693901";"Antagonist activity at CXCR2 in human PMN cells assessed as inhibition of CXCL8-induced chemotaxis after 2 hrs trans-well migration assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PMN";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687928";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL3084803";"ASTROMICIN";"-1.0";"405.50";"1";"-3.59";"ASTROMICIN";"CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL231922";"";"None";"402.66";"0";"3.39";"9z";"O=S1(=O)N=C(Nc2ccccc2Br)Nc2c(O)ccc(Cl)c21";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"15.69";"0.39";"2.93";"6.96";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL218665";"";"None";"506.30";"1";"3.78";"6q";"CN(C)S(=O)(=O)c1c(C(F)(F)F)ccc(N/C(=N/C#N)Nc2ccccc2Br)c1O";"IC50";"'='";"7.0";"nM";"8.15";"";"Antagonist";"UO_0000065";"16.11";"0.37";"4.37";"6.92";"0";"CHEMBL908413";"Displacement of [125I]IL8 from CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139694";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"ANTAGONIST";""
"CHEMBL218486";"";"None";"627.99";"2";"5.07";"6l";"CCC(CC)(NS(=O)(=O)c1c(Cl)ccc(N/C(=N/C#N)Nc2ccccc2Br)c1O)N1C[C@@H](C)O[C@@H](C)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"Antagonist";"UO_0000065";"12.81";"0.29";"2.98";"5.78";"0";"CHEMBL908413";"Displacement of [125I]IL8 from CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139694";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"ANTAGONIST";""
"CHEMBL3704562";"";"None";"455.54";"0";"2.99";"BDBM172355";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2(C)COC2)s1";"IC50";"'='";"146.0";"nM";"6.84";"";"317314";"UO_0000065";"15.01";"0.29";"3.85";"6.33";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL517712";"ATROPINE";"4.0";"289.38";"0";"1.93";"ATROPINE";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL404088";"";"None";"429.47";"0";"3.25";"26";"COc1cc2[nH]c(-c3ccc(F)cc3)c(CCCC(=O)NS(C)(=O)=O)c2cc1C#N";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"15.82";"0.31";"3.55";"6.07";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL258419";"";"None";"413.47";"0";"3.59";"18";"CN(C(=O)CCCc1c(-c2ccc(F)cc2)[nH]c2ccc(C#N)cc12)S(C)(=O)=O";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL254568";"";"None";"442.52";"0";"3.40";"36";"Cc1cc2[nH]c(-c3ccc(F)cc3)c(CCCC(=O)NS(=O)(=O)N(C)C)c2cc1C#N";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"17.22";"0.34";"4.22";"7.18";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL252897";"";"None";"383.40";"0";"2.59";"34";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccoc1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"21.12";"0.39";"5.51";"7.24";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL257829";"";"None";"414.46";"0";"2.75";"28";"CNS(=O)(=O)NC(=O)CCCc1c(-c2ccc(F)cc2)[nH]c2ccc(C#N)cc12";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL928889";"Antagonist activity at human cloned CXCR2 by calcium flux FLIPR assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL393248";"";"None";"294.31";"0";"2.78";"3g";"Cc1ccc(O)c(Nc2c(Nc3ccccc3)c(=O)c2=O)c1";"IC50";"'='";"308.0";"nM";"6.51";"";"";"UO_0000065";"22.12";"0.40";"3.73";"8.30";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL393452";"";"None";"294.31";"0";"2.78";"3i";"Cc1cccc(O)c1Nc1c(Nc2ccccc2)c(=O)c1=O";"IC50";"'='";"1720.0";"nM";"5.76";"";"";"UO_0000065";"19.59";"0.36";"2.98";"7.35";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL239135";"";"None";"325.28";"0";"2.38";"3j";"O=c1c(Nc2ccccc2)c(Nc2c(O)cccc2[N+](=O)[O-])c1=O";"IC50";"'='";"358.0";"nM";"6.45";"";"";"UO_0000065";"19.82";"0.37";"4.07";"5.30";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL397237";"";"None";"383.45";"0";"3.03";"3b";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(N)sc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.90";"0.46";"5.37";"8.66";"1";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL257659";"";"None";"377.42";"0";"3.09";"18";"Cc1cnc2c(N[C@H](C)CO)nc(SCc3cccc(F)c3F)nc2n1";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"17.36";"0.34";"3.46";"7.82";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL4071768";"";"None";"374.89";"0";"3.54";"17";"CC1CCCC1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)C)c1O";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"21.34";"0.46";"4.46";"8.38";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL253050";"";"None";"462.30";"0";"3.35";"9";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(Br)o1";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"18.01";"0.39";"4.98";"7.44";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL401939";"";"None";"462.30";"0";"3.35";"46";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cc(Br)co1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"18.82";"0.41";"5.35";"7.78";"0";"CHEMBL927217";"Inhibition of CXCR2-mediated chemotaxis in Ba/F3 cells expressing human CXCR2";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307634";"";"";""
"CHEMBL3948929";"";"None";"471.37";"0";"3.79";"Ex 38";"O=C(Nc1cccnc1Cl)Nc1ccc(Cl)c(S(=O)(=O)C2C[C@H]3CC[C@@H](C2)N3)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3953988";"";"None";"441.91";"0";"3.66";"Ex 14";"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CCCNC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3648347";"";"None";"507.51";"2";"6.56";"BDBM103368";"CCC(NC(=O)c1ccc2ccccc2c1OCc1ccc(C(F)(F)F)cc1)(C(=O)O)c1ccccc1";"IC50";"'='";"2200.0";"nM";"5.66";"";"221250";"UO_0000065";"";"";"";"";"0";"CHEMBL3705069";"Calicum Fluorescence Assay: The assay is based on the detection of intracellular calcium changes detected by the selective, calcium-chelating dye, Fluo-4 (Molecular Probes).";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639002";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL1586";"BECLOMETHASONE";"2.0";"408.92";"0";"2.17";"BECLOMETHASONE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3701192";"";"None";"481.51";"0";"2.30";"BDBM172335";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N4CCOCC4)c3O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"626.0";"nM";"6.20";"";"317330";"UO_0000065";"12.88";"0.24";"3.90";"4.76";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3704564";"";"None";"439.47";"0";"2.52";"BDBM172357";"Cc1coc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2(C)COC2)c1";"IC50";"'='";"32.0";"nM";"7.50";"";"317305";"UO_0000065";"17.05";"0.32";"4.97";"6.19";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3913959";"";"None";"526.04";"1";"3.59";"BDBM236813";"Cc1ccc(C(Nc2c(Nc3ccc(Cl)c(S(=O)(=O)N(C)C)c3O)c(=O)c2=O)C2CCCS2)o1";"IC50";"'='";"16.0";"nM";"7.80";"";"412479";"UO_0000065";"14.82";"0.31";"4.21";"6.05";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4062546";"";"None";"414.91";"0";"3.23";"66";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2(C)CCOC2)c1O";"IC50";"'='";"1.259";"nM";"8.90";"";"";"UO_0000065";"21.45";"0.45";"5.67";"8.50";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3342281";"";"None";"396.37";"1";"5.38";"19";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc(C(F)(F)F)o2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342277";"";"None";"339.40";"0";"4.16";"15";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccncc2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3658256";"";"None";"392.46";"1";"5.92";"BDBM150872";"CC1N=Nc2cc(CSc3ccc(C(=O)Nc4ccc(F)cc4)cn3)ccc21";"IC50";"'>'";"10000.0";"nM";"";"";"290382";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658261";"";"None";"380.40";"0";"4.30";"BDBM150877";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cccc3nonc23)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290387";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658262";"";"None";"392.46";"0";"4.65";"BDBM150878";"Cn1c(CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)nc2ccccc21";"IC50";"'>'";"10000.0";"nM";"";"";"290388";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658287";"";"None";"391.43";"0";"4.32";"BDBM150914";"N#Cc1cccc(C(=O)CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)c1";"IC50";"'>'";"5000.0";"nM";"";"";"290424";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342298";"";"None";"404.47";"0";"4.95";"BDBM150843";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc(-n3cccn3)cc2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290353";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL404490";"";"None";"417.85";"0";"3.24";"44";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(Cl)o1";"IC50";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"19.95";"0.39";"5.10";"7.45";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL4092148";"";"None";"482.05";"0";"4.46";"49";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2(C)CCN(C3CCC3)CC2)c1O";"IC50";"'='";"3.981";"nM";"8.40";"";"";"UO_0000065";"17.43";"0.36";"3.94";"8.51";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4079102";"";"None";"404.89";"0";"3.80";"40";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)(C)CF)c1O";"IC50";"'='";"0.631";"nM";"9.20";"";"";"UO_0000065";"22.72";"0.48";"5.40";"9.63";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4064349";"";"None";"376.84";"0";"3.37";"29";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)NC2CCC=C2F)c1O";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"21.23";"0.46";"4.63";"8.38";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4103634";"";"None";"388.92";"0";"3.93";"11";"CC1CCCCC1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)C)c1O";"IC50";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"16.71";"0.36";"2.57";"6.81";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL1201010";"FLUDROCORTISONE ACETATE";"4.0";"422.49";"0";"2.44";"FLUDROCORTISONE ACETATE";"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL41543";"";"None";"238.29";"0";"3.00";"10,11-DIHYDRO-CARBAMAZEPINE";"NC(=O)N1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL357995";"BOPINDOLOL";"2.0";"380.49";"0";"4.47";"BOPINDOLOL";"Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3";"NICOTINE";"4.0";"162.24";"0";"1.85";"NICOTINE";"CN1CCC[C@H]1c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL280711";"";"None";"273.25";"0";"2.94";"1a";"O=C(Nc1ccccc1)Nc1ccc([N+](=O)[O-])cc1O";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"23.77";"0.44";"3.55";"6.22";"0";"CHEMBL656551";"Inhibition of binding of IL-8 to membranes of cloned CXC chemokine receptor 2 expressed in CHO Cells using [125I]IL-8 radioligand";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149089";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL1172";"DESLORATADINE";"4.0";"310.83";"0";"4.02";"DESLORATADINE";"Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL233263";"";"None";"337.43";"0";"2.35";"3e";"C[C@H](CO)Nc1nc(SCc2ccco2)nc2nc(N)sc12";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"22.10";"0.46";"5.11";"6.77";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL38";"TRETINOIN";"4.0";"300.44";"1";"5.60";"retinoic acid";"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3311396";"";"None";"373.22";"0";"4.39";"32";"Oc1nc(SCc2cccc(F)c2F)nc(C2CC2)c1Br";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL1109";"SULFAPHENAZOLE";"4.0";"314.37";"0";"2.26";"SULFAPHENAZOLE";"Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1626";"CLEMASTINE";"4.0";"343.90";"1";"5.10";"CLEMASTINE";"CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1231107";"CYROMAZINE";"2.0";"166.19";"0";"-0.39";"CYROMAZINE";"Nc1nc(N)nc(NC2CC2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL57680";"";"None";"416.39";"0";"2.24";"7f";"O=C(O)c1cccc(S(=O)(=O)c2ccc(C(=O)Nc3ccc(F)cc3)c[n+]2[O-])c1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"18.00";"0.35";"5.25";"5.88";"0";"CHEMBL662153";"Evaluated using an SPA assay with recombinant human [125I]IL-8 and membranes prepared from Sf9 cells expressing human CXCR2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133879";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2001";"CHEMBL3308860";"";"";""
"CHEMBL583";"GREPAFLOXACIN";"4.0";"359.40";"0";"2.28";"GREPAFLOXACIN";"Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL248702";"DEXFENFLURAMINE";"4.0";"231.26";"0";"3.25";"DEXFENFLURAMINE";"CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL826";"ENOXACIN";"4.0";"320.32";"0";"0.66";"ENOXACINE";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL493";"BROMOCRIPTINE";"4.0";"654.61";"1";"3.19";"BROMOCRIPTINE";"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4536494";"";"None";"392.87";"0";"3.76";"1";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nnc(-c3ccccc3)[nH]2)c1O";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL278172";"BENZOCAINE";"4.0";"165.19";"0";"1.45";"BENZOCAINE";"CCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL926";"DOBUTAMINE";"4.0";"301.39";"0";"2.96";"DOBUTAMINE";"CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL691";"ETHINYL ESTRADIOL";"4.0";"296.41";"0";"3.61";"ETHINYLESTRADIOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2220442";"FLUVASTATIN";"4.0";"411.47";"0";"4.63";"FLUVASTATIN";"CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL31";"GATIFLOXACIN";"4.0";"375.40";"0";"1.98";"GATIFLOXACIN";"COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL427216";"GLICLAZIDE";"4.0";"323.42";"0";"1.63";"GLICLAZIDE";"Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1371937";"PANTHENOL";"3.0";"205.25";"0";"-1.14";"PANTHENOL";"CC(C)(CO)C(O)C(=O)NCCCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL153062";"4-NONYLPHENOL";"None";"220.36";"0";"4.69";"4-NONYLPHENOL";"CCCCCCCCCc1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL672";"FENOFIBRATE";"4.0";"360.84";"0";"4.68";"FENOFIBRATE";"CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL41";"FLUOXETINE";"4.0";"309.33";"0";"4.44";"SID170465374";"CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL540445";"PARTHENOLIDE";"2.0";"248.32";"0";"2.76";"PARTHENOLIDE";"C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3183075";"NIZATIDINE";"4.0";"331.47";"0";"1.32";"NIZATIDINE";"CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1536";"ERGOCALCIFEROL";"4.0";"396.66";"1";"7.64";"ERGOCALCIFEROL";"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4098979";"";"None";"459.97";"0";"3.48";"45";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CCN(CCF)CC2)c1O";"IC50";"'='";"199.53";"nM";"6.70";"";"";"UO_0000065";"14.57";"0.31";"3.22";"6.79";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL1130";"DOXIFLURIDINE";"3.0";"246.19";"0";"-1.69";"DOXIFLURIDINE";"C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL515";"CHLORAMBUCIL";"4.0";"304.22";"0";"3.38";"CHLORAMBUCIL";"O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL86002";"";"None";"336.25";"0";"4.59";"25";"Sc1nc(-c2cc(Cl)cc(Cl)c2)nn1Cc1ccccc1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"16.95";"0.37";"1.11";"18.56";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL315771";"";"None";"268.35";"0";"2.68";"1";"Sc1nc(-c2cccnc2)nn1Cc1ccccc1";"IC50";"'<'";"4600.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL84752";"";"None";"366.27";"0";"4.60";"38";"COc1ccc(Cn2nc(-c3ccc(Cl)cc3Cl)nc2S)cc1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"13.65";"0.30";"0.40";"12.52";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL1537";"AZLOCILLIN";"4.0";"461.50";"0";"0.09";"AZLOCILLIN";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL184";"ACYCLOVIR";"4.0";"225.21";"0";"-1.33";"1 (Acyclovir ACV)";"Nc1nc2c(ncn2COCCO)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL252556";"IDEBENONE";"4.0";"338.44";"0";"3.46";"IDEBENONE";"COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1466";"DICUMAROL";"4.0";"336.30";"0";"2.90";"DICUMAROL";"O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL15511";"ENROFLOXACIN";"2.0";"359.40";"0";"2.32";"ENROFLOXACIN";"CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL457299";"MACROGOL";"4.0";"62.07";"0";"-1.03";"ETHYLENE GLYCOL";"OCCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909068";"";"None";"None";"None";"None";"MC 258717";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1601669";"ALFACALCIDOL";"4.0";"400.65";"1";"6.59";"ALFACALCIDOL";"C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL686";"MEFENAMIC ACID";"4.0";"241.29";"0";"3.75";"MEFENAMIC ACID";"Cc1cccc(Nc2ccccc2C(=O)O)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3342302";"";"None";"370.42";"1";"5.21";"42";"Cc1cccc(CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)c1F";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342278";"";"None";"479.58";"1";"5.61";"16";"O=C(Nc1ccc(F)cc1)c1ccc(SCC2CCN(C(=O)OCc3ccccc3)CC2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342273";"";"None";"307.31";"0";"2.80";"11";"O=C(Nc1ccc(F)cc1)c1ccc(SC[N+](=O)[O-])nc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL39740";"";"None";"505.54";"2";"7.93";"2";"CCN(CC)CCCCNc1nc2cc(Cl)c(Cl)cc2nc1-c1ccc(-c2cccs2)s1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"13.76";"0.30";"-0.97";"16.95";"1";"CHEMBL656548";"Displacement of [125I]IL-8 from CHO cell membranes expressing human CX3C chemokine receptor 2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"CHEMBL3308072";"";"";""
"CHEMBL254219";"DIGITOXIN";"4.0";"764.95";"2";"3.25";"DIGITOXIN";"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1730";"CEFOTAXIME";"4.0";"455.47";"1";"-0.62";"CEFOTAXIME";"CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL14192";"BENZYLIMIDAZOLE";"None";"158.20";"0";"1.93";"1-BENZYLIMIDAZOLE";"c1ccc(Cn2ccnc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1697694";"AFLATOXIN";"None";"312.28";"0";"2.28";"AFLATOXIN B1";"COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)[C@@H]1C=CO[C@@H]1O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL701";"BACLOFEN";"4.0";"213.66";"0";"1.86";"BACLOFEN";"NCC(CC(=O)O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL139";"DICLOFENAC";"4.0";"296.15";"0";"4.36";"DICLOFENAC";"O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL53463";"DOXORUBICIN";"4.0";"543.53";"3";"0.00";"Doxorubicin";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL32749";"FERULATE";"-1.0";"194.19";"0";"1.50";"FERULIC ACID";"COc1cc(/C=C/C(=O)O)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1289";"HALOPROGIN";"4.0";"361.39";"0";"4.42";"HALOPROGIN";"Clc1cc(Cl)c(OCC#CI)cc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1425";"MERCAPTOPURINE ANHYDROUS";"4.0";"152.18";"0";"0.64";"6-MERCAPTOPURINE";"Sc1ncnc2nc[nH]c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL245416";"L-MIMOSINE";"None";"198.18";"0";"-1.03";"L-MIMOSINE";"N[C@@H](Cn1ccc(=O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL38737";"THIOACETAMIDE";"None";"75.14";"0";"0.91";"THIOACETAMIDE";"CC(=N)S";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1419";"SIBUTRAMINE";"4.0";"279.86";"0";"4.74";"SIBUTRAMINE";"CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1054";"TRICHLORMETHIAZIDE";"4.0";"380.66";"0";"0.82";"TRICHLORMETHIAZIDE";"NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL283736";"";"None";"273.25";"0";"2.94";"1b";"O=C(Nc1ccccc1)Nc1cccc([N+](=O)[O-])c1O";"IC50";"'='";"860.0";"nM";"6.07";"";"";"UO_0000065";"22.20";"0.41";"3.13";"5.80";"0";"CHEMBL656551";"Inhibition of binding of IL-8 to membranes of cloned CXC chemokine receptor 2 expressed in CHO Cells using [125I]IL-8 radioligand";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149089";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL1411979";"METHAPYRILENE";"4.0";"261.39";"0";"2.71";"METHAPYRILENE";"CN(C)CCN(Cc1cccs1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL24944";"TRIBROMSALAN";"4.0";"449.92";"0";"4.93";"TRIBROMSALAN";"O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL56367";"NIMESULIDE";"4.0";"308.31";"0";"2.76";"NIMESULIDE";"CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL16";"PHENYTOIN";"4.0";"252.27";"0";"1.77";"PHENYTOIN";"O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL547";"ISOTRETINOIN";"4.0";"300.44";"1";"5.60";"ISOTRETINOIN";"CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL188921";"BUFLOMEDIL";"4.0";"307.39";"0";"2.77";"BUFLOMEDIL";"COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL808";"ECONAZOLE";"4.0";"381.69";"1";"5.80";"ECONAZOLE";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL45245";"";"None";"195.22";"0";"2.68";"6(5H)-PHENANTHRIDINONE";"O=c1[nH]c2ccccc2c2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4106677";"";"None";"439.47";"0";"2.67";"BDBM236780";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)[C@H]2CCCO2)o1";"IC50";"'='";"176.0";"nM";"6.75";"";"412481";"UO_0000065";"15.37";"0.29";"4.08";"5.58";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL254366";"";"None";"470.53";"0";"2.86";"34";"N#Cc1ccc2[nH]c(-c3ccc(F)cc3)c(CCCC(=O)NS(=O)(=O)N3CCOCC3)c2c1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"14.50";"0.28";"3.96";"5.92";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL403313";"";"None";"428.49";"0";"3.09";"6";"CN(C)S(=O)(=O)NC(=O)CCCc1c(-c2ccc(F)cc2)[nH]c2ccc(C#N)cc12";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"17.04";"0.33";"4.21";"6.88";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL403313";"";"None";"428.49";"0";"3.09";"6";"CN(C)S(=O)(=O)NC(=O)CCCc1c(-c2ccc(F)cc2)[nH]c2ccc(C#N)cc12";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL928889";"Antagonist activity at human cloned CXCR2 by calcium flux FLIPR assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL404662";"";"None";"496.95";"0";"4.73";"40";"N#Cc1ccc2[nH]c(-c3ccc(F)cc3)c(CCNC(=O)NS(=O)(=O)c3ccccc3Cl)c2c1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"12.87";"0.26";"1.67";"5.57";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL402952";"";"None";"493.95";"0";"4.91";"16";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(-c2ccccc2Cl)o1";"IC50";"'='";"49.0";"nM";"7.31";"";"";"UO_0000065";"14.80";"0.29";"2.40";"6.53";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL252697";"";"None";"384.39";"0";"1.98";"29";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cocn1";"IC50";"'='";"10.9";"nM";"7.96";"";"";"UO_0000065";"20.71";"0.39";"5.98";"6.38";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL253927";"";"None";"398.42";"0";"2.29";"47";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cc(C)on1";"IC50";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"20.58";"0.39";"5.91";"6.57";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL401939";"";"None";"462.30";"0";"3.35";"46";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cc(Br)co1";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"18.29";"0.40";"5.11";"7.56";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL216981";"NAVARIXIN";"2.0";"397.43";"0";"2.90";"33, SCH 527123";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1";"IC50";"'='";"0.049";"nM";"10.31";"";"";"UO_0000065";"25.94";"0.49";"7.41";"9.22";"0";"CHEMBL2184853";"Binding affinity to CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176887";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL191413";"REPARIXIN";"3.0";"283.39";"0";"2.06";"32";"CC(C)Cc1ccc([C@@H](C)C(=O)NS(C)(=O)=O)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2184850";"Antagonist activity at CXCR2 assessed as inhibition of CXCL8-induced neutrophil chemotaxis";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176887";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2178579";"ELUBRIXIN";"2.0";"463.32";"0";"3.08";"31, SB-656933";"O=C(Nc1ccc(Cl)c(S(=O)(=O)N2CCNCC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"310.5";"nM";"6.51";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2184851";"Antagonist activity at CXCR2 assessed as inhibition of neutrophil shape change";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176887";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL404395";"";"None";"476.53";"0";"4.64";"32";"N#Cc1ccc2[nH]c(-c3ccc(F)cc3)c(CCCC(=O)NS(=O)(=O)Nc3ccccc3)c2c1";"IC50";"'='";"880.0";"nM";"6.06";"";"";"UO_0000065";"12.71";"0.24";"1.42";"5.27";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL257830";"";"None";"400.44";"0";"2.49";"29";"N#Cc1ccc2[nH]c(-c3ccc(F)cc3)c(CCCC(=O)NS(N)(=O)=O)c2c1";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"17.93";"0.35";"4.69";"5.57";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL257829";"";"None";"414.46";"0";"2.75";"28";"CNS(=O)(=O)NC(=O)CCCc1c(-c2ccc(F)cc2)[nH]c2ccc(C#N)cc12";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"16.70";"0.33";"4.17";"6.03";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL254774";"";"None";"480.50";"0";"4.22";"41";"N#Cc1ccc2[nH]c(-c3ccc(F)cc3)c(CCNC(=O)NS(=O)(=O)c3ccc(F)cc3)c2c1";"IC50";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"13.08";"0.25";"2.06";"5.47";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL254773";"";"None";"516.39";"1";"4.97";"39";"O=C(NCCc1c(-c2ccc(F)cc2)[nH]c2ccc(Br)cc12)NS(=O)(=O)c1ccccc1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"13.40";"0.30";"1.95";"7.60";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL440405";"";"None";"399.45";"0";"3.24";"17";"CS(=O)(=O)NC(=O)CCCc1c(-c2ccc(F)cc2)[nH]c2ccc(C#N)cc12";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL928889";"Antagonist activity at human cloned CXCR2 by calcium flux FLIPR assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL239348";"";"None";"404.18";"0";"3.15";"3m";"O=c1c(Nc2ccc([N+](=O)[O-])cc2O)c(Nc2ccccc2Br)c1=O";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"18.39";"0.41";"4.28";"6.11";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL239560";"";"None";"307.15";"0";"3.80";"Table 1 C5R11";"O=C(Nc1ccccc1O)Nc1ccccc1Br";"IC50";"'>'";"9000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL241694";"ETHISTERONE";"3.0";"312.45";"0";"3.88";"ETHISTERONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1020";"TOLMETIN";"4.0";"257.29";"0";"2.19";"TOLMETIN";"Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1236282";"THIAMPHENICOL";"2.0";"356.23";"0";"0.40";"THIAMPHENICOL";"CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1243";"SULFABENZAMIDE";"4.0";"276.32";"0";"1.39";"SULFABENZAMIDE";"Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1670";"MITOTANE";"4.0";"320.05";"1";"5.93";"MITOTANE";"Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL44814";"CARBON TETRACHLORIDE";"-1.0";"153.82";"0";"2.55";"CARBON TETRACHLORIDE";"ClC(Cl)(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL135";"ESTRADIOL";"4.0";"272.39";"0";"3.61";"BETA-ESTRADIOL";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1237174";"HYDRAZINE";"0.5";"32.05";"0";"-1.18";"HYDRAZINE";"NN";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL311469";"2-ACETYLAMINOFLUORENE";"None";"223.27";"0";"3.22";"2-ACETYLAMINOFLUORENE";"CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL106";"FLUCONAZOLE";"4.0";"306.28";"0";"0.74";"Fluconazole";"OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL315206";"";"None";"366.27";"0";"4.60";"39";"COc1cccc(Cn2nc(-c3ccc(Cl)cc3Cl)nc2S)c1";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"14.68";"0.32";"0.78";"13.46";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL1909050";"";"None";"293.41";"0";"4.09";"1-(2-METHYLBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"Cc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2018969";"";"None";"549.07";"1";"4.00";"6, GSK2239633A";"COc1cccc2c1c(NS(=O)(=O)c1ccc(Cl)s1)nn2Cc1cccc(CNC(=O)C(C)(C)O)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2330023";"Antagonist activity at CXCR2 receptor (unknown origin) by [35S]GTPgammaS binding assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321840";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL85820";"";"None";"336.25";"0";"4.59";"35";"Sc1nc(-c2ccc(Cl)cc2Cl)nn1Cc1ccccc1";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"19.00";"0.42";"1.80";"20.80";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL1395";"METHYLTESTOSTERONE";"4.0";"302.46";"0";"4.27";"17-METHYLTESTOSTERONE";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3951994";"";"None";"455.54";"0";"3.38";"BDBM236795";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2CCCS2)o1";"IC50";"'='";"135.0";"nM";"6.87";"";"412465";"UO_0000065";"15.08";"0.29";"3.49";"6.14";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3891755";"";"None";"541.60";"1";"3.89";"BDBM236801";"COC(=O)[C@@H]1CCCN1C(=O)c1cccc(Nc2c(NC(c3ccc(C)o3)[C@H]3CCCS3)c(=O)c2=O)c1F";"IC50";"'='";"195.0";"nM";"6.71";"";"412467";"UO_0000065";"12.39";"0.24";"2.82";"5.69";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL27";"PROPRANOLOL";"4.0";"259.35";"0";"2.58";"PROPRANOLOL";"CC(C)NCC(O)COc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1476898";"CADMIUM ACETATE";"None";"230.50";"None";"None";"CADMIUM ACETATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3342308";"";"None";"396.44";"0";"4.55";"48";"COC(=O)c1cccc(CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)c1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342304";"";"None";"354.41";"0";"4.47";"44";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccccc2O)nc1";"IC50";"'='";"277.0";"nM";"6.56";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342303";"";"None";"407.30";"1";"6.07";"43";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc(Cl)c(Cl)c2)nc1";"IC50";"'='";"1610.0";"nM";"5.79";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL269732";"TACROLIMUS ANHYDROUS";"4.0";"804.03";"2";"4.64";"TACROLIMUS";"C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1237044";"TRAMADOL";"4.0";"263.38";"0";"2.63";"TRAMADOL";"COc1cccc(C2(O)CCCCC2CN(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL109";"VALPROIC ACID";"4.0";"144.21";"0";"2.29";"VALPROIC ACID";"CCCC(CCC)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL571";"KETOPROFEN";"4.0";"254.29";"0";"3.11";"Ketoprofen";"CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL29292";"UBENIMEX";"2.0";"308.38";"0";"0.53";"UBENIMEX";"CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL972";"SELEGILINE";"4.0";"187.29";"0";"2.18";"SELEGILINE";"C#CCN(C)[C@H](C)Cc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL521606";"NADOLOL";"4.0";"309.41";"0";"0.63";"NADOLOL";"CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL384889";"";"None";"411.46";"0";"3.14";"23";"Cc1ccc([C@H](Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C(C)C)o1";"IC50";"'='";"6.2";"nM";"8.21";"";"";"UO_0000065";"19.95";"0.37";"5.07";"7.34";"0";"CHEMBL909848";"Displacement of [125I]hCXCL8 from human CXCR2 receptor expressed in BaF3 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307634";"";"";""
"CHEMBL220182";"";"None";"437.45";"0";"2.73";"17";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc2c(c1)OCO2";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"18.98";"0.35";"5.57";"7.08";"0";"CHEMBL909848";"Displacement of [125I]hCXCL8 from human CXCR2 receptor expressed in BaF3 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307634";"";"";""
"CHEMBL397809";"";"None";"367.77";"0";"2.33";"9s";"O=C(O)c1ccccc1NC1=NS(=O)(=O)c2cc(Cl)cc(O)c2N1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL233960";"";"None";"337.79";"0";"2.94";"9k";"Cc1ccccc1NC1=NS(=O)(=O)c2cc(Cl)cc(O)c2N1";"IC50";"'='";"390.0";"nM";"6.41";"";"";"UO_0000065";"18.97";"0.40";"3.47";"7.06";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL397869";"";"None";"420.65";"0";"3.53";"9j";"O=S1(=O)N=C(Nc2c(F)cccc2Br)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"13.78";"0.34";"2.27";"6.38";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL1752";"DYPHYLLINE";"4.0";"254.25";"0";"-2.21";"DYPHYLLINE";"Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1110";"ALOSETRON";"4.0";"294.36";"0";"2.41";"ALOSETRON";"Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3658311";"";"None";"501.40";"2";"6.43";"BDBM150938";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2csc3ccc(Br)cc23)nc1";"IC50";"'='";"1250.0";"nM";"5.90";"";"290448";"UO_0000065";"11.77";"0.27";"-0.53";"10.00";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658326";"";"None";"438.48";"0";"4.61";"BDBM150954";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2cccc3c2OCCCO3)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290464";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658336";"";"None";"456.54";"1";"5.97";"BDBM150964";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)C(c2ccccc2)c2ccccc2)nc1";"IC50";"'='";"1230.0";"nM";"5.91";"";"290474";"UO_0000065";"12.95";"0.24";"-0.06";"10.01";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342319";"";"None";"383.21";"None";"None";"BDBM150974";"O=C(Nc1ccc(F)cn1)c1ccc(SCc2ccccc2B(O)O)nc1";"IC50";"'='";"294.0";"nM";"6.53";"";"290485";"UO_0000065";"17.04";"None";"None";"None";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658345";"";"None";"371.39";"0";"2.84";"BDBM150983";"O=C(Nc1ccc(F)cn1)c1ccc(S(=O)(=O)Cc2ccccc2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290493";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658349";"";"None";"471.39";"0";"3.45";"BDBM150987";"O=C(Nc1ccc(F)cn1)c1ccc(S(=O)(=O)Cc2cc(OC(F)(F)F)ccc2O)nc1";"IC50";"'='";"1190.0";"nM";"5.92";"";"290497";"UO_0000065";"12.57";"0.25";"2.47";"5.00";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342293";"";"None";"422.40";"1";"5.66";"BDBM150852";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc(OC(F)(F)F)cc2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290362";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342283";"";"None";"370.45";"0";"4.15";"BDBM150858";"Cc1n[nH]c(C)c1CCSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"5000.0";"nM";"";"";"290368";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658251";"";"None";"491.90";"1";"6.99";"BDBM150867";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc3nc(C(F)(F)F)cc(Cl)c3c2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290377";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658265";"";"None";"368.43";"0";"4.64";"BDBM150883";"O=C(Nc1ccc(F)cc1)c1ccc(SCCOc2ccccc2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290393";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658289";"";"None";"444.51";"0";"3.85";"BDBM150916";"CS(=O)(=O)c1ccc(C(=O)CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"290426";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658305";"";"None";"372.45";"0";"4.51";"BDBM150932";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1ccsc1";"IC50";"'>'";"10000.0";"nM";"";"";"290442";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658306";"";"None";"372.45";"0";"4.51";"BDBM150933";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2cccs2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290443";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658309";"";"None";"422.51";"1";"5.66";"BDBM150936";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1ccc2sccc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"290446";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL657";"DIPHENHYDRAMINE";"4.0";"255.36";"0";"3.35";"DIPHENHYDRAMINE";"CN(C)CCOC(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL209859";"";"None";"305.29";"0";"2.18";"3c";"N#Cc1ccc(Nc2c(O)c(=O)/c2=N\c2ccccc2)c(O)c1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"25.63";"0.46";"5.64";"7.40";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL964";"DISULFIRAM";"4.0";"296.55";"0";"3.62";"DISULFIRAM";"CCN(CC)C(=S)SSC(=S)N(CC)CC";"IC50";"'='";"6013.0";"nM";"5.22";"";"";"UO_0000065";"17.61";"0.45";"1.60";"80.57";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL72";"DESIPRAMINE";"4.0";"266.39";"0";"3.53";"DESIPRAMINE";"CNCCCN1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL683";"CLOFIBRIC ACID";"2.0";"214.65";"0";"2.58";"CLOFIBRIC ACID";"CC(C)(Oc1ccc(Cl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1454946";"FLUBENDAZOLE";"2.0";"313.29";"0";"3.11";"FLUBENDAZOLE";"COC(=O)Nc1nc2cc(C(=O)c3ccc(F)cc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3658323";"";"None";"424.45";"0";"4.22";"BDBM150951";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1ccc2c(c1)OCCO2";"IC50";"'='";"194.0";"nM";"6.71";"";"290461";"UO_0000065";"15.81";"0.31";"2.49";"8.66";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342322";"";"None";"479.39";"None";"None";"BDBM150967";"O=C(c1ccc(SCc2ccccc2B(O)O)nc1)N(CC1CCCCN1)c1ccc(F)cc1";"IC50";"'>'";"5000.0";"nM";"";"";"290477";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342321";"";"None";"473.34";"None";"None";"BDBM150977";"O=C(c1ccc(SCc2ccccc2B(O)O)nc1)N(Cc1ccncc1)c1ccc(F)cc1";"IC50";"'='";"890.0";"nM";"6.05";"";"290478";"UO_0000065";"12.78";"None";"None";"None";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658339";"";"None";"426.23";"None";"None";"BDBM150976";"O=C(Nc1ccc(F)c(C(=O)O)c1)c1ccc(SCc2ccccc2B(O)O)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290487";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL241514";"";"None";"242.28";"0";"3.34";"Table 1 C5R4";"Cc1ccc(NC(=O)Nc2ccccc2)c(O)c1";"IC50";"'='";"25000.0";"nM";"4.60";"";"";"UO_0000065";"18.99";"0.35";"1.26";"7.50";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL391465";"";"None";"451.89";"0";"2.05";"10f";"COCCNS(=O)(=O)c1c(Cl)ccc(Nc2c(Nc3ccccc3)c(=O)c2=O)c1O";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"17.92";"0.37";"6.05";"6.05";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL9451";"";"None";"228.25";"0";"3.04";"Table 1 C5R1";"O=C(Nc1ccccc1)Nc1ccccc1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3342311";"";"None";"382.42";"0";"4.46";"BDBM150835";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccccc2C(=O)O)nc1";"IC50";"'='";"1480.0";"nM";"5.83";"";"290345";"UO_0000065";"15.24";"0.29";"1.37";"7.35";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342300";"";"None";"403.48";"1";"5.56";"BDBM150842";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc(-n3cccc3)cc2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290352";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342280";"";"None";"420.47";"1";"5.12";"BDBM150846";"Cc1nc(-c2cccc(CSc3ccc(C(=O)Nc4ccc(F)cc4)cn3)c2)no1";"IC50";"'>'";"10000.0";"nM";"";"";"290356";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342301";"";"None";"403.48";"1";"5.56";"BDBM150849";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cccc(-n3cccc3)c2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290359";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658286";"";"None";"391.43";"0";"4.32";"BDBM150913";"N#Cc1ccc(C(=O)CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"290423";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658310";"";"None";"422.51";"1";"5.66";"BDBM150937";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2csc3ccccc23)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290447";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342320";"";"None";"473.34";"None";"None";"BDBM150966";"O=C(c1ccc(SCc2ccccc2B(O)O)nc1)N(Cc1ccccn1)c1ccc(F)cc1";"IC50";"'='";"78.0";"nM";"7.11";"";"290476";"UO_0000065";"15.02";"None";"None";"None";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658341";"";"None";"367.14";"None";"None";"BDBM150979";"O=C(Nc1ccc(F)cn1)c1ccc(OCc2ccccc2B(O)O)nc1";"IC50";"'='";"32.0";"nM";"7.50";"";"290489";"UO_0000065";"20.41";"None";"None";"None";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL258334";"";"None";"347.47";"0";"2.75";"21";"C[C@H](CO)Nc1nc(SCc2ccccc2)nc2sc(N)nc12";"IC50";"'='";"850.0";"nM";"6.07";"";"";"UO_0000065";"17.47";"0.36";"3.32";"6.26";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL313465";"";"None";"350.27";"0";"4.90";"40";"Cc1cccc(Cn2nc(-c3ccc(Cl)cc3Cl)nc2S)c1";"IC50";"'='";"730.0";"nM";"6.14";"";"";"UO_0000065";"17.52";"0.38";"1.24";"19.98";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL3310775";"";"None";"413.45";"1";"5.08";"12";"CC(C)Oc1ccc(-c2nc(SCc3cccc(F)c3F)nc(O)c2C#N)cc1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3310783";"";"None";"319.34";"0";"3.50";"20";"N#Cc1c(O)nc(SCc2cccc(F)c2F)nc1C1CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL429791";"";"None";"399.90";"0";"3.55";"3a";"C[C@H](CO)Nc1nc(SCc2cccc(Cl)c2F)nc2nc(N)sc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.31";"0.47";"4.97";"8.79";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL509";"MECLOFENAMIC ACID";"4.0";"296.15";"0";"4.74";"meclofenamate";"Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3701184";"";"None";"453.50";"0";"2.91";"BDBM172323";"CCC1(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)c2ccc(C)o2)COC1";"IC50";"'='";"106.0";"nM";"6.97";"";"317313";"UO_0000065";"15.38";"0.29";"4.06";"5.76";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4072270";"";"None";"414.91";"0";"2.96";"70";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@@H]2CC[C@@H](O)C2)c1O";"IC50";"'='";"0.2512";"nM";"9.60";"";"";"UO_0000065";"23.14";"0.49";"6.64";"8.30";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4060060";"";"None";"428.94";"0";"3.62";"64";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2(C)CCCOC2)c1O";"IC50";"'='";"1.995";"nM";"8.70";"";"";"UO_0000065";"20.28";"0.42";"5.08";"8.31";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL241678";"";"None";"242.28";"0";"3.34";"Table 1 C5R9";"Cc1cccc(O)c1NC(=O)Nc1ccccc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL43882";"TRICHLOROETHANE";"None";"133.41";"0";"2.03";"TRICHLOROETHANE";"ClCC(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL573";"NIACIN";"4.0";"123.11";"0";"0.78";"NIACIN";"O=C(O)c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL803";"CYTARABINE";"4.0";"243.22";"0";"-2.56";"CYTARABINE";"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL139835";"CYPROTERONE ACETATE";"4.0";"416.95";"0";"4.61";"CYPROTERONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL107";"COLCHICINE";"4.0";"399.44";"0";"2.87";"1a";"COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1572";"NETILMICIN";"4.0";"475.59";"2";"-3.20";"NETILMICIN";"CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL108";"CARBAMAZEPINE";"4.0";"236.27";"0";"3.39";"CARBAMAZEPINE";"NC(=O)N1c2ccccc2C=Cc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL94";"PHYSOSTIGMINE";"4.0";"275.35";"0";"1.77";"PHYSOSTIGMINE";"CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1103";"FURAZOLIDONE";"4.0";"225.16";"0";"0.97";"FURAZOLIDONE";"O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1230333";"";"None";"170.23";"0";"2.16";"4-(2-THIENYL)BUTYRIC ACID";"O=C(O)CCCc1cccs1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL47";"ALPHA-TOCOPHEROL";"None";"430.72";"1";"8.84";"ALPHA-TOCOPHEROL";"Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL942";"BISACODYL";"4.0";"361.40";"0";"4.11";"BISACODYL";"CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1489";"AZACITIDINE";"4.0";"244.21";"0";"-3.17";"AZACITIDINE";"Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1256017";"ARCAINE SULFATE";"None";"270.31";"1";"-1.27";"ARCAINE SULFATE";"N=C(N)NCCCCNC(=N)N.O=S(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201207";"BETAMETHASONE PHOSPHORIC ACID";"4.0";"472.45";"0";"2.01";"BETAMETHASONE PHOSPHATE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL9419";"METACETAMOL";"2.0";"151.16";"0";"1.35";"table 1, 11";"CC(=O)Nc1cccc(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1458880";"CADMIUM DICHLORIDE";"None";"183.32";"None";"None";"CADMIUM CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL437002";"";"None";"297.37";"0";"3.92";"1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"O=C(c1ccccc1F)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1403281";"ERGOCRYPTINE";"None";"575.71";"1";"2.43";"ALPHA-ERGOCRYPTINE";"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2178579";"ELUBRIXIN";"2.0";"463.32";"0";"3.08";"31, SB-656933";"O=C(Nc1ccc(Cl)c(S(=O)(=O)N2CCNCC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"260.7";"nM";"6.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2184852";"Antagonist activity at CXCR2 assessed as inhibition of neutrophil CD11b up-regulation";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176887";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL4070506";"";"None";"468.02";"0";"4.07";"48";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CCN(C3CCC3)CC2)c1O";"IC50";"'='";"501.19";"nM";"6.30";"";"";"UO_0000065";"13.46";"0.28";"2.23";"6.38";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4072010";"";"None";"437.90";"0";"3.20";"44";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(F)(F)CN(C)C)c1O";"IC50";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"14.16";"0.30";"3.00";"6.28";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL158";"AZTREONAM";"4.0";"435.44";"0";"-1.17";"AZTREONAM";"C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL193482";"ESTRIOL";"4.0";"288.39";"0";"2.58";"ESTRIOL";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3342310";"";"None";"396.44";"0";"4.55";"BDBM150832";"COC(=O)c1ccccc1CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'='";"759.0";"nM";"6.12";"";"290342";"UO_0000065";"15.44";"0.30";"1.57";"8.96";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342302";"";"None";"370.42";"1";"5.21";"BDBM150839";"Cc1cccc(CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)c1F";"IC50";"'>'";"10000.0";"nM";"";"";"290349";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658248";"";"None";"389.46";"1";"5.31";"BDBM150864";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cccc3cccnc23)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290374";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL255289";"";"None";"427.50";"0";"4.02";"23";"CC(C)S(=O)(=O)NC(=O)CCCc1c(-c2ccc(F)cc2)[nH]c2ccc(C#N)cc12";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"15.57";"0.30";"2.64";"6.47";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL402942";"";"None";"458.52";"0";"2.77";"33";"COCCNS(=O)(=O)NC(=O)CCCc1c(-c2ccc(F)cc2)[nH]c2ccc(C#N)cc12";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"14.36";"0.28";"3.82";"5.31";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL3901913";"";"None";"539.61";"1";"3.46";"BDBM236806";"COC(=O)[C@H]1CCCN1C(=O)c1cccc(Nc2c(NC(c3ccc(C)o3)C3CCCS3)c(=O)c2=O)c1O";"IC50";"'='";"86.0";"nM";"7.07";"";"412474";"UO_0000065";"13.09";"0.25";"3.61";"5.11";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL945";"AMILORIDE";"4.0";"229.63";"0";"-1.08";"AMILORIDE";"N=C(N)NC(=O)c1nc(Cl)c(N)nc1N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL42710";"EUGENOL";"0.5";"164.20";"0";"2.13";"EUGENOL";"C=CCc1ccc(O)c(OC)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1628227";"DOXEPIN";"4.0";"279.38";"0";"3.96";"DOXEPIN";"CN(C)CCC=C1c2ccccc2COc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1732";"DIHYDROERGOTAMINE";"4.0";"583.69";"1";"2.08";"DIHYDROERGOTAMINE";"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL420";"GUANABENZ";"4.0";"231.09";"0";"1.81";"GUANABENZ";"N=C(N)N/N=C/c1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL461727";"AMYGDALIN";"None";"457.43";"2";"-3.11";"AMYGDALIN(D)";"N#C[C@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1747";"TOBRAMYCIN";"4.0";"467.52";"2";"-6.30";"TOBRAMYCIN";"NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL625";"THIABENDAZOLE";"4.0";"201.25";"0";"2.69";"THIABENDAZOLE";"c1ccc2[nH]c(-c3cscn3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1504";"TRIAMCINOLONE ACETONIDE";"4.0";"434.50";"0";"2.42";"TRIAMCINOLONE ACETONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL444633";"RIFABUTIN";"4.0";"847.02";"2";"4.62";"RIFABUTIN";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL18701";"RO-201724";"None";"278.35";"0";"2.10";"Ro-201724";"CCCCOc1cc(CC2CNC(=O)N2)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1388";"MONOBENZONE";"4.0";"200.24";"0";"2.97";"MONOBENZONE";"Oc1ccc(OCc2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1095699";"AZASERINE";"2.0";"173.13";"0";"-1.76";"AZASERINE";"[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL460291";"LACIDIPINE";"4.0";"455.55";"0";"4.40";"LACIDIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL418971";"BISPHENOL A";"None";"228.29";"0";"3.42";"BISPHENOL A";"CC(C)(c1ccc(O)cc1)c1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL585";"TRIAMTERENE";"4.0";"253.27";"0";"0.83";"TRIAMTERENE";"Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL54126";"NEOSTIGMINE BROMIDE";"4.0";"303.20";"0";"1.94";"NEOSTIGMINE BROMIDE";"CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200862";"METYROSINE";"4.0";"195.22";"0";"0.74";"METYROSINE";"C[C@](N)(Cc1ccc(O)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909079";"STANNOUS FLUORIDE";"4.0";"156.71";"None";"None";"STANNOUS FLUORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL621";"TRAZODONE";"4.0";"371.87";"0";"2.36";"TRAZODONE";"O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1321154";"ROXARSONE";"None";"263.04";"None";"None";"ROXARSONE";"O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL190";"THEOPHYLLINE";"4.0";"180.17";"0";"-1.04";"THEOPHYLLINE";"Cn1c(=O)c2[nH]cnc2n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909062";"LEAD (II) ACETATE";"None";"325.29";"None";"None";"LEAD (II) ACETATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL433257";"HARRINGTONINE";"None";"531.60";"1";"2.19";"HARRINGTONINE";"COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL26260";"BETA-NAPHTHOFLAVONE";"None";"272.30";"0";"4.61";"BETA-NAPHTHOFLAVONE";"O=c1cc(-c2ccccc2)oc2ccc3ccccc3c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL567597";"ARTEMISININ";"4.0";"282.34";"0";"2.39";"Artemisinin";"C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL271013";"";"None";"347.47";"0";"2.75";"1";"C[C@H](CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"22.70";"0.47";"5.14";"8.13";"1";"CHEMBL2351084";"Displacement of [125I]-IL8 from human CXCR2 transfected in HEK293 cells after 4 hrs by microbeta counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346562";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3307715";"";"";""
"CHEMBL3654435";"";"None";"409.53";"0";"4.56";"BDBM150259";"CC(C)(NC(=O)c1ccc2c(c1OCCCCc1ccccc1)CCCC2)C(=O)O";"IC50";"'='";"2000.0";"nM";"5.70";"";"289674";"UO_0000065";"";"";"";"";"0";"CHEMBL3705676";"Calcium Fluorescence Assay: The assay is based on the detection of intracellular calcium changes detected by the selective, calcium-chelating dye, Fluo-4 (Molecular Probes). A large fluorescence intensity increase is observed upon calcium association with Fluo-4. The dye is delivered to the cell interior using an acetoxymethylester form of Fluo-4, where the intracellular esterase activity results in the charged species being released and trapped within the cytoplasm of the cell. hence, influx of calcium to this cytoplasmic pocket, via release from intracellular pools and the phospholipase C cascade can be detected. By co-expressing the CXCR2 receptor and the promiscuous Galpha 16 protein, activation of this chemokine receptor is directed into this phospholipase C cascade resulting in intracellular calcium mobilization.The CHOK1 cells stably transfected with human CXCR2 and the promiscuous Galpha 16 protein were maintained in a log phase of growth at 37 C. and 5% CO2 in the following media: Iscove's.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638454";"37";"BindingDB Database";"";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3929680";"";"None";"445.33";"0";"3.26";"Ex 12";"O=C(Nc1cccnc1Cl)Nc1ccc(Cl)c(S(=O)(=O)C2CCCNC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL1201356";"METHYLERGONOVINE";"4.0";"339.44";"0";"1.92";"METHYLERGONOVINE";"CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL114";"SAQUINAVIR";"4.0";"670.86";"1";"3.09";"SAQUINAVIR";"CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1679";"LEUCOVORIN";"4.0";"473.45";"1";"-0.73";"LEUCOVORIN";"Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL374478";"RIFAMPIN";"4.0";"822.95";"3";"4.34";"RIFAMPIN";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL727";"THIOGUANINE";"4.0";"167.20";"0";"0.60";"THIOGUANINE";"Nc1nc2[nH]cnc2c(=S)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1630578";"TIRILAZAD";"3.0";"624.87";"2";"5.46";"TIRILAZAD";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL26";"SULPIRIDE";"4.0";"341.43";"0";"0.56";"SULPIRIDE";"CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3941989";"";"None";"481.98";"0";"4.54";"Ex 4";"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@@H]2C[C@H]3CC[C@@H](C2)N3C)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL1087";"MEPIVACAINE";"4.0";"246.35";"0";"2.73";"MEPIVACAINE";"Cc1cccc(C)c1NC(=O)C1CCCCN1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL86284";"";"None";"301.80";"0";"3.94";"31";"Sc1nc(-c2ccc(Cl)cc2)nn1Cc1ccccc1";"IC50";"'='";"830.0";"nM";"6.08";"";"";"UO_0000065";"20.15";"0.42";"2.14";"19.80";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL192";"SILDENAFIL";"4.0";"474.59";"0";"1.61";"SILDENAFIL";"CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL44";"GENISTEIN";"2.0";"270.24";"0";"2.58";"GENISTEIN";"O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201195";"CEFMETAZOLE";"4.0";"471.55";"1";"-0.73";"CEFMETAZOLE";"CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200629";"VECURONIUM BROMIDE";"4.0";"637.74";"2";"5.97";"VECURONIUM BROMIDE";"CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL19019";"NALTREXONE";"4.0";"341.41";"0";"1.53";"NALTREXONE";"O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL91";"MICONAZOLE";"4.0";"416.13";"1";"6.45";"MICONAZOLE";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1046";"AMINOCAPROIC ACID";"4.0";"131.18";"0";"0.59";"AMINOCAPROIC ACID";"NCCCCCC(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL40583";"3-METHYLCHOLANTHRENE";"None";"268.36";"1";"5.55";"3-METHYLCHOLANTHRENE";"Cc1ccc2cc3c(ccc4ccccc43)c3c2c1CC3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201346";"BALSALAZIDE";"4.0";"357.32";"0";"2.71";"BALSALAZIDE";"O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL227934";"STRYCHNINE";"-1.0";"334.42";"0";"2.09";"STRYCHNINE";"O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3951018";"";"None";"498.44";"0";"3.24";"14";"CC1CCN(C(=O)C(CCn2cccc2C#N)NS(=O)(=O)c2cc(Cl)c(N)c(Cl)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3863314";"Antagonist activity at human CXCR2 assessed as inhibition of GROalpha-induced calcium flux";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3862010";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3426950";"";"None";"426.23";"None";"None";"BDBM150816";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cc3c(cc2B(O)O)OCO3)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290326";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342287";"";"None";"419.48";"1";"5.73";"BDBM150857";"Cc1noc(-c2ccccc2)c1CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"290367";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342275";"";"None";"346.43";"0";"4.13";"BDBM150889";"O=C(Nc1ccc(F)cc1)c1ccc(SCC2CCCCO2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290399";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658297";"";"None";"367.40";"0";"3.84";"BDBM150924";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2ccccn2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290434";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL204552";"";"None";"453.59";"0";"4.94";"27";"CC(C)(CO)Nc1nc(SCc2cccc(Oc3ccccc3)c2)nc2nc(N)sc12";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"16.10";"0.32";"2.36";"6.88";"0";"CHEMBL862382";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 membranes by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149469";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307715";"";"";""
"CHEMBL429791";"";"None";"399.90";"0";"3.55";"29";"C[C@H](CO)Nc1nc(SCc2cccc(Cl)c2F)nc2nc(N)sc12";"IC50";"'='";"3.981";"nM";"8.40";"";"";"UO_0000065";"21.01";"0.46";"4.85";"8.66";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL389791";"";"None";"413.48";"0";"2.39";"3";"C[C@@H](O)[C@@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(N)sc12";"IC50";"'='";"15.85";"nM";"7.80";"";"";"UO_0000065";"18.86";"0.39";"5.41";"6.66";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL234184";"";"None";"323.76";"0";"2.63";"9a";"O=S1(=O)N=C(Nc2ccccc2)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"17.36";"0.37";"2.99";"6.19";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL234393";"";"None";"402.66";"0";"3.39";"9e";"O=S1(=O)N=C(Nc2cccc(Br)c2)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"6100.0";"nM";"5.21";"";"";"UO_0000065";"12.95";"0.32";"1.82";"5.74";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL234186";"";"None";"358.21";"0";"3.28";"9c";"O=S1(=O)N=C(Nc2ccccc2Cl)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL896517";"Antagonist activity at CXCR2 receptor expressed in CHOK1 cells assessed as human IL8-induced calcium mobilization by FLIPR";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3906495";"";"None";"462.33";"0";"4.01";"Ex 15";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCCNC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3916281";"";"None";"478.79";"0";"4.52";"Ex 16";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCCNC2)c1O)Nc1cccc(Cl)c1Cl";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3979652";"";"None";"453.50";"0";"3.06";"BDBM236792";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2(C)CCCO2)o1";"IC50";"'='";"89.0";"nM";"7.05";"";"412459";"UO_0000065";"15.55";"0.29";"3.99";"5.82";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3039531";"DANIRIXIN";"2.0";"441.91";"0";"3.66";"Ex 1";"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCCNC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3890888";"";"None";"423.92";"0";"3.39";"Ex 37";"CCc1ccccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@@H]2CCNC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL1221512";"";"None";"559.80";"1";"1.75";"L-744832";"CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4067429";"";"None";"414.91";"0";"3.23";"68";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@@]2(C)CCOC2)c1O";"IC50";"'='";"39.81";"nM";"7.40";"";"";"UO_0000065";"17.84";"0.37";"4.17";"7.07";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4070506";"";"None";"468.02";"0";"4.07";"48";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CCN(C3CCC3)CC2)c1O";"IC50";"'='";"0.3981";"nM";"9.40";"";"";"UO_0000065";"20.08";"0.41";"5.33";"9.52";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4103349";"";"None";"440.87";"0";"4.39";"41";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)(C)C(F)(F)F)c1O";"IC50";"'='";"0.5012";"nM";"9.30";"";"";"UO_0000065";"21.09";"0.45";"4.91";"9.74";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL450895";"NYSTATIN";"4.0";"926.11";"3";"0.94";"NYSTATIN";"C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909067";"";"None";"None";"None";"None";"MC 258714";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1518";"PROPYLTHIOURACIL";"4.0";"170.24";"0";"1.38";"PROPYLTHIOURACIL";"CCCc1cc(=O)[nH]c(=S)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL679";"EPINEPHRINE";"4.0";"183.21";"0";"0.35";"EPINEPHRINE";"CNC[C@H](O)c1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL6";"INDOMETHACIN";"4.0";"357.79";"0";"3.93";"INDOMETHACIN";"COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4088551";"";"None";"456.99";"0";"4.25";"58";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)(C)C2CCOCC2)c1O";"IC50";"'='";"0.5012";"nM";"9.30";"";"";"UO_0000065";"20.35";"0.42";"5.05";"8.88";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4062546";"";"None";"414.91";"0";"3.23";"66";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2(C)CCOC2)c1O";"IC50";"'='";"125.89";"nM";"6.90";"";"";"UO_0000065";"16.63";"0.35";"3.67";"6.59";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3979652";"";"None";"453.50";"0";"3.06";"60";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2(C)CCCO2)o1";"IC50";"'='";"63.1";"nM";"7.20";"";"";"UO_0000065";"15.88";"0.30";"4.14";"5.94";"0";"CHEMBL5257245";"Antagonist activity at CXCR2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5257017";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"ANTAGONIST";""
"CHEMBL3654443";"";"None";"478.40";"None";"None";"BDBM150826";"CC1(C)OB(c2ccccc2CCSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)OC1(C)C";"IC50";"'='";"611.0";"nM";"6.21";"";"290336";"UO_0000065";"12.99";"None";"None";"None";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342313";"";"None";"464.37";"None";"None";"BDBM150827";"CC1(C)OB(c2ccccc2CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)OC1(C)C";"IC50";"'='";"275.0";"nM";"6.56";"";"290337";"UO_0000065";"14.13";"None";"None";"None";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3654446";"";"None";"548.37";"None";"None";"BDBM150830";"CC1(C)OB(c2ccc(OC(F)(F)F)cc2CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)OC1(C)C";"IC50";"'='";"72.0";"nM";"7.14";"";"290340";"UO_0000065";"13.03";"None";"None";"None";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL832";"SULFINPYRAZONE";"4.0";"404.49";"0";"3.80";"SULFINPYRAZONE";"O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL218387";"";"None";"472.75";"0";"3.42";"6c";"CN(C)S(=O)(=O)c1c(Cl)ccc(N/C(=N/C#N)Nc2ccccc2Br)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"Antagonist";"UO_0000065";"17.56";"0.42";"4.88";"7.05";"0";"CHEMBL908413";"Displacement of [125I]IL8 from CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139694";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"ANTAGONIST";""
"CHEMBL213943";"";"None";"351.36";"0";"1.89";"13";"CCNC(=O)c1cccc(/N=c2\c(O)c(O)\c2=N/c2ccccc2)c1O";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"20.46";"0.38";"5.30";"6.28";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL527";"PIROXICAM";"4.0";"331.35";"0";"1.58";"PIROXICAM";"CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1729";"CISAPRIDE";"4.0";"465.95";"0";"3.36";"CISAPRIDE";"COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL12";"DIAZEPAM";"4.0";"284.75";"0";"3.15";"DIAZEPAM";"CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL411";"DIETHYLSTILBESTROL";"4.0";"268.36";"0";"4.83";"DIETHYLSTILBESTROL";"CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL34431";"CILOSTAMIDE";"2.0";"342.44";"0";"3.48";"CILOSTAMIDE";"CN(C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL451";"CHLORDIAZEPOXIDE";"4.0";"299.76";"0";"2.95";"Chlordiazepoxide";"CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1231530";"BETAMIPRON";"2.0";"193.20";"0";"0.89";"BETAMIPRON";"O=C(O)CCNC(=O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3215298";"ABAMECTIN";"3.0";"1732.15";"None";"None";"ABAMECTIN";"CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL218115";"";"None";"383.40";"0";"2.59";"19";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccco1";"IC50";"'='";"3.8";"nM";"8.42";"";"";"UO_0000065";"21.96";"0.41";"5.83";"7.53";"0";"CHEMBL909848";"Displacement of [125I]hCXCL8 from human CXCR2 receptor expressed in BaF3 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307634";"";"";""
"CHEMBL254370";"";"None";"393.44";"0";"3.00";"15";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccccc1";"IC50";"'='";"6.8";"nM";"8.17";"";"";"UO_0000065";"20.76";"0.38";"5.17";"8.27";"0";"CHEMBL909848";"Displacement of [125I]hCXCL8 from human CXCR2 receptor expressed in BaF3 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307634";"";"";""
"CHEMBL631";"PROPAFENONE";"4.0";"341.45";"0";"3.24";"PROPAFENONE";"CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL211468";"";"None";"351.36";"0";"1.85";"15";"CN(C)C(=O)c1cccc(/N=c2\c(O)c(O)\c2=N/c2ccccc2)c1O";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"24.76";"0.46";"6.85";"8.23";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL209782";"";"None";"309.28";"0";"2.51";"3";"O=c1c(O)c(Nc2ccc([N+](=O)[O-])cc2)/c1=N/c1ccccc1";"IC50";"'='";"8600.0";"nM";"5.07";"";"";"UO_0000065";"16.38";"0.30";"2.56";"4.83";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL387431";"";"None";"385.81";"0";"2.50";"16";"CN(C)C(=O)c1cc(Cl)cc(/N=c2\c(O)c(O)\c2=N/c2ccccc2)c1O";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"22.55";"0.44";"6.20";"8.23";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL4066510";"";"None";"428.94";"0";"3.62";"59";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2(C)CCOCC2)c1O";"IC50";"'='";"0.5012";"nM";"9.30";"";"";"UO_0000065";"21.68";"0.45";"5.68";"8.88";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4082031";"";"None";"453.32";"0";"3.70";"37";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2(F)CCOCC2)c1O)N[C@@H]1CCC=C1Cl";"IC50";"'='";"0.5012";"nM";"9.30";"";"";"UO_0000065";"20.52";"0.45";"5.60";"8.88";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4071499";"";"None";"407.32";"0";"4.02";"31";"CC1=C(Cl)CCC1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)C)c1O";"IC50";"'='";"3.162";"nM";"8.50";"";"";"UO_0000065";"20.87";"0.46";"4.48";"8.90";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3342309";"";"None";"382.42";"0";"4.46";"49";"O=C(O)c1cccc(CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)c1";"IC50";"'='";"2120.0";"nM";"5.67";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342291";"";"None";"338.41";"0";"4.77";"30";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccccc2)nc1";"IC50";"'='";"390.0";"nM";"6.41";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3818984";"";"None";"433.29";"0";"4.81";"15";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"0.3162";"nM";"9.50";"";"";"UO_0000065";"21.93";"0.48";"4.69";"9.95";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3342297";"";"None";"420.47";"1";"5.12";"BDBM150845";"Cc1nc(-c2ccc(CSc3ccc(C(=O)Nc4ccc(F)cc4)cn3)cc2)no1";"IC50";"'>'";"10000.0";"nM";"";"";"290355";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658245";"";"None";"410.47";"0";"4.93";"BDBM150861";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cccc3c2OCCCO3)nc1";"IC50";"'='";"350.0";"nM";"6.46";"";"290371";"UO_0000065";"15.73";"0.30";"1.53";"10.68";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658259";"";"None";"396.47";"0";"4.77";"BDBM150875";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cccc3nsnc23)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290385";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658263";"";"None";"395.48";"1";"5.38";"BDBM150879";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2nc3ccccc3s2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290389";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658324";"";"None";"424.45";"0";"4.22";"BDBM150952";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2cccc3c2OCCO3)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290462";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342316";"";"None";"432.27";"None";"None";"BDBM150971";"O=C(Nc1ccc(-c2nn[nH]n2)cc1)c1ccc(SCc2ccccc2B(O)O)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290482";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658344";"";"None";"355.39";"0";"3.18";"BDBM150982";"O=C(Nc1ccc(F)cn1)c1ccc([S+]([O-])Cc2ccccc2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290492";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3901913";"";"None";"539.61";"1";"3.46";"BDBM236806";"COC(=O)[C@H]1CCCN1C(=O)c1cccc(Nc2c(NC(c3ccc(C)o3)C3CCCS3)c(=O)c2=O)c1O";"IC50";"'='";"30.0";"nM";"7.52";"";"412472";"UO_0000065";"13.94";"0.27";"4.06";"5.44";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3935902";"";"None";"513.57";"2";"2.63";"BDBM236811";"COC(=O)CNCC(=O)c1cccc(Nc2c(NC(c3ccc(C)o3)C3CCCS3)c(=O)c2=O)c1O";"IC50";"'='";"153.0";"nM";"6.82";"";"412478";"UO_0000065";"13.27";"0.26";"4.19";"4.64";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL112";"ACETAMINOPHEN";"4.0";"151.16";"0";"1.35";"ACETAMINOPHEN";"CC(=O)Nc1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1513";"IRBESARTAN";"4.0";"428.54";"0";"4.78";"IRBESARTAN";"CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1741";"CLARITHROMYCIN";"4.0";"747.96";"2";"2.44";"CLARITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL30";"CIMETIDINE";"4.0";"252.35";"0";"0.60";"CIMETIDINE";"CN/C(=N\CCSCc1nc[nH]c1C)NC#N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL28079";"ZAPRINAST";"2.0";"271.28";"0";"1.50";"ZAPRINAST";"CCCOc1ccccc1-c1nc2[nH]nnc2c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL399223";"";"None";"490.74";"0";"4.13";"10n";"O=C(c1c(Cl)ccc(Nc2c(Nc3ccccc3Br)c(=O)c2=O)c1O)N1CCCC1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"15.39";"0.34";"3.42";"7.65";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL1454";"LEVAMISOLE";"4.0";"204.30";"0";"2.15";"LEVAMISOLE";"c1ccc([C@H]2CN3CCSC3=N2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL480";"LANSOPRAZOLE";"4.0";"369.37";"0";"3.52";"LANSOPRAZOLE";"Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL16073";"PHENACETIN";"4.0";"179.22";"0";"2.04";"PHENACETIN";"CCOc1ccc(NC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2108139";"POVIDONE";"4.0";"None";"None";"None";"POLYVINYLPYRROLIDONE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL184185";"";"None";"384.62";"0";"3.55";"3";"NC(=O)c1c(Cl)ccc(NC(=O)Nc2ccccc2Br)c1O";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"20.80";"0.50";"4.45";"7.66";"0";"CHEMBL828744";"Concentration required to inhibit [125I]IL-8 binding towards C-X-C chemokine receptor type 2 of human expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137097";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3308072";"";"";""
"CHEMBL220860";"";"None";"407.88";"0";"2.97";"6a";"Cc1ccccc1N/C(=N\C#N)Nc1ccc(Cl)c(S(=O)(=O)N(C)C)c1O";"IC50";"'='";"17.0";"nM";"7.77";"";"Antagonist";"UO_0000065";"19.05";"0.39";"4.80";"6.59";"0";"CHEMBL908413";"Displacement of [125I]IL8 from CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139694";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"ANTAGONIST";""
"CHEMBL452864";"";"None";"378.61";"0";"4.59";"1a";"C1=C(CS/C(=N\C2CCCCC2)NC2CCCCC2)N2CCN=C2S1";"IC50";"'<'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL958166";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151747";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";""
"CHEMBL4649901";"";"None";"1495.48";"None";"None";"BLEOMYCIN A2";"Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4100674";"";"None";"414.91";"0";"3.23";"67";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@]2(C)CCOC2)c1O";"IC50";"'='";"158.49";"nM";"6.80";"";"";"UO_0000065";"16.39";"0.34";"3.57";"6.49";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4077201";"";"None";"442.97";"0";"4.01";"60";"CCC1(S(=O)(=O)c2c(Cl)ccc(NC(=O)N[C@@H]3CCC=C3C)c2O)CCOCC1";"IC50";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"14.45";"0.30";"2.39";"6.11";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL508102";"CARBIMAZOLE";"4.0";"186.24";"0";"1.56";"CARBIMAZOLE";"CCOC(=O)n1ccn(C)c1=S";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL243862";"";"None";"409.49";"0";"3.20";"9";"Nc1nc2nc(SCc3cccc(F)c3F)nc(N3CCCC3CO)c2s1";"IC50";"'<'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL231711";"";"None";"386.20";"0";"2.88";"9y";"O=S1(=O)N=C(Nc2ccccc2Br)Nc2c(O)ccc(F)c21";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"14.30";"0.34";"2.64";"6.08";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3986396";"";"None";"401.49";"0";"2.31";"BDBM236786";"Cc1ccc(C(Nc2c(NC3=CC=CN(C)C3O)c(=O)c2=O)C2CCCS2)o1";"IC50";"'='";"44.0";"nM";"7.36";"";"412487";"UO_0000065";"18.32";"0.36";"5.05";"7.76";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL164290";"N-NITROSODIETHYLAMINE";"None";"102.14";"0";"1.01";"N-NITROSODIETHYLAMINE";"CCN(CC)N=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200600";"FLUOROMETHOLONE";"4.0";"376.47";"0";"2.92";"FLUOROMETHOLONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL90555";"VINCRISTINE";"4.0";"824.97";"2";"3.52";"VINCRISTINE";"CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL558551";"";"None";"258.23";"0";"0.09";"(+)-THALIDOMIDE";"O=C1CC[C@@H](N2C(=O)c3ccccc3C2=O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL532";"ERYTHROMYCIN";"4.0";"733.94";"2";"1.79";"ERYTHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL101168";"";"None";"134.14";"0";"0.15";"1-AMINOBENZOTRIAZOLE";"Nn1nnc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL44657";"ETOPOSIDE";"4.0";"588.56";"2";"1.34";"ETOPOSIDE";"COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1463";"FLUCYTOSINE";"4.0";"129.09";"0";"-0.51";"FLUCYTOSINE";"Nc1nc(=O)[nH]cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL577294";"2-HYDROXYPROPYL-BETA-CYCLODEXTRIN";"3.0";"1541.55";"None";"None";"2-HYDROXYPROPYL-BETA-CYCLODEXTRIN";"CC(O)COC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]8COCC(C)O)O[C@@H]7COCC(C)O)O[C@@H]6COCC(C)O)O[C@@H]5COCC(C)O)O[C@@H]4COCC(C)O)O[C@@H]3COCC(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL640";"PROCAINAMIDE";"4.0";"235.33";"0";"1.34";"Procainamide";"CCN(CC)CCNC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL809";"SERTRALINE";"4.0";"306.24";"1";"5.18";"SERTRALINE";"CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL537883";"";"None";"581.52";"1";"3.77";"10k";"Cl.O=c1c(Nc2ccccc2)c(Nc2ccc(Cl)c(S(=O)(=O)N3CCC(N4CCCCC4)CC3)c2O)c1=O";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"14.21";"0.29";"3.97";"6.51";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL241679";"";"None";"273.25";"0";"2.94";"Table 1 C5R10";"O=C(Nc1ccccc1)Nc1c(O)cccc1[N+](=O)[O-]";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL280711";"";"None";"273.25";"0";"2.94";"Table 1 C5R5";"O=C(Nc1ccccc1)Nc1ccc([N+](=O)[O-])cc1O";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"23.77";"0.44";"3.55";"6.22";"1";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL4072010";"";"None";"437.90";"0";"3.20";"44";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(F)(F)CN(C)C)c1O";"IC50";"'='";"1.995";"nM";"8.70";"";"";"UO_0000065";"19.87";"0.42";"5.50";"8.81";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4090813";"";"None";"372.87";"0";"3.46";"32";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)NC2C=CCCC2)c1O";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"21.46";"0.46";"4.54";"8.38";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4079718";"";"None";"446.93";"0";"3.57";"62";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2(CF)CCOCC2)c1O";"IC50";"'='";"1.259";"nM";"8.90";"";"";"UO_0000065";"19.91";"0.42";"5.33";"8.50";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4084077";"";"None";"402.90";"0";"3.08";"54";"COCC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)N[C@@H]2CCC=C2C)c1O";"IC50";"'='";"1.259";"nM";"8.90";"";"";"UO_0000065";"22.09";"0.47";"5.82";"8.50";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4095602";"";"None";"386.90";"0";"3.85";"39";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)(C)C)c1O";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"23.26";"0.49";"5.15";"9.42";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3105081";"";"None";"370.38";"0";"4.07";"25";"Oc1cc(CSc2cccc(F)c2F)nc2cc(-c3ccccn3)nn12";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3104907";"";"None";"410.93";"0";"4.98";"9";"Cc1cc(SCc2cc(O)n3nc(Cc4ccccc4)nc3n2)c(C)cc1Cl";"IC50";"'='";"7800.0";"nM";"5.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL569210";"";"None";"426.45";"0";"2.42";"5h";"CCN(Cc1ccc(F)cc1)Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O";"IC50";"'='";"6340.0";"nM";"5.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1043642";"Antagonist activity at CXCR2 expressed in CHO cells assessed as inhibition of IL-8-induced chemotaxis";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156021";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL852";"MELPHALAN";"4.0";"305.21";"0";"1.93";"MELPHALAN";"N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL61655";"";"None";"338.36";"0";"1.89";"7c";"CC(C)S(=O)(=O)c1ccc(C(=O)Nc2ccc(F)cc2)c[n+]1[O-]";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"18.91";"0.38";"4.51";"7.09";"0";"CHEMBL662153";"Evaluated using an SPA assay with recombinant human [125I]IL-8 and membranes prepared from Sf9 cells expressing human CXCR2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133879";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2001";"CHEMBL3308860";"";"";""
"CHEMBL60578";"";"None";"338.79";"0";"3.49";"4c";"O=C(NC(c1ccccc1)c1ccccc1)c1ccc(Cl)[n+]([O-])c1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL662153";"Evaluated using an SPA assay with recombinant human [125I]IL-8 and membranes prepared from Sf9 cells expressing human CXCR2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133879";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2001";"CHEMBL3308860";"";"";""
"CHEMBL3818793";"";"None";"465.74";"0";"4.56";"18";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCOC2)c1O)Nc1cccc(Cl)c1Cl";"IC50";"'='";"7.943";"nM";"8.10";"";"";"UO_0000065";"17.39";"0.40";"3.54";"7.73";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3818323";"";"None";"412.25";"0";"4.72";"30";"O=C(Nc1ccc(Cl)c(C(=O)N2CCCC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"7.943";"nM";"8.10";"";"";"UO_0000065";"19.65";"0.41";"3.38";"9.92";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL376414";"";"None";"425.49";"0";"3.53";"24";"Cc1ccc([C@H](Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C(C)(C)C)o1";"IC50";"'='";"3.8";"nM";"8.42";"";"";"UO_0000065";"19.79";"0.37";"4.89";"7.53";"0";"CHEMBL909848";"Displacement of [125I]hCXCL8 from human CXCR2 receptor expressed in BaF3 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307634";"";"";""
"CHEMBL219472";"";"None";"379.42";"0";"2.61";"12";"C[C@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccccc1";"IC50";"'='";"244.0";"nM";"6.61";"";"";"UO_0000065";"17.43";"0.32";"4.00";"6.70";"0";"CHEMBL909848";"Displacement of [125I]hCXCL8 from human CXCR2 receptor expressed in BaF3 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307634";"";"";""
"CHEMBL45";"MELATONIN";"4.0";"232.28";"0";"1.86";"MELATONIN";"COc1ccc2[nH]cc(CCNC(C)=O)c2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL267648";"PEFLOXACIN";"4.0";"333.36";"0";"1.61";"PEFLOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1566956";"TROXIPIDE";"2.0";"294.35";"0";"1.19";"TROXIPIDE";"COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1065";"METHYSERGIDE";"None";"353.47";"0";"1.94";"METHYSERGIDE";"CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1167";"SPECTINOMYCIN";"4.0";"332.35";"0";"-2.93";"SPECTINOMYCIN";"CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@@]3(O)C(=O)C[C@@H](C)O[C@H]3O[C@@H]2[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL34259";"METHOTREXATE";"4.0";"454.45";"0";"0.27";"METHOTREXATE";"CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL445206";"ISOEUGENOL";"None";"164.20";"0";"2.43";"ISOEUGENOL";"C/C=C\c1ccc(O)c(OC)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL866";"MYCOPHENOLIC ACID";"4.0";"320.34";"0";"2.73";"MYCOPHENOLIC ACID";"COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL15245";"YOHIMBINE";"4.0";"354.45";"0";"2.65";"YOHIMBINE";"COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1333512";"N,N'-DIPHENYL-P-PHENYLENEDIAMINE";"None";"260.34";"1";"5.17";"N,N'-DIPHENYL-P-PHENYLENEDIAMINE";"c1ccc(Nc2ccc(Nc3ccccc3)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3403850";"";"None";"445.52";"0";"2.20";"43";"C[C@H](CO)Nc1cc(NS(=O)(=O)N2CCC2)nc(SCc2cccc(F)c2F)n1";"IC50";"'='";"3.981";"nM";"8.40";"";"";"UO_0000065";"18.85";"0.40";"6.20";"7.82";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL526";"PROPOFOL";"4.0";"178.27";"0";"3.64";"2, propofol";"CC(C)c1cccc(C(C)C)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL101";"PHENYLBUTAZONE";"4.0";"308.38";"0";"3.79";"PHENYLBUTAZONE";"CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3559671";"POLYVINYL ALCOHOL";"4.0";"None";"None";"None";"POLYVINYL ALCOHOL";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL254370";"";"None";"393.44";"0";"3.00";"8";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccccc1";"IC50";"'='";"6.8";"nM";"8.17";"";"";"UO_0000065";"20.76";"0.38";"5.17";"8.27";"1";"CHEMBL929862";"Displacement of [125I]IL8 from human CXCR2 by SPA assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141536";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL63560";"(R)-BICALUTAMIDE";"None";"430.38";"0";"2.88";"(R)-BICALUTAMIDE";"C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL85728";"4,4'-METHYLENEDIANILINE";"None";"198.27";"0";"2.44";"4,4'-METHYLENEDIANILINE";"Nc1ccc(Cc2ccc(N)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL31184";"BENZO[DEF]CHRYSENE";"0.5";"252.32";"1";"5.74";"BENZO[A]PYRENE";"c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL257177";"";"None";"461.52";"0";"4.67";"24";"N#Cc1ccc2[nH]c(-c3ccc(F)cc3)c(CCCC(=O)NS(=O)(=O)c3ccccc3)c2c1";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"14.27";"0.27";"1.92";"6.40";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL255483";"";"None";"413.47";"0";"3.63";"20";"CCS(=O)(=O)NC(=O)CCCc1c(-c2ccc(F)cc2)[nH]c2ccc(C#N)cc12";"IC50";"'='";"64.0";"nM";"7.19";"";"";"UO_0000065";"17.40";"0.34";"3.56";"7.00";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL254569";"";"None";"400.44";"0";"2.65";"38";"CS(=O)(=O)NC(=O)NCCc1c(-c2ccc(F)cc2)[nH]c2ccc(C#N)cc12";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"15.47";"0.30";"3.54";"5.39";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL257178";"";"None";"453.42";"0";"4.13";"25";"N#Cc1ccc2[nH]c(-c3ccc(F)cc3)c(CCCC(=O)NS(=O)(=O)C(F)(F)F)c2c1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL928889";"Antagonist activity at human cloned CXCR2 by calcium flux FLIPR assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL246108";"";"None";"425.49";"0";"3.71";"16";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cc(C(C)C)co1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"20.88";"0.39";"5.18";"7.94";"0";"CHEMBL886375";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139955";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL4466314";"";"None";"395.46";"0";"2.57";"19";"O=C(c1cccc(Nc2c(NC3C[C@@H]4CC[C@H]3C4)c(=O)c2=O)c1O)N1CCCC1";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4324670";"Antagonist activity at CXCR2 (unknown origin) stably expressed in HEK293 cells co-expressing Galpha16 assessed as reduction in IL-8-induced intracellular calcium change incubated for 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321855";"1";"Scientific Literature";"Eur J Med Chem";"2020";"CHEMBL3307715";"";"";""
"CHEMBL282575";"ESTRADIOL BENZOATE";"4.0";"376.50";"1";"5.12";"SID29214996";"C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL499815";"ATRACTYLOSIDE";"None";"803.00";"2";"1.67";"ATRACTYLOSIDE";"C=C1[C@@H]2CCC3[C@@](CC[C@@H]4[C@H](C(=O)O)C[C@@H](O[C@@H]5O[C@H](CO)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OC(=O)CC(C)C)C[C@@]34C)(C2)[C@@H]1O.[K+].[K+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3104913";"";"None";"384.41";"0";"3.99";"15";"Oc1cc(CSc2ccc(F)c(F)c2)nc2nc(Cc3ccccc3)nn12";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3104904";"";"None";"431.55";"0";"4.84";"6";"Oc1cc(CSc2nc(-c3ccccc3)cs2)nc2nc(Cc3ccccc3)nn12";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3104903";"";"None";"366.45";"0";"3.92";"5";"Cc1cc(SCc2cc(O)n3nc(Cc4ccccc4)nc3n2)c(C)o1";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL165";"RESVERATROL";"3.0";"228.25";"0";"2.97";"RESVERATROL";"Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4085524";"";"None";"423.32";"0";"3.00";"35'";"CC(C)(CO)S(=O)(=O)c1c(Cl)ccc(NC(=O)N[C@H]2CCC=C2Cl)c1O";"IC50";"'='";"501.19";"nM";"6.30";"";"";"UO_0000065";"14.88";"0.33";"3.30";"5.44";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4061195";"";"None";"375.88";"0";"2.05";"24";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)NC2CCN(C)C2)c1O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL1566";"ACARBOSE";"4.0";"645.61";"3";"-8.56";"ACARBOSE";"C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL12131";"CLOSANTEL";"2.0";"663.08";"2";"7.12";"CLOSANTEL";"Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL56337";"EPALRESTAT";"4.0";"319.41";"0";"2.92";"EPALRESTAT";"CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1381098";"1-NAPHTHYLISOTHIOCYANATE";"None";"185.25";"0";"3.57";"1-NAPHTHYL ISOTHIOCYANATE";"S=C=Nc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1598608";"AZASETRON";"2.0";"349.82";"0";"1.52";"AZASETRON";"CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL24";"ATENOLOL";"4.0";"266.34";"0";"0.45";"ATENOLOL";"CC(C)NCC(O)COc1ccc(CC(N)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL60115";"";"None";"254.72";"0";"2.04";"4h";"O=C(NC1CCCCC1)c1ccc(Cl)[n+]([O-])c1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL662153";"Evaluated using an SPA assay with recombinant human [125I]IL-8 and membranes prepared from Sf9 cells expressing human CXCR2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133879";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2001";"CHEMBL3308860";"";"";""
"CHEMBL3310786";"";"None";"363.35";"0";"2.81";"ent-23a";"N#Cc1c(O)nc(SCc2cccc(F)c2F)nc1[C@H]1C[C@@H]1C(=O)O";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3818984";"";"None";"433.29";"0";"4.81";"15";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"12.59";"nM";"7.90";"";"";"UO_0000065";"18.23";"0.40";"3.09";"8.27";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL157101";"KETOCONAZOLE";"4.0";"531.44";"1";"4.21";"KETOCONAZOLE";"CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL18797";"SULINDAC SULFIDE";"-1.0";"340.42";"1";"5.35";"SULINDAC SULFIDE";"CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1009";"LEVODOPA";"4.0";"197.19";"0";"0.05";"LEVODOPA";"N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL54440";"MEVASTATIN";"2.0";"390.52";"0";"3.95";"MEVASTATIN";"CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3818820";"";"None";"479.77";"0";"4.95";"19";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCOCC2)c1O)Nc1cccc(Cl)c1Cl";"IC50";"'='";"0.7943";"nM";"9.10";"";"";"UO_0000065";"18.97";"0.43";"4.15";"8.69";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3342323";"";"None";"440.26";"None";"None";"63";"O=C(O)CN(C(=O)c1ccc(SCc2ccccc2B(O)O)nc1)c1ccc(F)cc1";"IC50";"'='";"1990.0";"nM";"5.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL127";"MEROPENEM";"4.0";"383.47";"0";"-0.31";"Meropenem";"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3403837";"";"None";"434.49";"0";"2.09";"30";"C[C@H](CO)Nc1cc(NS(C)(=O)=O)nc(SCCOc2cccc(F)c2F)n1";"IC50";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"14.27";"0.30";"4.11";"5.47";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3403840";"";"None";"422.45";"0";"2.82";"33";"C[C@H](CO)Nc1cc(NS(=O)(=O)C(F)(F)F)nc(SCc2ccccc2)n1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"18.94";"0.40";"5.18";"7.68";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3310773";"";"None";"369.40";"0";"4.60";"10";"Cc1ccc(-c2nc(SCc3cccc(F)c3F)nc(O)c2C#N)cc1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3310781";"";"None";"347.39";"0";"4.28";"18";"N#Cc1c(O)nc(SCc2cccc(F)c2F)nc1C1CCCC1";"IC50";"'='";"4900.0";"nM";"5.31";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3915145";"";"None";"539.61";"1";"3.46";"BDBM236807";"COC(=O)[C@@H]1CCCN1C(=O)c1cccc(Nc2c(NC(c3ccc(C)o3)C3CCCS3)c(=O)c2=O)c1O";"IC50";"'='";"37.0";"nM";"7.43";"";"412473";"UO_0000065";"13.77";"0.27";"3.97";"5.38";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3913959";"";"None";"526.04";"1";"3.59";"BDBM236813";"Cc1ccc(C(Nc2c(Nc3ccc(Cl)c(S(=O)(=O)N(C)C)c3O)c(=O)c2=O)C2CCCS2)o1";"IC50";"'='";"272.0";"nM";"6.57";"";"412480";"UO_0000065";"12.48";"0.26";"2.98";"5.09";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL84988";"";"None";"268.35";"0";"2.68";"19";"Sc1nc(-c2ccncc2)nn1Cc1ccccc1";"IC50";"'='";"7700.0";"nM";"5.11";"";"";"UO_0000065";"19.06";"0.37";"2.43";"11.73";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL3609000";"";"None";"365.17";"None";"None";"8";"O=C(Nc1ccc(F)cc1)c1ccc(NCc2ccccc2B(O)O)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL291368";"";"None";"278.70";"0";"2.23";"4f";"COc1ccc(NC(=O)c2ccc(Cl)[n+]([O-])c2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL662153";"Evaluated using an SPA assay with recombinant human [125I]IL-8 and membranes prepared from Sf9 cells expressing human CXCR2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133879";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2001";"CHEMBL3308860";"";"";""
"CHEMBL3609001";"";"None";"379.20";"None";"None";"9";"CN(Cc1ccccc1B(O)O)c1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL12948";"SEMUSTINE";"3.0";"247.73";"0";"2.50";"SEMUSTINE";"CC1CCC(NC(=O)N(CCCl)N=O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4079102";"";"None";"404.89";"0";"3.80";"40";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)(C)CF)c1O";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.29";"0.37";"3.20";"7.33";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3817901";"";"None";"421.28";"0";"4.66";"12";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2cccc(F)c2Cl)c1O";"IC50";"'='";"0.5012";"nM";"9.30";"";"";"UO_0000065";"22.08";"0.49";"4.64";"9.74";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL580";"LORAZEPAM";"4.0";"321.16";"0";"3.10";"LORAZEPAM";"O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1660";"RIFAPENTINE";"4.0";"877.04";"4";"5.65";"RIFAPENTINE";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL498";"CHLORPROPAMIDE";"4.0";"276.75";"0";"1.74";"CHLORPROPAMIDE";"CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL595";"PIOGLITAZONE";"4.0";"356.45";"0";"3.16";"PIOGLITAZONE";"CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL476";"DACARBAZINE";"4.0";"182.19";"0";"0.07";"DACARBAZINE";"CN(C)/N=N/c1[nH]cnc1C(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1108";"DROPERIDOL";"4.0";"379.44";"0";"3.68";"DROPERIDOL";"O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL407";"FLUMAZENIL";"4.0";"303.29";"0";"1.77";"FLUMAZENIL";"CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL56564";"TROPISETRON";"4.0";"284.36";"0";"2.95";"TROPISETRON";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)c1c[nH]c3ccccc13)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL865";"VALDECOXIB";"4.0";"314.37";"0";"2.96";"VALDECOXIB";"Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL817";"TOLAZAMIDE";"4.0";"311.41";"0";"1.77";"TOLAZAMIDE";"Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL427526";"(R)-IBUPROPHEN";"1.0";"206.28";"0";"3.07";"R(-)-IBUPROFEN";"CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL468";"THALIDOMIDE";"4.0";"258.23";"0";"0.09";"THALIDOMIDE";"O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200748";"CARBIDOPA";"4.0";"244.25";"0";"-0.05";"S(-)-CARBIDOPA";"C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL157138";"LISURIDE";"4.0";"338.46";"0";"2.84";"LISURIDE";"CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1168";"RAMIPRIL";"4.0";"416.52";"0";"2.38";"RAMIPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL121";"ROSIGLITAZONE";"4.0";"357.44";"0";"2.49";"ROSIGLITAZONE";"CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL242273";"SAFROLE";"-1.0";"162.19";"0";"2.14";"SAFROLE";"C=CCc1ccc2c(c1)OCO2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4066818";"";"None";"372.87";"0";"3.46";"26";"CC1=CCCC1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)C)c1O";"IC50";"'='";"0.3981";"nM";"9.40";"";"";"UO_0000065";"25.21";"0.53";"5.94";"9.84";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4060060";"";"None";"428.94";"0";"3.62";"64";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2(C)CCCOC2)c1O";"IC50";"'='";"199.53";"nM";"6.70";"";"";"UO_0000065";"15.62";"0.33";"3.08";"6.40";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL870";"ALENDRONIC ACID";"4.0";"249.10";"1";"-1.27";"ALENDRONIC ACID";"NCCCC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3819569";"";"None";"435.30";"1";"5.05";"14";"CC(C)(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2cccc(F)c2Cl)c1O";"IC50";"'='";"0.5012";"nM";"9.30";"";"";"UO_0000065";"21.36";"0.47";"4.25";"9.74";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL695";"TRIMETHADIONE";"4.0";"143.14";"0";"0.37";"TRIMETHADIONE";"CN1C(=O)OC(C)(C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL877";"TRANEXAMIC ACID";"4.0";"157.21";"0";"0.84";"TRANEXAMIC ACID";"NC[C@H]1CC[C@H](C(=O)O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL70586";"SPIRADOLINE";"None";"425.40";"0";"4.56";"SPIRADOLINE";"CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL310634";"";"None";"283.36";"0";"2.99";"14";"Oc1cccc(Cn2nc(-c3ccccc3)nc2S)c1";"IC50";"'='";"4400.0";"nM";"5.36";"";"";"UO_0000065";"18.90";"0.37";"2.37";"10.52";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL4091344";"";"None";"426.84";"0";"4.00";"28";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)NC2CCC=C2C(F)(F)F)c1O";"IC50";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"17.81";"0.38";"3.60";"7.96";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3310779";"";"None";"293.30";"0";"2.93";"16";"Cc1nc(SCc2cccc(F)c2F)nc(O)c1C#N";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3609010";"";"None";"366.16";"None";"None";"20";"O=C(Nc1ccc(F)cc1)c1cnc(NCc2ccc(B(O)O)cc2)nc1";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL25573";"";"None";"253.26";"0";"2.91";"1d";"N#Cc1ccc(NC(=O)Nc2ccccc2)c(O)c1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"26.45";"0.48";"3.79";"7.87";"0";"CHEMBL656551";"Inhibition of binding of IL-8 to membranes of cloned CXC chemokine receptor 2 expressed in CHO Cells using [125I]IL-8 radioligand";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149089";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL82328";"";"None";"336.25";"0";"4.59";"32";"Sc1nc(-c2ccc(Cl)c(Cl)c2)nn1Cc1ccccc1";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"18.13";"0.40";"1.51";"19.85";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL315811";"";"None";"370.69";"1";"5.24";"42";"Sc1nc(-c2ccc(Cl)cc2Cl)nn1Cc1ccc(Cl)cc1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"17.60";"0.40";"1.28";"21.24";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL375393";"";"None";"456.30";"0";"2.91";"6p";"CN(C)S(=O)(=O)c1c(F)ccc(N/C(=N/C#N)Nc2ccccc2Br)c1O";"IC50";"'='";"4.0";"nM";"8.40";"";"Antagonist";"UO_0000065";"18.40";"0.42";"5.49";"7.13";"0";"CHEMBL908413";"Displacement of [125I]IL8 from CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139694";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"ANTAGONIST";""
"CHEMBL222075";"";"None";"461.85";"0";"3.68";"6h";"CN(C)S(=O)(=O)c1c(Cl)ccc(N/C(=N/C#N)Nc2ccccc2C(F)(F)F)c1O";"IC50";"'='";"12.0";"nM";"7.92";"";"Antagonist";"UO_0000065";"17.15";"0.36";"4.24";"6.72";"0";"CHEMBL908413";"Displacement of [125I]IL8 from CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139694";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"ANTAGONIST";""
"CHEMBL386505";"";"None";"421.91";"0";"3.22";"6f";"CCc1ccccc1N/C(=N\C#N)Nc1ccc(Cl)c(S(=O)(=O)N(C)C)c1O";"IC50";"'='";"15.0";"nM";"7.82";"";"Antagonist";"UO_0000065";"18.54";"0.38";"4.60";"6.64";"0";"CHEMBL908413";"Displacement of [125I]IL8 from CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139694";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"ANTAGONIST";""
"CHEMBL1148";"TORSEMIDE";"4.0";"348.43";"0";"2.53";"TORSEMIDE";"Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL446458";"";"None";"384.43";"0";"2.74";"2";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2[nH]c(=O)sc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"23.41";"0.49";"6.26";"9.90";"1";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3403830";"";"None";"368.48";"0";"1.93";"16";"C[C@H](CO)Nc1cc(NS(C)(=O)=O)nc(SCc2ccccc2)n1";"IC50";"'='";"79.43";"nM";"7.10";"";"";"UO_0000065";"19.27";"0.40";"5.17";"6.81";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3403855";"";"None";"492.00";"0";"2.34";"48";"C[C@H](CO)Nc1cc(NS(=O)(=O)N2CCOCC2)nc(SCc2cccc(Cl)c2F)n1";"IC50";"'='";"5.012";"nM";"8.30";"";"";"UO_0000065";"16.87";"0.37";"5.96";"7.11";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL424694";"";"None";"280.28";"0";"2.31";"4";"O=c1c(O)c(Nc2ccccc2)/c1=N/c1ccccc1O";"IC50";"'='";"476.0";"nM";"6.32";"";"";"UO_0000065";"22.56";"0.41";"4.01";"7.72";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL436940";"";"None";"413.43";"0";"3.24";"14";"O=C(NCc1ccccc1)c1cccc(Nc2c(O)c(=O)/c2=N\c2ccccc2)c1O";"IC50";"'='";"139.0";"nM";"6.86";"";"";"UO_0000065";"16.59";"0.30";"3.62";"6.18";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL23";"DILTIAZEM";"4.0";"414.53";"0";"3.37";"DILTIAZEM";"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3342305";"";"None";"324.38";"0";"4.62";"45";"O=C(Nc1ccc(F)cc1)c1ccc(Sc2ccccc2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342313";"";"None";"464.37";"None";"None";"53";"CC1(C)OB(c2ccccc2CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)OC1(C)C";"IC50";"'='";"275.0";"nM";"6.56";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL380947";"";"None";"397.48";"0";"3.42";"1";"CC(C)(CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(N)sc12";"IC50";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"19.12";"0.40";"4.18";"7.84";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL380947";"";"None";"397.48";"0";"3.42";"1";"CC(C)(CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(N)sc12";"IC50";"'='";"15.85";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL893602";"Antagonistic activity against human CXCR2 in neutrophils assessed as blockade of GROalpha stimulated calcium mobilisation by FLIPR";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL233264";"";"None";"382.54";"0";"2.91";"33";"Cc1nc(CSc2nc(NC(C)(C)CO)c3sc(N)nc3n2)cs1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"15.68";"0.34";"3.09";"5.46";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL2178579";"ELUBRIXIN";"2.0";"463.32";"0";"3.08";"31, SB-656933";"O=C(Nc1ccc(Cl)c(S(=O)(=O)N2CCNCC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"17.90";"0.39";"5.21";"7.49";"0";"CHEMBL2184853";"Binding affinity to CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176887";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3609002";"";"None";"365.17";"None";"None";"12";"O=C(Nc1ccc(F)cc1)c1ccc(NCc2cccc(B(O)O)c2)nc1";"IC50";"'='";"733.0";"nM";"6.13";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3609015";"";"None";"464.31";"None";"None";"27";"O=C(Nc1ccc(F)cc1)c1ccc(N(Cc2ccc(B(O)O)cn2)CC2CCOCC2)nc1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL258438";"";"None";"427.50";"0";"4.02";"21";"CCCS(=O)(=O)NC(=O)CCCc1c(-c2ccc(F)cc2)[nH]c2ccc(C#N)cc12";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"13.77";"0.27";"1.87";"5.72";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL254567";"";"None";"458.52";"0";"3.10";"35";"COc1cc2[nH]c(-c3ccc(F)cc3)c(CCCC(=O)NS(=O)(=O)N(C)C)c2cc1C#N";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"15.80";"0.31";"4.14";"6.28";"0";"CHEMBL928888";"Displacement of europium labeled-human IL8 from human cloned CXCR2 expressed in Sf9 membrane with Galphai3-beta-1-gamma-2 by DELFIA binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308860";"";"";""
"CHEMBL201800";"";"None";"289.39";"0";"2.54";"18";"Nc1nc2nc(SCc3ccccc3)nc(N)c2s1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"17.28";"0.36";"2.46";"5.51";"0";"CHEMBL862382";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 membranes by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149469";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307715";"";"";""
"CHEMBL239136";"";"None";"384.19";"0";"3.11";"10d";"N#Cc1ccc(Nc2c(Nc3ccccc3Br)c(=O)c2=O)c(O)c1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"20.36";"0.45";"4.71";"7.65";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL4093313";"";"None";"360.86";"0";"3.29";"16";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)NC2CCCC2)c1O";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"22.17";"0.48";"4.71";"8.38";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL577075";"";"None";"346.39";"0";"1.10";"5b";"CCN(CC)Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1043642";"Antagonist activity at CXCR2 expressed in CHO cells assessed as inhibition of IL-8-induced chemotaxis";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156021";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL401893";"";"None";"400.46";"0";"2.45";"30";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1nccs1";"IC50";"'='";"9.8";"nM";"8.01";"";"";"UO_0000065";"20.00";"0.39";"5.56";"7.17";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL86001";"";"None";"273.39";"0";"3.34";"26";"Sc1nc(-c2cccs2)nn1Cc1ccccc1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"20.85";"0.43";"2.36";"18.56";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL38182";"";"None";"357.17";"0";"3.24";"1";"N#Cc1ccc(NC(=O)Nc2ccccc2Br)c2nn[nH]c12";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"22.40";"0.50";"4.76";"7.51";"0";"CHEMBL656548";"Displacement of [125I]IL-8 from CHO cell membranes expressing human CX3C chemokine receptor 2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"CHEMBL3308072";"";"";""
"CHEMBL403656";"";"None";"403.41";"0";"2.55";"25";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2[nH]c(=O)c(C#N)cc12";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"19.32";"0.38";"5.25";"6.80";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL404057";"";"None";"363.39";"0";"2.78";"20";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2nccnc12";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"18.03";"0.36";"3.77";"7.82";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL301424";"";"None";"372.38";"0";"2.54";"7e";"O=C(Nc1ccc(F)cc1)c1ccc(S(=O)(=O)c2ccccc2)[n+]([O-])c1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"18.92";"0.37";"4.51";"7.81";"0";"CHEMBL662153";"Evaluated using an SPA assay with recombinant human [125I]IL-8 and membranes prepared from Sf9 cells expressing human CXCR2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133879";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2001";"CHEMBL3308860";"";"";""
"CHEMBL571141";"";"None";"424.46";"0";"2.30";"5f";"CCN(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(OC)cc1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1043642";"Antagonist activity at CXCR2 expressed in CHO cells assessed as inhibition of IL-8-induced chemotaxis";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156021";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL252851";"";"None";"383.40";"0";"2.59";"6";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccco1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"21.65";"0.40";"5.71";"7.42";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL253498";"";"None";"462.30";"0";"3.35";"21";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cc(Br)co1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"17.96";"0.39";"4.95";"7.42";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL541";"BENZOIC ACID";"4.0";"122.12";"0";"1.38";"BENZOIC ACID";"O=C(O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL390191";"";"None";"368.51";"0";"2.52";"34";"Cc1nc(CSc2nc(N[C@H](C)CO)c3sc(N)nc3n2)cs1";"IC50";"'='";"125.89";"nM";"6.90";"";"";"UO_0000065";"18.72";"0.41";"4.38";"6.28";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL556367";"";"None";"606.33";"1";"3.22";"10i";"CN1CCCN(S(=O)(=O)c2c(Cl)ccc(Nc3c(Nc4ccccc4Br)c(=O)c3=O)c2O)CC1.Cl";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"14.04";"0.32";"4.78";"6.72";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3979652";"";"None";"453.50";"0";"3.06";"BDBM236792";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2(C)CCCO2)o1";"IC50";"'='";"94.0";"nM";"7.03";"";"412460";"UO_0000065";"15.49";"0.29";"3.97";"5.80";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL27577";"SALICYLAMIDE";"2.0";"137.14";"0";"0.49";"SALICYLAMIDE";"NC(=O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL58";"MITOXANTRONE";"4.0";"444.49";"1";"-0.14";"MITOXANTRONE";"O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL167911";"DICHLORVOS";"2.0";"220.98";"0";"2.68";"DICHLORVOS";"COP(=O)(OC)OC=C(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL233345";"";"None";"353.79";"0";"2.64";"9m";"COc1ccccc1NC1=NS(=O)(=O)c2cc(Cl)cc(O)c2N1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"18.66";"0.39";"3.96";"6.60";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL393046";"";"None";"341.75";"0";"2.77";"9b";"O=S1(=O)N=C(Nc2ccccc2F)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"740.0";"nM";"6.13";"";"";"UO_0000065";"17.94";"0.38";"3.36";"6.75";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL231710";"";"None";"382.24";"0";"3.05";"9x";"Cc1cc(O)c2c(c1)S(=O)(=O)N=C(Nc1ccccc1Br)N2";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"17.14";"0.41";"3.50";"7.22";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL239136";"";"None";"384.19";"0";"3.11";"3l";"N#Cc1ccc(Nc2c(Nc3ccccc3Br)c(=O)c2=O)c(O)c1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"19.38";"0.42";"4.33";"7.28";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL1688889";"";"None";"504.04";"0";"3.02";"17";"Cc1nn(C)c2nc(N(C)CCN(C)C)c(C(=O)NC(=O)Nc3cccc(OC(C)C)c3)cc12.Cl";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1693901";"Antagonist activity at CXCR2 in human PMN cells assessed as inhibition of CXCL8-induced chemotaxis after 2 hrs trans-well migration assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PMN";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687928";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL253052";"";"None";"433.41";"0";"3.53";"12";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C(F)F)o1";"IC50";"'='";"6.8";"nM";"8.17";"";"";"UO_0000065";"18.84";"0.36";"4.64";"7.30";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL252898";"";"None";"399.47";"0";"3.06";"35";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccsc1";"IC50";"'='";"5.8";"nM";"8.24";"";"";"UO_0000065";"20.62";"0.40";"5.18";"8.34";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL55";"PENTAMIDINE";"4.0";"340.43";"0";"2.88";"PENTAMIDINE";"N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL401894";"";"None";"398.42";"0";"2.29";"32";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cc(C)on1";"IC50";"'='";"7.5";"nM";"8.12";"";"";"UO_0000065";"20.39";"0.38";"5.83";"6.51";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL269707";"";"None";"394.43";"0";"2.39";"49";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccccn1";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"21.16";"0.39";"5.96";"7.48";"0";"CHEMBL927217";"Inhibition of CXCR2-mediated chemotaxis in Ba/F3 cells expressing human CXCR2";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307634";"";"";""
"CHEMBL635";"PREDNISONE";"4.0";"358.43";"0";"1.77";"PREDNISONE";"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL80";"NALOXONE";"4.0";"327.38";"0";"1.30";"NALOXONE";"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL251811";"";"None";"433.46";"0";"3.74";"26";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cc2ccccc2o1";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"19.51";"0.36";"4.72";"7.56";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL424";"SALICYLIC ACID";"4.0";"138.12";"0";"1.09";"SALICYLIC ACID";"O=C(O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL195437";"4-OCTYLPHENOL";"None";"206.33";"0";"4.30";"4-OCTYLPHENOL";"CCCCCCCCc1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3104897";"";"None";"461.52";"0";"3.66";"34";"CS(=O)(=O)Nc1cc(CSc2cccc(F)c2F)nc2nc(Cc3ccccc3)nn12";"IC50";"'='";"13900.0";"nM";"4.86";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3105079";"";"None";"398.44";"0";"4.19";"23";"Oc1cc(CSc2cccc(F)c2F)nc2nc(CCc3ccccc3)nn12";"IC50";"'='";"470.0";"nM";"6.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL1200656";"NATAMYCIN";"4.0";"665.73";"3";"0.12";"PIMARICIN";"C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3104909";"";"None";"438.56";"1";"5.69";"11";"Cc1ccc(-c2cccc(SCc3cc(O)n4nc(Cc5ccccc5)nc4n3)c2)cc1";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL429023";"ROTENONE";"None";"394.42";"0";"3.70";"ROTENONE";"C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL191413";"REPARIXIN";"3.0";"283.39";"0";"2.06";"32";"CC(C)Cc1ccc([C@@H](C)C(=O)NS(C)(=O)=O)cc1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"24.70";"0.50";"4.94";"11.07";"0";"CHEMBL2184853";"Binding affinity to CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176887";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL707";"DOXAZOSIN";"4.0";"451.48";"0";"1.72";"DOXAZOSIN";"COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL453";"SULFISOXAZOLE";"4.0";"267.31";"0";"1.67";"SULFISOXAZOLE";"Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2252949";"(-)-CAMPHOR";"None";"152.24";"0";"2.40";"L-CAMPHOR";"CC1(C)[C@H]2CC[C@]1(C)C(=O)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4086957";"";"None";"394.83";"0";"3.66";"42";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)(F)F)c1O";"IC50";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"15.70";"0.34";"2.54";"6.49";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL1489254";"TRIACETIN";"2.0";"218.21";"0";"0.04";"TRIACETIN";"CC(=O)OCC(COC(C)=O)OC(C)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL895";"NALBUPHINE";"4.0";"357.45";"0";"1.71";"NALBUPHINE";"Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL723";"CARVEDILOL";"4.0";"406.48";"0";"3.74";"CARVEDILOL";"COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL765";"GUANETHIDINE";"4.0";"198.31";"0";"0.74";"GUANETHIDINE";"N=C(N)NCCN1CCCCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL472";"GLYBURIDE";"4.0";"494.01";"0";"3.64";"GLYBURIDE";"COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL87282";"";"None";"281.38";"0";"3.59";"27";"Cc1ccccc1-c1nc(S)n(Cc2ccccc2)n1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"20.80";"0.40";"2.26";"19.06";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL456807";"PHENYLHYDRAZINE";"None";"108.14";"0";"0.97";"PHENYLHYDRAZINE";"NNc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1479";"DANAZOL";"4.0";"337.46";"0";"4.22";"DANAZOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL711";"PHENINDIONE";"4.0";"222.24";"0";"2.85";"PHENINDIONE";"O=C1c2ccccc2C(=O)C1c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL213130";"";"None";"357.41";"0";"1.85";"18";"CN(C)C(=O)c1cccc(/N=c2\c(O)c(O)\c2=N/C2CCCCC2)c1O";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"22.38";"0.42";"6.15";"7.57";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL211609";"";"None";"355.35";"0";"1.31";"25";"CN(C)C(=O)c1cccc(/N=c2\c(O)c(O)\c2=N/Cc2ccco2)c1O";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"20.79";"0.39";"6.08";"6.22";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL209121";"";"None";"294.31";"0";"2.50";"2";"CN(c1ccccc1O)c1c(Nc2ccccc2)c(=O)c1=O";"IC50";"'='";"28600.0";"nM";"4.54";"";"";"UO_0000065";"15.44";"0.28";"2.04";"6.52";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL209858";"";"None";"325.28";"0";"2.22";"5";"O=c1c(O)c(Nc2cc([N+](=O)[O-])ccc2O)/c1=N/c1ccccc1";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"22.29";"0.41";"5.03";"5.80";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL233263";"";"None";"337.43";"0";"2.35";"32";"C[C@H](CO)Nc1nc(SCc2ccco2)nc2nc(N)sc12";"IC50";"'='";"31.62";"nM";"7.50";"";"";"UO_0000065";"22.23";"0.47";"5.15";"6.81";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL437013";"";"None";"425.53";"0";"4.27";"14";"CC(C)Nc1nc2nc(SCc3cccc(F)c3F)nc(N[C@H](C)CO)c2s1";"IC50";"'='";"31.62";"nM";"7.50";"";"";"UO_0000065";"17.63";"0.37";"3.23";"9.04";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL396043";"";"None";"423.51";"0";"4.02";"12";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(NC3CC3)sc12";"IC50";"'='";"19.95";"nM";"7.70";"";"";"UO_0000065";"18.18";"0.38";"3.68";"9.28";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL238971";"";"None";"647.07";"1";"3.41";"10h";"CCCc1ccccc1Nc1c(Nc2ccc(Cl)c(S(=O)(=O)N3CCN(CC)CC3)c2O)c(=O)c1=O.O=C(O)C(F)(F)F";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"15.19";"0.31";"4.69";"6.80";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL239982";"";"None";"653.40";"1";"2.31";"10g";"CN1CCN(S(=O)(=O)c2c(F)ccc(Nc3c(Nc4ccccc4Br)c(=O)c3=O)c2O)CC1.O=C(O)C(F)(F)F";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"14.62";"0.33";"5.58";"6.62";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3355244";"";"None";"433.86";"0";"3.57";"3n";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)cc(C3CC(F)(F)C3)[nH]2)c1O";"IC50";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"14.29";"0.30";"2.63";"5.53";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL239768";"";"None";"415.47";"0";"2.34";"10e";"Cc1ccccc1Nc1c(Nc2ccc(C)c(S(=O)(=O)N(C)C)c2O)c(=O)c1=O";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"18.83";"0.37";"5.48";"6.76";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL221481";"";"None";"579.52";"1";"3.95";"6o";"CCC(CC)(NS(=O)(=O)c1c(C)ccc(N/C(=N/C#N)Nc2ccccc2Br)c1O)N1CCOCC1";"IC50";"'='";"6.0";"nM";"8.22";"";"Antagonist";"UO_0000065";"14.19";"0.31";"4.27";"5.91";"0";"CHEMBL908413";"Displacement of [125I]IL8 from CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139694";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"ANTAGONIST";""
"CHEMBL376540";"";"None";"452.33";"0";"3.07";"6n";"Cc1ccc(N/C(=N/C#N)Nc2ccccc2Br)c(O)c1S(=O)(=O)N(C)C";"IC50";"'='";"7.0";"nM";"8.15";"";"Antagonist";"UO_0000065";"18.03";"0.41";"5.08";"6.92";"0";"CHEMBL908413";"Displacement of [125I]IL8 from CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139694";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"ANTAGONIST";""
"CHEMBL386072";"";"None";"612.98";"1";"4.39";"6k";"CCC(CC)(NS(=O)(=O)c1c(Cl)ccc(N/C(=N/C#N)Nc2ccccc2Br)c1O)N1CCC(N)CC1";"IC50";"'='";"22.0";"nM";"7.66";"";"Antagonist";"UO_0000065";"12.49";"0.28";"3.27";"4.91";"0";"CHEMBL908413";"Displacement of [125I]IL8 from CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139694";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"ANTAGONIST";""
"CHEMBL425985";"";"None";"469.95";"0";"4.32";"6e";"CN(C)S(=O)(=O)c1c(Cl)ccc(N/C(=N/C#N)Nc2ccccc2-c2ccccc2)c1O";"IC50";"'='";"13.0";"nM";"7.89";"";"Antagonist";"UO_0000065";"16.78";"0.34";"3.57";"6.69";"0";"CHEMBL908413";"Displacement of [125I]IL8 from CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139694";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"ANTAGONIST";""
"CHEMBL240817";"";"None";"305.29";"0";"2.35";"3b";"N#Cc1cccc(Nc2c(Nc3ccccc3)c(=O)c2=O)c1O";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"24.55";"0.45";"5.14";"7.33";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL25573";"";"None";"253.26";"0";"2.91";"Table 1 C5R3";"N#Cc1ccc(NC(=O)Nc2ccccc2)c(O)c1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"26.45";"0.48";"3.79";"7.87";"1";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL238511";"";"None";"359.73";"0";"3.04";"3f";"O=c1c(Nc2ccccc2)c(Nc2cc(Cl)c([N+](=O)[O-])cc2O)c1=O";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"20.25";"0.40";"4.24";"5.99";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL27863";"";"None";"332.16";"0";"3.67";"1e";"N#Cc1ccc(NC(=O)Nc2ccccc2Br)c(O)c1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"22.89";"0.52";"3.93";"8.93";"0";"CHEMBL656551";"Inhibition of binding of IL-8 to membranes of cloned CXC chemokine receptor 2 expressed in CHO Cells using [125I]IL-8 radioligand";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149089";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL1194";"PRILOCAINE";"4.0";"220.32";"0";"2.32";"PRILOCAINE";"CCCNC(C)C(=O)Nc1ccccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1262";"OXICONAZOLE";"4.0";"429.13";"1";"6.12";"OXICONAZOLE";"Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL296419";"ASTEMIZOLE";"4.0";"458.58";"1";"5.35";"ASTEMIZOLE";"COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1502";"PANTOPRAZOLE";"4.0";"383.38";"0";"2.88";"PANTOPRAZOLE";"COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL175";"DEXIBUPROFEN";"4.0";"206.28";"0";"3.07";"DEXIBUPROFEN";"CC(C)Cc1ccc([C@H](C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL15770";"SULINDAC";"4.0";"356.42";"0";"4.37";"SULINDAC";"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL443";"SULFAMETHOXAZOLE";"4.0";"253.28";"0";"1.37";"SULFAMETHOXAZOLE";"Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3354822";"";"None";"393.85";"0";"3.21";"2a";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)c3ccccc3[nH]2)c1O";"IC50";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"15.74";"0.33";"2.99";"5.53";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3354826";"";"None";"419.89";"0";"3.72";"2e";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)c(-c3ccccc3)c[nH]2)c1O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3355238";"";"None";"411.91";"0";"3.71";"3h";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)cc(C3CCCC3)[nH]2)c1O";"IC50";"'='";"19.95";"nM";"7.70";"";"";"UO_0000065";"18.69";"0.39";"3.99";"6.87";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3355239";"";"None";"425.94";"0";"3.96";"3i";"CC1CCCC1c1cc(=O)nc(Nc2ccc(Cl)c(S(=O)(=O)C(C)C)c2O)[nH]1";"IC50";"'='";"31.62";"nM";"7.50";"";"";"UO_0000065";"17.61";"0.37";"3.54";"6.69";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3355240";"";"None";"411.91";"0";"3.50";"3j";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)cc(C3(C)CCC3)[nH]2)c1O";"IC50";"'='";"15.85";"nM";"7.80";"";"";"UO_0000065";"18.94";"0.39";"4.30";"6.95";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3355249";"";"None";"413.93";"0";"3.66";"3s";"Cc1c(C(C)(C)C)[nH]c(Nc2ccc(Cl)c(S(=O)(=O)C(C)C)c2O)nc1=O";"IC50";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"15.94";"0.33";"2.94";"5.88";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL457";"GEMFIBROZIL";"4.0";"250.34";"0";"3.57";"GEMFIBROZIL";"Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200545";"DIFLORASONE DIACETATE";"4.0";"494.53";"0";"2.99";"DIFLORASONE DIACETATE";"CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3403835";"";"None";"420.92";"0";"2.73";"28";"C[C@H](CO)Nc1cc(NS(C)(=O)=O)nc(SCc2cccc(Cl)c2F)n1";"IC50";"'='";"12.59";"nM";"7.90";"";"";"UO_0000065";"18.77";"0.41";"5.17";"7.58";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3310785";"";"None";"391.40";"0";"3.29";"ent-22b";"CCOC(=O)[C@H]1C[C@@H]1c1nc(SCc2cccc(F)c2F)nc(O)c1C#N";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3310785";"";"None";"391.40";"0";"3.29";"ent-22b";"CCOC(=O)[C@H]1C[C@@H]1c1nc(SCc2cccc(F)c2F)nc(O)c1C#N";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL44884";"ETHAMBUTOL";"4.0";"204.31";"0";"-0.29";"ETHAMBUTOL";"CC[C@@H](CO)NCCN[C@@H](CC)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL267044";"LEVOSULPIRIDE";"2.0";"341.43";"0";"0.56";"LEVOSULPIRIDE";"CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL7002";"CIGLITAZONE";"2.0";"333.45";"0";"3.93";"CIGLITAZONE";"CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL742";"KETAMINE";"4.0";"237.73";"0";"2.90";"KETAMINE";"CNC1(c2ccccc2Cl)CCCCC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL118";"CELECOXIB";"4.0";"381.38";"0";"3.51";"CELECOXIB";"Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1515";"METHIMAZOLE";"4.0";"114.17";"0";"0.71";"METHIMAZOLE";"Cn1ccnc1S";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1460";"DIDANOSINE";"4.0";"236.23";"0";"-0.21";"SID49718183";"O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1071";"OXAPROZIN";"4.0";"293.32";"0";"4.03";"OXAPROZIN";"O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1499";"CORTISONE";"3.0";"360.45";"0";"1.99";"CORTISONE";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL976";"PRAZIQUANTEL";"4.0";"312.41";"0";"2.53";"PRAZIQUANTEL";"O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1276308";"MIFEPRISTONE";"4.0";"429.60";"1";"5.41";"MIFEPRISTONE";"CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1467";"ALLOPURINOL";"4.0";"136.11";"0";"0.06";"ALLOPURINOL";"Oc1ncnc2[nH]ncc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3039531";"DANIRIXIN";"2.0";"441.91";"0";"3.66";"Ex 1";"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCCNC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3953055";"";"None";"417.27";"0";"2.48";"Ex 6";"O=C(Nc1cccnc1Cl)Nc1ccc(Cl)c(S(=O)(=O)C2CNC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3910854";"";"None";"462.33";"0";"3.87";"Ex 10";"O=C(Nc1ccc(Cl)c(S(=O)(=O)CC2CCNC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3926993";"";"None";"437.95";"0";"3.78";"Ex 11";"CCc1ccccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CCCNC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3951311";"";"None";"493.89";"0";"4.11";"Ex 13";"O=C(Nc1ccccc1OC(F)(F)F)Nc1ccc(Cl)c(S(=O)(=O)C2CCCNC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3952713";"";"None";"434.28";"0";"3.23";"Ex 8";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CNC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3967642";"";"None";"462.33";"0";"4.01";"Ex 17";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCNCC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL82566";"";"None";"370.69";"1";"5.24";"44";"Sc1nc(-c2ccc(Cl)cc2Cl)nn1Cc1cccc(Cl)c1";"IC50";"'='";"92.0";"nM";"7.04";"";"";"UO_0000065";"18.98";"0.44";"1.80";"22.91";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL1042";"CHOLECALCIFEROL";"4.0";"384.65";"1";"7.62";"CHOLECALCIFEROL";"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL75435";"DEXKETOPROFEN";"4.0";"254.29";"0";"3.11";"DEXKETOPROFEN";"C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3915853";"";"None";"469.56";"0";"3.63";"BDBM177693";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2CCSCC2)o1";"IC50";"'='";"111.0";"nM";"6.96";"";"323500";"UO_0000065";"14.81";"0.29";"3.32";"6.22";"0";"CHEMBL3887210";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the beta -arrestin recruitment after receptor activation type.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 beta -arrestin line results in the recruitment of beta -arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation.>>J. Immunol. 170: 2904-2911).In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with beta -arrestin 2, a beta -arrestin 2 recruitment test for CXCR2 or CXCR1 based on beta -galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886212";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL216981";"NAVARIXIN";"2.0";"397.43";"0";"2.90";"SCH-527123";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"15.97";"0.30";"3.45";"5.67";"0";"CHEMBL3388267";"Antagonist activity at CXCR2 in human whole blood by CD11b assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3701190";"";"None";"438.48";"0";"3.66";"BDBM172332";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)C(C)C)c3O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"100.0";"nM";"7.00";"";"317311";"UO_0000065";"15.96";"0.30";"3.34";"5.94";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL404661";"";"None";"454.32";"0";"3.54";"37";"CS(=O)(=O)NC(=O)NCCc1c(-c2ccc(F)cc2)[nH]c2ccc(Br)cc12";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL928889";"Antagonist activity at human cloned CXCR2 by calcium flux FLIPR assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL201204";"";"None";"453.59";"0";"4.94";"25";"CC[C@@H](CO)Nc1nc(SCc2cccc(Oc3ccccc3)c2)nc2nc(N)sc12";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"12.91";"0.26";"0.91";"5.51";"0";"CHEMBL862382";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 membranes by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149469";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307715";"";"";""
"CHEMBL274737";"";"None";"361.50";"0";"3.14";"24";"CC[C@H](CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"19.14";"0.39";"3.78";"7.14";"0";"CHEMBL862382";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 membranes by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149469";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307715";"";"";""
"CHEMBL201672";"";"None";"255.37";"0";"3.07";"5";"CCCCCSc1nc(O)c2scnc2n1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"19.58";"0.43";"1.93";"8.49";"0";"CHEMBL862382";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 membranes by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149469";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307715";"";"";""
"CHEMBL252896";"";"None";"399.41";"0";"1.69";"33";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1nc(C)no1";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"20.25";"0.38";"6.40";"5.87";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL402986";"";"None";"348.45";"0";"2.46";"3";"C[C@H](CO)Nc1nc(SCc2ccccc2)nc2[nH]c(=O)sc12";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"23.95";"0.50";"5.89";"9.18";"0";"CHEMBL2351084";"Displacement of [125I]-IL8 from human CXCR2 transfected in HEK293 cells after 4 hrs by microbeta counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346562";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3307715";"";"";""
"CHEMBL570043";"";"None";"412.42";"0";"2.43";"5e";"CCN(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(F)cc1";"IC50";"'='";"840.0";"nM";"6.08";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1043642";"Antagonist activity at CXCR2 expressed in CHO cells assessed as inhibition of IL-8-induced chemotaxis";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156021";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL577075";"";"None";"346.39";"0";"1.10";"5b";"CCN(CC)Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O";"IC50";"'='";"1860.0";"nM";"5.73";"";"";"UO_0000065";"16.54";"0.31";"4.63";"5.62";"0";"CHEMBL1043639";"Displacement of [125I]IL-8 from human CXCR2 expressed in mouse BaF3 cells by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156021";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307634";"";"";""
"CHEMBL253707";"";"None";"462.30";"0";"3.35";"27";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1occc1Br";"IC50";"'='";"16.5";"nM";"7.78";"";"";"UO_0000065";"16.83";"0.37";"4.43";"6.96";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL404251";"";"None";"440.50";"0";"2.65";"14";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(CN(C)C)o1";"IC50";"'='";"94.0";"nM";"7.03";"";"";"UO_0000065";"15.95";"0.30";"4.38";"6.10";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL3957549";"";"None";"574.06";"2";"5.88";"Ex 27";"CCOC(=O)N1CCC(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3ccccc3Oc3ccccc3)c2O)CC1";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3948111";"";"None";"501.99";"2";"5.01";"Ex 28";"O=C(Nc1ccccc1Oc1ccccc1)Nc1ccc(Cl)c(S(=O)(=O)C2CCNCC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3354829";"";"None";"409.85";"0";"3.31";"2h";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)cc(-c3ccco3)[nH]2)c1O";"IC50";"'='";"2511.89";"nM";"5.60";"";"";"UO_0000065";"13.66";"0.28";"2.29";"4.47";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3342312";"";"None";"406.45";"0";"3.95";"52";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccccc2-c2nn[nH]n2)nc1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342294";"";"None";"422.40";"1";"5.66";"33";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cccc(OC(F)(F)F)c2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3403836";"";"None";"437.37";"0";"3.24";"29";"C[C@H](CO)Nc1cc(NS(C)(=O)=O)nc(SCc2cccc(Cl)c2Cl)n1";"IC50";"'='";"158.49";"nM";"6.80";"";"";"UO_0000065";"15.55";"0.36";"3.56";"6.53";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3403839";"";"None";"444.58";"0";"3.50";"32";"C[C@H](CO)Nc1cc(NS(=O)(=O)Cc2ccccc2)nc(SCc2ccccc2)n1";"IC50";"'='";"50.12";"nM";"7.30";"";"";"UO_0000065";"16.42";"0.33";"3.80";"7.01";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3403846";"";"None";"470.53";"0";"2.37";"39";"C[C@H](CO)Nc1cc(NS(=O)(=O)c2cn(C)cn2)nc(SCc2cccc(F)c2F)n1";"IC50";"'='";"31.62";"nM";"7.50";"";"";"UO_0000065";"15.94";"0.33";"5.13";"6.15";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3403851";"";"None";"461.97";"0";"2.72";"44";"C[C@H](CO)Nc1cc(NS(=O)(=O)N2CCC2)nc(SCc2cccc(Cl)c2F)n1";"IC50";"'='";"2.512";"nM";"8.60";"";"";"UO_0000065";"18.62";"0.41";"5.88";"8.00";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3310772";"";"None";"389.81";"0";"4.94";"9";"N#Cc1c(O)nc(SCc2cccc(F)c2F)nc1-c1ccc(Cl)cc1";"IC50";"'='";"7400.0";"nM";"5.13";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL205596";"CHOLIC ACID";"4.0";"408.58";"0";"3.45";"CHOLIC ACID";"C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL503";"LOVASTATIN";"4.0";"404.55";"0";"4.20";"LOVASTATIN";"CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL238071";"VINDESINE";"4.0";"753.94";"1";"2.73";"VINDESINE";"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL253927";"";"None";"398.42";"0";"2.29";"47";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cc(C)on1";"IC50";"'='";"12.2";"nM";"7.91";"";"";"UO_0000065";"19.86";"0.37";"5.62";"6.34";"0";"CHEMBL927217";"Inhibition of CXCR2-mediated chemotaxis in Ba/F3 cells expressing human CXCR2";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307634";"";"";""
"CHEMBL3099716";"";"None";"443.55";"1";"5.12";"4";"CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1";"IC50";"'>'";"48500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3101866";"Binding affinity to CXCR2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3098003";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3102879";"";"None";"308.31";"0";"2.71";"19";"Cc1nc2nc(CSc3cccc(F)c3F)cc(O)n2n1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3904195";"";"None";"513.57";"1";"2.93";"BDBM236788";"COC(=O)CN(C)C(=O)c1cccc(Nc2c(N[C@@H](c3ccc(C)o3)C3CCCS3)c(=O)c2=O)c1O";"IC50";"'='";"20.0";"nM";"7.70";"";"412489";"UO_0000065";"14.99";"0.29";"4.77";"5.57";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1535";"HYDROXYCHLOROQUINE";"4.0";"335.88";"0";"3.78";"HYDROXYCHLOROQUINE";"CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL61835";"";"None";"310.31";"0";"1.11";"7a";"CS(=O)(=O)c1ccc(C(=O)Nc2ccc(F)cc2)c[n+]1[O-]";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"22.19";"0.45";"5.78";"7.64";"0";"CHEMBL662153";"Evaluated using an SPA assay with recombinant human [125I]IL-8 and membranes prepared from Sf9 cells expressing human CXCR2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133879";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2001";"CHEMBL3308860";"";"";""
"CHEMBL104";"CLOTRIMAZOLE";"4.0";"344.85";"1";"5.38";"CLOTRIMAZOLE";"Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL63323";"NIFLUMIC ACID";"2.0";"282.22";"0";"3.54";"NIFLUMIC ACID";"O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1162";"NORETHINDRONE";"4.0";"298.43";"0";"3.49";"NORETHINDRONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL165790";"IPRIFLAVONE";"2.0";"280.32";"0";"4.25";"IPRIFLAVONE";"CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL387136";"";"None";"627.95";"1";"4.51";"6j";"CCC(CC)(NS(=O)(=O)c1c(Cl)ccc(N/C(=N/C#N)Nc2ccccc2Br)c1O)N1CCC[C@@H]1C(=O)O";"IC50";"'='";"16.0";"nM";"7.80";"";"Antagonist";"UO_0000065";"12.41";"0.28";"3.29";"4.66";"0";"CHEMBL908413";"Displacement of [125I]IL8 from CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139694";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"ANTAGONIST";""
"CHEMBL3817901";"";"None";"421.28";"0";"4.66";"9";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2cccc(F)c2Cl)c1O";"IC50";"'='";"0.3981";"nM";"9.40";"";"";"UO_0000065";"22.31";"0.49";"4.74";"9.84";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4068230";"";"None";"407.28";"0";"2.62";"38'";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2COC2)c1O)N[C@H]1CCC=C1Cl";"IC50";"'='";"2511.89";"nM";"5.60";"";"";"UO_0000065";"13.75";"0.31";"2.98";"5.35";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4067429";"";"None";"414.91";"0";"3.23";"68";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@@]2(C)CCOC2)c1O";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"17.83";"0.37";"4.17";"7.06";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL373522";"";"None";"563.12";"1";"4.62";"6m";"CCC(CC)(NS(=O)(=O)c1c(Cl)ccc(N/C(=N/C#N)Nc2ccccc2C)c1O)N1C[C@@H](C)O[C@@H](C)C1";"IC50";"'='";"17.0";"nM";"7.77";"";"Antagonist";"UO_0000065";"13.80";"0.28";"3.15";"5.59";"0";"CHEMBL908413";"Displacement of [125I]IL8 from CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139694";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"ANTAGONIST";""
"CHEMBL702";"PIPERACILLIN";"4.0";"517.56";"1";"-0.24";"PIPERACILLIN";"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H]2SC(C)(C)[C@@H]3C(=O)O)c2ccccc2)C(=O)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1149";"LEVOCARNITINE";"4.0";"161.20";"0";"-1.81";"LEVOCARNITINE";"C[N+](C)(C)C[C@H](O)CC(=O)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1433";"DOXYCYCLINE ANHYDROUS";"4.0";"444.44";"1";"-0.35";"DOXYCYCLINE";"C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1630579";"MYRTECAINE";"2.0";"265.44";"0";"3.73";"MYRTECAINE";"CCN(CC)CCOCCC1=CCC2CC1C2(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL52440";"DEXTROMETHORPHAN";"4.0";"271.40";"0";"3.38";"DEXTROMETHORPHAN";"COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL991";"STAVUDINE";"4.0";"224.22";"0";"-0.71";"STAVUDINE";"Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3105077";"";"None";"376.43";"0";"4.45";"21";"Oc1cc(CSc2cccc(F)c2F)nc2nc(C3CCCCC3)nn12";"IC50";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3104901";"";"None";"342.47";"0";"3.84";"3";"CCCCCSCc1cc(O)n2nc(Cc3ccccc3)nc2n1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL481";"IRINOTECAN";"4.0";"586.69";"1";"4.09";"IRINOTECAN";"CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL584";"NELFINAVIR";"4.0";"567.80";"1";"4.75";"NELFINAVIR";"Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909073";"PIPERILATE ETHOBROMIDE";"None";"448.40";"0";"3.49";"PIPERILATE ETHOBROMIDE";"CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL748";"PRALIDOXIME CHLORIDE";"4.0";"172.62";"0";"0.32";"PRALIDOXIME CHLORIDE";"C[n+]1ccccc1/C=N/O.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1370";"BUDESONIDE";"4.0";"430.54";"0";"2.72";"BUDESONIDE";"CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL108545";"METHYL SALICYLATE";"4.0";"152.15";"0";"1.18";"METHYL SALICYLATE";"COC(=O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL12089";"BERBERINE CHLORIDE";"1.0";"371.82";"0";"3.10";"BERBERINE CHLORIDE";"COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201151";"MESTRANOL";"4.0";"310.44";"0";"3.92";"MESTRANOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL458019";"PARAQUAT DICHLORIDE";"None";"257.16";"0";"1.00";"PARAQUAT DICHLORIDE";"C[n+]1ccc(-c2cc[n+](C)cc2)cc1.[Cl-].[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2106399";"KITASAMYCIN";"2.0";"785.97";"2";"2.44";"KITASAMYCIN";"CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1612004";"";"None";"123.15";"0";"1.28";"O-ANISIDINE";"COc1ccccc1N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL239767";"";"None";"352.14";"0";"3.71";"30, SB 225002";"O=C(Nc1ccc([N+](=O)[O-])cc1O)Nc1ccccc1Br";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"21.75";"0.50";"3.95";"7.33";"1";"CHEMBL2184853";"Binding affinity to CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176887";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1909065";"MADURAMICIN";"2.0";"917.14";"2";"4.32";"LYSERGOL";"CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL572";"NITROFURANTOIN";"4.0";"238.16";"0";"0.07";"NITROFURANTOIN";"O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1618305";"NALOXONAZINE";"None";"650.78";"1";"3.28";"NALOXONAZINE";"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2/C(=N/N=C2\CC[C@@]4(O)[C@H]6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@H]2O8)CC[C@@]3(O)[C@H]1C5";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL64391";"ITRACONAZOLE";"4.0";"705.65";"3";"5.58";"Itraconazole";"CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1070";"NABUMETONE";"4.0";"228.29";"0";"3.37";"NABUMETONE";"COc1ccc2cc(CCC(C)=O)ccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL43064";"CINNARIZINE";"4.0";"368.52";"1";"5.11";"CINNARIZINE";"C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL398440";"CHLOROXYLENOL";"4.0";"156.61";"0";"2.66";"CHLOROXYLENOL";"Cc1cc(O)cc(C)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL214286";"";"None";"323.31";"0";"1.24";"11";"NC(=O)c1cccc(/N=c2\c(O)c(O)\c2=N/c2ccccc2)c1O";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"23.10";"0.42";"6.23";"5.81";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL214162";"";"None";"343.38";"0";"1.46";"19";"CN(C)C(=O)c1cccc(/N=c2\c(O)c(O)\c2=N/C2CCCC2)c1O";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"23.58";"0.44";"6.64";"7.66";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL3354827";"";"None";"419.89";"0";"3.72";"2f";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)cc(-c3ccccc3)[nH]2)c1O";"IC50";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"14.77";"0.30";"2.48";"5.53";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3354828";"";"None";"454.34";"0";"4.38";"2g";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)cc(-c3ccccc3Cl)[nH]2)c1O";"IC50";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"13.65";"0.29";"1.82";"5.53";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3354831";"";"None";"433.92";"0";"3.65";"2j";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)cc(Cc3ccccc3)[nH]2)c1O";"IC50";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"14.75";"0.30";"2.75";"5.71";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3354832";"";"None";"357.82";"0";"2.36";"3a";"Cc1cc(=O)nc(Nc2ccc(Cl)c(S(=O)(=O)C(C)C)c2O)[nH]1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3342299";"";"None";"435.55";"1";"6.20";"39";"Cc1nc(-c2cccc(CSc3ccc(C(=O)Nc4ccc(F)cc4)cn3)c2)cs1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342285";"";"None";"343.38";"0";"4.06";"23";"Cc1cc(CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)no1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342279";"";"None";"346.43";"0";"3.99";"17";"O=C(Nc1ccc(F)cc1)c1ccc(SCC2CCOCC2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3403843";"";"None";"455.57";"0";"3.23";"36";"C[C@H](CO)Nc1cc(NS(=O)(=O)c2ccc(C#N)cc2)nc(SCc2ccccc2)n1";"IC50";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"16.68";"0.33";"4.37";"5.94";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3403849";"";"None";"491.01";"0";"1.92";"42";"C[C@H](CO)Nc1cc(NS(=O)(=O)N2CCNCC2)nc(SCc2cccc(Cl)c2F)n1";"IC50";"'='";"7.943";"nM";"8.10";"";"";"UO_0000065";"16.50";"0.36";"6.18";"6.78";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL273348";"TOSUFLOXACIN";"2.0";"404.35";"0";"2.04";"TOSUFLOXACIN";"NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1542";"AZATHIOPRINE";"4.0";"277.27";"0";"1.15";"AZATHIOPRINE";"Cn1cnc([N+](=O)[O-])c1Sc1ncnc2[nH]cnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL862";"GUANFACINE";"4.0";"246.10";"0";"1.55";"GUANFACINE";"N=C(N)NC(=O)Cc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL406";"INDAPAMIDE";"4.0";"365.84";"0";"2.08";"INDAPAMIDE";"CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL179166";"SODIUM ORTHOVANAD";"None";"183.91";"None";"None";"SODIUM ORTHOVANADATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL76904";"TYRPHOSTIN 23";"None";"186.17";"0";"1.53";"TYRPHOSTIN A23";"N#CC(C#N)=Cc1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL940";"GABAPENTIN";"4.0";"171.24";"0";"1.37";"GABAPENTIN";"NCC1(CC(=O)O)CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200431";"GADOPENTETATE DIMEGLUMINE";"4.0";"742.79";"None";"None";"GADOPENTETATE DIMEGLUMINE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3310778";"";"None";"369.40";"0";"4.60";"15";"Cc1cccc(-c2nc(SCc3cccc(F)c3F)nc(O)c2C#N)c1";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3310768";"";"None";"388.28";"1";"5.32";"4";"N#Cc1c(O)nc(SCc2c(Cl)cccc2Cl)nc1-c1ccccc1";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"13.82";"0.29";"0.05";"7.69";"0";"CHEMBL3368863";"Displacement of [125I]-GRO-alpha from human recombinant CXCR2 receptor expressed in CHO cell membranes";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL1073";"GLIPIZIDE";"4.0";"445.55";"0";"2.08";"GLIPIZIDE";"Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201469";"GRAMICIDIN";"4.0";"None";"None";"None";"GRAMICIDIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL305660";"EBASTINE";"4.0";"469.67";"1";"7.22";"EBASTINE";"CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL363840";"";"None";"505.64";"1";"4.65";"74";"Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"9.89";"0.18";"0.35";"5.68";"0";"CHEMBL828098";"Inhibition of C-X-C chemokine receptor type 2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143552";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL110691";"CHLORMADINONE ACETATE";"4.0";"404.93";"0";"4.75";"CHLORMADINONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL289469";"GRANISETRON";"4.0";"312.42";"0";"2.32";"GRANISETRON";"CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL633";"AMIODARONE";"4.0";"645.32";"2";"6.94";"AMIODARONE";"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL696";"ETHOSUXIMIDE";"4.0";"141.17";"0";"0.45";"ETHOSUXIMIDE";"CCC1(C)CC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL174";"AMPICILLIN";"4.0";"349.41";"0";"0.32";"AMPICILLIN";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL282468";"CHOLINE CHLORIDE";"4.0";"139.63";"None";"None";"CHOLINE CHLORIDE";"C[N+](C)(C)CCO.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3818216";"";"None";"437.73";"1";"5.18";"13";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2cccc(Cl)c2Cl)c1O";"IC50";"'='";"0.631";"nM";"9.20";"";"";"UO_0000065";"21.02";"0.48";"4.02";"9.63";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL253376";"BROMHEXINE";"4.0";"376.14";"0";"4.56";"BROMHEXINE";"CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1006";"AMIFOSTINE";"4.0";"214.23";"0";"-0.25";"WR-2721";"NCCCNCCSP(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL13341";"NIMETAZEPAM";"2.0";"295.30";"0";"2.41";"NIMETAZEPAM";"CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1527608";"DOXOFYLLINE";"3.0";"266.26";"0";"-1.19";"DOXOFYLLINE";"Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200585";"OXYMETHOLONE";"4.0";"332.48";"0";"4.40";"OXYMETHOLONE";"C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3701194";"";"None";"369.38";"0";"2.22";"BDBM172340";"Cc1ccc(C(Nc2c(Nc3cccnc3O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"335.0";"nM";"6.47";"";"317322";"UO_0000065";"17.53";"0.33";"4.25";"5.70";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3704564";"";"None";"439.47";"0";"2.52";"BDBM172357";"Cc1coc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2(C)COC2)c1";"IC50";"'='";"207.0";"nM";"6.68";"";"317316";"UO_0000065";"15.21";"0.29";"4.16";"5.52";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3704565";"";"None";"467.52";"0";"3.34";"BDBM172358";"CC(C)c1coc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2(C)COC2)c1";"IC50";"'='";"25.0";"nM";"7.60";"";"317302";"UO_0000065";"16.26";"0.31";"4.26";"6.28";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1760";"TERBUTALINE";"4.0";"225.29";"0";"1.52";"TERBUTALINE";"CC(C)(C)NCC(O)c1cc(O)cc(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3889627";"";"None";"453.57";"0";"2.84";"eut-22";"CC1CCN(C(=O)C(CCn2cccc2C#N)NS(=O)(=O)c2cccc3[nH]ccc23)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3863314";"Antagonist activity at human CXCR2 assessed as inhibition of GROalpha-induced calcium flux";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3862010";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL131";"PREDNISOLONE";"4.0";"360.45";"0";"1.56";"PREDNISOLONE";"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201353";"DEXCHLORPHENIRAMINE";"4.0";"274.80";"0";"3.82";"DEXCHLORPHENIRAMINE";"CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909064";"LIPOPOLYSACCHARIDE E. COLI O55:B5";"None";"None";"None";"None";"LIPOPOLYSACCHARIDE E. COLI O55:B5";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1055";"CHLORTHALIDONE";"4.0";"338.77";"0";"0.92";"CHLORTHALIDONE";"NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3354825";"";"None";"383.86";"0";"2.54";"2d";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)c3c([nH]2)CCC3)c1O";"IC50";"'='";"2511.89";"nM";"5.60";"";"";"UO_0000065";"14.59";"0.31";"3.06";"4.99";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3355250";"";"None";"425.94";"0";"4.02";"3t";"Cc1c(C2CCCC2)[nH]c(Nc2ccc(Cl)c(S(=O)(=O)C(C)C)c2O)nc1=O";"IC50";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"14.56";"0.30";"2.18";"5.53";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL415";"CLOMIPRAMINE";"4.0";"314.86";"0";"4.53";"CLOMIPRAMINE";"CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909055";"COBALTOUS CHLORIDE";"4.0";"129.84";"None";"None";"COBALT (II) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201146";"NORETHINDRONE ACETATE";"4.0";"340.46";"0";"4.06";"NORETHINDRONE ACETATE";"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL414804";"OXALIPLATIN";"4.0";"395.27";"None";"None";"OXALIPLATIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3658247";"";"None";"426.47";"0";"4.42";"BDBM150863";"O=C(Nc1ccc(F)cc1)c1ccc(SCCOc2cccc3c2OCCO3)nc1";"IC50";"'='";"1585.0";"nM";"5.80";"";"290373";"UO_0000065";"13.60";"0.26";"1.38";"8.32";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658264";"";"None";"428.94";"1";"6.63";"BDBM150880";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2csc3ccc(Cl)cc23)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290390";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342273";"";"None";"307.31";"0";"2.80";"BDBM150895";"O=C(Nc1ccc(F)cc1)c1ccc(SC[N+](=O)[O-])nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290405";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658278";"";"None";"445.86";"1";"5.01";"BDBM150905";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1ccc(Cl)c([N+](=O)[O-])c1";"IC50";"'='";"16.0";"nM";"7.80";"";"290415";"UO_0000065";"17.49";"0.35";"2.79";"7.63";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658284";"";"None";"396.44";"0";"4.46";"BDBM150911";"COc1ccc(C(=O)CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"290421";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658312";"";"None";"422.51";"1";"5.66";"BDBM150939";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2cc3ccccc3s2)nc1";"IC50";"'='";"1810.0";"nM";"5.74";"";"290449";"UO_0000065";"13.59";"0.27";"0.08";"9.72";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342321";"";"None";"473.34";"None";"None";"61";"O=C(c1ccc(SCc2ccccc2B(O)O)nc1)N(Cc1ccncc1)c1ccc(F)cc1";"IC50";"'='";"890.0";"nM";"6.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342320";"";"None";"473.34";"None";"None";"60";"O=C(c1ccc(SCc2ccccc2B(O)O)nc1)N(Cc1ccccn1)c1ccc(F)cc1";"IC50";"'='";"78.0";"nM";"7.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342280";"";"None";"420.47";"1";"5.12";"37";"Cc1nc(-c2cccc(CSc3ccc(C(=O)Nc4ccc(F)cc4)cn3)c2)no1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342286";"";"None";"419.49";"0";"4.65";"24";"Cc1nn(-c2ccccc2)nc1CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL39835";"";"None";"306.32";"0";"2.65";"6";"O=C(O)CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3354644";"";"None";"332.36";"0";"2.88";"9";"O=C(Nc1ccc(F)cc1)c1ccc(SC2CCOC2=O)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342275";"";"None";"346.43";"0";"4.13";"13";"O=C(Nc1ccc(F)cc1)c1ccc(SCC2CCCCO2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL239767";"";"None";"352.14";"0";"3.71";"2, SB225002";"O=C(Nc1ccc([N+](=O)[O-])cc1O)Nc1ccccc1Br";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3104898";"";"None";"319.31";"0";"2.29";"33";"COc1cc(CCc2cccc(F)c2F)nc2cc(CO)nn12";"IC50";"'='";"10500.0";"nM";"4.98";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL499";"TIMOLOL";"4.0";"316.43";"0";"0.50";"TIMOLOL";"CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL553025";"VINORELBINE";"4.0";"778.95";"2";"4.75";"VINORELBINE";"CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1873703";"DIELDRIN";"2.0";"380.91";"0";"4.48";"DIELDRIN";"ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@@H]4C[C@@H]([C@H]5O[C@@H]45)[C@@H]3[C@@]1(Cl)C2(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1512";"FLUNISOLIDE";"4.0";"434.50";"0";"2.27";"FLUNISOLIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL77675";"";"None";"211.27";"0";"3.15";"1,3-DIPHENYLGUANIDINE";"N=C(Nc1ccccc1)Nc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL310555";"OXYQUINOLINE";"-1.0";"145.16";"0";"1.94";"OXYQUINOLINE";"Oc1cccc2cccnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL293492";"CINNAMALDEHYDE";"-1.0";"132.16";"0";"1.90";"CINNAMALDEHYDE";"O=C/C=C/c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL280998";"CATECHOL";"None";"110.11";"0";"1.10";"CATECHOL";"Oc1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL86";"METOCLOPRAMIDE";"4.0";"299.80";"0";"2.00";"Metoclopramide";"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL39740";"";"None";"505.54";"2";"7.93";"2";"CCN(CC)CCCCNc1nc2cc(Cl)c(Cl)cc2nc1-c1ccc(-c2cccs2)s1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"13.76";"0.30";"-0.97";"16.95";"0";"CHEMBL650907";"Compound binding was evaluated using an SPA assay with recombinant human [125I]IL-8 and membranes prepared from Sf9 cells expressing human C-X-C chemokine receptor type 2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133879";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2001";"CHEMBL3308860";"";"";""
"CHEMBL1480987";"CYCLANDELATE";"4.0";"276.38";"0";"3.48";"CYCLANDELATE";"CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL569";"PROCAINE";"4.0";"236.31";"0";"1.77";"PROCAINE";"CCN(CC)CCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909080";"STRONTIUM CHLORIDE HEXAHYDRATE";"None";"266.62";"None";"None";"STRONTIUM CHLORIDE HEXAHYDRATE";"O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL386630";"TESTOSTERONE";"4.0";"288.43";"0";"3.88";"TESTOSTERONE";"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL128";"SUMATRIPTAN";"4.0";"295.41";"0";"1.32";"Sumatriptan";"CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1908847";"SPARTEINE";"4.0";"234.39";"0";"2.35";"SPARTEINE";"C1CCN2C[C@@H]3C[C@@H](CN4CCCC[C@@H]34)[C@H]2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL123292";"CYCLOHEXIMIDE";"2.0";"281.35";"0";"1.04";"CYCLOHEXIMIDE";"C[C@@H]1C[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C(=O)[C@@H](C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL469912";"PUROMYCIN";"2.0";"471.52";"1";"-0.79";"GNF-Pf-2016";"COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)[C@H](n3cnc4c(N(C)C)ncnc43)O[C@@H]2CO)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1219";"RABEPRAZOLE";"4.0";"359.45";"0";"2.99";"RABEPRAZOLE";"COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200406";"DIMENHYDRINATE";"4.0";"469.97";"None";"None";"DIMENHYDRINATE";"CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909049";"";"None";"309.41";"0";"3.79";"1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"COc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1487";"ATORVASTATIN";"4.0";"558.65";"2";"6.31";"ATORVASTATIN";"CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL563";"FLURBIPROFEN";"4.0";"244.26";"0";"3.68";"FLURBIPROFEN";"CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL459";"METHYLDOPA";"4.0";"211.22";"0";"0.44";"METHYLDOPA";"C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL21";"SULFANILAMIDE";"4.0";"172.21";"0";"-0.08";"SULFANILAMIDE";"Nc1ccc(S(N)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201631";"INSULIN HUMAN";"4.0";"None";"None";"None";"INSULIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4066510";"";"None";"428.94";"0";"3.62";"59";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2(C)CCOCC2)c1O";"IC50";"'='";"199.53";"nM";"6.70";"";"";"UO_0000065";"15.62";"0.33";"3.08";"6.40";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL1068";"OXCARBAZEPINE";"4.0";"252.27";"0";"2.64";"OXCARBAZEPINE";"NC(=O)N1c2ccccc2CC(=O)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL460499";"CARMOFUR";"2.0";"257.26";"0";"0.81";"CARMOFUR";"CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3105085";"";"None";"293.30";"0";"3.01";"29";"Oc1cc(CSc2cccc(F)c2F)nc2ccnn12";"IC50";"'='";"810.0";"nM";"6.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3105080";"";"None";"359.36";"0";"4.27";"24";"Oc1cc(CSc2cccc(F)c2F)nc2cc(-c3ccco3)nn12";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL1201193";"LEVOBUPIVACAINE";"4.0";"288.44";"0";"3.90";"LEVOBUPIVACAINE";"CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL426123";"";"None";"258.23";"0";"0.09";"(-)-THALIDOMIDE";"O=C1CC[C@H](N2C(=O)c3ccccc3C2=O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1554";"DACTINOMYCIN";"4.0";"1255.44";"None";"None";"DACTINOMYCIN";"Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL975";"MESNA";"4.0";"164.18";"0";"-0.20";"MESNA";"O=S(=O)([O-])CCS.[Na+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL416";"METHOXSALEN";"4.0";"216.19";"0";"2.55";"METHOXSALEN";"COc1c2occc2cc2ccc(=O)oc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1771";"CLOPIDOGREL";"4.0";"321.83";"0";"3.67";"CLOPIDOGREL";"COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL648";"CYCLIZINE";"4.0";"266.39";"0";"3.02";"CYCLIZINE";"CN1CCN(C(c2ccccc2)c2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2107687";"VALETHAMATE BROMIDE";"-1.0";"386.37";"0";"3.85";"VALETHAMATE BROMIDE";"CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL421";"SULFASALAZINE";"4.0";"398.40";"0";"3.70";"SULFASALAZINE";"O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909054";"CARBOXYMETHYLCELLULOSE";"None";"None";"None";"None";"CARBOXYMETHYLCELLULOSE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL545";"ALCOHOL";"4.0";"46.07";"0";"0.00";"ETHANOL";"CCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL496";"HEXACHLOROPHENE";"4.0";"406.91";"1";"6.61";"HEXACHLOROPHENE";"Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL471";"SOTALOL";"4.0";"272.37";"0";"1.09";"SOTALOL";"CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL44618";"CHLOROFORM";"4.0";"119.38";"0";"1.99";"CHLOROFORM";"ClC(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL600325";"PROSCILLARIDIN";"4.0";"530.66";"1";"3.01";"PROSCILLARIDIN";"C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL35";"FUROSEMIDE";"4.0";"330.75";"0";"1.89";"FUROSEMIDE";"NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL726";"FLUPHENAZINE";"4.0";"437.53";"0";"4.31";"FLUPHENAZINE";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1220";"TINIDAZOLE";"4.0";"247.28";"0";"0.53";"TINIDAZOLE";"CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL46";"ONDANSETRON";"4.0";"293.37";"0";"3.13";"ONDANSETRON";"Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL193";"NIFEDIPINE";"4.0";"346.34";"0";"2.18";"Nifedipine";"COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3545252";"DOCETAXEL";"4.0";"861.94";"2";"3.26";"DOCETAXEL";"CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL65";"CAMPTOTHECIN";"-1.0";"348.36";"0";"2.08";"CAMPTOTHECIN";"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL510437";"";"None";"415.52";"0";"4.40";"24";"Cc1ccc([C@H](Nc2nsnc2Nc2cccc(C(=O)N(C)C)c2O)C(C)C)o1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"17.91";"0.35";"3.04";"7.19";"0";"CHEMBL963311";"Displacement of [125I]CXCL1 from CXCR2 receptor in human PMN assessed as myeloperoxidase release";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153271";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL16068";"BROMOBENZENE";"None";"157.01";"0";"2.45";"BROMOBENZENE";"Brc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1370561";"AMINOPHYLLINE";"4.0";"420.43";"0";"-1.04";"AMINOPHYLLINE";"Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL917";"FLOXURIDINE";"4.0";"246.19";"0";"-1.68";"5-FLUORO-2'-DEOXYURIDINE";"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1306";"TERCONAZOLE";"4.0";"532.47";"1";"4.46";"TERCONAZOLE";"CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL628";"PENTOXIFYLLINE";"4.0";"278.31";"0";"0.19";"PENTOXIFYLLINE";"CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3354823";"";"None";"428.30";"0";"3.86";"2b";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)c3cccc(Cl)c3[nH]2)c1O";"IC50";"'='";"501.19";"nM";"6.30";"";"";"UO_0000065";"14.71";"0.32";"2.44";"5.62";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1568";"FLUDARABINE";"None";"285.24";"0";"-1.84";"FLUDARABINE";"Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2221249";"COLISTIN";"4.0";"2296.97";"None";"None";"COLISTIN";"CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL338790";"";"None";"212.21";"0";"1.31";"4-AMINO-1,8-NAPHTHALIMIDE";"Nc1ccc2c3c(cccc13)C(=O)NC2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4076428";"";"None";"453.99";"0";"3.68";"51";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2C[C@H](N3CCCC3)C2)c1O";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"19.82";"0.41";"5.32";"9.11";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4084412";"";"None";"358.85";"0";"3.07";"25";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)NC2C=CCC2)c1O";"IC50";"'='";"6.31";"nM";"8.20";"";"";"UO_0000065";"22.85";"0.49";"5.13";"8.59";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4075365";"";"None";"389.91";"0";"2.44";"15";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)NC2CCN(C)CC2)c1O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4088965";"";"None";"376.86";"0";"2.53";"14";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)NC2CCOCC2)c1O";"IC50";"'='";"1258.93";"nM";"5.90";"";"";"UO_0000065";"15.66";"0.34";"3.37";"5.63";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4075487";"";"None";"376.86";"0";"2.53";"13";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)NC2CCCOC2)c1O";"IC50";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"16.45";"0.35";"3.67";"5.92";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4084545";"";"None";"404.92";"0";"3.31";"12";"COC1CCCCC1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)C)c1O";"IC50";"'='";"1584.89";"nM";"5.80";"";"";"UO_0000065";"14.32";"0.30";"2.49";"5.54";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4081963";"";"None";"414.91";"0";"3.23";"65";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CCCOC2)c1O";"IC50";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"15.91";"0.33";"3.37";"6.30";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4076676";"";"None";"477.96";"0";"3.78";"46";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CCN(CC(F)F)CC2)c1O";"IC50";"'='";"2.512";"nM";"8.60";"";"";"UO_0000065";"17.99";"0.38";"4.82";"8.71";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4065522";"";"None";"429.97";"0";"3.39";"43";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)(C)CN(C)C)c1O";"IC50";"'='";"125.89";"nM";"6.90";"";"";"UO_0000065";"16.05";"0.34";"3.51";"6.99";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4089896";"";"None";"423.32";"0";"3.00";"35";"CC(C)(CO)S(=O)(=O)c1c(Cl)ccc(NC(=O)N[C@@H]2CCC=C2Cl)c1O";"IC50";"'='";"3.981";"nM";"8.40";"";"";"UO_0000065";"19.84";"0.44";"5.40";"7.26";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4088551";"";"None";"456.99";"0";"4.25";"58";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)(C)C2CCOCC2)c1O";"IC50";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"14.00";"0.29";"2.15";"6.11";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL564";"PROMAZINE";"4.0";"284.43";"0";"4.24";"PROMAZINE";"CN(C)CCCN1c2ccccc2Sc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL608";"PROBUCOL";"4.0";"516.86";"2";"9.91";"PROBUCOL";"CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1766";"DESOXIMETASONE";"4.0";"376.47";"0";"2.78";"DESOXIMETASONE";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL891";"CLOXACILLIN";"4.0";"435.89";"0";"2.55";"CLOXACILLIN";"Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3701187";"";"None";"565.62";"1";"3.77";"BDBM172327";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N4CCC[C@@H]4C(=O)OC(C)(C)C)c3O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"100.0";"nM";"7.00";"";"317310";"UO_0000065";"12.38";"0.23";"3.23";"4.75";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL316561";"PROGLUMIDE";"4.0";"334.42";"0";"2.30";"PROGLUMIDE";"CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL13378";"(R,S)-AMPA";"None";"186.17";"0";"-0.36";"(RS)-AMPA";"Cc1onc(O)c1CC(N)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL485259";"EUCALYPTOL";"3.0";"154.25";"0";"2.74";"EUCALYPTOL";"CC12CCC(CC1)C(C)(C)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL10";"SB-203580";"None";"377.44";"0";"4.68";"SB-203580";"C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL184618";"FRAMYCETIN";"3.0";"614.65";"3";"-8.90";"Neomycine";"NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1754";"DOXAPRAM";"4.0";"378.52";"0";"3.17";"DOXAPRAM";"CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL659";"GALANTAMINE";"4.0";"287.36";"0";"1.85";"GALANTAMINE";"COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL504760";"CAMPHOR";"4.0";"152.24";"0";"2.40";"D-CAMPHOR";"CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2079587";"STANOZOLOL";"4.0";"328.50";"0";"4.12";"STANOZOLOL";"C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1464";"WARFARIN";"4.0";"308.33";"0";"3.61";"WARFARIN";"CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL25";"ASPIRIN";"4.0";"180.16";"0";"1.31";"aspirin";"CC(=O)Oc1ccccc1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1255834";"BW-723C86";"None";"286.40";"0";"3.70";"BW-723C86";"CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL456";"ETHACRYNIC ACID";"4.0";"303.14";"0";"3.61";"ETHACRYNIC ACID";"C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1196";"PROPARACAINE";"4.0";"294.39";"0";"2.56";"PROPARACAINE";"CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL157548";"DANOFLOXACIN";"-1.0";"357.39";"0";"2.07";"DANOFLOXACIN";"CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL222863";"OUABAIN";"4.0";"584.66";"3";"-1.51";"OUABAIN";"C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909078";"SODIUM ARSENITE";"None";"129.91";"None";"None";"SODIUM ARSENITE";"O=[As][O-].[Na+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL5183834";"";"None";"362.40";"0";"3.39";"35c";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2cnccc12";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"17.57";"0.35";"2.98";"8.98";"0";"CHEMBL5162230";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-binding incubated for 15 mins followed by addition of CXCL8 AF647 measured after 30 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.75 hr";"ANTAGONIST";""
"CHEMBL13209";"NITRAZEPAM";"4.0";"281.27";"0";"2.38";"NITRAZEPAM";"O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL506247";"TANNIC ACID";"4.0";"1701.21";"None";"None";"TANNIC ACID";"O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL959";"RIMANTADINE";"4.0";"179.31";"0";"2.55";"RIMANTADINE";"CC(N)C12CC3CC(CC(C3)C1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL822";"TERBINAFINE";"4.0";"291.44";"0";"4.88";"TERBINAFINE";"CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL894";"BUPROPION";"4.0";"239.75";"0";"3.30";"BUPROPION";"CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL5174137";"";"None";"362.40";"0";"3.39";"35b";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2cccnc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5162231";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-induced calcium response incubated for 10 mins followed by addition of CXCL8 AF647 measured by FLIPR Tetra system method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.1667 hr";"";""
"CHEMBL233961";"";"None";"399.86";"0";"4.29";"9l";"O=S1(=O)N=C(Nc2ccccc2-c2ccccc2)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"16.60";"0.34";"2.35";"7.31";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL234396";"";"None";"420.65";"0";"3.53";"9h";"O=S1(=O)N=C(Nc2ccc(F)cc2Br)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"16.45";"0.41";"3.39";"7.62";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL393253";"";"None";"376.20";"0";"3.42";"9g";"O=S1(=O)N=C(Nc2cccc(F)c2Cl)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"64.0";"nM";"7.19";"";"";"UO_0000065";"19.12";"0.43";"3.77";"7.92";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL269707";"";"None";"394.43";"0";"2.39";"49";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccccn1";"IC50";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"21.50";"0.40";"6.09";"7.60";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL253504";"";"None";"433.92";"0";"3.71";"38";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1sccc1Cl";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"17.69";"0.36";"3.97";"7.78";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL1517";"OXYTETRACYCLINE";"4.0";"460.44";"1";"-1.24";"OXYTETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL629";"AMITRIPTYLINE";"4.0";"277.41";"0";"4.17";"AMITRIPTYLINE";"CN(C)CCC=C1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4797191";"";"None";"425.87";"0";"3.01";"B5";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC2=NC(=O)C(c3ccc(F)cc3)N2)c1O";"IC50";"'='";"2190.0";"nM";"5.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL233972";"";"None";"408.87";"0";"2.46";"9q";"O=S1(=O)N=C(Nc2ccccc2N2CCOCC2)Nc2c(O)cc(Cl)cc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL397068";"";"None";"391.76";"0";"3.65";"9o";"O=S1(=O)N=C(Nc2ccccc2C(F)(F)F)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"830.0";"nM";"6.08";"";"";"UO_0000065";"15.52";"0.33";"2.43";"6.70";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL234596";"";"None";"420.65";"0";"3.53";"9i";"O=S1(=O)N=C(Nc2cc(F)ccc2Br)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"12.86";"0.32";"1.88";"5.96";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL443583";"";"None";"413.21";"0";"2.65";"9w";"O=[N+]([O-])c1cc(O)c2c(c1)S(=O)(=O)N=C(Nc1ccccc1Br)N2";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"18.36";"0.43";"4.94";"5.66";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL378503";"";"None";"305.29";"0";"2.18";"6";"N#Cc1ccc(O)c(Nc2c(O)c(=O)/c2=N\c2ccccc2)c1";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"23.36";"0.42";"4.95";"6.75";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL379438";"";"None";"325.28";"0";"2.22";"1";"O=c1c(O)c(Nc2ccc([N+](=O)[O-])cc2O)/c1=N/c1ccccc1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"22.88";"0.42";"5.22";"5.95";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL1909069";"";"None";"None";"None";"None";"MC 288769";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1113";"AMOXAPINE";"4.0";"313.79";"0";"3.43";"AMOXAPINE";"Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1321";"PROCARBAZINE";"4.0";"221.30";"0";"1.05";"PROCARBAZINE";"CNNCc1ccc(C(=O)NC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1560";"CAPTOPRIL";"4.0";"217.29";"0";"0.63";"Captopril, Capoten";"C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL7568";"QUINACRINE";"2.0";"399.97";"1";"5.97";"QUINACRINE";"CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1177";"PEMOLINE";"4.0";"176.18";"0";"0.60";"PEMOLINE";"NC1=NC(=O)C(c2ccccc2)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL757";"NANDROLONE";"3.0";"274.40";"0";"3.49";"NANDROLONE";"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL364713";"NOSCAPINE";"4.0";"413.43";"0";"2.88";"NOSCAPINE";"COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL5075434";"";"None";"380.85";"0";"3.72";"9j";"Cc1c(Cl)cccc1NC(=O)Nc1ccc2c(c1O)S(=O)(=O)CCC2";"IC50";"'='";"2430.0";"nM";"5.61";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL4782034";"";"None";"392.52";"1";"5.31";"23";"CCOC(=O)c1c(NC(=S)Nc2ccccc2F)sc2c1C(C)CCC2";"IC50";"'='";"7500.0";"nM";"5.12";"";"";"UO_0000065";"13.06";"0.27";"-0.19";"10.18";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4782078";"";"None";"421.59";"1";"6.25";"34";"CC1CCCc2sc(NC(=S)Nc3ccccc3)c(C(=O)Nc3ccccc3)c21";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"13.21";"0.26";"-0.68";"10.48";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4794006";"";"None";"403.57";"0";"4.50";"42";"CN1CCc2c(sc(NC(=S)Nc3ccccc3)c2C(=O)OC(C)(C)C)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"";""
"CHEMBL4782371";"";"None";"432.61";"1";"5.96";"44";"COc1cccc(NC(=S)Nc2sc3c(c2C(=O)OC(C)(C)C)C(C)CCC3)c1";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"12.87";"0.26";"-0.39";"9.34";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL661";"ALPRAZOLAM";"4.0";"308.77";"0";"3.58";"ALPRAZOLAM";"Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1455";"ALTRETAMINE";"4.0";"210.28";"0";"0.07";"ALTRETAMINE";"CN(C)c1nc(N(C)C)nc(N(C)C)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL806";"FLUTAMIDE";"4.0";"276.21";"0";"3.21";"FLUTAMIDE";"CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3310769";"";"None";"355.37";"0";"4.29";"5";"N#Cc1c(O)nc(SCc2cccc(F)c2F)nc1-c1ccccc1";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3701193";"";"None";"383.40";"0";"1.82";"BDBM172339";"Cc1ccc(C(Nc2c(Nc3cccn(C)c3=O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"394.0";"nM";"6.41";"";"317325";"UO_0000065";"16.70";"0.31";"4.58";"6.24";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4760919";"";"None";"421.91";"0";"2.74";"C8";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC2=NC(=O)[C@H](Cc3ccccc3)N2)c1O";"IC50";"'='";"25000.0";"nM";"4.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL3403828";"";"None";"319.39";"0";"2.26";"6";"C[C@H](CO)Nc1cc(C(=O)O)nc(SCc2ccccc2)n1";"IC50";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"20.04";"0.40";"4.14";"6.71";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3403841";"";"None";"430.56";"0";"3.36";"34";"C[C@H](CO)Nc1cc(NS(=O)(=O)c2ccccc2)nc(SCc2ccccc2)n1";"IC50";"'='";"79.43";"nM";"7.10";"";"";"UO_0000065";"16.49";"0.33";"3.74";"6.81";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3403844";"";"None";"369.47";"0";"1.18";"37";"C[C@H](CO)Nc1cc(NS(N)(=O)=O)nc(SCc2ccccc2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL221886";"SISOMICIN";"3.0";"447.53";"2";"-3.85";"SISOMICIN";"CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL11359";"CISPLATIN";"4.0";"300.05";"None";"None";"CISPLATIN";"";"IC50";"'='";"13516.0";"nM";"4.87";"";"";"UO_0000065";"16.23";"None";"None";"None";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201220";"DIATRIZOIC ACID";"4.0";"613.91";"1";"3.12";"DIATRIZOIC ACID";"CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL565";"CLOFIBRATE";"4.0";"242.70";"0";"3.06";"CLOFIBRATE";"CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909072";"PIPAMAZINE";"4.0";"401.96";"0";"4.53";"PIPAMAZINE";"NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL291338";"3,3',4',5-TETRACHLOROSALICYLANILIDE";"4.0";"351.02";"1";"5.26";"3,3',4',5-TETRACHLOROSALICYLANILIDE";"O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL267345";"AMPHOTERICIN B";"4.0";"924.09";"3";"0.71";"AMPHOTERICIN B";"C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL666";"FOSCARNET";"4.0";"126.00";"0";"-0.16";"FOSCARNET";"O=C(O)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL271012";"";"None";"366.44";"0";"2.60";"30c";"C[C@H](CO)Nc1nc(SCc2ccccc2F)nc2[nH]c(=O)sc12";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"23.74";"0.50";"6.10";"9.57";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL3342272";"";"None";"402.47";"0";"4.00";"10";"O=C(Nc1ccc(F)cc1)c1ccc(SCS(=O)(=O)c2ccccc2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL239767";"";"None";"352.14";"0";"3.71";"2, SB225002";"O=C(Nc1ccc([N+](=O)[O-])cc1O)Nc1ccccc1Br";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3387793";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307715";"";"";""
"CHEMBL3952996";"";"None";"581.12";"1";"3.27";"BDBM236791";"Cc1ccc(C(Nc2c(Nc3ccc(Cl)c(S(=O)(=O)N4CCN(C)CC4)c3O)c(=O)c2=O)C2CCCS2)o1";"IC50";"'='";"17.0";"nM";"7.77";"";"412492";"UO_0000065";"13.37";"0.28";"4.50";"5.88";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL293139";"";"None";"304.78";"0";"3.52";"4d";"CC(C)(C)c1ccc(NC(=O)c2ccc(Cl)[n+]([O-])c2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL662153";"Evaluated using an SPA assay with recombinant human [125I]IL-8 and membranes prepared from Sf9 cells expressing human CXCR2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133879";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2001";"CHEMBL3308860";"";"";""
"CHEMBL292767";"";"None";"264.67";"0";"1.93";"4e";"O=C(Nc1ccccc1O)c1ccc(Cl)[n+]([O-])c1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL662153";"Evaluated using an SPA assay with recombinant human [125I]IL-8 and membranes prepared from Sf9 cells expressing human CXCR2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133879";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2001";"CHEMBL3308860";"";"";""
"CHEMBL5081113";"";"None";"398.36";"0";"3.86";"11d";"O=C(Nc1ccccc1C(F)(F)F)Nc1ccc2c(c1O)S(=O)(=O)CC=C2";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5081756";"";"None";"434.83";"0";"3.07";"12e";"O=c1c(Nc2ccc3c(c2O)S(=O)(=O)CC=C3)c(Nc2cccc(F)c2Cl)c1=O";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL372795";"STREPTOMYCIN";"4.0";"581.58";"3";"-8.16";"STREPTOMYCIN";"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL643";"PROMETHAZINE";"4.0";"284.43";"0";"4.24";"promethazine";"CC(CN1c2ccccc2Sc2ccccc21)N(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL5087298";"";"None";"436.85";"0";"2.99";"10e";"O=c1c(Nc2ccc3c(c2O)S(=O)(=O)CCC3)c(Nc2cccc(F)c2Cl)c1=O";"IC50";"'='";"3450.0";"nM";"5.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5090422";"";"None";"344.39";"0";"3.15";"11f";"Cc1ccc(NC(=O)Nc2ccc3c(c2O)S(=O)(=O)CC=C3)cc1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5078246";"";"None";"382.80";"0";"3.63";"11j";"O=C(Nc1ccc2c(c1O)S(=O)(=O)CC=C2)Nc1cccc(F)c1Cl";"IC50";"'='";"19000.0";"nM";"4.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5078730";"";"None";"416.84";"0";"2.93";"12a";"O=c1c(Nc2ccccc2Cl)c(Nc2ccc3c(c2O)S(=O)(=O)CC=C3)c1=O";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL3819292";"";"None";"410.67";"0";"3.64";"SB332235";"NS(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2cccc(Cl)c2Cl)c1O";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5083610";"";"None";"350.37";"0";"2.90";"9c";"O=C(Nc1ccccc1F)Nc1ccc2c(c1O)S(=O)(=O)CCC2";"IC50";"'='";"1020.0";"nM";"5.99";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5079554";"";"None";"411.28";"0";"3.52";"9g";"O=C(Nc1ccc(Br)cc1)Nc1ccc2c(c1O)S(=O)(=O)CCC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"";""
"CHEMBL462547";"URETHANE";"4.0";"89.09";"0";"0.10";"URETHANE";"CCOC(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL395110";"MEPAZINE";"4.0";"310.47";"0";"4.63";"MEPAZINE";"CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL561";"LOMEFLOXACIN";"4.0";"351.35";"0";"1.80";"LOMEFLOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3342319";"";"None";"383.21";"None";"None";"59";"O=C(Nc1ccc(F)cn1)c1ccc(SCc2ccccc2B(O)O)nc1";"IC50";"'='";"294.0";"nM";"6.53";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL428880";"CROMOLYN";"4.0";"468.37";"0";"2.11";"CROMOLYN";"O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL71";"CHLORPROMAZINE";"4.0";"318.87";"0";"4.89";"CHLORPROMAZINE";"CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL404";"TAZOBACTAM";"4.0";"300.30";"0";"-1.52";"TAZOBACTAM";"C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL446";"SULFAMETHAZINE";"4.0";"278.34";"0";"1.48";"SULFAMETHAZINE";"Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4786309";"";"None";"345.81";"0";"1.51";"C1";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC2=NC(=O)[C@@H](C)N2)c1O";"IC50";"'='";"470.0";"nM";"6.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL4746698";"";"None";"373.86";"0";"2.29";"C3";"CCC[C@H]1NC(Nc2ccc(Cl)c(S(=O)(=O)C(C)C)c2O)=NC1=O";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL4797342";"";"None";"312.29";"0";"1.94";"A4";"O=C1N=C(Nc2ccc([N+](=O)[O-])cc2O)NC1c1ccccc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"";""
"CHEMBL315588";"";"None";"428.34";"1";"6.38";"43";"Sc1nc(-c2ccc(Cl)cc2Cl)nn1Cc1cccc(Oc2ccccc2)c1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"15.80";"0.33";"0.39";"16.95";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL5089441";"";"None";"399.25";"0";"4.14";"11g";"O=C(Nc1ccc2c(c1O)S(=O)(=O)CC=C2)Nc1cccc(Cl)c1Cl";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL379046";"";"None";"324.29";"0";"1.84";"8";"O=C(O)c1ccc(/N=c2\c(O)c(O)\c2=N/c2ccccc2)c(O)c1";"IC50";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"16.99";"0.31";"3.67";"4.49";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL375175";"";"None";"317.35";"0";"0.92";"23";"CC(C)/N=c1\c(O)c(O)\c1=N/c1cccc(C(=O)N(C)C)c1O";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"25.21";"0.48";"7.08";"7.57";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL211247";"";"None";"331.37";"0";"1.31";"24";"CN(C)C(=O)c1cccc(/N=c2\c(O)c(O)\c2=N/C(C)(C)C)c1O";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"23.70";"0.45";"6.54";"7.43";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL313556";"";"None";"346.25";"0";"4.04";"36";"Sc1nc(-c2ccccc2Br)nn1Cc1ccccc1";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"18.65";"0.44";"2.42";"21.02";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL3342290";"";"None";"435.55";"1";"6.20";"28";"Cc1nc(-c2ccccc2)sc1CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342269";"";"None";"382.23";"None";"None";"7, SX-517";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccccc2B(O)O)nc1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3387793";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307715";"";"";""
"CHEMBL3342292";"";"None";"383.40";"0";"4.67";"31";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc([N+](=O)[O-])cc2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3310789";"";"None";"283.36";"0";"3.22";"26";"N#Cc1c(O)nc(SCc2ccccc2)nc1C1CC1";"IC50";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3949893";"";"None";"445.33";"0";"3.26";"Ex 2";"O=C(Nc1cccnc1Cl)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCCNC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL84957";"";"None";"297.38";"0";"3.29";"28";"COc1ccccc1-c1nc(S)n(Cc2ccccc2)n1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"19.68";"0.38";"2.56";"14.66";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL1200709";"CROTAMITON";"4.0";"203.28";"0";"2.92";"CROTAMITON";"C/C=C/C(=O)N(CC)c1ccccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL34139";"GENACONAZOLE";"None";"331.34";"0";"0.88";"GENACONAZOLE (RR(+) ISOMER)";"C[C@H]([C@](O)(Cn1cncn1)c1ccc(F)cc1F)S(C)(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL871";"ETIDRONIC ACID";"4.0";"206.03";"0";"-0.99";"ETIDRONATE";"CC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1413";"CICLOPIROX";"4.0";"207.27";"0";"2.44";"CICLOPIROX";"Cc1cc(C2CCCCC2)n(O)c(=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL578";"ENALAPRIL";"4.0";"376.45";"0";"1.60";"ENALAPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4791845";"";"None";"442.53";"1";"6.19";"19";"CCOC(=O)c1c(NC(=S)Nc2ccc(C(F)(F)F)cc2)sc2c1C(C)CCC2";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"12.88";"0.27";"-0.49";"11.32";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4796058";"";"None";"418.58";"1";"5.36";"40";"CC(C)(C)OC(=O)c1c(NC(=S)Nc2ccccc2)sc2c1COC(C)(C)C2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"";""
"CHEMBL4779981";"";"None";"462.64";"1";"5.97";"49";"COc1ccc(NC(=S)Nc2sc3c(c2C(=O)OC(C)(C)C)C(C)CCC3)cc1OC";"IC50";"'='";"5700.0";"nM";"5.24";"";"";"UO_0000065";"11.34";"0.23";"-0.73";"7.62";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL38182";"";"None";"357.17";"0";"3.24";"SB265610";"N#Cc1ccc(NC(=O)Nc2ccccc2Br)c2nn[nH]c12";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"19.11";"0.42";"3.58";"6.41";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL1480";"FELODIPINE";"4.0";"384.26";"0";"3.96";"FELODIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL312060";"";"None";"297.38";"0";"3.29";"24";"COc1ccc(-c2nc(S)n(Cc3ccccc3)n2)cc1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"18.96";"0.37";"2.35";"14.12";"0";"CHEMBL656547";"Inhibition of binding of [125I]IL8 to human recombinant CXC chemokine receptor 2 (CXCR2) expressed in HEK 293 membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"CHEMBL3307715";"";"";""
"CHEMBL280711";"";"None";"273.25";"0";"2.94";"1";"O=C(Nc1ccccc1)Nc1ccc([N+](=O)[O-])cc1O";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"23.77";"0.44";"3.55";"6.22";"1";"CHEMBL4324668";"Displacement of [125I]IL-8 from CXCR2 (unknown origin) stably expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321855";"1";"Scientific Literature";"Eur J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4473520";"";"None";"457.41";"1";"6.88";"32";"CCN(CC)CCCCNc1nc2cc(Cl)c(Cl)cc2nc1-c1cc2ccccc2o1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"16.45";"0.33";"0.64";"13.88";"0";"CHEMBL4324678";"Displacement of [125I]IL-8 from CXCR2 in human neutrophils incubated for 3 hrs by gamma counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321855";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL3426948";"";"None";"382.23";"None";"None";"BDBM150817";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cccc(B(O)O)c2)nc1";"IC50";"'='";"1970.0";"nM";"5.71";"";"290327";"UO_0000065";"14.93";"None";"None";"None";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342308";"";"None";"396.44";"0";"4.55";"BDBM150833";"COC(=O)c1cccc(CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)c1";"IC50";"'>'";"5000.0";"nM";"";"";"290343";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658258";"";"None";"430.92";"1";"5.42";"BDBM150874";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cc3nsnc3cc2Cl)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290384";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342284";"";"None";"373.37";"0";"4.27";"BDBM150886";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc([N+](=O)[O-])o2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290396";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658276";"";"None";"414.89";"1";"5.41";"BDBM150903";"Cc1cc(C(=O)CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)ccc1Cl";"IC50";"'>'";"5000.0";"nM";"";"";"290413";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL47244";"PICROTOXININ";"None";"292.29";"0";"-0.06";"COCCULIN";"C=C(C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1(O)C[C@H]3O[C@]34C(=O)O[C@H]2[C@]14C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL233346";"";"None";"415.86";"0";"4.42";"9n";"O=S1(=O)N=C(Nc2ccccc2Oc2ccccc2)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"17.48";"0.35";"2.85";"7.27";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL233346";"";"None";"415.86";"0";"4.42";"9n";"O=S1(=O)N=C(Nc2ccccc2Oc2ccccc2)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL896517";"Antagonist activity at CXCR2 receptor expressed in CHOK1 cells assessed as human IL8-induced calcium mobilization by FLIPR";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307512";"";"";""
"CHEMBL392445";"";"None";"337.79";"0";"2.31";"10a";"O=S1(=O)N=C(NCc2ccccc2)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"15.09";"0.32";"2.79";"5.61";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL1308";"FOMEPIZOLE";"4.0";"82.11";"0";"0.72";"4-METHYLPYRAZOLE";"Cc1cn[nH]c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3701195";"";"None";"475.52";"0";"2.07";"BDBM172341";"Cc1ccc(C(Nc2c(Nc3cccc(S(=O)(=O)N(C)C)c3O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"257.0";"nM";"6.59";"";"317318";"UO_0000065";"13.86";"0.27";"4.52";"4.77";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL182";"GANCICLOVIR";"4.0";"255.23";"0";"-1.97";"GANCICLOVIR";"Nc1nc2c(ncn2COC(CO)CO)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL5314404";"AJMALINE";"3.0";"326.44";"0";"1.55";"AJMALINE";"CC[C@H]1[C@@H]2C[C@H]3[C@@H]4N(C)c5ccccc5[C@]45C[C@@H]([C@@H]2[C@H]5O)N3[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL264374";"BEZAFIBRATE";"4.0";"361.83";"0";"3.55";"BEZAFIBRATE";"CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL24912";"";"None";"273.25";"0";"2.94";"1c";"O=C(Nc1ccccc1)Nc1cc([N+](=O)[O-])ccc1O";"IC50";"'='";"10900.0";"nM";"4.96";"";"";"UO_0000065";"18.16";"0.34";"2.02";"4.75";"0";"CHEMBL656551";"Inhibition of binding of IL-8 to membranes of cloned CXC chemokine receptor 2 expressed in CHO Cells using [125I]IL-8 radioligand";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149089";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL58561";"";"None";"374.56";"0";"2.83";"4b";"O=C(Nc1ccc(I)cc1)c1ccc(Cl)[n+]([O-])c1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL662153";"Evaluated using an SPA assay with recombinant human [125I]IL-8 and membranes prepared from Sf9 cells expressing human CXCR2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133879";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2001";"CHEMBL3308860";"";"";""
"CHEMBL254773";"";"None";"516.39";"1";"4.97";"39";"O=C(NCCc1c(-c2ccc(F)cc2)[nH]c2ccc(Br)cc12)NS(=O)(=O)c1ccccc1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL928889";"Antagonist activity at human cloned CXCR2 by calcium flux FLIPR assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141538";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL396411";"";"None";"447.11";"0";"3.50";"9v";"O=S1(=O)N=C(Nc2ccccc2Br)Nc2c(O)cc(Br)cc21";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"16.00";"0.44";"3.65";"7.88";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL234178";"";"None";"386.20";"0";"2.88";"9u";"O=S1(=O)N=C(Nc2ccccc2Br)Nc2c(O)cc(F)cc21";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"16.68";"0.40";"3.56";"7.10";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL393047";"";"None";"402.66";"0";"3.39";"9d";"O=S1(=O)N=C(Nc2ccccc2Br)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"64.0";"nM";"7.19";"";"";"UO_0000065";"17.87";"0.45";"3.80";"7.92";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL234186";"";"None";"358.21";"0";"3.28";"9c";"O=S1(=O)N=C(Nc2ccccc2Cl)Nc2c(O)cc(Cl)cc21";"IC50";"'='";"92.0";"nM";"7.04";"";"";"UO_0000065";"19.64";"0.44";"3.76";"7.75";"0";"CHEMBL896516";"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL231924";"";"None";"368.76";"0";"2.54";"9ab";"O=[N+]([O-])c1cc(O)c2c(c1)S(=O)(=O)N=C(Nc1ccccc1Cl)N2";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL896517";"Antagonist activity at CXCR2 receptor expressed in CHOK1 cells assessed as human IL8-induced calcium mobilization by FLIPR";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307512";"";"";""
"CHEMBL443583";"";"None";"413.21";"0";"2.65";"9w";"O=[N+]([O-])c1cc(O)c2c(c1)S(=O)(=O)N=C(Nc1ccccc1Br)N2";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL896517";"Antagonist activity at CXCR2 receptor expressed in CHOK1 cells assessed as human IL8-induced calcium mobilization by FLIPR";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307512";"";"";""
"CHEMBL446458";"";"None";"384.43";"0";"2.74";"30b";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2[nH]c(=O)sc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"23.41";"0.49";"6.26";"9.90";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL257025";"";"None";"351.38";"0";"2.72";"29";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2[nH]ncc12";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"18.95";"0.38";"3.94";"7.68";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL403877";"";"None";"395.39";"0";"1.37";"27";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2[nH]c(=O)c(=O)[nH]c12";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"18.58";"0.37";"5.98";"5.94";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL272105";"";"None";"437.43";"0";"1.86";"26";"COC(=O)c1nc2c(N[C@H](C)CO)nc(SCc3cccc(F)c3F)nc2[nH]c1=O";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"19.89";"0.40";"6.84";"6.69";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL4776704";"";"None";"382.51";"0";"4.26";"CX797";"CSc1nnc2n(-c3ccccc3)c(=O)c3c4c(sc3n12)CCC[C@H]4C";"IC50";"'='";"7790.0";"nM";"5.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4774280";"Inhibition of CXCR2 (unknown origin) expressed in HEK293T cells cotransfected with GFP-p22F assessed as reduction in IL-8-induced cAMP incubated for 10 mins followed by IL-8 stimulation and measured after 10 mins by luminescence based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293T";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.3333 hr";"ANTAGONIST";""
"CHEMBL4787491";"";"None";"359.52";"0";"4.36";"33";"CNC(=O)c1c(NC(=S)Nc2ccccc2)sc2c1C(C)CCC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"";""
"CHEMBL4788927";"";"None";"479.67";"1";"6.07";"43";"CC(C)(C)OC(=O)c1c(NC(=S)Nc2ccccc2)sc2c1CCN(Cc1ccccc1)C2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"";""
"CHEMBL4776480";"";"None";"408.52";"0";"4.72";"52";"CC(C)(C)OC(=O)c1c(NC(=S)Nc2ccc(F)cc2)sc2c1CCOC2";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"14.59";"0.30";"1.24";"10.00";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL253497";"";"None";"417.85";"0";"3.24";"20";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cc(Cl)co1";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"19.98";"0.39";"5.11";"7.46";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL254516";"";"None";"493.95";"0";"4.91";"18";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(-c2cccc(Cl)c2)o1";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"14.65";"0.28";"2.33";"6.47";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL239558";"";"None";"253.26";"0";"2.91";"Table 1 C5R2";"N#Cc1cccc(NC(=O)Nc2ccccc2)c1O";"IC50";"'='";"276.0";"nM";"6.56";"";"";"UO_0000065";"25.90";"0.47";"3.65";"7.70";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL221753";"BENZETHONIUM CHLORIDE";"2.0";"448.09";"1";"6.07";"BENZETHONIUM CHLORIDE";"CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL597";"PHENTOLAMINE";"4.0";"281.36";"0";"2.84";"PHENTOLAMINE";"Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1076211";"TOLPERISONE";"3.0";"245.37";"0";"3.30";"TOLPERISONE";"Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL983";"SUCCINYLCHOLINE CHLORIDE";"4.0";"361.31";"0";"0.27";"SUXAMETHONIUM CHLORIDE";"C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL989";"FLUOCINOLONE ACETONIDE";"4.0";"452.49";"0";"2.37";"FLUOCINOLONE ACETONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL415446";"";"None";"413.50";"0";"3.37";"20";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)s1";"IC50";"'='";"5.3";"nM";"8.28";"";"";"UO_0000065";"20.01";"0.39";"4.91";"8.38";"0";"CHEMBL909848";"Displacement of [125I]hCXCL8 from human CXCR2 receptor expressed in BaF3 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307634";"";"";""
"CHEMBL3943808";"";"None";"453.50";"0";"2.91";"BDBM177692";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2CCOCC2)o1";"IC50";"'='";"212.0";"nM";"6.67";"";"323499";"UO_0000065";"14.72";"0.28";"3.76";"5.51";"0";"CHEMBL3887210";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the beta -arrestin recruitment after receptor activation type.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 beta -arrestin line results in the recruitment of beta -arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation.>>J. Immunol. 170: 2904-2911).In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with beta -arrestin 2, a beta -arrestin 2 recruitment test for CXCR2 or CXCR1 based on beta -galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886212";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL218964";"";"None";"345.40";"0";"2.03";"3";"CCC(CC)Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"22.65";"0.43";"5.79";"7.92";"0";"CHEMBL909848";"Displacement of [125I]hCXCL8 from human CXCR2 receptor expressed in BaF3 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307634";"";"";""
"CHEMBL385784";"";"None";"365.39";"0";"2.05";"11";"CN(C)C(=O)c1cccc(Nc2c(NCc3ccccc3)c(=O)c2=O)c1O";"IC50";"'='";"236.0";"nM";"6.63";"";"";"UO_0000065";"18.14";"0.34";"4.58";"6.71";"0";"CHEMBL909848";"Displacement of [125I]hCXCL8 from human CXCR2 receptor expressed in BaF3 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307634";"";"";""
"CHEMBL3645133";"";"None";"445.87";"0";"4.68";"BDBM100345";"CC(C)(NC(=O)c1ccc2ccccc2c1OCCOc1ccc(F)c(Cl)c1)C(=O)O";"IC50";"'='";"1250.0";"nM";"5.90";"";"217539";"UO_0000065";"";"";"";"";"0";"CHEMBL3705309";"Calcium Fluorescence Assay (FLIPR) : CXCR2 inhibition using calcium fluorescence assay (FLIPR).";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638729";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4098864";"";"None";"432.90";"0";"3.53";"61";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2(F)CCOCC2)c1O";"IC50";"'='";"0.1995";"nM";"9.70";"";"";"UO_0000065";"22.41";"0.47";"6.17";"9.26";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3658320";"";"None";"502.35";"2";"6.41";"BDBM150947";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2cc(-c3ccc(Cl)cc3Cl)no2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290457";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658337";"";"None";"396.25";"None";"None";"BDBM150965";"CN(C(=O)c1ccc(SCc2ccccc2B(O)O)nc1)c1ccc(F)cc1";"IC50";"'>'";"5000.0";"nM";"";"";"290475";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL529";"AZITHROMYCIN";"4.0";"749.00";"2";"1.90";"AZITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1790041";"RANITIDINE";"4.0";"314.41";"0";"1.46";"RANITIDINE";"CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200633";"IVERMECTIN";"4.0";"1736.18";"None";"None";"IVERMECTIN";"CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL6437";"MIANSERIN";"4.0";"264.37";"0";"3.08";"MIANSERIN";"CN1CCN2c3ccccc3Cc3ccccc3C2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL115";"INDINAVIR";"4.0";"613.80";"1";"2.87";"INDINAVIR";"CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4793669";"";"None";"404.56";"1";"5.18";"24";"CCOC(=O)c1c(NC(=S)Nc2cccc(OC)c2)sc2c1C(C)CCC2";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"13.65";"0.28";"0.34";"9.27";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4798148";"";"None";"370.50";"0";"3.81";"28";"CCOC(=O)NC(=S)Nc1sc2c(c1C(=O)OCC)C(C)CCC2";"IC50";"'='";"8700.0";"nM";"5.06";"";"";"UO_0000065";"13.66";"0.29";"1.25";"6.60";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4777868";"";"None";"388.56";"1";"5.39";"36";"CC(C)(C)OC(=O)c1c(NC(=S)Nc2ccccc2)sc2c1CCCC2";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"14.78";"0.30";"0.35";"11.41";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4562144";"";"None";"364.51";"0";"4.86";"35; CX4338";"CC1(C)CC(=O)C(C(=S)Nc2ccccc2)=C(NCc2ccccc2)C1";"IC50";"'='";"6300.0";"nM";"5.20";"";"";"UO_0000065";"14.27";"0.27";"0.34";"12.64";"0";"CHEMBL4324680";"Antagonist activity at CXCR2 in human U2OS cells assessed as effect on beta-arrestin2 recruitment by CCF4-AM staining based Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321855";"1";"Scientific Literature";"Eur J Med Chem";"2020";"CHEMBL3307757";"";"";""
"CHEMBL698";"TETRACAINE";"4.0";"264.37";"0";"2.62";"TETRACAINE";"CCCCNc1ccc(C(=O)OCCN(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL83668";"TOLNAFTATE";"4.0";"307.42";"0";"4.95";"TOLNAFTATE";"Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909076";"";"None";"270.38";"0";"1.21";"S-(N-BENZYLTHIOCARBAMOYL)-L-CYSTEINE";"N[C@H](CSC(=S)NCc1ccccc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200693";"MANGANESE CHLORIDE ANHYDROUS";"4.0";"125.84";"None";"None";"MANGANESE (II) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL5315124";"LEVOFLOXACIN";"4.0";"740.76";"0";"1.54";"LEVOFLOXACIN";"C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200559";"LACTIC ACID";"4.0";"90.08";"0";"-0.55";"LACTIC ACID";"CC(O)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1540";"PENCICLOVIR";"4.0";"253.26";"0";"-0.90";"PENCICLOVIR";"Nc1nc(O)c2ncn(CCC(CO)CO)c2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL130";"CHLORAMPHENICOL";"4.0";"323.13";"0";"0.91";"3";"O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL417";"EPIRUBICIN";"4.0";"543.53";"3";"0.00";"EPIRUBICIN";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL119443";"ERGONOVINE";"4.0";"325.41";"0";"1.53";"ERGONOVINE";"C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3704571";"";"None";"453.50";"0";"2.91";"BDBM172370";"CCN(C)C(=O)c1cccc(Nc2c(N[C@@H](c3ccc(C)o3)C3(C)COC3)c(=O)c2=O)c1O";"IC50";"'='";"72.0";"nM";"7.14";"";"317336";"UO_0000065";"15.75";"0.30";"4.23";"5.90";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1428";"NIMODIPINE";"4.0";"418.45";"0";"2.97";"NIMODIPINE";"COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL452";"CLONAZEPAM";"4.0";"315.72";"0";"3.04";"CLONAZEPAM";"O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1430";"PENICILLAMINE";"4.0";"149.21";"0";"0.11";"PENICILLAMINE";"CC(C)(S)[C@@H](N)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL588119";"SULOCTIDIL";"None";"337.57";"1";"5.56";"SULOCTIDIL";"CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1566249";"AMPIROXICAM";"2.0";"447.47";"0";"2.56";"AMPIROXICAM";"CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1385840";"ERGOCORNINE";"None";"561.68";"1";"2.04";"ERGOCORNINE";"CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL434063";"";"None";"495.58";"0";"4.94";"GW-1929";"CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201012";"FLURANDRENOLIDE";"4.0";"436.52";"0";"2.50";"FLURANDRENOLIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL413965";"FELBINAC";"4.0";"212.25";"0";"2.98";"FELBINAC";"O=C(O)Cc1ccc(-c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL720";"BENZYL ALCOHOL";"4.0";"108.14";"0";"1.18";"BENZYL ALCOHOL";"OCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1399";"ANASTROZOLE";"4.0";"293.37";"0";"2.93";"ANASTROZOLE";"CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1501";"FLUOCINONIDE";"4.0";"494.53";"0";"2.94";"FLUOCINONIDE";"CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200993";"GALLAMINE TRIETHIODIDE";"4.0";"891.54";"2";"5.45";"GALLAMINE TRIETHIODIDE";"CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL566534";"ARTEMETHER";"4.0";"298.38";"0";"2.84";"ARTEMETHER";"CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL632";"BETAMETHASONE";"4.0";"392.47";"0";"1.90";"BETAMETHASONE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL117405";"";"None";"248.33";"0";"1.91";"(S)-(-)-PINDOLOL";"CC(C)NC[C@H](O)COc1cccc2[nH]ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL941";"IMATINIB";"4.0";"493.62";"0";"4.59";"IMATINIB";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL153479";"AMBROXOL";"3.0";"378.11";"0";"3.19";"AMBROXOL";"Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1235242";"";"None";"183.18";"0";"0.78";"4-FLUORO-L-PHENYLALANINE";"N[C@@H](Cc1ccc(F)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1614641";"FLUNOXAPROFEN";"2.0";"285.27";"0";"3.82";"FLUNOXAPROFEN";"C[C@H](C(=O)O)c1ccc2oc(-c3ccc(F)cc3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1117";"IDARUBICIN";"4.0";"497.50";"0";"1.02";"IDARUBICIN";"CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1687";"TUBOCURARINE CHLORIDE";"None";"645.20";"2";"6.70";"D-TUBOCURARINE CHLORIDE";"COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL156455";"1,1-DICHLOROETHENE";"None";"96.94";"0";"1.94";"1,1-DICHLOROETHENE";"C=C(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL455431";"";"None";"429.55";"0";"4.79";"25";"Cc1ccc([C@H](Nc2nsnc2Nc2cccc(C(=O)N(C)C)c2O)C(C)(C)C)o1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"17.87";"0.35";"2.89";"7.42";"0";"CHEMBL963311";"Displacement of [125I]CXCL1 from CXCR2 receptor in human PMN assessed as myeloperoxidase release";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153271";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL232846";"";"None";"365.46";"0";"2.89";"3c";"C[C@H](CO)Nc1nc(SCc2ccccc2F)nc2nc(N)sc12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"21.58";"0.45";"5.00";"8.13";"1";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL403225";"";"None";"400.89";"0";"3.26";"30a";"C[C@H](CO)Nc1nc(SCc2cccc(Cl)c2F)nc2[nH]c(=O)sc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.45";"0.49";"5.74";"9.90";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL403702";"";"None";"377.42";"0";"3.09";"19";"Cc1cnc2nc(SCc3cccc(F)c3F)nc(N[C@H](C)CO)c2n1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"18.16";"0.36";"3.76";"8.18";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL270446";"";"None";"365.41";"0";"3.02";"16";"Cc1nc2c(N[C@H](C)CO)nc(SCc3cccc(F)c3F)nc2[nH]1";"IC50";"'='";"630.0";"nM";"6.20";"";"";"UO_0000065";"16.97";"0.34";"3.18";"7.15";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL402986";"";"None";"348.45";"0";"2.46";"30d";"C[C@H](CO)Nc1nc(SCc2ccccc2)nc2[nH]c(=O)sc12";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"23.82";"0.49";"5.84";"9.13";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL271013";"";"None";"347.47";"0";"2.75";"3d";"C[C@H](CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"22.70";"0.47";"5.14";"8.13";"0";"CHEMBL949060";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141618";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL177756";"FLUORESCEIN";"None";"332.31";"0";"3.97";"FLUORESCEIN";"O=C(O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL75880";"PERHEXILINE";"4.0";"277.50";"1";"5.30";"PERHEXILINE";"C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL898";"DIFLUNISAL";"4.0";"250.20";"0";"3.04";"DIFLUNISAL";"O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL783";"NATEGLINIDE";"4.0";"317.43";"0";"3.26";"NATEGLINIDE";"CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL40";"PHENOBARBITAL";"4.0";"232.24";"0";"0.70";"PHENOBARBITAL";"CCC1(c2ccccc2)C(=O)NC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL404060";"";"None";"433.92";"0";"3.71";"37";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(Cl)s1";"IC50";"'='";"6.2";"nM";"8.21";"";"";"UO_0000065";"18.92";"0.39";"4.50";"8.31";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL404059";"";"None";"399.47";"0";"3.06";"36";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cccs1";"IC50";"'='";"6.2";"nM";"8.21";"";"";"UO_0000065";"20.55";"0.40";"5.15";"8.31";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL1909083";"ZIRCONIUM(IV) CHLORIDE";"None";"233.04";"None";"None";"ZIRCONIUM(IV) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL6966";"VERAPAMIL";"4.0";"454.61";"1";"5.09";"VERAPAMIL";"COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL83";"TAMOXIFEN";"4.0";"371.52";"1";"6.00";"TAMOXIFEN";"CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4786074";"";"None";"407.88";"0";"2.87";"2";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC2=NC(=O)C(c3ccccc3)N2)c1O";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL4765070";"";"None";"331.78";"0";"1.13";"B1";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC2=NC(=O)CN2)c1O";"IC50";"'='";"29700.0";"nM";"4.53";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL3658325";"";"None";"438.48";"0";"4.61";"BDBM150953";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1ccc2c(c1)OCCCO2";"IC50";"'>'";"5000.0";"nM";"";"";"290463";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342323";"";"None";"440.26";"None";"None";"BDBM150968";"O=C(O)CN(C(=O)c1ccc(SCc2ccccc2B(O)O)nc1)c1ccc(F)cc1";"IC50";"'='";"1990.0";"nM";"5.70";"";"290479";"UO_0000065";"12.95";"None";"None";"None";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658338";"";"None";"398.22";"None";"None";"BDBM150975";"O=C(Nc1ccc(F)cc1O)c1ccc(SCc2ccccc2B(O)O)nc1";"IC50";"'='";"37.0";"nM";"7.43";"";"290486";"UO_0000065";"18.66";"None";"None";"None";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1255901";"HUPERZINE A";"2.0";"242.32";"0";"2.00";"HUPERZINE A";"C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL27863";"";"None";"332.16";"0";"3.67";"Table 1 C5R12";"N#Cc1ccc(NC(=O)Nc2ccccc2Br)c(O)c1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"22.89";"0.52";"3.93";"8.93";"1";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL430376";"";"None";"307.69";"0";"3.60";"Table 1 C5R6";"O=C(Nc1ccccc1)Nc1cc(Cl)c([N+](=O)[O-])cc1O";"IC50";"'='";"950.0";"nM";"6.02";"";"";"UO_0000065";"19.57";"0.39";"2.42";"5.76";"0";"CHEMBL903301";"Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139102";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL290916";"EDARAVONE";"4.0";"174.20";"0";"1.80";"EDARAVONE";"CC1=NN(c2ccccc2)C(=O)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL880";"FAMCICLOVIR";"4.0";"321.34";"0";"0.54";"Famciclovir";"CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200396";"BUPIVACAINE HYDROCHLORIDE";"4.0";"324.90";"0";"3.90";"BUPIVACAINE HYDROCHLORIDE";"CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL210448";"";"None";"324.29";"0";"1.84";"9";"O=C(O)c1cccc(/N=c2\c(O)c(O)\c2=N/c2ccccc2)c1O";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"18.50";"0.34";"4.16";"4.89";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL215464";"";"None";"365.39";"0";"2.04";"17";"CN(C)C(=O)c1cccc(/N=c2/c(N(C)c3ccccc3)c(O)c2=O)c1O";"IC50";"'='";"7200.0";"nM";"5.14";"";"";"UO_0000065";"14.07";"0.26";"3.10";"5.50";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL211353";"";"None";"379.42";"0";"1.76";"26";"CN(C)C(=O)c1cccc(/N=c2\c(O)c(O)\c2=N/CCc2ccccc2)c1O";"IC50";"'='";"926.0";"nM";"6.03";"";"";"UO_0000065";"15.90";"0.29";"4.27";"5.71";"0";"CHEMBL867334";"Displacement of [125I]IL8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146016";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL5090244";"";"None";"463.31";"0";"2.96";"10b";"O=c1c(Nc2ccccc2Br)c(Nc2ccc3c(c2O)S(=O)(=O)CCC3)c1=O";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5089049";"";"None";"414.41";"0";"2.72";"12d";"Cc1c(F)cccc1Nc1c(Nc2ccc3c(c2O)S(=O)(=O)CC=C3)c(=O)c1=O";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5094410";"";"None";"400.38";"0";"3.77";"9f";"O=C(Nc1ccccc1C(F)(F)F)Nc1ccc2c(c1O)S(=O)(=O)CCC2";"IC50";"'='";"4510.0";"nM";"5.35";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL4757674";"";"None";"523.01";"1";"3.37";"A2";"CC(C)(C)OC(=O)NCCCS(=O)(=O)c1c(Cl)ccc(NC2=NC(=O)C(c3ccccc3)N2)c1O";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL4742368";"";"None";"413.93";"0";"3.07";"C5";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC2=NC(=O)[C@@H](C3CCCCC3)N2)c1O";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL177";"AMIKACIN";"4.0";"585.61";"3";"-8.42";"Amikacin";"NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL744";"RILUZOLE";"4.0";"234.20";"0";"2.78";"RILUZOLE";"Nc1nc2ccc(OC(F)(F)F)cc2s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL423192";"ANISOMYCIN";"None";"265.31";"0";"0.50";"ANISOMYCIN";"COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1282";"IMIQUIMOD";"4.0";"240.31";"0";"2.82";"IMIQUIMOD";"CC(C)Cn1cnc2c(N)nc3ccccc3c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL799";"CILOSTAZOL";"4.0";"369.47";"0";"3.46";"CILOSTAZOL";"O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL6466";"COUMARIN";"4.0";"146.14";"0";"1.79";"COUMARIN";"O=c1ccc2ccccc2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201139";"MEGESTROL ACETATE";"4.0";"384.52";"0";"4.58";"MEGESTROL ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL307145";"PYROGALLOL";"4.0";"126.11";"0";"0.80";"PYROGALLOL";"Oc1cccc(O)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL216981";"NAVARIXIN";"2.0";"397.43";"0";"2.90";"4, SCH-527123";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL912820";"Inhibition of CXCL1-induced human neutrophil chemotaxis";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138214";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3355242";"";"None";"453.87";"0";"3.89";"3l";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)cc(C(C)(C)C(F)(F)F)[nH]2)c1O";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.42";"0.33";"3.11";"6.24";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3818853";"";"None";"447.32";"1";"5.20";"16";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCCC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"0.3162";"nM";"9.50";"";"";"UO_0000065";"21.24";"0.46";"4.30";"9.95";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3818331";"";"None";"490.38";"0";"4.74";"23";"CCN1CCC(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1";"IC50";"'='";"1.259";"nM";"8.90";"";"";"UO_0000065";"18.15";"0.39";"4.16";"9.01";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3819512";"";"None";"476.36";"0";"4.35";"22";"CN1CCC(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1";"IC50";"'='";"0.5012";"nM";"9.30";"";"";"UO_0000065";"19.52";"0.42";"4.95";"9.42";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL245190";"";"None";"399.45";"0";"2.00";"5";"Nc1nc2nc(SCc3cccc(F)c3F)nc(NC(CO)CO)c2s1";"IC50";"'='";"31.62";"nM";"7.50";"";"";"UO_0000065";"18.78";"0.39";"5.50";"6.40";"0";"CHEMBL893601";"Displacement of [125I]IL8 from human CXCR2 expressed in HEK 293 by SPA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147921";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307715";"";"";""
"CHEMBL3704557";"";"None";"465.51";"0";"2.63";"BDBM172349";"COc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2(C)COC2)cc1";"IC50";"'='";"433.0";"nM";"6.36";"";"317326";"UO_0000065";"13.67";"0.26";"3.73";"5.43";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3640034";"";"None";"445.50";"0";"2.59";"BDBM172345";"Cc1ccc([C@H](Nc2c(Nc3csc(C(=O)N(C)C)c3O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"96.0";"nM";"7.02";"";"317309";"UO_0000065";"15.75";"0.31";"4.43";"5.79";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3310768";"";"None";"388.28";"1";"5.32";"4";"N#Cc1c(O)nc(SCc2c(Cl)cccc2Cl)nc1-c1ccccc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3310790";"";"None";"297.38";"0";"3.78";"27";"CC(Sc1nc(O)c(C#N)c(C2CC2)n1)c1ccccc1";"IC50";"'='";"4800.0";"nM";"5.32";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3342269";"";"None";"382.23";"None";"None";"7, SX-517";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccccc2B(O)O)nc1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386567";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CVCL8-induced [35S]GTPgammaS binding after 60 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307715";"";"";""
"CHEMBL3342317";"";"None";"365.22";"None";"None";"57";"O=C(Nc1ccncc1)c1ccc(SCc2ccccc2B(O)O)nc1";"IC50";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342307";"";"None";"382.42";"0";"4.46";"47";"O=C(O)c1ccc(CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL86304";"MOCLOBEMIDE";"4.0";"268.74";"0";"1.40";"MOCLOBEMIDE";"O=C(NCCN1CCOCC1)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL475534";"NITRENDIPINE";"4.0";"360.37";"0";"2.57";"SID124880808";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1753";"CLINDAMYCIN";"4.0";"424.99";"0";"0.39";"CLINDAMYCIN";"CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL185";"FLUOROURACIL";"4.0";"130.08";"0";"-0.80";"FLUOROURACIL";"O=c1[nH]cc(F)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3704569";"";"None";"507.47";"1";"3.46";"BDBM172368";"Cc1ccc([C@H](Nc2c(Nc3cccc(C(=O)N(C)CC(F)(F)F)c3O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"26.0";"nM";"7.58";"";"317303";"UO_0000065";"14.95";"0.29";"4.13";"6.26";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL253499";"";"None";"459.50";"0";"4.26";"22";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1cc(-c2ccccc2)co1";"IC50";"'='";"6.1";"nM";"8.21";"";"";"UO_0000065";"17.88";"0.33";"3.95";"7.34";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL251890";"";"None";"527.50";"2";"5.28";"19";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(-c2cccc(C(F)(F)F)c2)o1";"IC50";"'='";"87.0";"nM";"7.06";"";"";"UO_0000065";"13.38";"0.25";"1.78";"6.31";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL3342284";"";"None";"373.37";"0";"4.27";"22";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc([N+](=O)[O-])o2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342270";"";"None";"330.35";"0";"2.28";"8";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2nn[nH]n2)nc1";"IC50";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL404250";"";"None";"451.40";"0";"3.61";"11";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C(F)(F)F)o1";"IC50";"'='";"17.2";"nM";"7.76";"";"";"UO_0000065";"17.20";"0.33";"4.15";"6.94";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL3658274";"";"None";"400.86";"1";"5.10";"BDBM150901";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1cccc(Cl)c1";"IC50";"'='";"210.0";"nM";"6.68";"";"290411";"UO_0000065";"16.66";"0.34";"1.58";"11.31";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658280";"";"None";"494.63";"1";"6.75";"BDBM150907";"CC(C)(C)c1cc(C(=O)CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)cc(C(C)(C)C)c1O";"IC50";"'>'";"10000.0";"nM";"";"";"290417";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658283";"";"None";"451.52";"0";"4.28";"BDBM150910";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1ccc(N2CCOCC2)cc1";"IC50";"'>'";"5000.0";"nM";"";"";"290420";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658255";"";"None";"522.56";"2";"5.33";"BDBM150871";"O=C(Nc1ccc(F)cc1)c1ccc(SCCCCCCN2C(=O)c3ccc([N+](=O)[O-])cc3C2=O)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290381";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342293";"";"None";"422.40";"1";"5.66";"32";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc(OC(F)(F)F)cc2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3704559";"";"None";"465.51";"0";"2.32";"BDBM172351";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N4CCC(O)C4)c3)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"716.0";"nM";"6.14";"";"317331";"UO_0000065";"13.20";"0.25";"3.83";"5.07";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342269";"";"None";"382.23";"None";"None";"5";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccccc2B(O)O)nc1";"IC50";"'='";"730.0";"nM";"6.14";"";"";"UO_0000065";"16.05";"None";"None";"None";"0";"CHEMBL3427963";"Inhibition of CXCR2 (unknown origin) expressed in PathHunter celline by beta-arrestin assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425456";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3973880";"";"None";"431.30";"0";"2.87";"Ex 23";"O=C(Nc1cccnc1Cl)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCNC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3895808";"";"None";"534.39";"1";"4.88";"Ex 30";"CCOC(=O)N1CCC(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3704570";"";"None";"439.47";"0";"2.52";"BDBM172369";"Cc1ccc([C@H](Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"72.0";"nM";"7.14";"";"317308";"UO_0000065";"16.25";"0.30";"4.62";"5.90";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3403834";"";"None";"404.46";"0";"2.21";"27";"C[C@H](CO)Nc1cc(NS(C)(=O)=O)nc(SCc2cccc(F)c2F)n1";"IC50";"'='";"31.62";"nM";"7.50";"";"";"UO_0000065";"18.54";"0.39";"5.29";"7.20";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3403842";"";"None";"465.00";"0";"4.02";"35";"C[C@H](CO)Nc1cc(NS(=O)(=O)c2ccc(Cl)cc2)nc(SCc2ccccc2)n1";"IC50";"'='";"31.62";"nM";"7.50";"";"";"UO_0000065";"16.13";"0.34";"3.48";"7.20";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3403848";"";"None";"449.96";"0";"2.57";"41";"C[C@H](CO)Nc1cc(NS(=O)(=O)N(C)C)nc(SCc2cccc(Cl)c2F)n1";"IC50";"'='";"5.012";"nM";"8.30";"";"";"UO_0000065";"18.45";"0.40";"5.73";"7.72";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3403854";"";"None";"475.54";"0";"1.83";"47";"C[C@H](CO)Nc1cc(NS(=O)(=O)N2CCOCC2)nc(SCc2cccc(F)c2F)n1";"IC50";"'='";"3.981";"nM";"8.40";"";"";"UO_0000065";"17.66";"0.37";"6.57";"7.20";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL218964";"";"None";"345.40";"0";"2.03";"73";"CCC(CC)Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"22.35";"0.42";"5.69";"7.82";"0";"CHEMBL5215022";"Inhibition of human CXCR2-mediated chemotaxis expressed in mouse BaF3 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214881";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3342297";"";"None";"420.47";"1";"5.12";"18";"Cc1nc(-c2ccc(CSc3ccc(C(=O)Nc4ccc(F)cc4)cn3)cc2)no1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3310784";"";"None";"335.38";"0";"3.92";"21";"CC(C)(C)c1nc(SCc2cccc(F)c2F)nc(O)c1C#N";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3342318";"";"None";"380.23";"None";"None";"58";"O=C(Nc1ccc(O)cc1)c1ccc(SCc2ccccc2B(O)O)nc1";"IC50";"'='";"105.0";"nM";"6.98";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342269";"";"None";"382.23";"None";"None";"7, SX-517";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccccc2B(O)O)nc1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL277474";"ANTIPYRINE";"4.0";"188.23";"0";"1.48";"ANTIPYRINE";"Cc1cc(=O)n(-c2ccccc2)n1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3654444";"";"None";"516.45";"None";"None";"BDBM150828";"CC1(C)C2CC3OB(c4ccccc4CSc4ccc(C(=O)Nc5ccc(F)cc5)cn4)OC3(C)C1C2";"IC50";"'='";"59.0";"nM";"7.23";"";"290338";"UO_0000065";"14.00";"None";"None";"None";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658285";"";"None";"411.41";"0";"4.36";"BDBM150912";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1ccc([N+](=O)[O-])cc1";"IC50";"'>'";"10000.0";"nM";"";"";"290422";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658294";"";"None";"502.41";"2";"6.49";"BDBM150921";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1";"IC50";"'>'";"10000.0";"nM";"";"";"290431";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1503";"OMEPRAZOLE";"4.0";"345.42";"0";"2.90";"OMEPRAZOLE";"COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL833";"TICLOPIDINE";"4.0";"263.79";"0";"3.96";"TICLOPIDINE";"Clc1ccccc1CN1CCc2sccc2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1567463";"CHOLINE ALFOSCERATE";"None";"257.22";"0";"-1.45";"CHOLINE ALFOSCERATE";"C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1214185";"ROXITHROMYCIN";"4.0";"837.06";"2";"2.21";"ROXITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL429";"LABETALOL";"4.0";"328.41";"0";"2.14";"LABETALOL";"CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL772";"RESERPINE";"4.0";"608.69";"1";"4.17";"RESERPINE";"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1373";"MODAFINIL";"4.0";"273.36";"0";"2.01";"MODAFINIL";"NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL599";"MELOXICAM";"4.0";"351.41";"0";"1.95";"meloxicam";"Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1431";"METFORMIN";"4.0";"129.17";"0";"-1.03";"Meltformin";"CN(C)C(=N)NC(=N)N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL254308";"";"None";"527.50";"2";"5.28";"17";"CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(-c2ccccc2C(F)(F)F)o1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"12.94";"0.25";"1.54";"6.10";"0";"CHEMBL927214";"Inhibition of CXCR2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141493";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL5079979";"";"None";"415.25";"0";"3.70";"8a";"O=C(Nc1ccc2c(c1O)S(=O)(=O)CCC2=O)Nc1cccc(Cl)c1Cl";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5084752";"";"None";"453.30";"0";"3.50";"10c";"O=c1c(Nc2ccc3c(c2O)S(=O)(=O)CCC3)c(Nc2cccc(Cl)c2Cl)c1=O";"IC50";"'='";"9990.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL3403847";"";"None";"486.98";"0";"2.89";"40";"C[C@H](CO)Nc1cc(NS(=O)(=O)c2cn(C)cn2)nc(SCc2cccc(Cl)c2F)n1";"IC50";"'='";"12.59";"nM";"7.90";"";"";"UO_0000065";"16.22";"0.35";"5.01";"6.47";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3310787";"";"None";"349.36";"0";"2.72";"ent-24a";"N#Cc1c(O)nc(SCc2cccc(F)c2F)nc1[C@H]1C[C@@H]1CO";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3901031";"";"None";"413.86";"0";"2.88";"Ex 9";"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CNC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3342300";"";"None";"403.48";"1";"5.56";"40";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc(-n3cccc3)cc2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342311";"";"None";"382.42";"0";"4.46";"51";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccccc2C(=O)O)nc1";"IC50";"'='";"1480.0";"nM";"5.83";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342310";"";"None";"396.44";"0";"4.55";"50";"COC(=O)c1ccccc1CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'='";"759.0";"nM";"6.12";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342295";"";"None";"420.53";"1";"6.49";"34";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccccc2-c2cccs2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342287";"";"None";"419.48";"1";"5.73";"25";"Cc1noc(-c2ccccc2)c1CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342298";"";"None";"404.47";"0";"4.95";"38";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc(-n3cccn3)cc2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3701191";"";"None";"465.51";"0";"3.06";"BDBM172334";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N4CCCC4)c3O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"262.0";"nM";"6.58";"";"317319";"UO_0000065";"14.14";"0.26";"3.52";"5.43";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL134342";"THIOCTIC ACID";"None";"206.33";"0";"2.79";"THIOCTIC ACID";"O=C(O)CCCC[C@@H]1CCSS1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3704558";"";"None";"479.49";"0";"2.35";"BDBM172350";"CN(C)C(=O)c1cccc(Nc2c(NC(c3ccc4c(c3)OCO4)C3(C)COC3)c(=O)c2=O)c1O";"IC50";"'='";"349.0";"nM";"6.46";"";"317324";"UO_0000065";"13.47";"0.25";"4.11";"5.11";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL302795";"TENOXICAM";"4.0";"337.38";"0";"1.64";"TENOXICAM";"CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3658332";"";"None";"465.54";"0";"4.67";"BDBM150960";"Cc1nc(-c2cnccn2)sc1C(=O)CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"290470";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658343";"";"None";"417.66";"None";"None";"BDBM150981";"O=C(Nc1ccc(F)cn1)c1cnc(SCc2ccccc2B(O)O)c(Cl)c1";"IC50";"'='";"166.0";"nM";"6.78";"";"290491";"UO_0000065";"16.23";"None";"None";"None";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL960";"LEFLUNOMIDE";"4.0";"270.21";"0";"3.25";"LEFLUNOMIDE";"Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3342289";"";"None";"503.55";"2";"7.22";"BDBM150882";"Cc1nc(-c2ccc(C(F)(F)F)cc2)sc1CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"290392";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342281";"";"None";"396.37";"1";"5.38";"BDBM150885";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc(C(F)(F)F)o2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290395";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658282";"";"None";"448.54";"1";"6.18";"BDBM150909";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1ccc(-c2cccs2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"290419";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL14053";"TRICHLOROACETIC ACID";"4.0";"163.39";"0";"1.44";"TRICHLOROACETIC ACID";"O=C(O)C(Cl)(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909071";"";"None";"None";"None";"None";"NOVARTIS P-38 INHIBITOR";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL559147";"Y-27632";"None";"247.34";"0";"2.17";"Y-27632";"C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL447";"SECOBARBITAL";"4.0";"238.29";"0";"1.35";"SECOBARBITAL";"C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3912983";"";"None";"448.30";"0";"3.62";"Ex 25; Ex 29";"O=C(Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCNC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3645134";"";"None";"423.44";"0";"4.17";"BDBM100346";"O=C(NC1(C(=O)O)CCC1)c1ccc2ccccc2c1OCCOc1ccc(F)cc1";"IC50";"'='";"3230.0";"nM";"5.49";"";"217540";"UO_0000065";"";"";"";"";"0";"CHEMBL3705309";"Calcium Fluorescence Assay (FLIPR) : CXCR2 inhibition using calcium fluorescence assay (FLIPR).";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638729";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL923";"RISEDRONIC ACID";"4.0";"283.11";"0";"-0.37";"RISEDRONIC ACID";"O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1231";"OXYBUTYNIN";"4.0";"357.49";"0";"3.34";"OXYBUTYNIN";"CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3310782";"";"None";"333.36";"0";"3.89";"19";"N#Cc1c(O)nc(SCc2cccc(F)c2F)nc1C1CCC1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL4";"OFLOXACIN";"4.0";"361.37";"0";"1.54";"OFLOXACIN";"CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200528";"CHROMIC CHLORIDE";"4.0";"158.36";"None";"None";"CHROMIUM(III) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3354834";"";"None";"385.87";"0";"3.01";"3c";"CCCc1cc(=O)nc(Nc2ccc(Cl)c(S(=O)(=O)C(C)C)c2O)[nH]1";"IC50";"'='";"199.53";"nM";"6.70";"";"";"UO_0000065";"17.36";"0.37";"3.69";"5.97";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3355234";"";"None";"399.90";"0";"3.25";"3d";"CC(C)Cc1cc(=O)nc(Nc2ccc(Cl)c(S(=O)(=O)C(C)C)c2O)[nH]1";"IC50";"'='";"125.89";"nM";"6.90";"";"";"UO_0000065";"17.25";"0.36";"3.65";"6.15";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3355248";"";"None";"415.87";"0";"3.46";"3r";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)c(F)c(C3CCC3)[nH]2)c1O";"IC50";"'='";"50.12";"nM";"7.30";"";"";"UO_0000065";"17.55";"0.37";"3.84";"6.51";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3890888";"";"None";"423.92";"0";"3.39";"Ex 37";"CCc1ccccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@@H]2CCNC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3953055";"";"None";"417.27";"0";"2.48";"Ex 6";"O=C(Nc1cccnc1Cl)Nc1ccc(Cl)c(S(=O)(=O)C2CNC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL319244";"CAFFEIC ACID PHENETHYL ESTER";"None";"284.31";"0";"2.90";"CAFFEIC ACID PHENETHYL ESTER";"O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2367892";"TEICOPLANIN";"None";"1767.46";"None";"None";"TEICOPLANIN";"CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL49";"BUSPIRONE";"4.0";"385.51";"0";"2.09";"BUSPIRONE";"O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL84";"TOPOTECAN";"4.0";"421.45";"0";"1.85";"TPT";"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL5071577";"";"None";"348.36";"0";"2.98";"11a";"O=C(Nc1ccccc1F)Nc1ccc2c(c1O)S(=O)(=O)CC=C2";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5076154";"";"None";"409.26";"0";"3.60";"11c";"O=C(Nc1ccccc1Br)Nc1ccc2c(c1O)S(=O)(=O)CC=C2";"IC50";"'='";"49.0";"nM";"7.31";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5088825";"";"None";"411.28";"0";"3.52";"9e";"O=C(Nc1ccccc1Br)Nc1ccc2c(c1O)S(=O)(=O)CCC2";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL1493";"FLAVOXATE";"4.0";"391.47";"0";"4.41";"FLAVOXATE";"Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL19215";"METERGOLINE";"4.0";"403.53";"0";"4.06";"METERGOLINE";"CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL189171";"ACEMETACIN";"4.0";"415.83";"0";"3.47";"ACEMETACIN";"COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1483";"ALBENDAZOLE";"4.0";"265.34";"0";"3.24";"ALBENDAZOLE";"CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL515914";"AZARIBINE";"4.0";"371.30";"1";"-1.74";"AZARIBINE";"CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL900";"ORPHENADRINE";"4.0";"269.39";"0";"3.66";"ORPHENADRINE";"Cc1ccccc1C(OCCN(C)C)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4095602";"";"None";"386.90";"0";"3.85";"39";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)(C)C)c1O";"IC50";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"16.80";"0.36";"2.65";"6.81";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL514";"LOMUSTINE";"4.0";"233.70";"0";"2.25";"LOMUSTINE";"O=NN(CCCl)C(=O)NC1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1902627";"CLORPRENALINE";"-1.0";"213.71";"0";"2.37";"CLORPRENALINE";"CC(C)NCC(O)c1ccccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2";"PRAZOSIN";"4.0";"383.41";"0";"1.78";"PRAZOSIN";"COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3645131";"";"None";"431.53";"1";"5.37";"BDBM100343";"CC(CCc1ccccc1)Oc1c(C(=O)NC2(C(=O)O)CCCC2)ccc2ccccc12";"IC50";"'='";"920.0";"nM";"6.04";"";"217537";"UO_0000065";"";"";"";"";"0";"CHEMBL3705309";"Calcium Fluorescence Assay (FLIPR) : CXCR2 inhibition using calcium fluorescence assay (FLIPR).";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638729";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL1371";"CHLORZOXAZONE";"4.0";"169.57";"0";"1.77";"CHLORZOXAZONE";"O=c1[nH]c2cc(Cl)ccc2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3658333";"";"None";"446.51";"0";"4.94";"BDBM150961";"Cc1c(C(=O)CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)cnn1-c1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"290471";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658335";"";"None";"487.35";"1";"5.15";"BDBM150963";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2cc(Br)cc3c2OCC3)nc1";"IC50";"'='";"529.0";"nM";"6.28";"";"290473";"UO_0000065";"12.88";"0.29";"1.13";"9.19";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342317";"";"None";"365.22";"None";"None";"BDBM150972";"O=C(Nc1ccncc1)c1ccc(SCc2ccccc2B(O)O)nc1";"IC50";"'='";"520.0";"nM";"6.28";"";"290483";"UO_0000065";"17.21";"None";"None";"None";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658342";"";"None";"323.33";"0";"3.45";"BDBM150980";"O=C(Nc1ccc(F)cn1)c1ccc(OCc2ccccc2)nc1";"IC50";"'='";"3100.0";"nM";"5.51";"";"290490";"UO_0000065";"17.04";"0.31";"2.06";"8.59";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL788";"IDOXURIDINE";"4.0";"354.10";"0";"-1.22";"IDOXURIDINE";"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL20";"ACETAZOLAMIDE";"4.0";"222.25";"0";"-0.86";"ACETAZOLAMIDE";"CC(=O)Nc1nnc(S(N)(=O)=O)s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL30008";"FLUNARIZINE";"4.0";"404.50";"1";"5.39";"FLUNARIZINE";"Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL614";"PYRAZINAMIDE";"4.0";"123.11";"0";"-0.42";"PYRAZINAMIDE";"NC(=O)c1cnccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1351";"CARBOPLATIN";"4.0";"371.25";"None";"None";"CARBOPLATIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL196";"ASCORBIC ACID";"4.0";"176.12";"0";"-1.41";"Vitamin C";"O=C1O[C@H]([C@@H](O)CO)C(O)=C1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL531";"PERGOLIDE";"4.0";"314.50";"0";"4.27";"PERGOLIDE";"CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3654434";"";"None";"397.47";"0";"3.62";"BDBM150258";"CC(C)(NC(=O)c1ccc2c(c1OCCOc1ccccc1)CCCC2)C(=O)O";"IC50";"'='";"1000.0";"nM";"6.00";"";"289673";"UO_0000065";"";"";"";"";"0";"CHEMBL3705676";"Calcium Fluorescence Assay: The assay is based on the detection of intracellular calcium changes detected by the selective, calcium-chelating dye, Fluo-4 (Molecular Probes). A large fluorescence intensity increase is observed upon calcium association with Fluo-4. The dye is delivered to the cell interior using an acetoxymethylester form of Fluo-4, where the intracellular esterase activity results in the charged species being released and trapped within the cytoplasm of the cell. hence, influx of calcium to this cytoplasmic pocket, via release from intracellular pools and the phospholipase C cascade can be detected. By co-expressing the CXCR2 receptor and the promiscuous Galpha 16 protein, activation of this chemokine receptor is directed into this phospholipase C cascade resulting in intracellular calcium mobilization.The CHOK1 cells stably transfected with human CXCR2 and the promiscuous Galpha 16 protein were maintained in a log phase of growth at 37 C. and 5% CO2 in the following media: Iscove's.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638454";"37";"BindingDB Database";"";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3654436";"";"None";"411.50";"0";"4.01";"BDBM150260";"CC(C)(NC(=O)c1ccc2c(c1OCCCOc1ccccc1)CCCC2)C(=O)O";"IC50";"'='";"2100.0";"nM";"5.68";"";"289675";"UO_0000065";"";"";"";"";"0";"CHEMBL3705676";"Calcium Fluorescence Assay: The assay is based on the detection of intracellular calcium changes detected by the selective, calcium-chelating dye, Fluo-4 (Molecular Probes). A large fluorescence intensity increase is observed upon calcium association with Fluo-4. The dye is delivered to the cell interior using an acetoxymethylester form of Fluo-4, where the intracellular esterase activity results in the charged species being released and trapped within the cytoplasm of the cell. hence, influx of calcium to this cytoplasmic pocket, via release from intracellular pools and the phospholipase C cascade can be detected. By co-expressing the CXCR2 receptor and the promiscuous Galpha 16 protein, activation of this chemokine receptor is directed into this phospholipase C cascade resulting in intracellular calcium mobilization.The CHOK1 cells stably transfected with human CXCR2 and the promiscuous Galpha 16 protein were maintained in a log phase of growth at 37 C. and 5% CO2 in the following media: Iscove's.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638454";"37";"BindingDB Database";"";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3342303";"";"None";"407.30";"1";"6.07";"BDBM150838";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc(Cl)c(Cl)c2)nc1";"IC50";"'='";"1610.0";"nM";"5.79";"";"290348";"UO_0000065";"14.22";"0.30";"-0.28";"13.80";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658243";"";"None";"399.40";"0";"4.38";"BDBM150851";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cc([N+](=O)[O-])ccc2O)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290361";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658315";"";"None";"447.49";"1";"5.41";"BDBM150942";"Cc1onc(-c2ccccc2)c1C(=O)CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"5000.0";"nM";"";"";"290452";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658321";"";"None";"415.40";"0";"3.22";"BDBM150948";"COC(=O)c1cc(C(=O)CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)on1";"IC50";"'='";"14.0";"nM";"7.85";"";"290458";"UO_0000065";"18.91";"0.37";"4.63";"7.05";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658331";"";"None";"531.56";"2";"6.90";"BDBM150959";"Cc1nc(-c2ccc(C(F)(F)F)cc2)sc1C(=O)CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"5000.0";"nM";"";"";"290469";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3354830";"";"None";"422.89";"0";"3.06";"2i";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)cc(-c3cccn3C)[nH]2)c1O";"IC50";"'='";"2511.89";"nM";"5.60";"";"";"UO_0000065";"13.24";"0.27";"2.54";"4.78";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3355236";"";"None";"383.86";"0";"2.93";"3f";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)cc(C3CC3)[nH]2)c1O";"IC50";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"16.67";"0.35";"3.47";"5.71";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3310783";"";"None";"319.34";"0";"3.50";"20";"N#Cc1c(O)nc(SCc2cccc(F)c2F)nc1C1CC1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"23.17";"0.46";"3.90";"10.60";"0";"CHEMBL3368863";"Displacement of [125I]-GRO-alpha from human recombinant CXCR2 receptor expressed in CHO cell membranes";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3609008";"";"None";"366.16";"None";"None";"18";"O=C(Nc1ccc(F)cc1)c1cnc(NCc2cccc(B(O)O)c2)nc1";"IC50";"'='";"918.0";"nM";"6.04";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3951994";"";"None";"455.54";"0";"3.38";"BDBM236795";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2CCCS2)o1";"IC50";"'='";"35.0";"nM";"7.46";"";"412462";"UO_0000065";"16.37";"0.32";"4.08";"6.66";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3900726";"";"None";"541.60";"1";"3.89";"BDBM236803";"COC(=O)C1CCCN1C(=O)c1cccc(Nc2c(NC(c3ccc(C)o3)C3CCCS3)c(=O)c2=O)c1F";"IC50";"'='";"221.0";"nM";"6.66";"";"412468";"UO_0000065";"12.29";"0.24";"2.77";"5.64";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL216981";"NAVARIXIN";"2.0";"397.43";"0";"2.90";"SCH527123; MK-7123";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL4757462";"";"None";"442.32";"0";"3.52";"B2";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC2=NC(=O)C(c3ccc(Cl)cc3)N2)c1O";"IC50";"'='";"915.0";"nM";"6.04";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL3342296";"";"None";"405.46";"0";"4.35";"36";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc(-n3cncn3)cc2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3946021";"";"None";"441.91";"0";"3.52";"Ex 7";"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)CC2CCNC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL1727";"CEPHALEXIN ANHYDROUS";"4.0";"347.40";"0";"0.44";"CEPHALEXIN";"CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL428647";"PACLITAXEL";"4.0";"853.92";"2";"3.74";"Taxol";"CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3817880";"";"None";"508.81";"1";"4.79";"10";"C[C@@H]1CN(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(Cl)c3Cl)c2O)C[C@H](C)O1";"IC50";"'='";"15848.93";"nM";"4.80";"";"";"UO_0000065";"9.43";"0.21";"0.01";"4.45";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3818179";"";"None";"478.79";"0";"4.47";"24";"CN1CC[C@H](S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(Cl)c3Cl)c2O)C1";"IC50";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"13.78";"0.31";"2.13";"6.68";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3658296";"";"None";"504.67";"2";"7.36";"BDBM150923";"CCc1cc2c(cc1C(=O)CSc1ccc(C(=O)Nc3ccc(F)cc3)cn1)C(C)(C)CCC2(C)C";"IC50";"'='";"3690.0";"nM";"5.43";"";"290433";"UO_0000065";"10.77";"0.21";"-1.93";"9.20";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4472754";"";"None";"546.67";"1";"2.62";"18";"Cc1ccc([C@H](Nc2c(Nc3cccc(S(=O)(=O)N4CCN(C)CC4)c3O)c(=O)c2=O)[C@H]2CCCS2)o1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"14.21";"0.29";"5.15";"5.88";"0";"CHEMBL4324666";"Antagonist activity at CXCR2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321855";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4465379";"";"None";"483.93";"0";"3.03";"14";"CC[C@@H](Nc1c(Nc2ccc(Cl)c(S(=O)(=O)N(C)OC)c2O)c(=O)c1=O)c1ccc(C)o1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4324671";"Antagonist activity at CXCR2 (unknown origin) by [35S]-GTPgammaS binding assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321855";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL3658329";"";"None";"463.56";"1";"5.88";"BDBM150957";"Cc1nc(-c2ccccc2)sc1C(=O)CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"290467";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1417864";"";"None";"435.55";"1";"6.20";"38";"CC(=O)c1c(C)oc2c1cc(NS(=O)(=O)c1ccc(C(C)(C)C)cc1)c1ccccc12";"IC50";"'='";"7600.0";"nM";"5.12";"";"";"UO_0000065";"11.75";"0.23";"-1.08";"6.70";"0";"CHEMBL4324682";"Antagonist activity at CXCR2 (unknown origin) expressed in human U2OS cells cp-expressing betaarrestin-2/TEV protease and beta lactamase assessed as effect on beta-arrestin2 recruitment preincubated for 30 mins followed by IL-8 addition and further incubated for 5 hrs subsequently adding CCF4-AM staining and measured after 2 hrs by Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321855";"1";"Scientific Literature";"Eur J Med Chem";"2020";"CHEMBL3307757";"";"";""
"CHEMBL431511";"";"None";"320.35";"0";"2.74";"22";"COC(=O)CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"23.03";"0.46";"4.64";"10.80";"0";"CHEMBL4324683";"Antagonist activity at CXCR2 in human neutrophils assessed as reduction in GRO-alpha mediated chemotaxis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321855";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL5076384";"";"None";"418.86";"0";"2.85";"10a";"O=c1c(Nc2ccccc2Cl)c(Nc2ccc3c(c2O)S(=O)(=O)CCC3)c1=O";"IC50";"'='";"1050.0";"nM";"5.98";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5078788";"";"None";"364.81";"0";"3.49";"11b";"O=C(Nc1ccccc1Cl)Nc1ccc2c(c1O)S(=O)(=O)CC=C2";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5092474";"";"None";"451.29";"0";"3.58";"12c";"O=c1c(Nc2ccc3c(c2O)S(=O)(=O)CC=C3)c(Nc2cccc(Cl)c2Cl)c1=O";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL4084135";"";"None";"442.97";"0";"3.86";"56";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)(C)[C@H]2CCOC2)c1O";"IC50";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"14.67";"0.31";"2.64";"6.21";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4082136";"";"None";"377.47";"0";"3.07";"52";"CC1=CCC[C@H]1NC(=O)Nc1ccc(C#N)c(S(=O)(=O)C(C)(C)C)c1O";"IC50";"'='";"158.49";"nM";"6.80";"";"";"UO_0000065";"18.01";"0.36";"3.73";"5.70";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4097602";"";"None";"427.95";"0";"3.14";"50";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2C[C@H](N(C)C)C2)c1O";"IC50";"'='";"125.89";"nM";"6.90";"";"";"UO_0000065";"16.12";"0.34";"3.76";"6.99";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3818458";"";"None";"479.77";"0";"3.59";"4";"O=C(Nc1ccc(Cl)c(S(=O)(=O)N2CCNCC2)c1O)Nc1cccc(Cl)c1Cl";"IC50";"'='";"0.631";"nM";"9.20";"";"";"UO_0000065";"19.18";"0.43";"5.61";"8.31";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3819542";"";"None";"493.80";"0";"3.93";"5";"CN1CCN(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(Cl)c3Cl)c2O)CC1";"IC50";"'='";"0.7943";"nM";"9.10";"";"";"UO_0000065";"18.43";"0.41";"5.17";"8.92";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3819542";"";"None";"493.80";"0";"3.93";"5";"CN1CCN(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(Cl)c3Cl)c2O)CC1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"12.15";"0.27";"2.07";"5.88";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3658295";"";"None";"476.62";"1";"6.80";"BDBM150922";"CC1(C)CCC(C)(C)c2cc(C(=O)CSc3ccc(C(=O)Nc4ccc(F)cc4)cn3)ccc21";"IC50";"'>'";"5000.0";"nM";"";"";"290432";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658317";"";"None";"433.46";"1";"5.10";"BDBM150944";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2cc(-c3ccccc3)no2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290454";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658322";"";"None";"410.43";"0";"4.18";"BDBM150950";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1ccc2c(c1)OCO2";"IC50";"'>'";"5000.0";"nM";"";"";"290460";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3426945";"";"None";"412.25";"None";"None";"BDBM150814";"COc1ccc(B(O)O)c(CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)c1";"IC50";"'='";"79.0";"nM";"7.10";"";"290324";"UO_0000065";"17.23";"None";"None";"None";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3426946";"";"None";"442.28";"None";"None";"BDBM150815";"COc1cc(CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)c(B(O)O)cc1OC";"IC50";"'>'";"10000.0";"nM";"";"";"290325";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3426951";"";"None";"396.25";"None";"None";"BDBM150819";"O=C(Nc1ccc(F)cc1)c1ccc(SCCc2ccccc2B(O)O)nc1";"IC50";"'='";"387.0";"nM";"6.41";"";"290329";"UO_0000065";"16.18";"None";"None";"None";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342312";"";"None";"406.45";"0";"3.95";"BDBM150837";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccccc2-c2nn[nH]n2)nc1";"IC50";"'='";"173.0";"nM";"6.76";"";"290347";"UO_0000065";"16.64";"0.32";"2.81";"7.01";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342295";"";"None";"420.53";"1";"6.49";"BDBM150841";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccccc2-c2cccs2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290351";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342296";"";"None";"405.46";"0";"4.35";"BDBM150844";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc(-n3cncn3)cc2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290354";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342276";"";"None";"435.55";"1";"6.20";"BDBM150847";"Cc1nc(-c2ccc(CSc3ccc(C(=O)Nc4ccc(F)cc4)cn3)cc2)cs1";"IC50";"'>'";"10000.0";"nM";"";"";"290357";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658266";"";"None";"468.55";"1";"5.72";"BDBM150884";"CC(=O)c1ccc(OCCCCCSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)cc1O";"IC50";"'>'";"5000.0";"nM";"";"";"290394";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658298";"";"None";"367.40";"0";"3.84";"BDBM150925";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1cccnc1";"IC50";"'>'";"5000.0";"nM";"";"";"290435";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658308";"";"None";"449.53";"1";"5.57";"BDBM150935";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2ccc(-c3ccccn3)s2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290445";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3704566";"";"None";"399.40";"0";"2.23";"BDBM172359";"COc1ccc(Nc2c(NC(c3ccc(C)o3)C3(C)COC3)c(=O)c2=O)c(O)n1";"IC50";"'='";"1035.0";"nM";"5.99";"";"317334";"UO_0000065";"14.99";"0.28";"3.76";"4.87";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4795585";"";"None";"430.64";"1";"6.47";"16";"CCOC(=O)c1c(NC(=S)Nc2ccc(C(C)(C)C)cc2)sc2c1C(C)CCC2";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"11.97";"0.24";"-1.32";"10.24";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4574181";"";"None";"398.42";"0";"2.29";"15";"CC[C@@H](Nc1c(Nc2ccnc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"21.83";"0.41";"6.41";"6.97";"0";"CHEMBL4324672";"Displacement of [125I]IL-8 from human CXCR2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321855";"1";"Scientific Literature";"Eur J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL577075";"";"None";"346.39";"0";"1.10";"17";"CCN(CC)Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O";"IC50";"'='";"0.12";"nM";"9.92";"";"";"UO_0000065";"28.64";"0.54";"8.82";"9.73";"0";"CHEMBL4324666";"Antagonist activity at CXCR2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321855";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL309253";"";"None";"336.25";"0";"4.59";"34";"Sc1nc(-c2ccccc2Cl)nn1Cc1cccc(Cl)c1";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4324673";"Antagonist activity at CXCR2 in human neutrophils assessed as reduction in GROalpha stimulated intracellular calcium mobilisation by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321855";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL3658299";"";"None";"367.40";"0";"3.84";"BDBM150926";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1ccncc1";"IC50";"'>'";"10000.0";"nM";"";"";"290436";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342315";"";"None";"408.24";"None";"None";"55";"O=C(O)c1ccc(NC(=O)c2ccc(SCc3ccccc3B(O)O)nc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342314";"";"None";"448.23";"None";"None";"54";"O=C(Nc1ccc(OC(F)(F)F)cc1)c1ccc(SCc2ccccc2B(O)O)nc1";"IC50";"'='";"278.0";"nM";"6.56";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342301";"";"None";"403.48";"1";"5.56";"41";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cccc(-n3cccc3)c2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342289";"";"None";"503.55";"2";"7.22";"27";"Cc1nc(-c2ccc(C(F)(F)F)cc2)sc1CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3386566";"Antagonist activity at CXCR2 in human PMNs assessed as inhibition of CXCL1-induced intracellular Ca2+ release by fluorescence based calcium flux assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352272";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3310792";"";"None";"283.36";"0";"3.22";"29";"N#Cc1c(O)nc(CSc2ccccc2)nc1C1CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL5093947";"";"None";"364.40";"0";"3.20";"9b";"Cc1c(F)cccc1NC(=O)Nc1ccc2c(c1O)S(=O)(=O)CCC2";"IC50";"'='";"95.0";"nM";"7.02";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5078087";"";"None";"346.41";"0";"3.06";"9h";"Cc1ccc(NC(=O)Nc2ccc3c(c2O)S(=O)(=O)CCC3)cc1";"IC50";"'='";"1320.0";"nM";"5.88";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL3105084";"";"None";"343.36";"0";"4.16";"28";"Oc1cc(CSc2cccc(F)c2F)nc2c3ccccc3nn12";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL5075579";"";"None";"399.25";"0";"4.14";"11k";"O=C(Nc1ccc(Cl)cc1Cl)Nc1ccc2c(c1O)S(=O)(=O)CC=C2";"IC50";"'='";"5920.0";"nM";"5.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL3609020";"";"None";"410.22";"None";"None";"29";"NCCN(Cc1ccc(B(O)O)cn1)c1ncc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3310785";"";"None";"391.40";"0";"3.29";"ent-22a";"CCOC(=O)[C@H]1C[C@@H]1c1nc(SCc2cccc(F)c2F)nc(O)c1C#N";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3310788";"";"None";"362.36";"0";"2.21";"ent-25a";"N#Cc1c(O)nc(SCc2cccc(F)c2F)nc1[C@H]1C[C@@H]1C(N)=O";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3311397";"";"None";"420.22";"0";"4.23";"33";"Oc1nc(SCc2cccc(F)c2F)nc(C2CC2)c1I";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3892666";"";"None";"489.88";"0";"3.54";"Ex 22";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCNCC2)c1O)Nc1cccc2c1OC(F)(F)O2";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL3403831";"";"None";"368.48";"0";"1.93";"24";"C[C@H](O)CNc1cc(NS(C)(=O)=O)nc(SCc2ccccc2)n1";"IC50";"'='";"7943.28";"nM";"5.10";"";"";"UO_0000065";"13.84";"0.29";"3.17";"4.89";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3105083";"";"None";"347.39";"0";"3.88";"27";"Oc1cc(CSc2cccc(F)c2F)nc2c3c(nn12)CCCC3";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3104910";"";"None";"417.32";"1";"5.02";"12";"Oc1cc(CSc2ccc(Cl)cc2Cl)nc2nc(Cc3ccccc3)nn12";"IC50";"'='";"4800.0";"nM";"5.32";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3104902";"";"None";"380.48";"0";"3.32";"4";"CCCn1ccnc1SCc1cc(O)n2nc(Cc3ccccc3)nc2n1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107238";"Antagonist activity at human recombinant CXCR2 receptor expressed in CHO cells assessed as inhibition of IL8-induced [35S]GTPgammaS binding by SPA method";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL5201451";"";"None";"361.42";"0";"3.99";"35d";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2ccccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5162230";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-binding incubated for 15 mins followed by addition of CXCL8 AF647 measured after 30 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.75 hr";"";""
"CHEMBL4128926";"";"None";"583.78";"2";"5.76";"1j";"CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12";"IC50";"'='";"0.24";"nM";"9.62";"";"";"UO_0000065";"16.48";"0.33";"3.86";"7.67";"0";"CHEMBL4121480";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor after 60 mins by scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118122";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4786254";"";"None";"500.73";"2";"5.70";"48";"CC1CCCc2sc(NC(=S)Nc3ccc(N4CCN(C)CC4)cc3)c(C(=O)OC(C)(C)C)c21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"";""
"CHEMBL4787874";"";"None";"418.58";"0";"4.82";"56";"C[C@@H](NC(=S)Nc1sc2c(c1C(=O)OC(C)(C)C)CCOC2)c1ccccc1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"13.85";"0.28";"0.98";"9.73";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL3819521";"";"None";"492.81";"0";"4.86";"21";"CN1CCC(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(Cl)c3Cl)c2O)CC1";"IC50";"'='";"158.49";"nM";"6.80";"";"";"UO_0000065";"13.80";"0.31";"1.94";"6.89";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3819070";"";"None";"516.42";"2";"5.13";"28";"CN1CCC2(CC1)CC(S(=O)(=O)c1c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c1O)C2";"IC50";"'='";"1.995";"nM";"8.70";"";"";"UO_0000065";"16.85";"0.36";"3.57";"8.81";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3609003";"";"None";"379.20";"None";"None";"13";"CN(Cc1cccc(B(O)O)c1)c1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3310793";"";"None";"319.34";"0";"3.50";"30";"N#Cc1c(O)nc(CSc2cccc(F)c2F)nc1C1CC1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3819163";"";"None";"488.37";"0";"4.35";"27";"CN1CC2(CC(S(=O)(=O)c3c(Cl)ccc(NC(=O)Nc4cccc(F)c4Cl)c3O)C2)C1";"IC50";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"12.70";"0.27";"1.85";"6.28";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3895808";"";"None";"534.39";"1";"4.88";"Ex 30";"CCOC(=O)N1CCC(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3645135";"";"None";"399.49";"0";"4.81";"BDBM100347";"CC(C)(NC(=O)c1ccc2ccccc2c1C#CCCCc1ccccc1)C(=O)O";"IC50";"'='";"1670.0";"nM";"5.78";"";"217541";"UO_0000065";"";"";"";"";"0";"CHEMBL3705309";"Calcium Fluorescence Assay (FLIPR) : CXCR2 inhibition using calcium fluorescence assay (FLIPR).";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638729";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL28009";"";"None";"411.05";"0";"4.43";"2";"N#Cc1ccc(NC(=O)Nc2ccccc2Br)c(O)c1Br";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"20.00";"0.53";"3.79";"9.66";"1";"CHEMBL4324668";"Displacement of [125I]IL-8 from CXCR2 (unknown origin) stably expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321855";"1";"Scientific Literature";"Eur J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4089421";"";"None";"418.87";"0";"3.14";"69";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2(F)CCOC2)c1O";"IC50";"'='";"0.7943";"nM";"9.10";"";"";"UO_0000065";"21.73";"0.46";"5.96";"8.69";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4067429";"";"None";"414.91";"0";"3.23";"68";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@@]2(C)CCOC2)c1O";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"21.69";"0.46";"5.77";"8.59";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4062361";"";"None";"428.94";"0";"3.47";"55";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)(C)C2COC2)c1O";"IC50";"'='";"0.2512";"nM";"9.60";"";"";"UO_0000065";"22.38";"0.47";"6.13";"9.17";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4097602";"";"None";"427.95";"0";"3.14";"50";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2C[C@H](N(C)C)C2)c1O";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"21.03";"0.44";"5.86";"9.11";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4098979";"";"None";"459.97";"0";"3.48";"45";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CCN(CCF)CC2)c1O";"IC50";"'='";"0.631";"nM";"9.20";"";"";"UO_0000065";"20.00";"0.42";"5.72";"9.32";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4085657";"";"None";"386.90";"0";"3.68";"22";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)NC2CCCC23CC3)c1O";"IC50";"'='";"39.81";"nM";"7.40";"";"";"UO_0000065";"19.13";"0.40";"3.72";"7.75";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4093397";"";"None";"390.89";"0";"2.92";"20";"CO[C@@H]1CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)C)c1O";"IC50";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"16.88";"0.36";"3.68";"6.30";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3819292";"";"None";"410.67";"0";"3.64";"1; SB-332235";"NS(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2cccc(Cl)c2Cl)c1O";"IC50";"'='";"1.995";"nM";"8.70";"";"";"UO_0000065";"21.19";"0.50";"5.06";"7.16";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3818216";"";"None";"437.73";"1";"5.18";"13";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2cccc(Cl)c2Cl)c1O";"IC50";"'='";"158.49";"nM";"6.80";"";"";"UO_0000065";"15.53";"0.36";"1.62";"7.12";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3654437";"";"None";"397.50";"0";"4.51";"BDBM150261";"CC(C)(NC(=O)c1ccc2ccsc2c1OCCCc1ccccc1)C(=O)O";"IC50";"'='";"600.0";"nM";"6.22";"";"289676";"UO_0000065";"";"";"";"";"0";"CHEMBL3705676";"Calcium Fluorescence Assay: The assay is based on the detection of intracellular calcium changes detected by the selective, calcium-chelating dye, Fluo-4 (Molecular Probes). A large fluorescence intensity increase is observed upon calcium association with Fluo-4. The dye is delivered to the cell interior using an acetoxymethylester form of Fluo-4, where the intracellular esterase activity results in the charged species being released and trapped within the cytoplasm of the cell. hence, influx of calcium to this cytoplasmic pocket, via release from intracellular pools and the phospholipase C cascade can be detected. By co-expressing the CXCR2 receptor and the promiscuous Galpha 16 protein, activation of this chemokine receptor is directed into this phospholipase C cascade resulting in intracellular calcium mobilization.The CHOK1 cells stably transfected with human CXCR2 and the promiscuous Galpha 16 protein were maintained in a log phase of growth at 37 C. and 5% CO2 in the following media: Iscove's.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638454";"37";"BindingDB Database";"";"2015";"CHEMBL3307512";"";"";""
"CHEMBL4787966";"";"None";"454.52";"1";"5.50";"17";"CCOC(=O)c1c(NC(=S)Nc2ccc3c(c2)OC(F)(F)O3)sc2c1C(C)CCC2";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"12.59";"0.26";"0.22";"8.31";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4792945";"";"None";"389.55";"0";"4.76";"20";"CCOC(=O)c1c(NC(=S)Nc2ccc(N)cc2)sc2c1C(C)CCC2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"";""
"CHEMBL4787028";"";"None";"390.53";"0";"4.88";"22";"CCOC(=O)c1c(NC(=S)Nc2ccccc2O)sc2c1C(C)CCC2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"";""
"CHEMBL4785912";"";"None";"427.53";"1";"5.02";"51";"O=C(Nc1ccccc1)c1c(NC(=S)Nc2ccc(F)cc2)sc2c1CCOC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"";""
"CHEMBL3658241";"";"None";"464.37";"None";"None";"BDBM150831";"CC1(C)OB(c2ccc(CSc3ccc(C(=O)Nc4ccc(F)cc4)cn3)cc2)OC1(C)C";"IC50";"'='";"112.0";"nM";"6.95";"";"290341";"UO_0000065";"14.97";"None";"None";"None";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342277";"";"None";"339.40";"0";"4.16";"BDBM150854";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccncc2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290364";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658271";"";"None";"394.47";"1";"5.06";"BDBM150898";"Cc1ccc(C(=O)CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)c(C)c1";"IC50";"'>'";"5000.0";"nM";"";"";"290408";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3819480";"";"None";"461.34";"1";"5.59";"17";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCCCC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"0.3162";"nM";"9.50";"";"";"UO_0000065";"20.59";"0.45";"3.91";"9.95";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3819603";"";"None";"505.40";"1";"4.20";"8";"CC(C)N1CCN(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1";"IC50";"'='";"1995.26";"nM";"5.70";"";"";"UO_0000065";"11.28";"0.24";"1.50";"5.59";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3609011";"";"None";"380.19";"None";"None";"21";"CN(Cc1ccc(B(O)O)cc1)c1ncc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'='";"121.0";"nM";"6.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3609007";"";"None";"380.19";"None";"None";"17";"CN(Cc1ccccc1B(O)O)c1ncc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3610856";"Antagonist activity at CXCR2 (unknown origin) transfected in RBL cells assessed as inhibition of IL-8-mediated intracellular calcium release preincubated for 30 mins followed by IL-8 addition by FLUO-4AM-based fluorescent microplate reader analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3608245";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3640000";"";"None";"523.54";"1";"2.60";"BDBM172329";"COC(=O)[C@@H]1CCCN1C(=O)c1cccc(Nc2c(N[C@@H](c3ccc(C)o3)C3(C)COC3)c(=O)c2=O)c1O";"IC50";"'='";"60.0";"nM";"7.22";"";"317307";"UO_0000065";"13.79";"0.26";"4.62";"4.90";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3902863";"";"None";"523.53";"1";"4.32";"BDBM236810";"Cc1ccc([C@@H](Nc2c(Nc3cccc(C(=O)N(C)CC(F)(F)F)c3O)c(=O)c2=O)C2CCCS2)o1";"IC50";"'='";"115.0";"nM";"6.94";"";"412476";"UO_0000065";"13.25";"0.26";"2.62";"6.20";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3654442";"";"None";"480.44";"1";"5.59";"BDBM150825";"CC(=O)Oc1ccc(OC(F)(F)F)cc1CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'='";"1060.0";"nM";"5.97";"";"290335";"UO_0000065";"12.44";"0.25";"0.38";"7.71";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342285";"";"None";"343.38";"0";"4.06";"BDBM150855";"Cc1cc(CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)no1";"IC50";"'>'";"5000.0";"nM";"";"";"290365";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4076478";"";"None";"442.97";"0";"3.86";"57";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)(C)[C@@H]2CCOC2)c1O";"IC50";"'='";"1.259";"nM";"8.90";"";"";"UO_0000065";"20.09";"0.42";"5.04";"8.50";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4082136";"";"None";"377.47";"0";"3.07";"52";"CC1=CCC[C@H]1NC(=O)Nc1ccc(C#N)c(S(=O)(=O)C(C)(C)C)c1O";"IC50";"'='";"0.1995";"nM";"9.70";"";"";"UO_0000065";"25.70";"0.51";"6.63";"8.13";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4086957";"";"None";"394.83";"0";"3.66";"42";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)(F)F)c1O";"IC50";"'='";"0.3981";"nM";"9.40";"";"";"UO_0000065";"23.81";"0.51";"5.74";"9.84";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4072677";"";"None";"388.92";"0";"3.93";"21";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)NC2CCCC2(C)C)c1O";"IC50";"'='";"158.49";"nM";"6.80";"";"";"UO_0000065";"17.48";"0.37";"2.87";"7.12";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4102423";"";"None";"388.92";"0";"3.93";"19";"CCC1CCCC1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)C)c1O";"IC50";"'='";"63.1";"nM";"7.20";"";"";"UO_0000065";"18.51";"0.39";"3.27";"7.54";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3976863";"";"None";"569.66";"1";"4.67";"BDBM236804";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N4CCC[C@H]4C(=O)OC(C)C)c3F)c(=O)c2=O)C2CCCS2)o1";"IC50";"'='";"109.0";"nM";"6.96";"";"412470";"UO_0000065";"12.22";"0.24";"2.29";"5.90";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3935902";"";"None";"513.57";"2";"2.63";"BDBM236811";"COC(=O)CNCC(=O)c1cccc(Nc2c(NC(c3ccc(C)o3)C3CCCS3)c(=O)c2=O)c1O";"IC50";"'='";"80.0";"nM";"7.10";"";"412477";"UO_0000065";"13.82";"0.27";"4.47";"4.83";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3819521";"";"None";"492.81";"0";"4.86";"21";"CN1CCC(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(Cl)c3Cl)c2O)CC1";"IC50";"'='";"1.585";"nM";"8.80";"";"";"UO_0000065";"17.86";"0.40";"3.94";"8.91";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3818827";"";"None";"490.38";"0";"4.74";"26";"CN1CCC[C@H](S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1";"IC50";"'='";"0.5012";"nM";"9.30";"";"";"UO_0000065";"18.96";"0.41";"4.56";"9.42";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3819163";"";"None";"488.37";"0";"4.35";"27";"CN1CC2(CC(S(=O)(=O)c3c(Cl)ccc(NC(=O)Nc4cccc(F)c4Cl)c3O)C2)C1";"IC50";"'='";"0.3981";"nM";"9.40";"";"";"UO_0000065";"19.25";"0.41";"5.05";"9.52";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3818917";"";"None";"477.35";"0";"3.42";"6";"CN1CCN(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1";"IC50";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"13.62";"0.30";"3.08";"6.37";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3819295";"";"None";"423.70";"0";"4.79";"11";"CCS(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2cccc(Cl)c2Cl)c1O";"IC50";"'='";"6309.57";"nM";"5.20";"";"";"UO_0000065";"12.27";"0.28";"0.41";"5.45";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3817901";"";"None";"421.28";"0";"4.66";"12";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2cccc(F)c2Cl)c1O";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"18.99";"0.42";"3.34";"8.38";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3818277";"";"None";"462.33";"0";"3.96";"25";"CN1CC[C@H](S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)C1";"IC50";"'='";"79.43";"nM";"7.10";"";"";"UO_0000065";"15.36";"0.33";"3.14";"7.19";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3818581";"";"None";"544.48";"2";"5.91";"29";"CN1CCC2(CCC(S(=O)(=O)c3c(Cl)ccc(NC(=O)Nc4cccc(F)c4Cl)c3O)CC2)CC1";"IC50";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"13.96";"0.30";"1.69";"7.70";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3342309";"";"None";"382.42";"0";"4.46";"BDBM150836";"O=C(O)c1cccc(CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)c1";"IC50";"'='";"2120.0";"nM";"5.67";"";"290346";"UO_0000065";"14.84";"0.29";"1.21";"7.16";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3704563";"";"None";"425.44";"0";"2.22";"BDBM172356";"CN(C)C(=O)c1cccc(Nc2c(NC(c3ccco3)C3(C)COC3)c(=O)c2=O)c1O";"IC50";"'='";"198.0";"nM";"6.70";"";"317315";"UO_0000065";"15.76";"0.30";"4.48";"5.53";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4779885";"";"None";"434.58";"1";"5.19";"18";"CCOC(=O)c1c(NC(=S)Nc2ccc(OC)c(OC)c2)sc2c1C(C)CCC2";"IC50";"'='";"7700.0";"nM";"5.11";"";"";"UO_0000065";"11.77";"0.24";"-0.08";"7.43";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4777482";"";"None";"345.49";"0";"4.10";"32";"CC1CCCc2sc(NC(=S)Nc3ccccc3)c(C(N)=O)c21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"";""
"CHEMBL4794114";"";"None";"435.62";"1";"5.93";"35";"CC1CCCc2sc(NC(=S)Nc3ccccc3)c(C(=O)NCc3ccccc3)c21";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"12.86";"0.26";"-0.33";"10.54";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4795943";"";"None";"404.56";"1";"5.15";"37";"CC1COCc2sc(NC(=S)Nc3ccccc3)c(C(=O)OC(C)(C)C)c21";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"14.26";"0.29";"0.62";"9.68";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4800160";"";"None";"486.58";"1";"6.85";"45";"CC1CCCc2sc(NC(=S)Nc3ccc(OC(F)(F)F)cc3)c(C(=O)OC(C)(C)C)c21";"IC50";"'='";"10600.0";"nM";"4.97";"";"";"UO_0000065";"10.22";"0.21";"-1.88";"8.35";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL3426949";"";"None";"400.22";"None";"None";"BDBM150813";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cc(F)ccc2B(O)O)nc1";"IC50";"'='";"52.0";"nM";"7.28";"";"290323";"UO_0000065";"18.20";"None";"None";"None";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3654441";"";"None";"438.40";"1";"5.37";"BDBM150824";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2cc(OC(F)(F)F)ccc2O)nc1";"IC50";"'='";"28.0";"nM";"7.55";"";"290334";"UO_0000065";"17.23";"0.34";"2.18";"10.57";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342306";"";"None";"396.44";"0";"4.55";"BDBM150834";"COC(=O)c1ccc(CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"290344";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3654433";"";"None";"387.52";"0";"4.51";"BDBM150257";"CC(C)(NC(=O)c1ccc2c(c1OCCC1CCCCC1)CCCC2)C(=O)O";"IC50";"'='";"1400.0";"nM";"5.85";"";"289672";"UO_0000065";"";"";"";"";"0";"CHEMBL3705676";"Calcium Fluorescence Assay: The assay is based on the detection of intracellular calcium changes detected by the selective, calcium-chelating dye, Fluo-4 (Molecular Probes). A large fluorescence intensity increase is observed upon calcium association with Fluo-4. The dye is delivered to the cell interior using an acetoxymethylester form of Fluo-4, where the intracellular esterase activity results in the charged species being released and trapped within the cytoplasm of the cell. hence, influx of calcium to this cytoplasmic pocket, via release from intracellular pools and the phospholipase C cascade can be detected. By co-expressing the CXCR2 receptor and the promiscuous Galpha 16 protein, activation of this chemokine receptor is directed into this phospholipase C cascade resulting in intracellular calcium mobilization.The CHOK1 cells stably transfected with human CXCR2 and the promiscuous Galpha 16 protein were maintained in a log phase of growth at 37 C. and 5% CO2 in the following media: Iscove's.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638454";"37";"BindingDB Database";"";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3342272";"";"None";"402.47";"0";"4.00";"BDBM150894";"O=C(Nc1ccc(F)cc1)c1ccc(SCS(=O)(=O)c2ccccc2)nc1";"IC50";"'>'";"5000.0";"nM";"";"";"290404";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658269";"";"None";"380.44";"0";"4.76";"BDBM150896";"Cc1ccc(C(=O)CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"290406";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658272";"";"None";"445.31";"1";"5.21";"BDBM150899";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1ccc(Br)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"290409";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658273";"";"None";"445.31";"1";"5.21";"BDBM150900";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1cccc(Br)c1";"IC50";"'='";"852.0";"nM";"6.07";"";"290410";"UO_0000065";"13.63";"0.31";"0.86";"10.28";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3704574";"";"None";"439.47";"0";"2.52";"BDBM172374";"Cc1ccc([C@@H](Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"733.0";"nM";"6.13";"";"317332";"UO_0000065";"13.96";"0.26";"3.61";"5.07";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3704568";"";"None";"393.40";"0";"2.69";"BDBM172362";"Cc1ccc(C(Nc2c(Nc3cccc(C#N)c3O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"311.0";"nM";"6.51";"";"317321";"UO_0000065";"16.54";"0.31";"3.82";"5.22";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3403852";"";"None";"459.54";"0";"2.59";"45";"C[C@H](CO)Nc1cc(NS(=O)(=O)N2CCCC2)nc(SCc2cccc(F)c2F)n1";"IC50";"'='";"7.943";"nM";"8.10";"";"";"UO_0000065";"17.63";"0.37";"5.51";"7.54";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3403853";"";"None";"473.57";"0";"2.98";"46";"C[C@H](CO)Nc1cc(NS(=O)(=O)N2CCCCC2)nc(SCc2cccc(F)c2F)n1";"IC50";"'='";"7.943";"nM";"8.10";"";"";"UO_0000065";"17.10";"0.36";"5.12";"7.54";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL4100674";"";"None";"414.91";"0";"3.23";"67";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@]2(C)CCOC2)c1O";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"21.69";"0.46";"5.77";"8.59";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3819292";"";"None";"410.67";"0";"3.64";"1; SB-332235";"NS(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2cccc(Cl)c2Cl)c1O";"IC50";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"15.83";"0.37";"2.86";"5.35";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3819013";"";"None";"492.36";"0";"4.28";"9";"C[C@@H]1CN(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)C[C@H](C)O1";"IC50";"'='";"3162.28";"nM";"5.50";"";"";"UO_0000065";"11.17";"0.24";"1.22";"5.09";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3819382";"";"None";"491.37";"0";"3.81";"7";"CCN1CCN(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"18.32";"0.40";"5.19";"8.83";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3818179";"";"None";"478.79";"0";"4.47";"24";"CN1CC[C@H](S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(Cl)c3Cl)c2O)C1";"IC50";"'='";"1.259";"nM";"8.90";"";"";"UO_0000065";"18.59";"0.42";"4.43";"9.01";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4066904";"";"None";"445.46";"0";"4.00";"53";"CC1=CCC[C@H]1NC(=O)Nc1ccc(C#N)c(S(=O)(=O)C(C)(C)CC(F)(F)F)c1O";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"13.47";"0.27";"2.00";"5.03";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3658270";"";"None";"434.41";"1";"5.47";"BDBM150897";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1ccc(C(F)(F)F)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"290407";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658316";"";"None";"470.98";"1";"6.62";"BDBM150943";"Cc1c(C(=O)CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)sc2ccc(Cl)cc12";"IC50";"'='";"780.0";"nM";"6.11";"";"290453";"UO_0000065";"12.97";"0.27";"-0.51";"10.34";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3639571";"";"None";"401.38";"0";"3.13";"BDBM150949";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2cc(C(=O)O)no2)nc1";"IC50";"'='";"81.0";"nM";"7.09";"";"290459";"UO_0000065";"17.67";"0.35";"3.96";"5.79";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658334";"";"None";"420.47";"0";"4.33";"BDBM150962";"Cn1c(C(=O)CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)nc2ccccc21";"IC50";"'='";"703.0";"nM";"6.15";"";"290472";"UO_0000065";"14.63";"0.28";"1.82";"8.00";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342292";"";"None";"383.40";"0";"4.67";"BDBM150850";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc([N+](=O)[O-])cc2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290360";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342270";"";"None";"330.35";"0";"2.28";"BDBM150860";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2nn[nH]n2)nc1";"IC50";"'='";"3900.0";"nM";"5.41";"";"290370";"UO_0000065";"16.37";"0.32";"3.13";"5.61";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658246";"";"None";"396.44";"0";"4.41";"BDBM150862";"O=C(Nc1ccc(F)cc1)c1ccc(SCC2COc3ccccc3O2)nc1";"IC50";"'='";"760.0";"nM";"6.12";"";"290372";"UO_0000065";"15.44";"0.30";"1.71";"10.12";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658257";"";"None";"396.47";"0";"4.77";"BDBM150873";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccc3nsnc3c2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290383";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342282";"";"None";"332.40";"0";"3.74";"BDBM150887";"O=C(Nc1ccc(F)cc1)c1ccc(SCC2CCCO2)nc1";"IC50";"'='";"542.0";"nM";"6.27";"";"290397";"UO_0000065";"18.85";"0.37";"2.53";"12.23";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342278";"";"None";"479.58";"1";"5.61";"BDBM150891";"O=C(Nc1ccc(F)cc1)c1ccc(SCC2CCN(C(=O)OCc3ccccc3)CC2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290401";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3818277";"";"None";"462.33";"0";"3.96";"25";"CN1CC[C@H](S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)C1";"IC50";"'='";"0.5012";"nM";"9.30";"";"";"UO_0000065";"20.12";"0.44";"5.34";"9.42";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3818581";"";"None";"544.48";"2";"5.91";"29";"CN1CCC2(CCC(S(=O)(=O)c3c(Cl)ccc(NC(=O)Nc4cccc(F)c4Cl)c3O)CC2)CC1";"IC50";"'='";"0.3981";"nM";"9.40";"";"";"UO_0000065";"17.26";"0.37";"3.49";"9.52";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3654439";"";"None";"399.47";"0";"3.95";"BDBM150263";"CC(C)(NC(=O)c1ccc2sccc2c1OCCOc1ccccc1)C(=O)O";"IC50";"'='";"1700.0";"nM";"5.77";"";"289678";"UO_0000065";"";"";"";"";"0";"CHEMBL3705676";"Calcium Fluorescence Assay: The assay is based on the detection of intracellular calcium changes detected by the selective, calcium-chelating dye, Fluo-4 (Molecular Probes). A large fluorescence intensity increase is observed upon calcium association with Fluo-4. The dye is delivered to the cell interior using an acetoxymethylester form of Fluo-4, where the intracellular esterase activity results in the charged species being released and trapped within the cytoplasm of the cell. hence, influx of calcium to this cytoplasmic pocket, via release from intracellular pools and the phospholipase C cascade can be detected. By co-expressing the CXCR2 receptor and the promiscuous Galpha 16 protein, activation of this chemokine receptor is directed into this phospholipase C cascade resulting in intracellular calcium mobilization.The CHOK1 cells stably transfected with human CXCR2 and the promiscuous Galpha 16 protein were maintained in a log phase of growth at 37 C. and 5% CO2 in the following media: Iscove's.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638454";"37";"BindingDB Database";"";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3658252";"";"None";"422.45";"0";"2.66";"BDBM150868";"Nc1nc(N)c2nc(CSc3ccc(C(=O)Nc4ccc(F)cc4)cn3)cnc2n1";"IC50";"'>'";"10000.0";"nM";"";"";"290378";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342279";"";"None";"346.43";"0";"3.99";"BDBM150888";"O=C(Nc1ccc(F)cc1)c1ccc(SCC2CCOCC2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290398";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658268";"";"None";"346.38";"0";"3.13";"BDBM150892";"O=C1CC(CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)CO1";"IC50";"'>'";"5000.0";"nM";"";"";"290402";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658314";"";"None";"450.56";"1";"6.28";"BDBM150941";"Cc1ccc2sc(C(=O)CSc3ccc(C(=O)Nc4ccc(F)cc4)cn3)c(C)c2c1";"IC50";"'>'";"10000.0";"nM";"";"";"290451";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3819221";"";"None";"426.28";"1";"5.11";"31";"O=C(Nc1ccc(Cl)c(C(=O)N2CCCCC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"0.5012";"nM";"9.30";"";"";"UO_0000065";"21.82";"0.45";"4.19";"11.39";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4442431";"";"None";"397.33";"0";"1.09";"164; DF2156A";"C[C@@H](C(=O)[N-]S(C)(=O)=O)c1ccc(OS(=O)(=O)C(F)(F)F)cc1.[Na+]";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"26.64";"0.59";"8.91";"9.38";"0";"CHEMBL4309943";"Inhibition of CXCR2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4308844";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4482876";"";"None";"396.54";"0";"4.65";"37; CX797";"CCSc1nnc2n(-c3ccccc3)c(=O)c3c4c(sc3n12)CCC[C@H]4C";"IC50";"'='";"7800.0";"nM";"5.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4324681";"Antagonist activity at GFP-tagged CXCR2 (unknown origin) expressed in 293T cells assessed as suppression of IL-8-induced inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by IL-8 addition and measured after 10 mins by cAMP assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321855";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL3926993";"";"None";"437.95";"0";"3.78";"Ex 11";"CCc1ccccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CCCNC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3906495";"";"None";"462.33";"0";"4.01";"Ex 15";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCCNC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3970321";"";"None";"441.91";"0";"3.66";"Ex 18";"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CCNCC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3892206";"";"None";"445.33";"0";"3.26";"Ex 21";"O=C(Nc1cccnc1Cl)Nc1ccc(Cl)c(S(=O)(=O)C2CCNCC2)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3936567";"";"None";"488.37";"0";"4.54";"Ex 31";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2C[C@H]3CC[C@@H](C2)N3)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3950195";"";"None";"475.86";"0";"3.15";"Ex 35";"O=C(Nc1ccc(Cl)c(S(=O)(=O)[C@@H]2CCNC2)c1O)Nc1cccc2c1OC(F)(F)O2";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3948929";"";"None";"471.37";"0";"3.79";"Ex 38";"O=C(Nc1cccnc1Cl)Nc1ccc(Cl)c(S(=O)(=O)C2C[C@H]3CC[C@@H](C2)N3)c1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882305";"Antagonist activity at CXCR2 (unknown origin) expressed in CHO-K1 cells co-expressing Galpha-16 assessed as inhibition of IL8-induced calcium mobilization measured after 10 mins by Fluo-4AM dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3307512";"";"";""
"CHEMBL3342304";"";"None";"354.41";"0";"4.47";"BDBM150822";"O=C(Nc1ccc(F)cc1)c1ccc(SCc2ccccc2O)nc1";"IC50";"'='";"277.0";"nM";"6.56";"";"290332";"UO_0000065";"18.50";"0.36";"2.09";"10.54";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342274";"";"None";"398.40";"0";"4.79";"BDBM150893";"CCOP(=O)(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)OCC";"IC50";"'>'";"10000.0";"nM";"";"";"290403";"UO_0000065";"";"";"";"";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3701196";"";"None";"509.97";"1";"2.73";"BDBM172342";"Cc1ccc(C(Nc2c(Nc3ccc(Cl)c(S(=O)(=O)N(C)C)c3O)c(=O)c2=O)C2(C)COC2)o1";"IC50";"'='";"31.0";"nM";"7.51";"";"317304";"UO_0000065";"14.72";"0.30";"4.78";"5.43";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4536494";"";"None";"392.87";"0";"3.76";"8";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nnc(-c3ccccc3)[nH]2)c1O";"IC50";"'='";"14800.0";"nM";"4.83";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4324670";"Antagonist activity at CXCR2 (unknown origin) stably expressed in HEK293 cells co-expressing Galpha16 assessed as reduction in IL-8-induced intracellular calcium change incubated for 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321855";"1";"Scientific Literature";"Eur J Med Chem";"2020";"CHEMBL3307715";"";"";""
"CHEMBL397237";"";"None";"383.45";"0";"3.03";"1";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(N)sc12";"IC50";"'='";"3.981";"nM";"8.40";"";"";"UO_0000065";"21.91";"0.46";"5.37";"8.66";"1";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3403832";"";"None";"354.46";"0";"1.54";"25";"CS(=O)(=O)Nc1cc(NCCO)nc(SCc2ccccc2)n1";"IC50";"'='";"3162.28";"nM";"5.50";"";"";"UO_0000065";"15.52";"0.33";"3.96";"5.28";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3403845";"";"None";"397.53";"0";"1.78";"38";"C[C@H](CO)Nc1cc(NS(=O)(=O)N(C)C)nc(SCc2ccccc2)n1";"IC50";"'='";"63.1";"nM";"7.20";"";"";"UO_0000065";"18.11";"0.38";"5.42";"6.70";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3701188";"";"None";"523.54";"1";"2.60";"BDBM172328";"COC(=O)[C@H]1CCCN1C(=O)c1cccc(Nc2c(N[C@@H](c3ccc(C)o3)C3(C)COC3)c(=O)c2=O)c1O";"IC50";"'='";"37.0";"nM";"7.43";"";"317306";"UO_0000065";"14.20";"0.27";"4.83";"5.04";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3355241";"";"None";"417.89";"0";"3.30";"3k";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)cc(C(C)(C)CF)[nH]2)c1O";"IC50";"'='";"125.89";"nM";"6.90";"";"";"UO_0000065";"16.51";"0.35";"3.60";"6.15";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3355245";"";"None";"387.85";"0";"2.20";"3o";"COCc1cc(=O)nc(Nc2ccc(Cl)c(S(=O)(=O)C(C)C)c2O)[nH]1";"IC50";"'='";"2511.89";"nM";"5.60";"";"";"UO_0000065";"14.44";"0.31";"3.40";"4.61";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4799848";"";"None";"442.32";"0";"3.52";"B3";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC2=NC(=O)C(c3cccc(Cl)c3)N2)c1O";"IC50";"'='";"305.0";"nM";"6.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL4752486";"";"None";"442.32";"0";"3.52";"B4";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC2=NC(=O)C(c3ccccc3Cl)N2)c1O";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL4750465";"";"None";"359.84";"0";"1.90";"B7";"CCC1NC(Nc2ccc(Cl)c(S(=O)(=O)C(C)C)c2O)=NC1=O";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL4793352";"";"None";"373.86";"0";"2.29";"B8";"CCCC1NC(Nc2ccc(Cl)c(S(=O)(=O)C(C)C)c2O)=NC1=O";"IC50";"'='";"68.0";"nM";"7.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL4755486";"";"None";"373.86";"0";"2.29";"C4";"CCC[C@@H]1NC(Nc2ccc(Cl)c(S(=O)(=O)C(C)C)c2O)=NC1=O";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL4745933";"";"None";"413.93";"0";"3.07";"C6";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC2=NC(=O)[C@H](C3CCCCC3)N2)c1O";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL3658319";"";"None";"502.35";"2";"6.41";"BDBM150946";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2cc(-c3ccc(Cl)c(Cl)c3)no2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290456";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658330";"";"None";"498.00";"1";"6.53";"BDBM150958";"Cc1nc(-c2ccc(Cl)cc2)sc1C(=O)CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1";"IC50";"'>'";"5000.0";"nM";"";"";"290468";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342318";"";"None";"380.23";"None";"None";"BDBM150973";"O=C(Nc1ccc(O)cc1)c1ccc(SCc2ccccc2B(O)O)nc1";"IC50";"'='";"105.0";"nM";"6.98";"";"290484";"UO_0000065";"18.35";"None";"None";"None";"1";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658347";"";"None";"387.39";"0";"2.55";"BDBM150985";"O=C(Nc1ccc(F)cn1)c1ccc(S(=O)(=O)Cc2ccccc2O)nc1";"IC50";"'='";"10230.0";"nM";"4.99";"";"290495";"UO_0000065";"12.88";"0.25";"2.44";"4.57";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4763312";"";"None";"423.88";"0";"2.10";"A1";"COCCS(=O)(=O)c1c(Cl)ccc(NC2=NC(=O)C(c3ccccc3)N2)c1O";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL3403829";"";"None";"396.49";"0";"1.25";"9";"C[C@H](CO)Nc1cc(C(=O)NS(C)(=O)=O)nc(SCc2ccccc2)n1";"IC50";"'='";"794.33";"nM";"6.10";"";"";"UO_0000065";"15.39";"0.32";"4.85";"5.03";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3403833";"";"None";"382.51";"0";"2.32";"26";"CC[C@H](CO)Nc1cc(NS(C)(=O)=O)nc(SCc2ccccc2)n1";"IC50";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"16.73";"0.35";"4.08";"6.14";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3819013";"";"None";"492.36";"0";"4.28";"9";"C[C@@H]1CN(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)C[C@H](C)O1";"IC50";"'='";"3.981";"nM";"8.40";"";"";"UO_0000065";"17.06";"0.37";"4.12";"7.78";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3818853";"";"None";"447.32";"1";"5.20";"16";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2CCCC2)c1O)Nc1cccc(F)c1Cl";"IC50";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"16.99";"0.37";"2.40";"7.96";"0";"CHEMBL3821597";"Antagonist activity at human recombinant CXCR2 assessed as inhibition of CXCL1-induced neutrophil chemotaxis after 45 mins by calcein-AM dye based plate reader method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4777007";"";"None";"390.53";"0";"4.88";"21";"CCOC(=O)c1c(NC(=S)Nc2ccc(O)cc2)sc2c1C(C)CCC2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"";""
"CHEMBL4787532";"";"None";"388.56";"1";"5.56";"30";"CC(C)OC(=O)c1c(NC(=S)Nc2ccccc2)sc2c1C(C)CCC2";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"14.33";"0.29";"0.01";"11.06";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4794294";"";"None";"418.58";"0";"4.82";"55";"C[C@H](NC(=S)Nc1sc2c(c1C(=O)OC(C)(C)C)CCOC2)c1ccccc1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"13.43";"0.27";"0.80";"9.43";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL3403838";"";"None";"396.54";"0";"2.71";"31";"CCCS(=O)(=O)Nc1cc(N[C@H](C)CO)nc(SCc2ccccc2)n1";"IC50";"'='";"158.49";"nM";"6.80";"";"";"UO_0000065";"17.15";"0.36";"4.09";"6.53";"0";"CHEMBL3404716";"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor expressed in HEK293 cells by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400046";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3310774";"";"None";"385.40";"0";"4.30";"11";"COc1ccc(-c2nc(SCc3cccc(F)c3F)nc(O)c2C#N)cc1";"IC50";"'='";"710.0";"nM";"6.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3310780";"";"None";"321.35";"0";"3.75";"17";"CC(C)c1nc(SCc2cccc(F)c2F)nc(O)c1C#N";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3368862";"Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes by SPA based [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351490";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL4777637";"";"None";"292.30";"0";"1.90";"A5";"N#Cc1ccc(NC2=NC(=O)C(c3ccccc3)N2)c(O)c1";"IC50";"'='";"23600.0";"nM";"4.63";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL5083848";"";"None";"416.43";"0";"2.64";"10d";"Cc1c(F)cccc1Nc1c(Nc2ccc3c(c2O)S(=O)(=O)CCC3)c(=O)c1=O";"IC50";"'='";"1360.0";"nM";"5.87";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5083131";"";"None";"401.27";"0";"4.06";"9a";"O=C(Nc1ccc2c(c1O)S(=O)(=O)CCC2)Nc1cccc(Cl)c1Cl";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5076418";"";"None";"409.26";"0";"3.60";"11e";"O=C(Nc1ccc(Br)cc1)Nc1ccc2c(c1O)S(=O)(=O)CC=C2";"IC50";"'='";"1480.0";"nM";"5.83";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL4594419";"BMS-813160";"2.0";"484.65";"0";"2.25";"3";"CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4842053";"Displacement of [125I]-interleukin-8 from human CXCR2 expressed in human pEAK rapid cells incubated for 90 mins by microscintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"pEAK Rapid";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840365";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4747035";"";"None";"387.89";"0";"2.68";"B9";"CCCCC1NC(Nc2ccc(Cl)c(S(=O)(=O)C(C)C)c2O)=NC1=O";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL3658279";"";"None";"402.40";"0";"4.73";"BDBM150906";"O=C(CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1)c1ccc(F)c(F)c1";"IC50";"'>'";"5000.0";"nM";"";"";"290416";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658281";"";"None";"436.55";"1";"6.18";"BDBM150908";"CCCCCc1ccc(C(=O)CSc2ccc(C(=O)Nc3ccc(F)cc3)cn2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"290418";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658292";"";"None";"434.41";"1";"5.47";"BDBM150919";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2ccccc2C(F)(F)F)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290429";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658300";"";"None";"356.38";"0";"4.04";"BDBM150927";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2ccco2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"290437";"UO_0000065";"";"";"";"";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3658303";"";"None";"485.33";"1";"5.96";"BDBM150930";"O=C(Nc1ccc(F)cc1)c1ccc(SCC(=O)c2cc3ccc(Br)cc3o2)nc1";"IC50";"'='";"981.0";"nM";"6.01";"";"290440";"UO_0000065";"12.38";"0.27";"0.05";"8.32";"0";"CHEMBL3705746";"In Vitro Inhibition Assay: An in vitro assay showed inhibition of CXCR2-mediated intracellular calcium release. Briefly, human neutrophils were suspended in HBSS- (without Ca2+ and Mg2+) containing 10 mM HEPES and FLIPR Calcium 3 dye (3.1x107 cells in total volume 1.7 mL). Cells were aliquoted (200 uL of the cell suspension per tube, 8 tubes total) and 2 uL of the designated compound (with appropriate dilutions) were added to each of 6 tubes. As controls, 2 uL of DMSO (1% final concentration) were added to 2 other tubes. Cells were incubated for 30 min at 37 C. After dye loading, tubes were centrifuged at 6,000 rpm for 1 min, supernatant was removed and the cell pellet was re-suspended in 200 uL of HBSS+ (with Ca2+ and Mg2+) containing 10 mM HEPES. The test compound or DMSO (control) was added again at the same concentrations that were used during cell loading. The cell suspension was aliquoted into a 96-well Reading Plate (Corning) in a volume of 90 uL (105 cells/well).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639254";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3892206";"";"None";"445.33";"0";"3.26";"Ex 21";"O=C(Nc1cccnc1Cl)Nc1ccc(Cl)c(S(=O)(=O)C2CCNCC2)c1O";"IC50";"'<'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3882303";"Displacement of [125I]IL8 from recombinant human CXCR2 expressed in CHO cell membranes measured after 1 hr by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882244";"38";"Patent Bioactivity Data";"";"2007";"CHEMBL3308072";"";"";""
"CHEMBL207725";"";"None";"504.75";"2";"5.48";"64";"CCCCCCCCSc1cc(N[C@@H](CC(C)C)C(=O)NCCCOCC)nc(-n2ccnc2)n1";"IC50";"'='";"10000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5261122";"Inhibition of wild type CXCR2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5260798";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"INHIBITOR";""
"CHEMBL3701183";"";"None";"457.46";"0";"2.47";"BDBM172322";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2(CF)COC2)o1";"IC50";"'='";"272.0";"nM";"6.57";"";"317320";"UO_0000065";"14.35";"0.27";"4.10";"5.42";"0";"CHEMBL3707937";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638995";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3819070";"";"None";"516.42";"2";"5.13";"28";"CN1CCC2(CC1)CC(S(=O)(=O)c1c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c1O)C2";"IC50";"'='";"1.995";"nM";"8.70";"";"";"UO_0000065";"16.85";"0.36";"3.57";"8.81";"0";"CHEMBL3821596";"Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after overnight incubation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817840";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3355246";"";"None";"427.91";"0";"2.95";"3p";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)cc(C3CCOCC3)[nH]2)c1O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3388266";"Antagonist activity at CXCR2 (unknown origin) by beta-arrestin assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3355235";"";"None";"399.90";"0";"3.35";"3e";"CC(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc(=O)cc(C(C)(C)C)[nH]2)c1O";"IC50";"'='";"580.0";"nM";"6.24";"";"";"UO_0000065";"15.60";"0.33";"2.89";"5.56";"0";"CHEMBL3388267";"Antagonist activity at CXCR2 in human whole blood by CD11b assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351964";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL216981";"NAVARIXIN";"2.0";"397.43";"0";"2.90";"40";"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"21.60";"0.40";"5.69";"7.67";"1";"CHEMBL5223233";"Antagonist activity at CXCR2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223063";"1";"Scientific Literature";"RSC Med Chem";"2021";"None";"";"ANTAGONIST";""
"CHEMBL5199496";"";"None";"366.44";"0";"2.49";"31a";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2c1CCNC2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5162230";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-binding incubated for 15 mins followed by addition of CXCL8 AF647 measured after 30 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.75 hr";"";""
"CHEMBL5183117";"";"None";"350.39";"0";"3.09";"10d";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nn2cccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5162230";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-binding incubated for 15 mins followed by addition of CXCL8 AF647 measured after 30 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.75 hr";"";""
"CHEMBL5184465";"";"None";"362.40";"0";"3.39";"35a";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2ncccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5162230";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-binding incubated for 15 mins followed by addition of CXCL8 AF647 measured after 30 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.75 hr";"";""
"CHEMBL397237";"";"None";"383.45";"0";"3.03";"6";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(N)sc12";"IC50";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"18.52";"0.39";"4.07";"7.33";"0";"CHEMBL5162231";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-induced calcium response incubated for 10 mins followed by addition of CXCL8 AF647 measured by FLIPR Tetra system method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL5203743";"";"None";"351.38";"0";"2.72";"10b";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2[nH]cnc12";"IC50";"'='";"2490.0";"nM";"5.60";"";"";"UO_0000065";"15.95";"0.32";"2.88";"6.46";"0";"CHEMBL5162231";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-induced calcium response incubated for 10 mins followed by addition of CXCL8 AF647 measured by FLIPR Tetra system method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL4076769";"";"None";"374.89";"0";"3.68";"10";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)NC2CCCCC2)c1O";"IC50";"'='";"50.12";"nM";"7.30";"";"";"UO_0000065";"19.47";"0.42";"3.62";"7.64";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL5173775";"";"None";"352.37";"0";"2.11";"19";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2[nH]nnc12";"IC50";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"17.54";"0.35";"4.07";"6.20";"0";"CHEMBL5162231";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-induced calcium response incubated for 10 mins followed by addition of CXCL8 AF647 measured by FLIPR Tetra system method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL5203131";"";"None";"366.44";"0";"2.49";"31b";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2c1CNCC2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5162230";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-binding incubated for 15 mins followed by addition of CXCL8 AF647 measured after 30 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.75 hr";"";""
"CHEMBL3938406";"";"None";"467.52";"0";"3.30";"BDBM177694";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2(C)CCOCC2)o1";"IC50";"'='";"157.0";"nM";"6.80";"";"323501";"UO_0000065";"14.55";"0.27";"3.50";"5.62";"0";"CHEMBL3887210";"In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the beta -arrestin recruitment after receptor activation type.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 beta -arrestin line results in the recruitment of beta -arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation.>>J. Immunol. 170: 2904-2911).In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with beta -arrestin 2, a beta -arrestin 2 recruitment test for CXCR2 or CXCR1 based on beta -galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886212";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3979652";"";"None";"453.50";"0";"3.06";"BDBM236792";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2(C)CCCO2)o1";"IC50";"'='";"53.0";"nM";"7.28";"";"412458";"UO_0000065";"16.04";"0.30";"4.22";"6.01";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3951994";"";"None";"455.54";"0";"3.38";"BDBM236795";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2CCCS2)o1";"IC50";"'='";"15.0";"nM";"7.82";"";"412461";"UO_0000065";"17.18";"0.33";"4.44";"6.99";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3951994";"";"None";"455.54";"0";"3.38";"BDBM236795";"Cc1ccc(C(Nc2c(Nc3cccc(C(=O)N(C)C)c3O)c(=O)c2=O)C2CCCS2)o1";"IC50";"'='";"273.0";"nM";"6.56";"";"412466";"UO_0000065";"14.41";"0.28";"3.18";"5.87";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3909470";"";"None";"523.53";"1";"4.32";"BDBM236787";"Cc1ccc([C@H](Nc2c(Nc3cccc(C(=O)N(C)CC(F)(F)F)c3O)c(=O)c2=O)C2CCCS2)o1";"IC50";"'='";"47.0";"nM";"7.33";"";"412475";"UO_0000065";"14.00";"0.28";"3.01";"6.55";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3980279";"";"None";"435.48";"0";"2.77";"BDBM236782";"CN(C)C(=O)c1cccc(Nc2c(NC(c3ccccc3)C3CCCO3)c(=O)c2=O)c1O";"IC50";"'='";"170.0";"nM";"6.77";"";"412483";"UO_0000065";"15.55";"0.29";"4.00";"6.27";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3909470";"";"None";"523.53";"1";"4.32";"BDBM236787";"Cc1ccc([C@H](Nc2c(Nc3cccc(C(=O)N(C)CC(F)(F)F)c3O)c(=O)c2=O)C2CCCS2)o1";"IC50";"'='";"15.0";"nM";"7.82";"";"412488";"UO_0000065";"14.94";"0.30";"3.50";"6.99";"0";"CHEMBL3888717";"In Vitro Affinity Assay: â¿¿PathHunter HEK293-CXCR2â¿ or â¿¿U2OS hCXCR1 β-arrestinâ¿ cells (DiscoveRx Corporation) were seeded overnight at 10 000 cells/well (384-well format) in 20 μl of Opti MEM I medium. A preincubation with the antagonist or the vehicle for 30 min at 37° C. and 5% CO2 was followed by 60 minutes of stimulation with CXCL8 at 37° C. and 5% CO2. The cells were then placed at ambient temperature for 30 minutes. The PathHunter detection reagent (DiscoveRx Corporation) was added. After incubation for 60 min at ambient temperature, the β-galactosidase induced by the luminescence during the β-arrestin-CXCR2 interaction was measured for 0.3 s in an Envision 2102 Multilabel Reader (PerkinElmer Life and Analytical Sciences).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886800";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL397237";"";"None";"383.45";"0";"3.03";"6";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(N)sc12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"20.57";"0.43";"4.86";"8.13";"0";"CHEMBL5162230";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-binding incubated for 15 mins followed by addition of CXCL8 AF647 measured after 30 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.75 hr";"ANTAGONIST";""
"CHEMBL5179622";"";"None";"350.39";"0";"3.32";"16";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2[nH]ccc12";"IC50";"'='";"2710.0";"nM";"5.57";"";"";"UO_0000065";"15.89";"0.32";"2.25";"7.54";"0";"CHEMBL5162230";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-binding incubated for 15 mins followed by addition of CXCL8 AF647 measured after 30 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.75 hr";"ANTAGONIST";""
"CHEMBL5183117";"";"None";"350.39";"0";"3.09";"10d";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nn2cccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5162231";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-induced calcium response incubated for 10 mins followed by addition of CXCL8 AF647 measured by FLIPR Tetra system method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.1667 hr";"";""
"CHEMBL5179345";"";"None";"367.45";"0";"4.05";"13";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2ccsc12";"IC50";"'='";"24670.0";"nM";"4.61";"";"";"UO_0000065";"12.54";"0.26";"0.56";"7.94";"0";"CHEMBL5162231";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-induced calcium response incubated for 10 mins followed by addition of CXCL8 AF647 measured by FLIPR Tetra system method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL5070965";"";"None";"461.29";"0";"3.04";"12b";"O=c1c(Nc2ccccc2Br)c(Nc2ccc3c(c2O)S(=O)(=O)CC=C3)c1=O";"IC50";"'='";"78.0";"nM";"7.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5086977";"";"None";"378.84";"0";"3.80";"11i";"Cc1c(Cl)cccc1NC(=O)Nc1ccc2c(c1O)S(=O)(=O)CC=C2";"IC50";"'='";"1640.0";"nM";"5.79";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5088269";"";"None";"362.38";"0";"3.28";"11h";"Cc1c(F)cccc1NC(=O)Nc1ccc2c(c1O)S(=O)(=O)CC=C2";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL4762597";"";"None";"345.81";"0";"1.51";"C2";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC2=NC(=O)[C@H](C)N2)c1O";"IC50";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL4741864";"";"None";"421.91";"0";"2.74";"C7";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC2=NC(=O)[C@@H](Cc3ccccc3)N2)c1O";"IC50";"'='";"98.0";"nM";"7.01";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL5174137";"";"None";"362.40";"0";"3.39";"35b";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2cccnc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5162230";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-binding incubated for 15 mins followed by addition of CXCL8 AF647 measured after 30 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.75 hr";"";""
"CHEMBL5276296";"";"None";"351.36";"0";"2.18";"38";"CN(C)C(=O)c1cccc(Nc2c(Nc3ccccc3)c(=O)c2=O)c1O";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"24.76";"0.46";"6.52";"8.81";"0";"CHEMBL5223233";"Antagonist activity at CXCR2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223063";"1";"Scientific Literature";"RSC Med Chem";"2021";"None";"";"ANTAGONIST";""
"CHEMBL5171358";"";"None";"367.45";"0";"4.05";"10a";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2sccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5162231";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-induced calcium response incubated for 10 mins followed by addition of CXCL8 AF647 measured by FLIPR Tetra system method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.1667 hr";"";""
"CHEMBL5203743";"";"None";"351.38";"0";"2.72";"10b";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2[nH]cnc12";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"18.79";"0.38";"3.88";"7.61";"0";"CHEMBL5162230";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-binding incubated for 15 mins followed by addition of CXCL8 AF647 measured after 30 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.75 hr";"ANTAGONIST";""
"CHEMBL38182";"";"None";"357.17";"0";"3.24";"61; SB-265610";"N#Cc1ccc(NC(=O)Nc2ccccc2Br)c2nn[nH]c12";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"19.60";"0.43";"3.76";"6.57";"0";"CHEMBL5261122";"Inhibition of wild type CXCR2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5260798";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"INHIBITOR";""
"CHEMBL5081049";"";"None";"384.82";"0";"3.55";"9k";"O=C(Nc1ccc2c(c1O)S(=O)(=O)CCC2)Nc1cccc(F)c1Cl";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL4746803";"";"None";"387.89";"0";"2.54";"B10";"CC(C)CC1NC(Nc2ccc(Cl)c(S(=O)(=O)C(C)C)c2O)=NC1=O";"IC50";"'='";"305.0";"nM";"6.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715191";"Antagonist activity in CXCR2 (unknown origin) expressed in human HEK293 cells co-expressing Galpha16 assessed as reduction in calcium immobilization pretreated with Fluo-4AM for 45 mins followed by compound addition and measured after 10 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706753";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL5195797";"";"None";"352.37";"0";"2.98";"25";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2oncc12";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"19.87";"0.40";"4.02";"8.33";"0";"CHEMBL5162231";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-induced calcium response incubated for 10 mins followed by addition of CXCL8 AF647 measured by FLIPR Tetra system method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL5184465";"";"None";"362.40";"0";"3.39";"35a";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2ncccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5162231";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-induced calcium response incubated for 10 mins followed by addition of CXCL8 AF647 measured by FLIPR Tetra system method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.1667 hr";"";""
"CHEMBL5182926";"";"None";"350.39";"0";"3.32";"10c";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2cc[nH]c12";"IC50";"'='";"1060.0";"nM";"5.97";"";"";"UO_0000065";"17.05";"0.34";"2.65";"8.09";"0";"CHEMBL5162230";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-binding incubated for 15 mins followed by addition of CXCL8 AF647 measured after 30 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.75 hr";"ANTAGONIST";""
"CHEMBL5173775";"";"None";"352.37";"0";"2.11";"19";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2[nH]nnc12";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"20.88";"0.42";"5.25";"7.39";"0";"CHEMBL5162230";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-binding incubated for 15 mins followed by addition of CXCL8 AF647 measured after 30 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.75 hr";"ANTAGONIST";""
"CHEMBL5195797";"";"None";"352.37";"0";"2.98";"25";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2oncc12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"22.38";"0.45";"4.91";"9.38";"0";"CHEMBL5162230";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-binding incubated for 15 mins followed by addition of CXCL8 AF647 measured after 30 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.75 hr";"ANTAGONIST";""
"CHEMBL5199496";"";"None";"366.44";"0";"2.49";"31a";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2c1CCNC2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5162231";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-induced calcium response incubated for 10 mins followed by addition of CXCL8 AF647 measured by FLIPR Tetra system method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.1667 hr";"";""
"CHEMBL4087900";"";"None";"453.32";"0";"3.70";"37'";"O=C(Nc1ccc(Cl)c(S(=O)(=O)C2(F)CCOCC2)c1O)N[C@H]1CCC=C1Cl";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.44";"0.34";"3.30";"6.68";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4098536";"";"None";"390.86";"0";"3.76";"30";"CC1=C(F)CCC1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C(C)C)c1O";"IC50";"'='";"1.585";"nM";"8.80";"";"";"UO_0000065";"22.51";"0.48";"5.04";"9.21";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4064083";"";"None";"372.87";"0";"3.15";"23";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)NC2CCC3CC32)c1O";"IC50";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"20.38";"0.43";"4.45";"7.96";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL5186932";"";"None";"368.43";"0";"3.45";"7";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2ncsc12";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"17.83";"0.37";"3.12";"9.26";"0";"CHEMBL5162231";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-induced calcium response incubated for 10 mins followed by addition of CXCL8 AF647 measured by FLIPR Tetra system method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL5182926";"";"None";"350.39";"0";"3.32";"10c";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2cc[nH]c12";"IC50";"'='";"15720.0";"nM";"4.80";"";"";"UO_0000065";"13.71";"0.27";"1.48";"6.51";"0";"CHEMBL5162231";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-induced calcium response incubated for 10 mins followed by addition of CXCL8 AF647 measured by FLIPR Tetra system method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL4076053";"";"None";"426.92";"0";"3.23";"71";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CC3(COC3)C2)c1O";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"21.08";"0.44";"5.77";"8.59";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4077201";"";"None";"442.97";"0";"4.01";"60";"CCC1(S(=O)(=O)c2c(Cl)ccc(NC(=O)N[C@@H]3CCC=C3C)c2O)CCOCC1";"IC50";"'='";"0.3162";"nM";"9.50";"";"";"UO_0000065";"21.45";"0.45";"5.49";"9.07";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4094324";"";"None";"393.29";"0";"3.63";"27";"CC(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)NC2CCC=C2Cl)c1O";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.88";"0.51";"5.37";"9.42";"0";"CHEMBL4037524";"Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV protease tagged human CXCL1-stimulated beta-arrestin recruitment by CCF4-AM-fluorescence based FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4079718";"";"None";"446.93";"0";"3.57";"62";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2(CF)CCOCC2)c1O";"IC50";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"14.77";"0.31";"3.03";"6.30";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4098864";"";"None";"432.90";"0";"3.53";"61";"CC1=CCC[C@H]1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2(F)CCOCC2)c1O";"IC50";"'='";"63.1";"nM";"7.20";"";"";"UO_0000065";"16.63";"0.35";"3.67";"6.87";"0";"CHEMBL4037528";"Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROalpha-stimulated CD11b upregulation preincubated for 15 mins followed by GROalpha stimulation measured after 15 mins by FITC-staining based FACS analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033786";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4793810";"";"None";"392.52";"1";"5.31";"12";"CCOC(=O)c1c(NC(=S)Nc2ccc(F)cc2)sc2c1C(C)CCC2";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"14.46";"0.30";"0.37";"11.27";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4790233";"";"None";"458.53";"1";"6.07";"14";"CCOC(=O)c1c(NC(=S)Nc2ccc(OC(F)(F)F)cc2)sc2c1C(C)CCC2";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"12.34";"0.26";"-0.41";"9.49";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4788608";"";"None";"474.69";"1";"7.13";"46";"CC1CCCc2sc(NC(=S)Nc3ccc(OC(C)(C)C)cc3)c(C(=O)OC(C)(C)C)c21";"IC50";"'='";"6800.0";"nM";"5.17";"";"";"UO_0000065";"10.89";"0.22";"-1.96";"8.67";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4781241";"";"None";"482.57";"1";"6.27";"50";"CC1CCCc2sc(NC(=S)Nc3ccc4c(c3)OC(F)(F)O4)c(C(=O)OC(C)(C)C)c21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"";""
"CHEMBL4798569";"";"None";"474.53";"1";"5.48";"53";"CC(C)(C)OC(=O)c1c(NC(=S)Nc2ccc(OC(F)(F)F)cc2)sc2c1CCOC2";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"12.21";"0.26";"0.32";"8.42";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL4784641";"";"None";"450.58";"0";"4.60";"54";"COc1ccc(NC(=S)Nc2sc3c(c2C(=O)OC(C)(C)C)CCOC3)cc1OC";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"12.14";"0.25";"0.87";"7.01";"0";"CHEMBL4774281";"Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765436";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 5.5 hr";"ANTAGONIST";""
"CHEMBL5186932";"";"None";"368.43";"0";"3.45";"7";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2ncsc12";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"18.69";"0.39";"3.44";"9.71";"0";"CHEMBL5162230";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-binding incubated for 15 mins followed by addition of CXCL8 AF647 measured after 30 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.75 hr";"ANTAGONIST";""
"CHEMBL239767";"";"None";"352.14";"0";"3.71";"SB225002";"O=C(Nc1ccc([N+](=O)[O-])cc1O)Nc1ccccc1Br";"IC50";"'='";"197.5";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033580";"Antagonist activity against CXCR2 (unknown origin) by calcium flux assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032521";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"ANTAGONIST";""
"CHEMBL5171358";"";"None";"367.45";"0";"4.05";"10a";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2sccc12";"IC50";"'='";"4260.0";"nM";"5.37";"";"";"UO_0000065";"14.62";"0.31";"1.32";"9.25";"0";"CHEMBL5162230";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-binding incubated for 15 mins followed by addition of CXCL8 AF647 measured after 30 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.75 hr";"ANTAGONIST";""
"CHEMBL5201451";"";"None";"361.42";"0";"3.99";"35d";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2ccccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5162231";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-induced calcium response incubated for 10 mins followed by addition of CXCL8 AF647 measured by FLIPR Tetra system method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.1667 hr";"";""
"CHEMBL5203131";"";"None";"366.44";"0";"2.49";"31b";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2c1CNCC2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5162231";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-induced calcium response incubated for 10 mins followed by addition of CXCL8 AF647 measured by FLIPR Tetra system method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.1667 hr";"";""
"CHEMBL5183834";"";"None";"362.40";"0";"3.39";"35c";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2cnccc12";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"19.20";"0.38";"3.57";"9.81";"0";"CHEMBL5162231";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-induced calcium response incubated for 10 mins followed by addition of CXCL8 AF647 measured by FLIPR Tetra system method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL5080880";"";"None";"378.38";"0";"2.84";"8b";"Cc1c(F)cccc1NC(=O)Nc1ccc2c(c1O)S(=O)(=O)CCC2=O";"IC50";"'='";"420.0";"nM";"6.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5087256";"";"None";"366.83";"0";"3.41";"9d";"O=C(Nc1ccccc1Cl)Nc1ccc2c(c1O)S(=O)(=O)CCC2";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"ANTAGONIST";""
"CHEMBL5094132";"";"None";"401.27";"0";"4.06";"9i";"O=C(Nc1ccc(Cl)cc1Cl)Nc1ccc2c(c1O)S(=O)(=O)CCC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033752";"Antagonist activity at human CXCR2 expressed in HEK293 cells assessed as inhibition of CXCL8-induced beta-arrestin recruitment preincubated for 30 mins followed by addition of agonist incubated for 90 mins by beta arrestin assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032530";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"";""
"CHEMBL5179622";"";"None";"350.39";"0";"3.32";"16";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2[nH]ccc12";"IC50";"'='";"7730.0";"nM";"5.11";"";"";"UO_0000065";"14.59";"0.29";"1.79";"6.92";"0";"CHEMBL5162231";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-induced calcium response incubated for 10 mins followed by addition of CXCL8 AF647 measured by FLIPR Tetra system method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.1667 hr";"ANTAGONIST";""
"CHEMBL5179345";"";"None";"367.45";"0";"4.05";"13";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2ccsc12";"IC50";"'='";"17170.0";"nM";"4.76";"";"";"UO_0000065";"12.97";"0.27";"0.72";"8.21";"0";"CHEMBL5162230";"Binding affinity to human CXCR2 expressed in human U87 cells assessed as inhibition of CXCL8 AF647-binding incubated for 15 mins followed by addition of CXCL8 AF647 measured after 30 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U87";"None";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154809";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.75 hr";"ANTAGONIST";""
